{
  "meta": {
    "title": "Inicet_Nov_2022_Session_1_2022_11_13",
    "url": "https://brainandscalpel.vercel.app/inicet-nov-2022-session-1-2022-11-13-b454900a.html",
    "scrapedAt": "2025-11-29T18:21:37.776Z"
  },
  "questions": [
    {
      "id": 50000,
      "choices": [
        {
          "id": 200000,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">High HDV viral load</span></span></span></p>"
        },
        {
          "id": 200001,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">High HBV viral load</span></span></span></p>"
        },
        {
          "id": 200002,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Presence of IgM anti-HDV antibodies</span></span></span></p>"
        },
        {
          "id": 200003,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Absence of anti-HBc IgG antibodies</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Serologic findings of a patient with hepatitis are given below: (INICET NOV 2022)</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">HBsAg positive</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Anti-HBc IgM positive</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Anti-HDV IgM positive</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Anti-HBc IgG negative</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Titer of HBV DNA: 7.4 x 10⁸</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Titer of HDV DNA: 4.1 x 10⁴</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is most useful in diagnosing HDV co-infection over superinfection?</span></span></span></p>",
      "unique_key": "Q7704542",
      "question_audio": null,
      "question_video": null,
      "map_id": 34992207,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D) Absence of anti-HBc IgG antibodies</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Anti-HBc IgG antibodies</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> are markers of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">chronic hepatitis B infection</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Their presence along with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">anti-HDV antibodies</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> would suggest a </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">superinfection</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> of hepatitis D virus (HDV) on top of chronic hepatitis B infection.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">absence of anti-HBc IgG antibodies</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> indicates an </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">acute episode</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> of hepatitis B, which suggests </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">HBV/HDV co-infection</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Co-infection occurs when a person is simultaneously infected with both HBV and HDV, leading to </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">acute hepatitis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> with signs and symptoms such as fatigue, jaundice, and dark urine. Co-infection typically resolves with recovery and viral eradication in most cases.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In contrast, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">HDV superinfection</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> occurs when an individual who is already </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">chronically infected</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> with HBV acquires HDV. Superinfection tends to result in more severe disease progression, and the absence of anti-HBc IgG helps differentiate co-infection from superinfection.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. High HDV viral load: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">The viral load of HDV can be elevated in both </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">co-infection</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">superinfection</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, making it not a reliable marker for distinguishing between the two conditions.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. High HBV viral load: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">HBV viral load is not the most relevant marker in distinguishing between co-infection and superinfection, as it may vary depending on the phase of infection and other factors. HBV viral load can be high in both conditions.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Presence of IgM anti-HDV antibodies: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">The presence of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">IgM anti-HDV antibodies</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> indicates a recent or ongoing HDV infection, but it does not differentiate between co-infection and superinfection since both can result in the production of these antibodies.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/11/screenshot-2024-10-11-192226.jpg\" style=\"height:507px; width:1000px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><strong><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></span></span></strong></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In cases of hepatitis B and D, the </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">absence of anti-HBc IgG antibodies</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> indicates an </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">acute co-infection</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> of HBV and HDV. This finding helps distinguish co-infection from </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">superinfection</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">, which typically occurs in patients with </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">chronic HBV infection</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> and is marked by the presence of anti-HBc IgG antibodies. Co-infection generally has a better prognosis compared to superinfection, which is more likely to lead to chronic disease and cirrhosis.</span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/11/screenshot-2024-10-11-192226.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50001,
      "choices": [
        {
          "id": 200004,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 200005,
          "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
        },
        {
          "id": 200006,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        },
        {
          "id": 200007,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The viruses of the filoviridae family like Ebola and Marburg resemble which of the following morphologies?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-123335.png\" alt=\"\" width=\"600\" height=\"386\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-123335.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q7793014",
      "question_audio": null,
      "question_video": null,
      "map_id": 34294258,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 3</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Viruses belonging to the filoviridae family, such as Ebola and Marburg, resemble the morphology shown in image 3.</span></li><li><span style=\"font-size:12.0pt;\">Image 3 - Ebola viruses are filamentous viruses with nonsegmented single-stranded RNA as genetic material.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-123451.png\" alt=\"\" width=\"400\" height=\"264\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Image 1- Influenza viruses have linear segmented, single-stranded RNA.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-123609.png\" alt=\"\" width=\"500\" height=\"355\"></p><p> </p><p><span style=\"font-size:12.0pt;\">Image 2- Adenovirus is an icosahedroal symmetry with fibres extruding from vertices and contains double-stranded DNA.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-99.jpg\" alt=\"\" width=\"740\" height=\"368\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Image 4 - Corona virus is non-segmented single-stranded RNA virus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Coronavirus Structure</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-101.jpg\" alt=\"\" width=\"743\" height=\"479\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Filoviruses, such as Ebola and Marburg, are filamentous and contain nonsegmented single-stranded RNA.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-123451.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200004,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50002,
      "choices": [
        {
          "id": 200008,
          "text": "<p><span style=\"font-size:12pt;\">Gottron's papules - Juvenile dermatomyositis</span></p>"
        },
        {
          "id": 200009,
          "text": "<p><span style=\"font-size:12pt;\">Rheumatoid nodules - Juvenile rheumatic arthritis</span></p>"
        },
        {
          "id": 200010,
          "text": "<p><span style=\"font-size:12pt;\">Sclerodactyly - Systemic sclerosis</span></p>"
        },
        {
          "id": 200011,
          "text": "<p><span style=\"font-size:12pt;\">Mechanic's hand - Systemic lupus erythematosus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The clinical finding in the 10-year-old boy includes fever, joint pain, and a hand lesion as shown in the image below. What is the likely diagnosis based on these findings? (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/1_3RUwRSy.jpg\" alt=\"\" width=\"300\" height=\"224\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/1_3RUwRSy.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9276514",
      "question_audio": null,
      "question_video": null,
      "map_id": 34250080,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Gottron's papules - Juvenile dermatomyositis.</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Juvenile dermatomyositis </strong>is a rare <strong>inflammatory</strong> disease affecting the skin and <strong>muscles</strong>. It typically presents in children with a characteristic <strong>skin rash</strong> and <strong>muscle weakness</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Gottron's papules </strong>are distinctive <strong>red or violet</strong>, raised, scaly lesions seen over <strong>knuckles </strong>(dorsal interphalangeal or metacarpophalangeal joints)<strong>, elbows, knees</strong>, and other <strong>extensor</strong> surfaces, highly suggestive of dermatomyositis.</span></li><li><span style=\"font-size:12pt;\">The combination of <strong>fever, joint pain, and Gottron's papules strongly indicates juvenile dermatomyositis.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other features associated with Dermatomyositis are:</strong></span></p><p><span style=\"font-size:12pt;\"><strong> </strong></span></p><ul><li><span style=\"font-size:12pt;\"><strong>The Gottron's sign </strong>is a distribution of symmetric, <strong>non-scaling</strong>, <strong>violaceous, erythematous macules or plaques</strong> that are frequently <strong>atrophic</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture1.jpg\" alt=\"\" width=\"300\" height=\"201\"></strong></i></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Gottron's sign: seen in the above image</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Shawl sign or V-sign: </strong>Fixed <strong>macular erythema</strong> spanning the <strong>shoulders</strong> and <strong>outer arms</strong> (Shawl distribution) as seen in the image below</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture2.jpg\" alt=\"\" width=\"300\" height=\"228\"></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Periungual telangiectasias: </strong>enlarged capillaries in the <strong>nail folds</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3_TWy4qiE.jpg\" alt=\"\" width=\"300\" height=\"222\"></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Mechanic's hand:</strong> <strong>Roughening </strong>and cracking of the <strong>fingertip</strong> and <strong>side</strong> skin that results in <strong>scuffed, crooked lines</strong> that resemble those of a <strong>mechanic or manual laborer.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture4.jpg\" alt=\"\" width=\"300\" height=\"224\"></strong></i></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Proximal myopathy: </strong>Patients have trouble performing everyday activities like <strong>climbing stairs, getting up</strong>, and <strong>lifting their arms</strong> above their heads.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Laboratory evaluation </strong>of patients with <strong>dermatomyositis</strong> will reveal <strong>elevated serum creatinine kinase</strong> and <strong>antinuclear antibodies.</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Rheumatoid nodules - Juvenile rheumatoid arthritis:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Juvenile rheumatoid arthritis </strong>is an <strong>autoimmune disorder </strong>causing chronic <strong>joint inflammation </strong>in <strong>children.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Rheumatoid nodules </strong>are <strong>firm, painless</strong>, <strong>subcutaneous nodules </strong>that usually occur in areas of <strong>pressure</strong> but are <strong>not typically </strong>seen in the <strong>hands</strong> in this form.</span></li><li><span style=\"font-size:12pt;\">The lesion in the image doesn't match the typical appearance of rheumatoid nodules.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C Sclerodactyly - Systemic sclerosis:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Systemic sclerosis </strong>is a <strong>connective tissue</strong> disease characterized by skin <strong>thickening</strong> and <strong>hardening</strong> <strong>(scleroderma).</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Sclerodactyly </strong>refers to <strong>thickening and tightening</strong> of the skin on the <strong>fingers</strong> and <strong>hands</strong>, leading to a <strong>claw-like appearance</strong>.</span></li><li><span style=\"font-size:12pt;\">The lesion shown doesn't indicate the skin thickening or tightness characteristic of sclerodactyly.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D Mechanic's hand - Systemic lupus erythematosus (SLE):</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>SLE </strong>is an <strong>autoimmune</strong> disease affecting <strong>multiple organ</strong> systems.</span></li><li><span style=\"font-size:12pt;\"><strong>Mechanic's hand </strong>is a sign associated more with <strong>dermatomyositis</strong> than SLE, characterized by <strong>rough, cracked skin</strong> on the sides of the <strong>fingers,</strong> mimicking the hands of a <strong>manual labourer</strong>.</span></li><li><span style=\"font-size:12pt;\">The presentation of mechanic's hand in SLE is less common and the symptoms described do not align well with SLE.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">In a case involving <strong>fever, joint pain, and hand lesions in a child</strong>, the presence of <strong>Gottron's papules</strong> is indicative of <strong>Juvenile dermatomyositis</strong>.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition Chapter 53 page no 53.1-53.12</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrison’s principles of internal medicine 21<sup>st</sup> edition Page 2820-2821</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture1.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200008,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50003,
      "choices": [
        {
          "id": 200012,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Masson's trichrome</span></span></span></p>"
        },
        {
          "id": 200013,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prussian blue</span></span></span></p>"
        },
        {
          "id": 200014,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PAS</span></span></span></p>"
        },
        {
          "id": 200015,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fite-Faraco</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What of the following stain can be used for staining Iron in tissues? </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q6402092",
      "question_audio": null,
      "question_video": null,
      "map_id": 34440713,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) Prussian blue </strong> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Perl's iron stain </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is the classic method for demonstrating iron in tissues. The section is treated with dilute hydrochloric acid to release ferric ions from binding proteins. These ions then react with potassium ferrocyanide to produce an insoluble blue compound (<strong>the Prussian blue reaction).</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/52_XMAcGmy.jpg\" style=\"height:379px; width:577px\" /></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Used in <strong>hereditary hemochromatosis</strong> to stain liver tissue, lead toxicity to visualize iron-laden mitochondria <strong>of ring sideroblasts and myelodysplastic syndrome</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Masson's trichrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This stain is used to differentiate between collagen and other tissue components. It stains collagen fibers blue or green, muscle fibers red, and cytoplasm light red or pink. It is not used for detecting iron.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. PAS (Periodic Acid-Schiff)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: PAS stain is primarily used to detect glycogen and other polysaccharides in tissues. It stains these components magenta. PAS is not useful for detecting iron in tissues.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Fite-Faraco</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a special stain used for detecting <strong>Mycobacterium leprae</strong>, the bacterium responsible for leprosy. It is not used for staining iron.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prussian blue stain is specifically used for detecting iron deposits in tissues, particularly in cases of iron overload or iron-related disorders.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/52_XMAcGmy.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200013,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50004,
      "choices": [
        {
          "id": 200016,
          "text": "<p><span style=\"font-size:12pt;\">Yellow fluorescence</span></p>"
        },
        {
          "id": 200017,
          "text": "<p><span style=\"font-size:12pt;\">Coral red fluorescence</span></p>"
        },
        {
          "id": 200018,
          "text": "<p><span style=\"font-size:12pt;\">Blue fluorescence</span></p>"
        },
        {
          "id": 200019,
          "text": "<p><span style=\"font-size:12pt;\">Green fluorescence</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a diabetic patient, the following lesions are present in the armpit. What would be observed during a Wood's lamp examination? </span>(INICET NOVEMBER 2022)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13579.jpg\" alt=\"\" width=\"300\" height=\"224\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13579.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2746993",
      "question_audio": null,
      "question_video": null,
      "map_id": 34211464,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Coral red fluorescence.</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The clinical scenario of a <strong>diabetic patient</strong>, along with the observed <strong>hyperpigmented </strong>lesion in <strong>axilla</strong> strongly suggests e<strong>rythrasma</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Coral-red fluorescence under Wood's lamp examination </strong>is the characteristic finding in this disease.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture20.jpg\" alt=\"\" width=\"400\" height=\"224\"></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Erythrasma</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It is a skin infection caused by <strong>Corynebacterium minutissimum</strong>. This condition is commonly seen in individuals with diabetes and weakened immune systems and is associated with factors such as <strong>obesity, excessive sweating, and poor hygiene.</strong></span></li><li><span style=\"font-size:12pt;\">The characteristic feature of erythrasma is the <strong>presence of hyperpigmented patches that are typically asymptomatic.</strong> These patches commonly appear in areas like the <strong>axilla, groin, intergluteal, and sub-mammary regions.</strong></span></li><li><span style=\"font-size:12pt;\">The <strong>coral pink fluorescence observed during Wood's lamp examination</strong> is a defining feature of erythrasma and is caused by <strong>coproporphyrin III</strong>, a pigment produced by the <strong>bacterium</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture21.jpg\" alt=\"\" width=\"300\" height=\"249\"></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Wood's lamp uses ultraviolet wavelength light at <strong>365nm (320-400nm)</strong> with a peak at 365nm. <strong>The filter of the Wood's lamp is composed of Barium silicate and 9% Nickel oxide.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options: </strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Yellow fluorescence: </strong>Often seen with <strong>Pityriasis versicolor</strong>, which fluoresces yellow or apple green due to the presence of tryptophan metabolites produced by Malassezia species.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Blue fluorescence: </strong>Not commonly associated with bacterial or fungal infections of the skin but may appear in certain conditions unrelated to common skin infections.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Green fluorescence: </strong>Typically observed with <strong>Pseudomonas infections</strong> or some cases of <strong>Tinea capitis</strong> caused by fungi that produce substances that fluoresce green.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Additional Information</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Table: Various diseases & their colour on woods lamp examination</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-22-175903.jpg\" alt=\"\" width=\"1000\" height=\"422\"></strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture22.jpg\" alt=\"\" width=\"300\" height=\"211\"></strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture23.jpg\" alt=\"\" width=\"400\" height=\"166\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-182645.png\" alt=\"\" width=\"500\" height=\"228\"></p><p> </p><p><span style=\"color:black;font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12pt;\">The <strong>Wood's</strong> lamp uses <strong>UVA</strong> light with a wavelength of <strong>365nm</strong> (<strong>320</strong>-<strong>400</strong> nm) for the diagnosis of various skin conditions based on the <strong>fluorescence</strong> characteristics of the skin under this specific range of ultraviolet light.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition volume I Chapter 4 page no 4.20</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Rook's Textbook of Dermatology -9th Edition, Chapter 26 Page no 26.40</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Image source: </strong></span><a href=\"https://dermnetnz.org/assets/Uploads/bacterial/erythrasma13__WatermarkedWyJXYXRlcm1hcmtlZCJd.jpg\"><span style=\"font-size:12pt;\"><strong><u>https://dermnetnz.org/assets/Uploads/bacterial/erythrasma13__WatermarkedWyJXYXRlcm1hcmtlZCJd.jpg</u></strong></span></a></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture20.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200017,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50005,
      "choices": [
        {
          "id": 200020,
          "text": "<p><span style=\"font-size:12.0pt;\">Hendra virus</span></p>"
        },
        {
          "id": 200021,
          "text": "<p><span style=\"font-size:12.0pt;\">West Nile Virus</span></p>"
        },
        {
          "id": 200022,
          "text": "<p><span style=\"font-size:12.0pt;\">Ebola virus</span></p>"
        },
        {
          "id": 200023,
          "text": "<p><span style=\"font-size:12.0pt;\">Yellow fever</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which virus can be identified by a PCR method and is endemic to India?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p>",
      "unique_key": "Q6778521",
      "question_audio": null,
      "question_video": null,
      "map_id": 34004757,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) West Nile Virus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">West Nile Virus (WNV) can cause neurological disease and death in people. WNV is commonly found in Africa, Europe, the Middle East, North America and West Asia. In Mumbai in the year 1952, the antibodies against WNV were first detected in humans. Since then, the virus activity has been reported in southern, central, and western India. WNV is maintained in nature in a cycle involving transmission between birds and mosquitoes. Humans, horses and other mammals can be infected.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">West Nile Virus (WNV) is a member of the flavivirus genus and belongs to the Japanese encephalitis antigenic complex of the family Flaviviridae.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">West Nile virus can be diagnosed by a number of different tests:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">IgG antibody sero-conversion (or significant increase in antibody titers) in two serial specimen collected at a one week interval by enzyme-linked immunosorbent assay (ELISA);</span></li><li><span style=\"font-size:12.0pt;\">IgM antibody capture enzyme-linked immunosorbent assay (ELISA);</span></li><li><span style=\"font-size:12.0pt;\">neutralisation assays;</span></li><li><span style=\"font-size:12.0pt;\">viral detection by reverse transcription polymerase chain reaction (RT-PCR) assay, and</span></li><li><span style=\"font-size:12.0pt;\">virus isolation by cell culture.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">IgM can be detected in nearly all cerebrospinal fluid (CSF) and serum specimens received from WNV infected patients at the time of their clinical presentation. Serum IgM antibody may persist for more than a year.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>: <strong>Hendra virus </strong>is endemic to Australia</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>: <strong>Ebola virus </strong>is endemic to Africa.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>: <strong>Yellow fever </strong>endemic to South and Central America, and certain parts of Africa.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">West Nile Virus (WNV) can be identified by PCR and is endemic to India, with significant historical and ongoing presence, making it a critical pathogen for regional public health monitoring and response.</span></p>",
      "correct_choice_id": 200021,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50006,
      "choices": [
        {
          "id": 200024,
          "text": "<p><span style=\"font-size:12.0pt;\">Symblepharon</span></p>"
        },
        {
          "id": 200025,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Ankyloblepharon</span></p>"
        },
        {
          "id": 200026,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Congenital blepharophimosis</span></p>"
        },
        {
          "id": 200027,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Congenital ptosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the condition given in the image:(INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture1_j7cTqzr.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture1_j7cTqzr.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7549938",
      "question_audio": null,
      "question_video": null,
      "map_id": 34672049,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ankyloblepharon</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Ankyloblepharon is a condition where the upper and lower eyelids become attached to each other. This can happen as a congenital anomaly or due to adhesions that form during the healing process of traumatic wounds, ulcers, or chemical burns affecting the eyelid margins. Treatment involves removing the adhesions between the eyelid margins. In cases where adhesions extend to the angles, epithelial grafts should be used.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong> </span><span style=\"font-size:12.0pt;\"><strong>Symblepharon</strong> is the adhesion between the palpebral and bulbar conjunctiva in which the eyelids become adherent to the eyeball.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image given below shows symblepharon.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture2_0mFcOxL.jpg\" alt=\"\" width=\"300\" height=\"212\"></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong> </span><span style=\"font-size:12.0pt;\"><strong>Congenital blepharophimosis</strong> is a condition in which the extent of the palpebral fissure is decreased. It can be congenital or acquired and is due to a vertical skin fold at the lateral canthus. No treatment is required. In some cases, canthoplasty is done.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture3_162BtKJ.jpg\" alt=\"\" width=\"300\" height=\"179\"></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong> </span><span style=\"font-size:12.0pt;\"><strong>Congenital ptosis</strong> is a condition present since birth and is characterized by drooping of one or both upper eyelids due to developmental defects or weakness of the levator palpebrae superioris (LPS) muscle. The affected individuals may also have lid lag on downward gaze. The most common treatment for congenital ptosis is surgical correction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Ankyloblepharon involves the fusion of the eyelid margins, which can be congenital or acquired, and requires surgical intervention to correct the adhesion and restore normal eyelid function and appearance.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture2_0mFcOxL.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200025,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50007,
      "choices": [
        {
          "id": 200028,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Raltegravir</span></span></span></span></span></p>"
        },
        {
          "id": 200029,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Enfuvirtide</span></span></span></span></span></p>"
        },
        {
          "id": 200030,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Tenofovir</span></span></span></span></span></p>"
        },
        {
          "id": 200031,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Zidovudine</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The image below shows the life cycle of human immunodeficiency virus. Which of the following drugs acts at step 5? (INICET NOV 2022)</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/752.jpg\" style=\"height:262px; width:300px\" /></span></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/752.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9106671",
      "question_audio": null,
      "question_video": null,
      "map_id": 34599553,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A. </span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Raltegravir</span></span></strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The step 5 in the given image shows the step of integration of the viral genome into the host DNA with the help of Integrase enzyme. Among the above given drugs, Raltegravir can be used to block this step as it is an integrase inhibitor.</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/8.jpg\" style=\"height:491px; width:600px\" /></span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Enfuvirtide: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">It is fusion inhibitor, which acts by binding to gp41 protein on the surface of the virus. This inhibits the Step 1 of this diagram.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Tenofovir & Option D) Zidovudine</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">: These are NRTIs which are used in combination therapy against HIV virus. NRTI works by inhibiting the activity of reverse transcriptase (Step 6 of the diagram), thereby, preventing the viral replication.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/8.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200028,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50008,
      "choices": [
        {
          "id": 200032,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Kreb's cycle</span></span></span></p>"
        },
        {
          "id": 200033,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prostaglandin</span></span></span></p>"
        },
        {
          "id": 200034,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leukotriene</span></span></span></p>"
        },
        {
          "id": 200035,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin K</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In Which of the following pathways, cyclooxygenase is involved? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(INICET NOV 2022)</span></span></p>",
      "unique_key": "Q9032909",
      "question_audio": null,
      "question_video": null,
      "map_id": 34055941,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Prostaglandin</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prostaglandins are derived from arachidonic acid, which is an essential fatty acid found in cell membranes. This process is mediated by Cyclooxygenases called, COX-1 and COX-2</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture7.jpg\" style=\"height:233px; width:600px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Kreb's cycle</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Kreb's cycle is the terminal pathway for the oxidative catabolism of carbohydrates, amino acids, and fatty acids.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Leukotrienes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Leukotrienes are also produced from arachidonic acid with the help of lipoxygenases.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Vitamin K</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Vitamin K is essential for the carboxylation of glutamate residues in certain proteins required for blood clotting. This process does not involve cyclooxygenase.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cyclooxygenase is involved in the prostaglandin synthesis pathway, converting arachidonic acid into prostaglandins, which are key mediators of inflammation, pain, and other physiological responses.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture7.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200033,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50009,
      "choices": [
        {
          "id": 200036,
          "text": "<p><span style=\"font-size:12.0pt;\">30% malignant transformation</span></p>"
        },
        {
          "id": 200037,
          "text": "<p><span style=\"font-size:12.0pt;\">Epiphyseal</span></p>"
        },
        {
          "id": 200038,
          "text": "<p><span style=\"font-size:12.0pt;\">Ground glass opacity is diagnostic</span></p>"
        },
        {
          "id": 200039,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiotherapy is the treatment</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following statements is correct regarding the tumor shown in the radiograph? </span>(INICET NOVEMBER 2022)</p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102700.jpg\" alt=\"\" width=\"250\" height=\"344\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102700.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8502831",
      "question_audio": null,
      "question_video": null,
      "map_id": 34553955,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Epiphyseal</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>GIANT-CELL TUMOR (Osteoclastoma):</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">It is bone lesion of uncertain origin, most commonly seen in distal femur, proximal tibia, proximal humerus and distal radius.</span></li><li><span style=\"font-size:12.0pt;\">Most commonly seen in 20-40 years of age, after epiphyseal fusion.</span></li><li><span style=\"font-size:12.0pt;\">There is a slight <strong>female predominance</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Histology</strong><i><strong>:</strong></i></span><ul><li><span style=\"font-size:12.0pt;\">Multinucleated giant cells are seen on a background of stromal cells with little or no visible intercellular tissue.</span></li><li><span style=\"font-size:12.0pt;\">The osteoclast giant cells are the malignant cells, which induce the proliferation of mononuclear macrophage-lineage cells, hence the dividing cell population is the mononuclear cells which form the matrix.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">GCT has egg shell crackling on palpation.</span></li><li><span style=\"font-size:12.0pt;\">Although these tumors typically are benign, pulmonary metastases occur in approximately 3% of patients.</span></li><li><span style=\"font-size:12.0pt;\">Malignant giant cell tumors represent less than 5% of total GCT.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Most commonly presents with pain, with or without swelling</span></li><li><span style=\"font-size:12.0pt;\">Pathological fracture occurs in 10-15% of cases</span></li><li><span style=\"font-size:12.0pt;\">Pulmonary metastasis occurs in 4% of cases, but they usually regress spontaneously.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Radiological features:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Eccentric lytic lesion at epiphyseal region</strong>, bounded by subchondral bone plate, with <strong>soap bubble appearance </strong>without any calcifications & reactive sclerosis.</span></li><li><span style=\"font-size:12.0pt;\">Biopsy is necessary for confirming the diagnosis.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Curettage and ‘stripping’ of the cavity</strong>, followed by swabbing with hydrogen peroxide or by the application of liquid nitrogen.</span></li><li><span style=\"font-size:12.0pt;\">More aggressive tumors and recurrent lesions<i>: </i><strong>Excision followed by bone grafting</strong>.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 30% malignant transformation</strong>. This is incorrect. Pulmonary metastases occur in approximately 3% of patients. Malignant giant cell tumors represent less than 5% of total GCT.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ground glass opacity is diagnostic</strong>. This is incorrect. Ground glass opacity of the bone is seen in fibrous dysplasia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Radiotherapy is the treatment</strong>. This is incorrect. The mainstay of treatment of GCT is curettage and stripping of the cavity. More aggressive tumors are treated by excision and bone grafting.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Giant cell tumors are epiphyseal tumors of the long bones.</span></li></ul>",
      "correct_choice_id": 200037,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50010,
      "choices": [
        {
          "id": 200040,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumococcal vaccine</span></p>"
        },
        {
          "id": 200041,
          "text": "<p><span style=\"font-size:12.0pt;\">Typhoid vaccine</span></p>"
        },
        {
          "id": 200042,
          "text": "<p><span style=\"font-size:12.0pt;\">Haemophilus influenza B vaccine</span></p>"
        },
        {
          "id": 200043,
          "text": "<p><span style=\"font-size:12.0pt;\">Meningococcal vaccine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which vaccine is not recommended to be given before splenectomy in a 5-year-old child with hereditary spherocytosis and hypersplenism? (INICET NOV 2022)</span></p>",
      "unique_key": "Q3063002",
      "question_audio": null,
      "question_video": null,
      "map_id": 34884493,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Typhoid vaccine</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The typhoid vaccine is typically not recommended before splenectomy in a child with hereditary spherocytosis and hypersplenism. Typhoid vaccination may lead to a transient decrease in platelet count, which can exacerbate the existing hypersplenism and increase the risk of bleeding. Therefore, it is often deferred until after splenectomy when the risk of post-vaccination thrombocytopenia is reduced.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pneumococcal vaccine</strong>: The pneumococcal vaccine is recommended for individuals with asplenia (absence of the spleen) or hyposplenism (reduced spleen function) because they are at an increased risk of severe infections, including those caused by Streptococcus pneumoniae. However, for individuals with hereditary spherocytosis who have an intact spleen, the pneumococcal vaccine may be administered as part of routine immunization.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Haemophilus influenza B vaccine</strong>: The Haemophilus influenzae type B (Hib) vaccine is recommended as part of routine childhood immunization and does not have specific contraindications related to hereditary spherocytosis or splenectomy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Meningococcal vaccine</strong>: The meningococcal vaccine is recommended for individuals with asplenia or hyposplenism, as they are at an increased risk of meningococcal infections. However, for individuals with hereditary spherocytosis who have an intact spleen, the meningococcal vaccine may be administered as part of routine immunization.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Typhoid vaccine is often deferred in children with hereditary spherocytosis and hypersplenism before splenectomy due to the risk of transiently reduced platelet count, which can be problematic in the presence of hypersplenism. Other vaccines, such as the pneumococcal, Haemophilus influenzae B, and meningococcal vaccines, may be administered based on routine immunization recommendations and the individual's spleen status.</span></p>",
      "correct_choice_id": 200041,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50011,
      "choices": [
        {
          "id": 200044,
          "text": "<p><span style=\"font-size:12.0pt;\">Systolic blood pressure + Intracranial pressure</span></p>"
        },
        {
          "id": 200045,
          "text": "<p><span style=\"font-size:12.0pt;\">Systolic blood pressure - intracranial pressure</span></p>"
        },
        {
          "id": 200046,
          "text": "<p><span style=\"font-size:12.0pt;\">Mean arterial pressure/intracranial pressure</span></p>"
        },
        {
          "id": 200047,
          "text": "<p><span style=\"font-size:12.0pt;\">Mean arterial pressure - intracranial pressure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">How is cerebral perfusion pressure calculated? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q5892794",
      "question_audio": null,
      "question_video": null,
      "map_id": 34807737,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Mean arterial pressure - intracranial pressure</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Cerebral perfusion pressure (CPP) is calculated as mean arterial pressure (MAP) - intracranial pressure (ICP).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cerebral perfusion pressure (CPP) is the net pressure gradient that drives oxygen delivery to cerebral tissue. It is the difference between the mean arterial pressure (MAP) and the intracranial pressure (ICP), measured in millimeters of mercury (mm Hg). If ICP values are not readily available, central venous pressure (CVP) may be used.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Normal CPP lies between 60- and 80-mm Hg,</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cerebral perfusion pressure (CPP) is calculated by subtracting the intracranial pressure (ICP) from the mean arterial pressure (MAP). This measurement is crucial for ensuring adequate blood flow and oxygen delivery to the brain.</span></p>",
      "correct_choice_id": 200047,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50012,
      "choices": [
        {
          "id": 200048,
          "text": "<p><span style=\"font-size:12.0pt;\">Median nerve</span></p>"
        },
        {
          "id": 200049,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulnar nerve</span></p>"
        },
        {
          "id": 200050,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior interosseous nerve</span></p>"
        },
        {
          "id": 200051,
          "text": "<p><span style=\"font-size:12.0pt;\">Radial nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Book test is for:</span> (INICET NOVEMBER 2022)</p>",
      "unique_key": "Q8882811",
      "question_audio": null,
      "question_video": null,
      "map_id": 34938791,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Ulnar nerve</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>TESTS FOR ULNAR NERVE PALSY</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Froment sign/book test: </strong>Hyperflexion of the thumb IP joint while attempting to pinch. This indicates a substitution of flexor pollicis longus (innervated by median nerve) for adductor pollicis (innervated by ulnar nerve).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102203.jpg\" alt=\"\" width=\"400\" height=\"193\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Jeanne sign:</strong> Reciprocal hyperextension of the thumb MCP joint indicating substitution of flexor pollicis longus (FPL) for adductor pollicis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102224.jpg\" alt=\"\" width=\"400\" height=\"300\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Wartenburg sign:</strong> Abduction of the small finger at MCP joint indicating deficient palmar intrinsic muscle (innervated by ulnar nerve) with abduction from extensor digiti minimi (innervated by the radial nerve).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102238.jpg\" alt=\"\" width=\"300\" height=\"260\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Duchenne sign:</strong> Clawing of the ring and small fingers, hyperextension of MCP joints, and flexion of PIP joints indicating deficient interosseous and lumbrical muscles of the ring and small fingers.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102251.jpg\" alt=\"\" width=\"300\" height=\"228\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Median nerve</strong>. <strong>Special tests for median nerve injury are:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Pen Test</strong><i><strong>:</strong></i></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Test: </strong>Patient keeps his/her hand flat on the table and at the same time, examiner brings a pen above the thumb.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interpretation: </strong>Patient tries to touch the pen by abduction the thumb and examiner feels the tendon of abductor pollicis brevis (APB) at the wrist. Patient fails to touch in APB paralysis and examiner will not be able to palpate the tendon.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Note</strong>: Median nerve invariably and exclusively supply APB.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102308.jpg\" alt=\"\" width=\"300\" height=\"192\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Pointing Index Sign/Ochsner’s Clasping/Benediction Test:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Test: </strong>Patient clasps his both hand together.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interpretation</strong>: The index finger fails to flex in median nerve injury and it points outward as pointing index.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Note</strong>: It occur in high median nerve palsy where flexor digitorum superficialis and lateral half of flexor digitorum profundus gets involved.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102320.jpg\" alt=\"\" width=\"300\" height=\"164\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>A. Pointing index; B. Benediction test</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Posterior interosseous nerve. The</strong> patient may exhibit weakness with finger extension. When asked to make a fist, the wrist may deviate radially due to extensor carpi ulnaris weakness. Depending on injury severity there may be a positive Tinel sign at the site of injury.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Radial nerve. Special tests for radial nerve palsy are:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Wrist drop test:</strong></span><ul><li><span style=\"font-size:12.0pt;\">The patient is asked to extend wrist with the elbow flexed 90°.</span></li><li><span style=\"font-size:12.0pt;\">In radial nerve palsy affecting the wrist extensors, the patient will be unable to extend the wrist. The hand will hang down in a deformity known as a “<strong>wrist drop</strong>“.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102333.jpg\" alt=\"\" width=\"300\" height=\"160\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>a. Normal; b. Wrist drop</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">In a second stage of the test, the patient is asked to abduct the thumb.</span></li><li><span style=\"font-size:12.0pt;\">In radial nerve palsy, the patient will be unable to abduct the thumb because of the paralysis of the abductor pollicis longus muscle and, to a lesser extent, the extensor pollicis brevis muscle.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102348.jpg\" alt=\"\" width=\"300\" height=\"229\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>a. Thumb abduction; b. Paralysis</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Thumb extension test:</span><ul><li><span style=\"font-size:12.0pt;\">The examiner grasps the patient’s wrist with one hand and presses the thumb into adduction with the other hand.</span></li><li><span style=\"font-size:12.0pt;\">Then the patient is asked to extend or abduct both the metacarpophalangeal and interphalangeal joints of the thumb.</span></li><li><span style=\"font-size:12.0pt;\">Where this nerve is damaged, thumb extension will be weakened or impossible as a result of paralysis of the extensor pollicis longus and brevis.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102400.jpg\" alt=\"\" width=\"500\" height=\"136\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>a. Starting position; b. Normal; c. Weak thumb extension</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Supination test:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Supination Test evaluates compression neuropathy of the deep branch of the radial nerve.</span></li><li><span style=\"font-size:12.0pt;\">The patient is seated, holding the elbow slightly flexed and the forearm pronated.</span></li><li><span style=\"font-size:12.0pt;\">The elbow is held alongside the trunk to minimize motion in the shoulder.</span></li><li><span style=\"font-size:12.0pt;\">The patient is then asked to supinate forearm, at first normally and then against the examiner’s resistance.</span></li><li><span style=\"font-size:12.0pt;\">Weakness or loss of supination of the forearm is a sign of paresis of the supinator muscle, which is supplied by the deep branch of the radial nerve.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102415.jpg\" alt=\"\" width=\"700\" height=\"287\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>a. Starting position; b. Normal supination; c. Supination against resistance</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Book test is done for ulnar nerve palsy where there is hyperflexion of the thumb IP joint while attempting to pinch, indicating a substitution of flexor pollicis longus (innervated by median nerve) for adductor pollicis (innervated by ulnar nerve).</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102203.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200049,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50013,
      "choices": [
        {
          "id": 200052,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1 and 2 only</span></span></p>"
        },
        {
          "id": 200053,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1 and 4 only</span></span></p>"
        },
        {
          "id": 200054,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 3, and 4</span></span></p>"
        },
        {
          "id": 200055,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 2, and 4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">An HIV patient presented with a headache and altered sensorium. Consider the following statements and identify the essential criteria for the diagnosis of neurocysticercosis. (INICET NOV 2022) </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Brain biopsy showing the parasite.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Muscle biopsy showing foci of calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">MRI sequence as seen in A.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">MRI sequence as seen in B.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Image A</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/10/screenshot-2024-10-10-183057.jpg\" style=\"height:274px; width:300px\" /></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Image B</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/10/screenshot-2024-10-10-183111.jpg\" style=\"height:275px; width:300px\" /></span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/10/screenshot-2024-10-10-183057.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8756797",
      "question_audio": null,
      "question_video": null,
      "map_id": 34242466,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans.</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">B) 1 and 4 only </span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The <strong><span style=\"font-family:\"Calibri\",sans-serif\">MRI brain</span></strong> labeled as B shows <strong><span style=\"font-family:\"Calibri\",sans-serif\">multiple cysticerci</span></strong> within the brain suggesting <strong><span style=\"font-family:\"Calibri\",sans-serif\">neurocysticercosis</span></strong>. Among the given statements, the essential criteria for the diagnosis of neurocysticercosis include <strong><span style=\"font-family:\"Calibri\",sans-serif\">1 and 4</span></strong> (option B), i.e.,</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Brain biopsy showing the parasite.</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Neuroradiologic demonstration of cystic lesions with scolex</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (MRI labeled B in this case).</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Neurocysticercosis is a condition caused by the larvae of <em><span style=\"font-family:\"Calibri\",sans-serif\">Taenia solium</span></em>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Criteria for diagnosis of neurocysticercosis:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<h4><span style=\"font-size:12pt\"><span style=\"font-family:\"Calibri Light\",sans-serif\"><em><strong><span style=\"font-family:\"Calibri\",sans-serif\">1. Absolute criteria</span></strong></em></span></span></h4>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Demonstration of cysticerci by <strong><span style=\"font-family:\"Calibri\",sans-serif\">histologic or microscopic examination of a biopsy</span></strong> taken from the brain or spinal cord lesion.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Visualization of the parasite</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> in the eye by funduscopy.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Neuroradiologic demonstration</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> of cystic lesions containing a characteristic scolex.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<h4><span style=\"font-size:12pt\"><span style=\"font-family:\"Calibri Light\",sans-serif\"><em><strong><span style=\"font-family:\"Calibri\",sans-serif\">2. Neuroimaging criteria</span></strong></em></span></span></h4>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Major neuroimaging criteria:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Cystic lesions without a discernible scolex, multilobulated cystic lesions in the subarachnoid space, typical small enhancing lesions, typical parenchymal brain calcifications.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Confirmative neuroimaging criteria:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Resolution of cystic lesions spontaneously or after cysticidal drug therapy and migration of ventricular cysts documented on sequential neuroimaging studies.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Minor neuroimaging criteria:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Obstructive hydrocephalus or abnormal enhancement of basal leptomeninges.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<h4><span style=\"font-size:12pt\"><span style=\"font-family:\"Calibri Light\",sans-serif\"><em><strong><span style=\"font-family:\"Calibri\",sans-serif\">3. Clinical/exposure criteria</span></strong></em></span></span></h4>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Major clinical/exposure criteria:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Demonstration of antibodies to cysticerci or cysticerci antigen in cerebrospinal fluid by enzyme-linked immunosorbent assay; Household contact with an individual infected with <em><span style=\"font-family:\"Calibri\",sans-serif\">T. solium</span></em>; Evidence of cysticercosis outside the central nervous system (e.g., cigar-shaped soft-tissue calcifications).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Minor clinical/exposure criteria:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Clinical manifestations suggestive of neurocysticercosis; Residence in a cysticercosis-endemic area; Frequent travel to a cysticercosis-endemic area.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. 1 and 2 only</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: While brain biopsy is crucial (1), muscle biopsy (2) is not an essential criterion for diagnosing neurocysticercosis. MRI or neuroimaging findings are more relevant.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. 1, 3, and 4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: MRI sequence A (3) is not relevant to the diagnosis of neurocysticercosis based on the images shown. MRI B (4) is the correct neuroimaging that supports the diagnosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. 1, 2, and 4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Muscle biopsy (2) showing calcification is not part of the essential criteria, although it might provide supportive evidence.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Neurocysticercosis diagnosis requires evidence from neuroimaging (e.g., cystic lesions with scolex) and/or histologic confirmation through biopsy.</span></span></span></p>",
      "correct_choice_id": 200053,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50014,
      "choices": [
        {
          "id": 200056,
          "text": "<p><span style=\"font-size:12.0pt;\">Source of NADPH</span></p>"
        },
        {
          "id": 200057,
          "text": "<p><span style=\"font-size:12.0pt;\">Source of ribose 5 phosphate</span></p>"
        },
        {
          "id": 200058,
          "text": "<p><span style=\"font-size:12.0pt;\">Source of acetyl CoA</span></p>"
        },
        {
          "id": 200059,
          "text": "<p><span style=\"font-size:12.0pt;\">Utilizes ribose</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The significance of HMP shunt are all except? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q2560038",
      "question_audio": null,
      "question_video": null,
      "map_id": 34664688,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Utilizes ribose</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The Hexose Monophosphate (HMP) shunt, also known as the pentose phosphate pathway (PPP), has several significant roles:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Source of NADPH: </strong>The HMP shunt produces NADPH in its oxidative phase. NADPH is essential for various biosynthetic reactions, including fatty acid synthesis and maintaining the reduced state of glutathione in red blood cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Source of ribose 5 phosphate: </strong>At the end of the oxidative phase, ribulose 5-phosphate is produced, which can be further converted into ribose 5-phosphate. Ribose 5-phosphate is a crucial precursor for the synthesis of nucleotides and nucleic acids.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Source of acetyl CoA: </strong>One of the end products of the HMP shunt is glyceraldehyde 3-phosphate, which can enter glycolysis. Through glycolysis, it can eventually form pyruvate, which can be converted into acetyl CoA in the presence of oxygen.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Utilizes ribose: </strong>This statement is incorrect as the HMP shunt primarily produces ribose 5-phosphate rather than utilizing it. Ribose 5-phosphate is a significant product of this pathway and is used in the synthesis of nucleotides and nucleic acids.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The overall reaction of the HMP shunt can be summarized as:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">3G-6-P+6NADP+→2G-6-P+Glyceraldehyde-3-P+3CO2+6NADPH</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The HMP shunt is significant for producing NADPH and ribose 5-phosphate and indirectly contributing to the formation of acetyl CoA, but it does not utilize ribose.</span></p><p> </p><p><span style=\"color:#212529;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture1_4nsrjPd.jpg\" alt=\"\" width=\"350\" height=\"417\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture1_4nsrjPd.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200059,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50015,
      "choices": [
        {
          "id": 200060,
          "text": "<p><span style=\"font-size:12.0pt;\">0.5 to 1 mEq/dL</span></p>"
        },
        {
          "id": 200061,
          "text": "<p><span style=\"font-size:12.0pt;\">0.1 to 0.5 mEq/dL</span></p>"
        },
        {
          "id": 200062,
          "text": "<p><span style=\"font-size:12.0pt;\">0.6 to 1.5 mEq/dL</span></p>"
        },
        {
          "id": 200063,
          "text": "<p><span style=\"font-size:12.0pt;\">2 to 3 mEq/dL</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the dose range of lithium in mEq/dL for acute attacks of mania and long-term maintenance?</span></p>",
      "unique_key": "Q3788171",
      "question_audio": null,
      "question_video": null,
      "map_id": 34769059,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 0.6 to 1.5 mEq/dL</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Lithium has a narrow therapeutic window and its serum concentrations need careful monitoring.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">0.6 to 1.5 mEq/dL represents the general therapeutic range for lithium. According to 12th edition of Synopsis of Psychiatry,  for acute manic episodes, the target serum lithium level is between 1.0 to 1.2 mEq/dL, while for long-term maintenance, it is 0.4 to 0.8 mEq/dL. The option closes to this range is option C.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 0.5 to 1 mEq/dL</strong> is close but not the typical therapeutic range. It is on the lower end and might not be effective for many patients, especially during acute mania.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 0.1 to 0.5 mEq/dL</strong> is subtherapeutic. Such low levels wouldn't be effective for the treatment of bipolar disorder and would not offer the necessary mood-stabilizing effects.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 2 to 3 mEq/dL</strong> is a toxic range. Lithium concentrations at this level can result in severe side effects and even life-threatening toxicity.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan & Sadock’s Synopsis of Psychiatry, 12th edition, Page No 655</strong></span></p>",
      "correct_choice_id": 200062,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50016,
      "choices": [
        {
          "id": 200064,
          "text": "<p><span style=\"font-size:12.0pt;\">Echocardiogram</span></p>"
        },
        {
          "id": 200065,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest x-ray</span></p>"
        },
        {
          "id": 200066,
          "text": "<p><span style=\"font-size:12.0pt;\">Spirometry</span></p>"
        },
        {
          "id": 200067,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI to rule out enlarged heart</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The parents notice that their child is tired and that he has shortness of breath on climbing stairs and while lying down. What is the first investigation that you would do? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q5095436",
      "question_audio": null,
      "question_video": null,
      "map_id": 34815965,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Chest x-ray</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The first investigation to be done for a child who feels shortness of breath on climbing stairs and in the supine position is a chest x-ray.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The child having shortness of breath on dyspnea on exertion worsened in the supine position is orthopnea could be suggestive of congestive heart failure.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Causes -</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Respiratory causes include asthma, chronic obstructive pulmonary disorder (COPD), pneumonia, and pulmonary embolism.</span></li><li><span style=\"font-size:12.0pt;\">Cardiovascular causes include congestive heart failure (CH), pulmonary edema, valvular heart defect, and pulmonary hypertension.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Evaluation</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Oxygen saturation at rest and during physical activity</span></li><li><span style=\"font-size:12.0pt;\">Chest x-ray is the first diagnostic test as pulmonary pathology or pulmonary edema and signs of CHF may be seen</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong> An echocardiogram to evaluate cardiac cause if the chest X-ray is abnormal</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> Spirometry to assess lung function when the chest x-ray is normal.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Cardiac MRI (Magnetic resonance imaging) is an emerging modality done to look for cardiomegaly.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">For a child presenting with shortness of breath on exertion and orthopnea, the first investigation should be a chest x-ray to evaluate potential pulmonary pathology and signs of congestive heart failure.</span></p>",
      "correct_choice_id": 200065,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50017,
      "choices": [
        {
          "id": 200068,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ACL injury</span></span></span></p>"
        },
        {
          "id": 200069,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ACL and medial collateral ligament injury </span></span></span></p>"
        },
        {
          "id": 200070,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lateral collateral ligament injury </span></span></span></p>"
        },
        {
          "id": 200071,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Medial meniscus injury </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The injury shown in the radiograph can result in: </span></span></span>(INICET NOVEMBER 2022)</p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103255.jpg\" style=\"height:338px; width:250px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103255.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7506391",
      "question_audio": null,
      "question_video": null,
      "map_id": 34649992,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. ACL injury </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SEGOND FRACTURE</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Segond fracture </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is an avulsion fracture of the knee that involves the lateral aspect of the tibial plateau and is <strong>very frequently (</strong></span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:Symbol\">»</span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">75% of cases) associated with disruption of the anterior cruciate ligament (ACL)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">On the frontal knee radiograph, it may appear as a curvilinear or elliptic bone fragment projected parallel to the lateral aspect of the tibial plateau, referred to as the <strong>lateral capsular sign</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103307.jpg\" style=\"height:319px; width:250px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Contrary to the more common causes of an ACL tear, which typically involves valgus stress, a Segond fracture usually occurs as a result of internal rotation and varus stress.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment:</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Although the fracture itself is small, the extensive ligamentous injury associated with it usually requires surgical intervention. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spontaneous healing of the Segond fracture may occur following ACL reconstruction.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given image in the question shows Segond fracture, which is frequently seen with ACL injuries. </span></span></span></li>\r\n</ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103307.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200068,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50018,
      "choices": [
        {
          "id": 200072,
          "text": "<p><span style=\"font-size:12.0pt;\">Novus actus interveniens</span></p>"
        },
        {
          "id": 200073,
          "text": "<p><span style=\"font-size:12.0pt;\">Res ipsa loquitur</span></p>"
        },
        {
          "id": 200074,
          "text": "<p><span style=\"font-size:12.0pt;\">Res judicata </span></p>"
        },
        {
          "id": 200075,
          "text": "<p><span style=\"font-size:12.0pt;\">Vicarious liability</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 50-year-old lady underwent a total abdominal hysterectomy. She came to the hospital after one week with acute pain in the abdomen with features suggestive of perforation. An X-ray showed the following picture. Identify the type of offense for which the surgeon can be held responsible? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2022)</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-38.jpg\" alt=\"\" width=\"400\" height=\"266\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-38.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7561604",
      "question_audio": null,
      "question_video": null,
      "map_id": 34570216,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Res ipsa loquitur</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The X-ray indicates surgical scissors accidentally left behind during surgery.</span></li><li><span style=\"font-size:12.0pt;\">The surgeon can be held guilty for Res ipsa loquitur.</span></li><li><span style=\"font-size:12.0pt;\">\"Res ipsa loquitur\" means \"the thing or fact speaks for itself.\"</span></li><li><span style=\"font-size:12.0pt;\">The negligent act by the doctor is obvious from the Xray and the patient need not prove the negligence.</span></li><li><span style=\"font-size:12.0pt;\">Conditions to be fulfilled to prove negligence:</span></li><li><span style=\"font-size:12.0pt;\">In the absence of negligence, there would not have been any injury usually</span></li><li><span style=\"font-size:12.0pt;\">The doctor had complete control over the injury-producing instrument or treatment.</span></li><li><span style=\"font-size:12.0pt;\">There was no contributory negligence from the patient.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Novus actus interveniens:</strong> Refers to a new intervening act that breaks the chain of causation. It is not applicable here as the negligence was directly related to the surgery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Res judicata:</strong> Refers to a matter that has been adjudicated by a competent court and therefore cannot be pursued further by the same parties. It is not relevant to the context of proving negligence.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vicarious liability:</strong> Refers to the liability of one party for the actions of another, typically an employer for an employee. This does not directly apply to the surgeon's individual negligence in this context.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The presence of surgical instruments left inside a patient post-operation is a clear case of negligence, aptly described by the legal principle of \"Res ipsa loquitur,\" meaning the fact speaks for itself.</span></p>",
      "correct_choice_id": 200073,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50019,
      "choices": [
        {
          "id": 200076,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-a, 2-b, 3-c, 4-d</span></span></span></p>"
        },
        {
          "id": 200077,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-c, 2-d, 3-a, 4-b</span></span></span></p>"
        },
        {
          "id": 200078,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-d, 2-a, 3-b, 4-c</span></span></span></p>"
        },
        {
          "id": 200079,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-b, 2-a, 3-c, 4-d</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following cells with their locations: (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-113620_lLxRHlh.jpg\" style=\"height:278px; width:600px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-113620_lLxRHlh.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5959010",
      "question_audio": null,
      "question_video": null,
      "map_id": 34523108,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>D) 1-b, 2-a, 3-c, 4-d </strong> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The correct matches for the cells and their respective locations are as follows:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kupffer cells (b) Liver:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Kupffer cells are specialized macrophages located in the liver, involved in the breakdown of red blood cells and the immune response within the liver.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parietal cells (a) Stomach:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Parietal cells are found in the lining of the stomach and are responsible for secreting hydrochloric acid (HCl), which aids in digestion.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dust cells (c) Alveoli:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Dust cells, also known as alveolar macrophages, are found in the alveoli of the lungs. They play a crucial role in removing inhaled particles and pathogens from the alveolar spaces.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clara cells (d) Bronchioles:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Clara cells, now more commonly referred to as club cells, are found in the bronchioles of the lungs. They secrete surfactant proteins and detoxify harmful substances inhaled into the lungs.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-113757.jpg\" style=\"height:444px; width:1000px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-113757.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200079,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50020,
      "choices": [
        {
          "id": 200080,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myoglobin</span></span></span></p>"
        },
        {
          "id": 200081,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fetal hemoglobin</span></span></span></p>"
        },
        {
          "id": 200082,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carbon monoxide poisoning</span></span></span></p>"
        },
        {
          "id": 200083,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acidosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the left curve, given the fact that the right curve is of adult hemoglobin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#212529\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture6_yokrhNY.jpg\" style=\"height:350px; width:350px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture6_yokrhNY.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8686228",
      "question_audio": null,
      "question_video": null,
      "map_id": 34524793,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Myoglobin</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The left curve is for myoglobin as it is a rectangular hyperbola curve which is characteristic of Michaelis Menton kinetics.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fetal hemoglobin, CO poisoning and acidosis will shift the sigmoidal shape of hemoglobin saturation curve as shown in the image below:</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:#212529\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture7_N22vVT4.jpg\" style=\"height:327px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Fetal hemoglobin: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fetal hemoglobin has a higher affinity for oxygen than adult hemoglobin, which shifts the curve to the left. However, the curve still maintains a sigmoidal shape.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Carbon monoxide poisoning: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carbon monoxide binds to hemoglobin with a much higher affinity than oxygen, shifting the hemoglobin dissociation curve to the left and making it more difficult for oxygen to be released to tissues. This also retains the sigmoidal shape.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Acidosis: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acidosis generally causes a rightward shift of the hemoglobin oxygen dissociation curve, reducing hemoglobin's affinity for oxygen. This is the opposite of what is observed with myoglobin.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The left shift observed in the myoglobin curve reflects its high affinity for oxygen, distinguishing it from the sigmoidal curves seen in hemoglobin variations.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myoglobin has a hyperbolic oxygen dissociation curve due to its single polypeptide chain and high oxygen affinity, contrasting with the sigmoidal curve of hemoglobin due to its cooperative binding.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture7_N22vVT4.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200080,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50021,
      "choices": [
        {
          "id": 200084,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta oxidation of branched chain fatty acid</span></p>"
        },
        {
          "id": 200085,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha oxidation of branched chain fatty acid</span></p>"
        },
        {
          "id": 200086,
          "text": "<p><span style=\"font-size:12.0pt;\">Omega oxidation of branched chain fatty acid</span></p>"
        },
        {
          "id": 200087,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha oxidation of dicarboxylic acids</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Refsum’s disease is caused by the defect of? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q6421889",
      "question_audio": null,
      "question_video": null,
      "map_id": 34858530,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Alpha oxidation of branched-chain fatty acid</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Refsum's disease is a peroxisomal disorder caused by the impaired alpha-oxidation of branched-chain fatty acids, which results in the buildup of phytanic acid in the body. This accumulation of phytanic acid is a characteristic feature of the disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Beta oxidation of branched-chain fatty acid: </strong>Refsum's disease is not caused by the defect in beta oxidation of branched-chain fatty acids. Beta oxidation is a different metabolic process.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Omega oxidation of branched-chain fatty acid: </strong>Refsum's disease is not caused by the defect in omega oxidation of branched-chain fatty acids. Omega oxidation is a different metabolic pathway.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alpha oxidation of dicarboxylic acids: </strong>Refsum's disease primarily involves the defect in the alpha oxidation of branched-chain fatty acids, not the alpha oxidation of dicarboxylic acids.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Characteristic of Peroxisomal pathways:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">No ATP production in any of peroxisomal pathways</span></li><li><span style=\"font-size:12.0pt;\">H<sub>2</sub>O<sub>2 </sub>is regularly formed which is neutralized by peroxisomal enzymes catalase & peroxidase.</span></li><li><span style=\"font-size:12.0pt;\">Two pathways which occur in peroxisomes are:</span></li></ul><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">1. α-Oxidation of branched chain fatty acids (BCFA)</span></p><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">2. Oxidation of Very Long Chain Fatty Acid (VLCFA)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Refsum's disease: </strong>Occur due to defect in α-oxidation of BCFA in peroxisomes due to defect in phytanic acid hydroxylase. So, Phytanic acid not oxidised.</span></p><ul><li><span style=\"font-size:12.0pt;\">Beta-oxidation occurs for saturated and even chain fatty acids like palmitic and stearic acid</span></li><li><span style=\"font-size:12.0pt;\">In Omega-oxidation dicarboxylic acids are formed. In MCAD deficiency there is dicarboxylic acidosis and non-ketotic hypoglycemia.</span></li></ul>",
      "correct_choice_id": 200085,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50022,
      "choices": [
        {
          "id": 200088,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 200089,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        },
        {
          "id": 200090,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 200091,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following increase the risk of recurrence of febrile seizures? (INICET MAY 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Age < 1 year</span></li><li><span style=\"font-size:12.0pt;\">Temperature of 38-39°C</span></li><li><span style=\"font-size:12.0pt;\">Duration of fever < 24 h</span></li><li><span style=\"font-size:12.0pt;\">Duration of fever > 48 h</span></li></ol>",
      "unique_key": "Q4087111",
      "question_audio": null,
      "question_video": null,
      "map_id": 34237622,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 2, 3</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The risk of recurrent febrile seizures is increased in children who are less than 1 year old, have a fever with a temperature between 38-39°C, and have a fever duration of less than 24 hours. Febrile seizures typically occur in children between the ages of 6 and 60 months and are generalized tonic-clonic seizures that occur in the setting of fever without any underlying intracranial infection or a previous history of unprovoked seizures.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Risk Factors:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. Age < 1 year: </strong>Younger age increases the likelihood of recurrent febrile seizures.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2. Temperature of 38-39°C: </strong>Lower fever temperatures (38-39°C) are associated with a higher risk of recurrence.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3. Duration of fever < 24 h: </strong>A shorter duration of fever before the onset of seizures is associated with an increased risk of recurrence.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Information:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Minor risk factors </strong>for recurrence include male gender, attending daycare, having complex febrile seizures, a family history of febrile seizures, and lower serum sodium levels at presentation.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4. Duration of fever > 48 hours: </strong>A duration of fever greater than 48 hours is not considered a risk factor for febrile seizures.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The risk of recurrent febrile seizures is increased in children under 1 year of age, with fever temperatures between 38-39°C, and fever lasting less than 24 hours.</span></p>",
      "correct_choice_id": 200090,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50023,
      "choices": [
        {
          "id": 200092,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4, 3</span></p>"
        },
        {
          "id": 200093,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4, 3, 2</span></p>"
        },
        {
          "id": 200094,
          "text": "<p><span style=\"font-size:12.0pt;\">4, 3, 2, 1</span></p>"
        },
        {
          "id": 200095,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4, 3, 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with fever and nuchal rigidity. The resident was instructed to perform a lumbar puncture on this patient. What is the correct order of managing this patient?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Place IV cannula and give fluids at 40 mL/h</span></li><li><span style=\"font-size:12.0pt;\">Start injection ceftriaxone</span></li><li><span style=\"font-size:12.0pt;\">Send CSF sample for biochemistry and microanalysis</span></li><li><span style=\"font-size:12.0pt;\">Perform guarded lumbar puncture</span></li></ol>",
      "unique_key": "Q5345146",
      "question_audio": null,
      "question_video": null,
      "map_id": 34022230,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1, 4, 3, 2</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">When managing a patient with fever and nuchal rigidity (suggesting possible meningitis), the correct order of steps is:</span></p><ol><li><span style=\"font-size:12.0pt;\">Place IV cannula and give fluids at 40 mL/h: Establishing IV access is the first priority to ensure hydration and create a route for medication administration.</span></li><li><span style=\"font-size:12.0pt;\">4. Perform guarded lumbar puncture: The lumbar puncture should be performed early to collect CSF samples before antimicrobial therapy alters the CSF findings.</span></li><li><span style=\"font-size:12.0pt;\">Send CSF sample for biochemistry and microanalysis: Once the CSF is collected, it must be promptly sent for laboratory analysis to identify potential pathogens and guide targeted therapy.</span></li><li><span style=\"font-size:12.0pt;\">Start injection ceftriaxone: After CSF collection, empiric antibiotic therapy with ceftriaxone should be initiated. This ensures that treatment doesn't interfere with CSF culture results while still providing timely antimicrobial coverage.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">This sequence prioritizes obtaining diagnostic samples before starting antimicrobial therapy, which is critical for accurate diagnosis while not unduly delaying treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In suspected meningitis, the ideal sequence is to secure samples for microbiological diagnosis before starting antibiotics, when clinically feasible. However, if there will be a significant delay in performing the lumbar puncture or if the patient is critically ill, antibiotics should not be delayed. The sequence emphasizes balancing the need for accurate diagnosis with timely intervention.</span></p>",
      "correct_choice_id": 200093,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50024,
      "choices": [
        {
          "id": 200096,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a dematiaceous fungus</span></span></span></p>"
        },
        {
          "id": 200097,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Infection can spread and involve underlying subcutaneous tissue, tendon, muscle or joints</span></span></span></p>"
        },
        {
          "id": 200098,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Angioinvasion is common especially in people with hemolytic anemia</span></span></span></p>"
        },
        {
          "id": 200099,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">These bodies are formed by engulfment of the dead fungi by the macrophages</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A forest worker developed skin lesions over the forearm, which initially started as macules but then became nodules. Histology of the nodules shows the following findings. Which of the following is true regarding this condition?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">INICET NOV 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/40.jpg\" style=\"height:307px; width:400px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/40.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7866765",
      "question_audio": null,
      "question_video": null,
      "map_id": 34460179,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) It is a dematiaceous fungus</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chromoblastomycosis (CBM) is defined as a <strong>chronic cutaneous and subcutaneous </strong>fungal infection resulting from traumatic implantation of certain <strong>dematiaceous fungi</strong> through the skin. </span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most frequent aetiological agents of CBM are the following species: Fonsecaea pedrosoi, Phialophora verrucosa and Cladophialophora carrionii.</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The aetiological agents gain entrance through transcutaneous puncture wounds, usually by parts of plants. </span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In a typical manifestation the dermal lesions form cauliflower-like nodules. In the infected tissue, characteristic dark-colored, thick-walled, muriform cells i.e. sclerotic cells (Medlar bodies) are observed, which is a histopathological criterion for the diagnosis.</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The aetiological agent (i.e. fungal fragment) gains entrance through transcutaneous puncture wounds. A primary lesion is represented by an erythematous papule or a <strong>warty growth</strong>, which gradually enlarges from the site of infection assuming various forms and sizes. The infection may occur anywhere on the body, however most frequently it affects limbs, especially feet and shins. Cases of buttock, trunk and face infection have also been reported. In more advanced stages of the disease dissemination may occur in the form of satellite lesions which arise from scratching autoinoculation and spread via the lymphatic system.</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment – Antifungal therapy with <strong>itraconazole or terbinafine. Surgical excision</strong> is the therapy of choice for small lesions.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt\"><strong>Infection can spread and involve underlying subcutaneous tissue, tendon, muscle, or joints:</strong> This statement is more characteristic of eumycetoma, not chromoblastomycosis. Eumycetoma, caused by various fungal species, can invade deeper tissues including bone, leading to severe deformities.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt\"><strong>Angioinvasion is common especially in people with hemolytic anemia:</strong> Angioinvasion is typically seen in infections caused by Aspergillus species, which can lead to invasive aspergillosis, particularly in immunocompromised individuals. This is not a feature of chromoblastomycosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt\"><strong>These bodies are formed by the engulfment of the dead fungi by the macrophages:</strong> The bodies seen in the histological image (Medlar bodies) are not formed by macrophage engulfment. They are a morphological form of the fungi present in the infected tissue, indicative of chromoblastomycosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chromoblastomycosis is a chronic fungal infection characterized by the presence of dark-coloured, thick-walled sclerotic cells (Medlar bodies) in histological sections, resulting from traumatic implantation of dematiaceous fungi.</span></span></span></p>",
      "correct_choice_id": 200096,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50025,
      "choices": [
        {
          "id": 200100,
          "text": "<p><span style=\"font-size:12.0pt;\">Emergency room thoracotomy</span></p>"
        },
        {
          "id": 200101,
          "text": "<p><span style=\"font-size:12.0pt;\">ICD placement</span></p>"
        },
        {
          "id": 200102,
          "text": "<p><span style=\"font-size:12.0pt;\">Needle thoracocentesis</span></p>"
        },
        {
          "id": 200103,
          "text": "<p><span style=\"font-size:12.0pt;\">Finger thoracotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old male presents to the emergency department with multiple stab injuries to the chest. On examination, there is reduced chest movement on the right side and tracheal deviation to the left side. Additionally, the neck veins are distended. What is the next best step in the management of this patient? (INICET NOV 2022)</span></p>",
      "unique_key": "Q8479058",
      "question_audio": null,
      "question_video": null,
      "map_id": 34081940,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Needle thoracocentesis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Patient with stab to chest with reduced chest movement on right, mediastinal shift to left with distended neck veins is suffering from tension pneumothorax. Next step is placement of wide bore needle in triangle of safety to decompress the pneumothorax, followed by ICD insertion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">This is the correct answer. Needle thoracocentesis is the next best step in the management of the patient with tension pneumothorax. It is a procedure that involves inserting a needle into the pleural space to aspirate the air or fluid. It is performed initially to decompress the tension pneumothorax in the triangle of safety (between Pect. Major anteriorly, Latissimus dorsi posteriorly, 5th intercostal space inferiorly).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Emergency room thoracotomy</strong>: This is not the next best step in the management of the patient with tension pneumothorax. Resuscitative thoracotomy is an emergency surgical procedure that is performed in the presence of cardiac arrest due to penetrating chest trauma.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>B.</strong> <strong>ICD placement</strong>: This is not the next best step in the management of the patient with tension pneumothorax. An ICD (intercostal drainage) is a tube inserted into the pleural space to drain the air or fluid. ICD placement is the definitive management of tension pneumothorax but is not the next step in the management.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D. Finger thoracotomy</strong>: This is not the next best step in the management of the patient with tension pneumothorax. Finger thoracotomy is an alternative approach when needle decompression fails or is not possible. It involves making a small incision in the chest wall and using the finger to manually decompress the pneumothorax. However, needle decompression should be attempted first before considering finger thoracostomy.</span></p>",
      "correct_choice_id": 200102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50026,
      "choices": [
        {
          "id": 200104,
          "text": "<p><span style=\"font-size:12.0pt;\">Head circumference</span></p>"
        },
        {
          "id": 200105,
          "text": "<p><span style=\"font-size:12.0pt;\">Arm span</span></p>"
        },
        {
          "id": 200106,
          "text": "<p><span style=\"font-size:12.0pt;\">Crown-rump length</span></p>"
        },
        {
          "id": 200107,
          "text": "<p><span style=\"font-size:12.0pt;\">Knee height</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which alternative method can be used for the procedure shown in the image below? (INICET MAY 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/97.jpg\" alt=\"\" width=\"300\" height=\"352\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/97.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9449789",
      "question_audio": null,
      "question_video": null,
      "map_id": 34477927,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Arm span</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image shows the measurement of a child's height using a stadiometer. The alternative method that can be used for measuring height is arm span. The arm span is a measurement from the tip of one middle finger to the tip of the other middle finger when the arms are outstretched horizontally. This measurement is typically close to the child's height and can be used as an alternative method, especially in cases where the child is unable to stand properly.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The proportion of arm span to height changes with age but is generally close to the height measurement. In clinical practice, when direct measurement of height is not feasible, arm span can be a reliable surrogate.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Head circumference</strong>: Head circumference is measured using a measuring tape and is an important metric in assessing brain growth and development, especially in infants and young children, but it is not an alternative for height measurement.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Crown-rump length</strong>:<strong> </strong>Crown-rump length is a measurement used during an ultrasound in early pregnancy to estimate the gestational age of the fetus, not a method for height measurement in children.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Knee height</strong>: Knee height is not typically used for measuring height in children and is more often used in adults, particularly the elderly, to estimate height when they are unable to stand.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Arm span can be used as an alternative method for measuring height, especially when direct height measurement is not feasible.</span></p>",
      "correct_choice_id": 200105,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50027,
      "choices": [
        {
          "id": 200108,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rickettsia rickettsii</span></span></span></p>"
        },
        {
          "id": 200109,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rickettsia conorii</span></span></span></p>"
        },
        {
          "id": 200110,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ehrlichia chaffeensis</span></span></span></p>"
        },
        {
          "id": 200111,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anaplasma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image of Rickettsial morula in a monocyte is shown below. Identify the organism? (</span></span></span>INICET Nov 2022)</p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-102120.png\" style=\"height:211px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-102120.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q8554539",
      "question_audio": null,
      "question_video": null,
      "map_id": 34630751,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Ehrlichia chaffeensis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ehrlichia chaffeensis is an obligate intracellular, Gram-negative species of Rickettsiales bacteria. It is a zoonotic pathogen transmitted to humans by the lone star tick (Amblyomma americanum) and is the causative agent of human monocytic ehrlichiosis (HME).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ehrlichiosis is evidenced by the presence of intracytoplasmic inclusions known as morulae in monocytes, which can be observed on a Giemsa-stained blood film.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Characteristics and Clinical Presentation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Transmission:</span></strong><span style=\"font-size:12.0pt\"> By the lone star tick (Amblyomma americanum).</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Symptoms:</span></strong><span style=\"font-size:12.0pt\"> Patients typically exhibit symptoms within 1 to 2 weeks after tick infection. Early symptoms include fever, headache, malaise, low-back pain, and gastrointestinal symptoms. Some patients may also have myalgias, arthralgias, coughing, pharyngitis, diarrhea, vomiting, abdominal pain, and changes in mental status.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diagnosis:</span></strong><span style=\"font-size:12.0pt\"> Besides observing morulae in monocytes, serological tests like indirect fluorescent antibody tests and polymerase chain reaction (PCR) are also used for diagnosis.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Treatment:</span></strong><span style=\"font-size:12.0pt\"> TOC Doxycycline.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Rickettsia rickettsii</span></strong><span style=\"font-size:12.0pt\">: <strong>Incorrect.</strong> Rickettsia rickettsii is the causative agent of Rocky Mountain spotted fever (RMSF), typically associated with rash and vascular endothelial damage, not morulae in monocytes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Rickettsia conorii: Incorrect.</span></strong><span style=\"font-size:12.0pt\"> Rickettsia conorii causes Mediterranean spotted fever, which also does not present with morulae in monocytes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Anaplasma: Incorrect.</span></strong><span style=\"font-size:12.0pt\"> Anaplasma phagocytophilum causes human granulocytic anaplasmosis (HGA), where morulae are found in granulocytes, not monocytes. The presence of morulae in granulocytes is characteristic of Anaplasma infection.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ehrlichia chaffeensis is identified by the presence of morulae in monocytes and is the causative agent of human monocytic ehrlichiosis. The proper treatment is doxycycline, and diagnosis is confirmed through blood smear, serological tests, and PCR.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GAME – Granulocytes: Anaplasma; Monocytes: Ehrlichiosis</span></strong></span></span></p>",
      "correct_choice_id": 200110,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50028,
      "choices": [
        {
          "id": 200112,
          "text": "<p><span style=\"font-size:12.0pt;\">Bansdola</span></p>"
        },
        {
          "id": 200113,
          "text": "<p><span style=\"font-size:12.0pt;\">Garroting</span></p>"
        },
        {
          "id": 200114,
          "text": "<p><span style=\"font-size:12.0pt;\">Mugging</span></p>"
        },
        {
          "id": 200115,
          "text": "<p><span style=\"font-size:12.0pt;\">Throttling</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The image below shows strangulation by Spanish windlass method. What type of strangulation method does it belong to? (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-37.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-37.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9907969",
      "question_audio": null,
      "question_video": null,
      "map_id": 34123232,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Garroting</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Spanish windlass</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Method:</strong> It involves tightening an iron collar (Spanish windlass) around the neck and forcing a spike against the neck into the spinal cord.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Garroting</strong>- It involves attacking the victim by throwing the ligature from behind over the victim's neck and then tightened by twisting with a lever.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bansdola: </strong>A method of strangulation where a ligature is applied in a different manner, often using a stick or rod to twist and tighten the ligature.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mugging: </strong>Refers to a method where the assailant uses their limbs, such as the crook of their elbow, to compress the neck.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Throttling: </strong>Throttling involves using hands to manually compress the neck, leading to asphyxia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Spanish windlass method of strangulation, shown in the image, belongs to the category of garroting, which involves the use of a ligature tightened by a lever or similar mechanism.</span></p>",
      "correct_choice_id": 200113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50029,
      "choices": [
        {
          "id": 200116,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Piperacillin-Tazobactam</span></span></p>"
        },
        {
          "id": 200117,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Amoxicillin-Clavulanate</span></span></p>"
        },
        {
          "id": 200118,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ceftriaxone</span></span></p>"
        },
        {
          "id": 200119,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Nitrofurantoin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with diabetes develops a UTI, which gets complicated with hypotension that is resistant to IV fluids. Which of the following antibiotics can be used? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q5803527",
      "question_audio": null,
      "question_video": null,
      "map_id": 34395471,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Piperacillin-Tazobactam</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient with diabetes has developed a urinary tract infection (UTI) complicated by hypotension resistant to IV fluids, indicating septic shock. In cases of septic shock, it is critical to start with empirical broad-spectrum antibiotics. These antibiotics are designed to cover a wide range of potential pathogens until the specific causative organism can be identified and targeted.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Broad-spectrum antibiotics suitable for such severe infections include:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Piperacillin-Tazobactam</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carbapenems like Meropenem or Imipenem</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Certain third-generation cephalosporins like Ceftazidime</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this case, Piperacillin-Tazobactam is chosen because it is a broad-spectrum antibiotic that covers many of the common pathogens responsible for severe infections and septic shock. Although a combination of Meropenem with Vancomycin would be ideal, the given options do not include Meropenem. Therefore, Piperacillin-Tazobactam is the best choice among the provided options.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Amoxicillin-Clavulanate:</span></strong><span style=\"font-size:12.0pt\"> This antibiotic is generally not sufficient for treating severe infections or septic shock due to its narrower spectrum of activity compared to Piperacillin-Tazobactam.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ceftriaxone:</span></strong><span style=\"font-size:12.0pt\"> While Ceftriaxone is a third-generation cephalosporin, it is not as broad-spectrum as Ceftazidime and does not provide the same coverage needed for septic shock.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nitrofurantoin:</span></strong><span style=\"font-size:12.0pt\"> This antibiotic is typically used for uncomplicated lower urinary tract infections and is not effective for severe systemic infections or septic shock.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the management of septic shock, especially in a patient with diabetes and complicated UTI, broad-spectrum antibiotics such as Piperacillin-Tazobactam are critical for empirical therapy.</span></span></span></p>",
      "correct_choice_id": 200116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50030,
      "choices": [
        {
          "id": 200120,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Squamous cell carcinoma</span></span></span></p>"
        },
        {
          "id": 200121,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenocarcinoma lung</span></span></span></p>"
        },
        {
          "id": 200122,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Small cell cancer lung</span></span></span></p>"
        },
        {
          "id": 200123,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Large cell carcinoma</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 55-year-old male patient presented in OPD with hemoptysis. On examination, a hilar mass was noticed. The histopathological image is shown below. Immunohistochemistry revealed that the cells were positive for p40. What is the likely diagnosis? (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/11_kocFFZn.jpg\" style=\"height:200px; width:300px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/11_kocFFZn.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5666633",
      "question_audio": null,
      "question_video": null,
      "map_id": 34997955,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Squamous cell carcinoma</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given clinical history and the histopathological findings showing keratin pearls are suggestive of squamous cell carcinoma of the lung.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tumor arises in a large bronchus and are prone to massive necrosis and cavitation. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The tumor is diagnosed microscopically by identification of either intercellular bridges or keratinization or keratin/squamous pearls.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is positive for p40 and p63 markers.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-120453.jpg\" style=\"height:505px; width:1000px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Adenocarcinoma lung</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Generally occurs in the peripheral regions of the lung and is often associated with mutations like KRAS, EGFR, or ALK. Immunohistochemical markers like TTF-1 and Napsin-A would be positive, not p40.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Small cell cancer lung</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This type is strongly associated with smoking and typically occurs centrally. However, it is identified by markers such as chromogranin, synaptophysin, and CD56, not p40.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Large cell carcinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a diagnosis of exclusion, where the tumor lacks the histological characteristics of other types of lung cancers. It is not associated with p40 positivity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-115311_T9eOCZG.jpg\" style=\"height:917px; width:1000px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-113157_GHno4ZQ.jpg\" style=\"height:747px; width:1000px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-120453.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50031,
      "choices": [
        {
          "id": 200124,
          "text": "<p><span style=\"font-size:12.0pt;\">Radial nerve</span></p>"
        },
        {
          "id": 200125,
          "text": "<p><span style=\"font-size:12.0pt;\">Median nerve</span></p>"
        },
        {
          "id": 200126,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulnar nerve</span></p>"
        },
        {
          "id": 200127,
          "text": "<p><span style=\"font-size:12.0pt;\">Musculocutaneous nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the nerve supply of the structure marked in the image?</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/7.jpg\" alt=\"\" width=\"200\" height=\"278\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/7.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2660595",
      "question_audio": null,
      "question_video": null,
      "map_id": 34842433,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Median nerve</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The median nerve supplies the 1st lumbrical which is marked.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The 1st lumbrical muscle is innervated by the median nerve. It is a small, quadrilateral muscle located in the hand that arises from the tendon of the flexor digitorum profundus muscle of the index finger and inserts into the extensor expansion of the index finger. Its main function is to flex the metacarpophalangeal joint of the index finger and extend the interphalangeal joints of the index finger. The 1st lumbrical muscle is named because it is associated with the first (index) finger, and there are a total of four lumbrical muscles in the hand - one for each of the four fingers (excluding the thumb).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The first and second lumbrical nerves are innervated by the median nerve. The third and fourth lumbricals are innervated by the deep terminal branch of the ulnar nerve.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/8.jpg\" alt=\"\" width=\"500\" height=\"456\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Radial Nerve:</strong> The radial nerve primarily innervates the extensor muscles of the forearm and hand, including the wrist and finger extensors. It does not supply the lumbrical muscles.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Ulnar Nerve:</strong> The ulnar nerve supplies several intrinsic hand muscles, including the lumbrical muscles. However, the first lumbrical is typically innervated by the median nerve, as mentioned earlier.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Musculocutaneous Nerve:</strong> The musculocutaneous nerve primarily innervates the muscles in the anterior compartment of the arm. It does not supply the lumbrical muscles.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">T</span><span style=\"background-color:white;color:#0d0d0d;font-size:11pt;\">he 1st lumbrical muscle of the hand is innervated by the median nerve is crucial for clinical assessments of hand function, especially in cases of nerve injury or compression syndromes like carpal tunnel syndrome, where the median nerve's functionality can be compromised.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/8.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200125,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50032,
      "choices": [
        {
          "id": 200128,
          "text": "<p><span style=\"font-size:12.0pt;\">6 Fr</span></p>"
        },
        {
          "id": 200129,
          "text": "<p><span style=\"font-size:12.0pt;\">14 Fr</span></p>"
        },
        {
          "id": 200130,
          "text": "<p><span style=\"font-size:12.0pt;\">16 Fr</span></p>"
        },
        {
          "id": 200131,
          "text": "<p><span style=\"font-size:12.0pt;\">22 Fr</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following option is a common size of a Foley catheter used in female patients and patients who have had urethral surgery or who have strictures? (INICET NOV 2022)</span></p>",
      "unique_key": "Q5558666",
      "question_audio": null,
      "question_video": null,
      "map_id": 34735594,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 14 Fr</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">14 Fr Foley catheters with a size of 14 Fr are commonly used in adult female patients. They are also used in patients who have had urethral surgery or who have strictures.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>6 Fr</strong>: 6 Fr Foley catheters with a size of 6 Fr are commonly used in pediatric patients or in adults with narrow urethras. They are also used in urodynamic studies to measure bladder pressures.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>C. 16 Fr</strong>: 16 Fr Foley catheters with a size of 16 Fr are commonly used in adult male patients. They are also used in patients who have had urethral surgery or who have strictures.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D.</strong> <strong>22 Fr</strong>: 22 Fr Foley catheters with a size of 22 Fr are commonly used in patients for suprapubic cystostomy. They are also used in patients who have undergone prostate surgery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>FOLEY’S CATHETER</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The size in French (12F, 14F, 16F etc.) represents the outer diameter. 1 F = 1/3<sup>rd</sup> mm.</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture5_Z8axJaw.jpg\" alt=\"\" width=\"200\" height=\"178\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture5_Z8axJaw.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200129,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50033,
      "choices": [
        {
          "id": 200132,
          "text": "<p><span style=\"font-size:12pt;\">11-year-old girl with Tanner stage 1 breasts</span></p>"
        },
        {
          "id": 200133,
          "text": "<p><span style=\"font-size:12pt;\">14-year-old girl with Tanner stage 1 breasts</span></p>"
        },
        {
          "id": 200134,
          "text": "<p><span style=\"font-size:12pt;\">13-year-old girl with Tanner stage 5 breasts</span></p>"
        },
        {
          "id": 200135,
          "text": "<p><span style=\"font-size:12pt;\">12-year-old with Tanner stage 4 breasts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following patients would be classified as having primary amenorrhea?</span> (INICET NOV 2022)</p>",
      "unique_key": "Q7727140",
      "question_audio": null,
      "question_video": null,
      "map_id": 34043715,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 14-year-old girl with Tanner stage 1 breasts</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Primary amenorrhea</strong> is defined as:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">No menstruation by age 13 in the absence of secondary sexual characteristics.</span></li><li><span style=\"font-size:12pt;\">No menstruation by age 15 in the presence of secondary sexual characteristics.</span></li></ul></li><li><span style=\"font-size:12pt;\">In this context:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Option A</strong>: An 11-year-old girl with Tanner stage 1 breasts would not be classified as having primary amenorrhea since she is not yet 13.</span></li><li><span style=\"font-size:12pt;\"><strong>Option B</strong>: A 14-year-old girl with Tanner stage 1 breasts meets the criteria for primary amenorrhea because she is older than 13 and has no secondary sexual characteristics (Tanner stage 1 breasts).</span></li><li><span style=\"font-size:12pt;\"><strong>Option C</strong>: A 13-year-old girl with Tanner stage 5 breasts is developing normally and does not meet the criteria for primary amenorrhea.</span></li><li><span style=\"font-size:12pt;\"><strong>Option D</strong>: A 12-year-old with Tanner stage 4 breasts is developing normally and does not meet the criteria for primary amenorrhea.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. 11-year-old girl with Tanner stage 1 breasts</strong>: The girl is too young to be classified as having primary amenorrhea.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. 13-year-old girl with Tanner stage 5 breasts</strong>: The girl has developed secondary sexual characteristics and is within the normal age range for the onset of menstruation.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. 12-year-old with Tanner stage 4 breasts</strong>: The girl has developed secondary sexual characteristics and is within the normal age range for the onset of menstruation.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Primary amenorrhea is defined as the absence of menstruation by age 13 without secondary sexual characteristics or by age 15 with secondary sexual characteristics.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: ACOG Committee opinion menstruation in girls and adolescents (2015), Speroff’s gynecologic endocrinology 7th edition pg401, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 450</strong></span></p>",
      "correct_choice_id": 200133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50034,
      "choices": [
        {
          "id": 200136,
          "text": "<p><span style=\"font-size:12.0pt;\">If the hands are visibly soiled</span></p>"
        },
        {
          "id": 200137,
          "text": "<p><span style=\"font-size:12.0pt;\">While moving from a contaminated site to a clean site during patient care</span></p>"
        },
        {
          "id": 200138,
          "text": "<p><span style=\"font-size:12.0pt;\">Before donning on gloves</span></p>"
        },
        {
          "id": 200139,
          "text": "<p><span style=\"font-size:12.0pt;\">During direct patient contact</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A healthcare worker is performing patient care in a hospital setting. Which of the following is not a correct situation for using hand rub according to standard hand hygiene protocol? (INICET NOV 2022)</span></p>",
      "unique_key": "Q9340038",
      "question_audio": null,
      "question_video": null,
      "map_id": 34653779,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) If the hands are visibly soiled</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hand rub, typically alcohol-based hand sanitizer, is not effective when hands are visibly soiled or contaminated with dirt, blood, or other body fluids. In such cases, healthcare workers should wash their hands with soap and water to physically remove the visible contaminants before using hand rub. This is a crucial step to ensure proper hand hygiene.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>While moving from a contaminated site to a clean site during patient care</strong>: Correct. Healthcare workers should use hand rub when transitioning from a contaminated site to a clean site during patient care. This helps prevent the spread of pathogens and maintain aseptic conditions. It's an essential practice in infection control</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Before donning on gloves</strong>: Correct. Hand hygiene, including the use of hand rub, is recommended before putting on gloves. This step ensures that any potential contaminants on the hands are removed before glove use, reducing the risk of contamination during procedures .</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. During direct patient contact</strong>: Correct. Healthcare workers should use hand rub before and after direct patient contact to reduce the risk of transmitting pathogens to or from the patient.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hand hygiene is essential for infection prevention in healthcare settings. Alcohol-based hand rubs are preferred in most cases, but soap and water should be used for visibly soiled hands and in cases of outbreaks of certain pathogens like Clostridium difficile. Hand hygiene should be performed before and after every direct patient contact, before donning gloves, and after removing gloves. Additionally, hand hygiene should be performed while moving from a contaminated site to a clean site during patient care. It is important to note that using hand rub is not appropriate if the hands are visibly soiled, as the rub cannot effectively remove dirt and debris from the hands. In such cases, soap and water handwashing is recommended.</span></p>",
      "correct_choice_id": 200136,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50035,
      "choices": [
        {
          "id": 200140,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reduce FiO2</span></span></span></p>"
        },
        {
          "id": 200141,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase tidal volume</span></span></span></p>"
        },
        {
          "id": 200142,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase respiratory rate</span></span></span></p>"
        },
        {
          "id": 200143,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase PEEP</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old female patient weighing 60 kg is on mechanical ventilation for ARDS secondary to urosepsis. </span></span></span><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">The respiratory parameters are as follows: tidal volume- 360 mL; frequency- 30 breaths/min; PEEP- 5 cm of H2O; and FiO2- 90%. </span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The arterial blood gas findings are as follows: paO2- 50 mmHg; paCO2- 38 mmHg and pH- 7.38. </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the next step?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q7866308",
      "question_audio": null,
      "question_video": null,
      "map_id": 34223117,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Increase PEEP</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute Respiratory Distress Syndrome (ARDS) requires careful management of mechanical ventilation settings to optimize oxygenation while minimizing lung injury. The patient's current settings and blood gas findings suggest hypoxemia (paO2 of 50 mmHg) with an FiO2 of 90%. The goal in managing ARDS is to maintain adequate oxygenation (paO2 > 60 mmHg) while reducing the FiO2 to less than 60% to avoid oxygen toxicity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increasing PEEP is the best option to improve oxygenation. PEEP helps to keep alveoli open, improving gas exchange and oxygenation. By increasing PEEP, we can potentially increase the paO2 and eventually reduce the FiO2 to safer levels.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt\"><strong>Reduce FiO2</strong>: Although reducing FiO2 is a long-term goal to prevent oxygen toxicity, it is not advisable to reduce it immediately because the patient is currently hypoxemic (paO2 of 50 mmHg).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt\"><strong>Increase tidal volume</strong>: Not appropriate as it can increase the risk of ventilator-induced lung injury in ARDS patients. The current tidal volume is within the safe range (360 mL), which is appropriate for a 60 kg patient as it falls within the recommended range of 4-6 mL/kg for ARDS patients to prevent ventilator-induced lung injury.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt\"><strong>Increase respiratory rate</strong>: Increasing the respiratory rate is not necessary in this situation as the paCO2 (38 mmHg) and pH (7.38) indicate normal ventilation and no significant respiratory acidosis (paCO2 is normal).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In ARDS management, if the patient remains hypoxemic despite a high FiO2, the next step is to increase the PEEP to improve oxygenation while maintaining lung-protective ventilation strategies.</span></span></span></p>",
      "correct_choice_id": 200143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50036,
      "choices": [
        {
          "id": 200144,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Beta blockers</span></span></span></p>"
        },
        {
          "id": 200145,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Calcium channel blockers</span></span></span></p>"
        },
        {
          "id": 200146,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Acetaminophen</span></span></span></p>"
        },
        {
          "id": 200147,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Aspirin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Urinary alkalinization will be most useful in toxicity of which of the following drugs? (INICET NOV 2020)</span></span></p>",
      "unique_key": "Q4073511",
      "question_audio": null,
      "question_video": null,
      "map_id": 34215974,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D. Aspirin</span></strong></span></span><br />\r\n </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Urinary alkalinization is a key treatment in aspirin toxicity. Aspirin (salicylate) is a weak acid, and alkalinizing the urine increases the ionization of salicylates. This ionization traps salicylates in the urine, preventing their reabsorption and enhancing their elimination.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Beta blockers:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Urinary alkalinization is not a standard treatment for beta blocker toxicity. Management of beta blocker overdose typically involves supportive care and, in severe cases, specific antidotes like glucagon or high-dose insulin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Calcium channel blockers:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Similar to beta blockers, urinary alkalinization is not a primary treatment for calcium channel blocker overdose. Treatment often includes calcium infusions, glucagon, and other supportive measures.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Acetaminophen:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> For acetaminophen toxicity, the antidote N-acetylcysteine (NAC) is used. Urinary alkalinization is not effective for acetaminophen overdose.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Urinary alkalinization is most useful in the treatment of aspirin (salicylate) toxicity because it increases the elimination of salicylates by trapping them in the urine through ionization. This method is not effective for beta blockers, calcium channel blockers, or acetaminophen toxicity.</span></span></span></p>",
      "correct_choice_id": 200147,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50037,
      "choices": [
        {
          "id": 200148,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Amniotic fluid volume</span></span></span></p>"
        },
        {
          "id": 200149,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Fetal tone</span></span></span></p>"
        },
        {
          "id": 200150,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Daily fetal movement count</span></span></span></p>"
        },
        {
          "id": 200151,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Non-stress test</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is not a component of biophysical profile? </span></span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q7527910",
      "question_audio": null,
      "question_video": null,
      "map_id": 34111562,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) Daily fetal movement count</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Daily fetal movement count (DFMC) is not a component of the BPP. DFMC, often assessed using Cardiff’s count of 10, is a separate method for monitoring fetal movements.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The Biophysical Profile (BPP) is a comprehensive test used in the assessment of fetal wellbeing. It includes five components, which are scored using the Manning score:</span></span></span>\r\n\r\n\t<ol>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Non-stress test (NST)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Amniotic fluid volume (AFV)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Fetal movements</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Fetal tone</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Fetal breathing movements</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A low Manning score is indicative of fetal hypoxia and may necessitate further clinical intervention.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Additionally, the Modified Biophysical Profile (BPP) includes only two components:</span></span></span>\r\n\t<ol>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Non-stress test (NST)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Amniotic fluid index (AFI)</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Amniotic fluid volume</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Amniotic fluid volume is a component of the BPP and helps assess the amount of amniotic fluid surrounding the fetus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Fetal tone</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Fetal tone is another component of the BPP, assessing the baby's muscle tone.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Non-stress test</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Non-stress test (NST) is part of the BPP and evaluates the fetal heart rate in response to fetal movements.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The Biophysical Profile (BPP) consists of five components: NST, AFV, fetal movements, fetal tone, and fetal breathing movements. Daily fetal movement count (DFMC) is not part of the BPP.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg 342, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 122</span></strong></span></span></p>",
      "correct_choice_id": 200150,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50038,
      "choices": [
        {
          "id": 200152,
          "text": "<p><span style=\"font-size:12.0pt;\">Wearing clothes of opposite sex</span></p>"
        },
        {
          "id": 200153,
          "text": "<p><span style=\"font-size:12.0pt;\">Public display of genitalia</span></p>"
        },
        {
          "id": 200154,
          "text": "<p><span style=\"font-size:12.0pt;\">Seeing a male undressing</span></p>"
        },
        {
          "id": 200155,
          "text": "<p><span style=\"font-size:12.0pt;\">Seeing a female undressing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Eonism can be defined as? </span>(INICET NOVEMBER 2022)</p>",
      "unique_key": "Q8814730",
      "question_audio": null,
      "question_video": null,
      "map_id": 34197239,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A. Wearing clothes of opposite sex</strong></span></p><p><span style=\"font-size:11pt;\"> </span></p><ul><li><span style=\"font-size:12.0pt;\">Eonism /Transvestism involves wearing clothes of the opposite sex to derive pleasure.</span></li><li><span style=\"font-size:12.0pt;\">Eonism is named for Charles Eon de Beaumont, a French political adventurer who died in 1810 after posing as a woman for many years.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.<strong> Public display of genitalia</strong> – Exhibitionism, where an individual derives pleasure from exposing their genitals to others in public.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Seeing a male undressing: </strong>This can be a form of voyeurism, though it is not specifically defined as such. Voyeurism typically involves deriving pleasure from secretly observing others who are undressing or engaging in sexual activities.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Seeing a female undressing</strong>- Voyeurism, where an individual derives pleasure from observing females undressing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Eonism or transvestism is the act of wearing clothes of the opposite sex for pleasure, named after Charles Eon de Beaumont.</span></p>",
      "correct_choice_id": 200152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50039,
      "choices": [
        {
          "id": 200156,
          "text": "<p><span style=\"font-size:12.0pt;\">Isotonic</span></p>"
        },
        {
          "id": 200157,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypotonic</span></p>"
        },
        {
          "id": 200158,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertonic</span></p>"
        },
        {
          "id": 200159,
          "text": "<p><span style=\"font-size:12.0pt;\">Depends on fluid intake</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">How would you describe the tonicity of the fluid leaving the proximal convoluted tubule in the absence of antidiuretic hormone (ADH)?</span></p>",
      "unique_key": "Q2672711",
      "question_audio": null,
      "question_video": null,
      "map_id": 34259950,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Isotonic</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Fluid leaving the proximal convoluted tubule (PCT in the absence of antidiuretic hormone (ADH) is isotonic.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Normally, about 65 per cent of the filtered load of sodium and water and a slightly lower percentage of filtered chloride are reabsorbed by the proximal tubule before the filtrate reaches the loops of Henle. The PCT is the site of maximum water reabsorption under normal physiological conditions. Isosmotic reabsorption occurs in the PCT, so the amount of solute and water reabsorbed are coupled and proportional to each other. Water reabsorption in the PCT also occurs through aquaporin-1 which are active water channels. Reabsorption of sodium and water in PCT is not affected by ADH levels.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Thus, even in the absence of ADH, fluid is isotonic in PCT.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypotonic:</strong> This is incorrect because the fluid in the PCT remains isotonic due to the proportional reabsorption of solutes and water.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hypertonic:</strong> This is incorrect because the reabsorption process in the PCT maintains the isotonic nature of the fluid.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Depends on fluid intake:</strong> This is incorrect because the tonicity of the fluid in the PCT does not depend on fluid intake but on the intrinsic reabsorption processes that maintain isotonic conditions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Fluid leaving the proximal convoluted tubule (PCT) is isotonic due to the isosmotic reabsorption of solutes and water, regardless of the presence of antidiuretic hormone (ADH). This ensures that the fluid entering the loop of Henle has the same osmolarity as plasma.</span></p>",
      "correct_choice_id": 200156,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50040,
      "choices": [
        {
          "id": 200160,
          "text": "<p><span style=\"font-size:12.0pt;\">10% of lung cancers in smokers is not associated with smoking</span></p>"
        },
        {
          "id": 200161,
          "text": "<p><span style=\"font-size:12.0pt;\">90% cases of lung cancer can be eliminated in population if smoking is eliminated</span></p>"
        },
        {
          "id": 200162,
          "text": "<p><span style=\"font-size:12.0pt;\">90% cases of lung cancer can be eliminated in smokers if smoking is eliminated</span></p>"
        },
        {
          "id": 200163,
          "text": "<p><span style=\"font-size:12.0pt;\">10% cases of lung cancer can be eliminated in population if smoking is eliminated</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old researcher is keenly interested in understanding the relationship between lung cancer and smoking habits. After conducting an extensive study and analyzing his data, he finds that the attributable risk is 90%. Which of the following is the most accurate interpretation of this result? (INICET NOV 2022)</span></p>",
      "unique_key": "Q1434359",
      "question_audio": null,
      "question_video": null,
      "map_id": 34530595,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 10% of lung cancers in smokers is not associated with smoking</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">In the given scenario, the attributable risk of cigarette smoking to lung cancer is 90%; hence, 90% cases of lung cancer are due to smoking as a risk factor</span></li><li><span style=\"font-size:12.0pt;\">The difference between the incidence of disease among exposed and the incidence among non-exposed is given by the attributable risk.</span></li><li><span style=\"font-size:12.0pt;\">Attributable risk is the difference in risk of disease between two groups (exposed and non-exposed) and represents the proportion of disease occurrence that can be attributed to the exposure.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-125535.png\" alt=\"\" width=\"800\" height=\"95\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Interpretation of AR (attributable risk): AR is indicative of the extent of the disease attributed to the exposure</span></li><li><span style=\"font-size:12.0pt;\">Interpretation of PAR (Population attributable risk): If risk factor is modified or eliminated, there will be so much annual reduction in incidence of disease in the given population</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-125535.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200160,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50041,
      "choices": [
        {
          "id": 200164,
          "text": "<p><span style=\"font-size:12.0pt;\">Transferrin</span></p>"
        },
        {
          "id": 200165,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferroportin</span></p>"
        },
        {
          "id": 200166,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepcidin</span></p>"
        },
        {
          "id": 200167,
          "text": "<p><span style=\"font-size:12.0pt;\">Divalent metal transporter - 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Transport of iron into enterocytes is done by which of the following proteins: (</span>INICET Nov 2022)</p>",
      "unique_key": "Q7823501",
      "question_audio": null,
      "question_video": null,
      "map_id": 34728986,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Divalent metal transporter – 1</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Transport of iron into enterocytes is done by divalent metal transporter-1 protein.</span></p><p><span style=\"font-size:12.0pt;\">Iron absorption occurs in the duodenum. Iron is reduced to Fe2+ (ferrous) iron by ferrireductases and then transported across the apical membrane by divalent metal transporter 1 (DMT1).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/1_8K6VXRG.jpg\" alt=\"\" width=\"700\" height=\"406\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Transferrin</strong>: This protein binds iron in the bloodstream and transports it to various tissues, but it is not involved in the transport of iron into enterocytes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ferroportin</strong>: This protein exports iron from enterocytes into the bloodstream but does not transport iron into the cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hepcidin</strong>: This hormone regulates iron egress from enterocytes by inhibiting ferroportin but is not involved in the transport of iron into enterocytes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The primary transporter responsible for iron uptake into enterocytes from the intestinal lumen is the divalent metal transporter-1 (DMT1).</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/1_8K6VXRG.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200167,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50042,
      "choices": [
        {
          "id": 200168,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 2, 3, 4</span></span></span></p>"
        },
        {
          "id": 200169,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 2</span></span></span></p>"
        },
        {
          "id": 200170,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">3, 4</span></span></span></p>"
        },
        {
          "id": 200171,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 2, 3</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following statements is true regarding memantine? (INICET NOV 2022)</span></span></span><br />\r\n </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1. Its therapeutic effect is due to its antagonistic action on NMDA receptors.</span></span></span><br />\r\n </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2. It is reserved for moderate-to-severe cases of Alzheimer’s disease.</span></span></span><br />\r\n </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">3. It is used only as a monotherapy and should not be used with cholinesterase inhibitors.</span></span></span><br />\r\n </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">4. It is given at a daily dose of 20-30 mg/day.</span></span></span></span></p>",
      "unique_key": "Q3804075",
      "question_audio": null,
      "question_video": null,
      "map_id": 34260410,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B. 1, 2</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">1. Its therapeutic effect is due to its antagonistic action on NMDA receptors: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">True. Memantine is an NMDA (N-methyl-D-aspartate) receptor antagonist. It works by blocking the action of glutamate at the NMDA receptors, which is thought to play a role in the symptoms of Alzheimer's disease.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">2. It is reserved for moderate-to-severe cases of Alzheimer’s disease: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">True. Memantine is typically used in the treatment of moderate to severe Alzheimer's disease. It is not commonly used in the early stages of the disease.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">3. It is used only as a monotherapy and should not be used with cholinesterase inhibitors: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">False. Memantine can be used alone (as monotherapy) or in combination with cholinesterase inhibitors, such as donepezil, rivastigmine, or galantamine, in the treatment of Alzheimer's disease.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">4. It is given at a daily dose of 20-30 mg/day: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">False. Memantine is started at a lower dose of 5 mg daily and is titrated up to a target dose, which is usually 20 mg/day. Therefore, it is more precise to say that the standard dose is up to 20 mg/day.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Memantine is an NMDA receptor antagonist used for moderate to severe Alzheimer's disease. It can be used alone or in combination with cholinesterase inhibitors, and the standard maximum dose is 20 mg/day.</span></span></span></p>",
      "correct_choice_id": 200169,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50043,
      "choices": [
        {
          "id": 200172,
          "text": "<p><span style=\"font-size:12.0pt;\">Superficial perineal pouch</span></p>"
        },
        {
          "id": 200173,
          "text": "<p><span style=\"font-size:12.0pt;\">Deep perineal pouch</span></p>"
        },
        {
          "id": 200174,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin around penis</span></p>"
        },
        {
          "id": 200175,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin around the scrotum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The rupture of penile urethra does not cause extravasation of blood into which of the following spaces? (INICET MAY 2022)</span></p>",
      "unique_key": "Q7484986",
      "question_audio": null,
      "question_video": null,
      "map_id": 34216119,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><strong>Ans. B. Deep perineal pouch</strong></p><p> </p><p><strong>Option B. Deep perineal pouch</strong>: This is a space situated superior to the perineal membrane and inferior to the pelvic diaphragm. It contains the membranous urethra, deep transverse perineal muscles, and parts of the external urethral sphincter. Extravasation of urine is possible in deep perineal pouch.</p><p> </p><p>When there is a rupture of the penile urethra (often due to trauma, such as a straddle injury), the extravasation of urine and blood can occur into various anatomical spaces, depending on the location and nature of the injury.</p><p> </p><p><strong>Other Options:</strong></p><p> </p><p><strong>Option A. Superficial perineal pouch</strong>: This is a space located in the urogenital triangle of the perineum, bounded above by the perineal membrane and below by the perineal (Colles') fascia. The pouch contains the root of the penis (including the bulb of the penis) and the associated muscles. A rupture of the penile urethra can cause extravasation of urine and blood into this space.</p><p> </p><p><strong>Option C. Skin around penis</strong>. The skin around base of penis may get involved if the rupture is located in the bulbous part of urethra.</p><p> </p><p><strong>Option D. Skin around the scrotum</strong>: With a rupture of the penile urethra, especially if the rupture occurs in the bulbous part located within the superficial perineal pouch, the extravasated urine and blood can dissect through the fascial layers and present as swelling and bruising around the scrotum and base of the penis. This is often referred to as a \"butterfly\" pattern of bruising, as the extravasated fluid can spread anteriorly onto the anterior abdominal wall and laterally to the thighs but is typically limited superiorly by Scarpa's fascia.</p><p> </p><p><strong>Educational Objective:</strong></p><p> </p><p>Rupture of the penile urethra causes extravasation of blood into the superficial perineal pouch, scrotum, penis, and then up to the lower anterior abdominal wall.</p><p> </p><p>The membranous layer of superficial fascia attaches to the ischiopubic rami and forms the lateral borders of the urogenital triangle. Thus, the urine does not extravasate to the thigh.</p>",
      "correct_choice_id": 200173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50044,
      "choices": [
        {
          "id": 200176,
          "text": "<p><span style=\"font-size:12.0pt;\">Right superior gluteal nerve palsy</span></p>"
        },
        {
          "id": 200177,
          "text": "<p><span style=\"font-size:12.0pt;\">Left superior gluteal nerve palsy</span></p>"
        },
        {
          "id": 200178,
          "text": "<p><span style=\"font-size:12.0pt;\">Right inferior gluteal nerve palsy</span></p>"
        },
        {
          "id": 200179,
          "text": "<p><span style=\"font-size:12.0pt;\">Left inferior gluteal nerve palsy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Patient had difficulty in walking upstairs. When he was made to bear weight on right lower limb, the left-sided pelvis dropped down, but when he was standing on the left lower limb, the right-sided pelvis moved up. Which of the following is the likely lesion? (INICET NOV 2022)</span></p>",
      "unique_key": "Q3183061",
      "question_audio": null,
      "question_video": null,
      "map_id": 34305752,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Right superior gluteal nerve palsy</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>WADDLING (GLUTEAL OR TRENDELENBURG) GAIT</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">This gait is <strong>characteristic of the gluteal muscle weakness</strong> that is seen in the progressive muscular dystrophies, but it occurs as well in chronic forms of spinal muscular atrophy, in certain inflammatory myopathies, lumbosacral nerve root compression, and with congenital dislocation of the hips.</span></li><li><span style=\"font-size:12.0pt;\">It can also <strong>occur in neurogenic conditions in which the superior gluteal nerve is involved</strong>.</span></li><li><span style=\"font-size:12.0pt;\">In normal walking, as weight is placed alternately on each leg, the hip is fixated by the gluteal muscles, particularly the gluteus medius, allowing for a slight rise of the opposite hip and tilt of the trunk to the weight-bearing side.</span></li><li><span style=\"font-size:12.0pt;\">With weakness of the glutei, however, there is a failure to stabilize the weight-bearing hip, causing it to bulge outward and the opposite side of the pelvis to drop, with inclination of the trunk to that side.</span></li><li><span style=\"font-size:12.0pt;\"><strong>The alternation in lateral trunk movements results in the roll or waddle</strong>.</span></li><li><span style=\"font-size:12.0pt;\">With unilateral gluteal weakness, often the result of damage to the first sacral nerve root, tilting and dropping of the pelvis <strong>(“pelvic ptosis”)</strong> is apparent on only one side as the patient overlifts the leg when walking.</span></li><li><span style=\"font-size:12.0pt;\">In several of the muscular dystrophies, an accentuation of lumbar lordosis is often seen.</span></li><li><span style=\"font-size:12.0pt;\">Also, childhood cases may be complicated by muscular contractures, leading to an <strong>equinovarus position of the foot</strong>, so that the waddle is combined with walking on the toes <strong>(“toe walking”)</strong>.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102139.jpg\" alt=\"\" width=\"400\" height=\"331\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Left superior gluteal nerve palsy</strong>. When the patient is standing on one leg, the opposite pelvis should be lifted upwards by abduction of the ipsilateral hip joint, in a normal patient. When the abductors are weak due to superior gluteal nerve paresis, the pelvis will sag, called positive Trendelenburg sign. In a patient with a positive Trendelenburg sign, the pelvis sags toward the normal unsupported side, which is the swing leg. When the left superior gluteal nerve is affected, on standing on the left lower limb, the right side pelvis will drop and when the patient stands on the right leg, the left side pelvis will be lifted up.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Right inferior gluteal nerve palsy</strong>. The inferior gluteal nerve supplies the gluteus maximus muscle. It is therefore, responsible for extending the trunk from a forward bending position and extending the hip from sitting-to-standing or during stair-climbing or rising from a squatted position. The nerve does not confer any sensation. Injury to this nerve is most commonly iatrogenic in origin and is the most at risk nerve during total hip arthroplasty via a posterior approach. Injury typically leads to an altered gait pattern known as <strong>gluteus maximus ‘lurch’. </strong>The sequelae of nerve injury are denervation of the ipsilateral gluteus maximus muscle. The lurching gait results from the weakening or absence of an ipsilateral hip extension. Clinically, patients may also report wasting of the ipsilateral gluteus maximus muscle and loss of the defined shape to the affected buttock. In a normal gait cycle, the gluteus maximus begin to contract at the moment of the ipsilateral heel-strike to initiate ipsilateral hip extension. In inferior gluteal nerve injury, the trunk will extend when the heel strikes on the ground on the affected side to compensate for weak/absent hip extension. This backward trunk lurch is present in the whole stance phase of the gait cycle and locks the hip in extension. In some cases, the hamstrings muscle compensates to an extent. Therefore, in the right inferior gluteal nerve palsy, the right side hip will not extend during the initial heel strike and the trunk will lean backwards/extend.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Left inferior gluteal nerve palsy</strong>. In the injury of left sided gluteal nerve, the left hip will not extend during the initial heel strike, leading to backward lurch or extension of the trunk.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">On standing on the right lower limb, the left side pelvis drops and while standing on the left leg, the right side pelvis lifted up. This is indicative of right superior gluteal nerve palsy. This sign is called Trendelenburg Sign.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102139.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200176,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50045,
      "choices": [
        {
          "id": 200180,
          "text": "<p><span style=\"font-size:12.0pt;\">Sufficient component cause model</span></p>"
        },
        {
          "id": 200181,
          "text": "<p><span style=\"font-size:12.0pt;\">Epidemiological triad</span></p>"
        },
        {
          "id": 200182,
          "text": "<p><span style=\"font-size:12.0pt;\">PERT model</span></p>"
        },
        {
          "id": 200183,
          "text": "<p><span style=\"font-size:12.0pt;\">Web of causation model</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Based on the depiction in the accompanying image, which model of disease causation is being illustrated? (INICET NOV 2022)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip46.jpg\" alt=\"\" width=\"466\" height=\"463\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip46.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1500783",
      "question_audio": null,
      "question_video": null,
      "map_id": 34473391,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Sufficient component cause model </strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The model of disease causation depicted is a sufficient component cause model.</span></li><li><span style=\"font-size:12.0pt;\">It was developed by Rothman based on the idea that an outcome can only happen when a sufficient cause is present.</span></li><li><span style=\"font-size:12.0pt;\">A disease can have multiple sufficient causes. But each sufficient cause can consist of a pie chart of component causes, a causal pie.</span></li><li><span style=\"font-size:12.0pt;\">One component cause can be a part of more than one sufficient cause.</span></li><li><span style=\"font-size:12.0pt;\">A component cause can be considered necessary if it is a part of a disease's sufficient causes.</span></li><li><span style=\"font-size:12.0pt;\">In the given model, each pie chart represents a sufficient cause made of component causes.</span></li><li><span style=\"font-size:12.0pt;\">Since B is present in all the charts, it can be considered a necessary cause. All the others are contributing causes.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Epidemiological triad</strong>: An epidemiological triad depicts the interrelationship between the causative agent, the host, and the environment. All of them contribute to disease development. The aim of an epidemiological triad is to identify how to break this relationship and prevent the outbreak of the disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. PERT model</strong>: PERT is used for network analysis. It is a type of quantitative management technique that helps in detailed planning and comprehensive supervision.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture4444.jpg\" alt=\"\" width=\"500\" height=\"383\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Web of causation model:</strong> The web of causation considers all the predisposing factors and their complex interrelationship with each other. This model is ideally suited to study chronic disease. The web of causation does not imply that the disease is controlled only when all the multiple chains of causation are removed.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/psm-pyq-11.jpg\" alt=\"\" width=\"700\" height=\"601\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The sufficient component cause model illustrates how multiple factors contribute to disease causation, with some factors being necessary components in multiple causal pathways.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture4444.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200180,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50046,
      "choices": [
        {
          "id": 200184,
          "text": "<p><span style=\"font-size:12.0pt;\">20cc</span></p>"
        },
        {
          "id": 200185,
          "text": "<p><span style=\"font-size:12.0pt;\">50cc</span></p>"
        },
        {
          "id": 200186,
          "text": "<p><span style=\"font-size:12.0pt;\">75cc</span></p>"
        },
        {
          "id": 200187,
          "text": "<p><span style=\"font-size:12.0pt;\">100cc</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the volume of the prostate in normal adult males? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q5852040",
      "question_audio": null,
      "question_video": null,
      "map_id": 34004996,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. 20cc</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The volume of the prostate in normal adult males is 20cc.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The volume of the prostate gland in normal adult males can vary depending on age and other factors. However, on average, the volume of the prostate gland in an adult male is around 20-30 cubic centimeters (cc) or milliliters (mL).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/anatomy-nov-inicet-2022-02.jpg\" alt=\"\" width=\"600\" height=\"419\"> </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"background-color:white;color:#0d0d0d;font-size:11pt;\">The typical volume of the prostate in a normal adult male is around 20cc</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/anatomy-nov-inicet-2022-02.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50047,
      "choices": [
        {
          "id": 200188,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Contusion</span></span></p>"
        },
        {
          "id": 200189,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Abrasion</span></span></p>"
        },
        {
          "id": 200190,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Laceration</span></span></p>"
        },
        {
          "id": 200191,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Stab wound</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The image given below is a type of _______. (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/07/screenshot-2024-10-05-130616.jpg\" style=\"height:204px; width:300px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/07/screenshot-2024-10-05-130616.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1197380",
      "question_audio": null,
      "question_video": null,
      "map_id": 34229386,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Contusion</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The type of injury shown in the image is a <strong>contusion</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A <strong>contusion</strong> is characterized by the infiltration of extravasated blood into the subcutaneous and/or subepithelial tissues. It results from the rupture of small blood vessels due to the application of <strong>blunt force</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A pure bruise lies beneath an <strong>intact epidermis</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Bruises</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> are caused by damage to veins, venules, and small arteries.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The usual bruise from a blunt impact is situated in the <strong>subcutaneous tissues</strong>, often in the fat layer. (Fat individuals tend to bruise more easily than thin individuals due to the greater volume of soft subcutaneous tissue.)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Delayed bruising</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is a common phenomenon, where a bruise may become more prominent after hours or days due to continued bleeding from ruptured vessels, with blood percolating from deeper tissues toward the epidermis.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Abrasion</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Abrasion, also known as <strong>gravel rash</strong>, is the destruction of the <strong>superficial layers</strong> of the epidermis, usually due to friction against a rough surface. Abrasions can be classified into scratches, grazes, pressure abrasions, or impact abrasions.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Laceration</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Laceration refers to a <strong>tear or split</strong> of the skin, mucous membranes, or muscles caused by blunt force trauma. The shape and depth of a laceration can help determine the cause of the injury.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Stab wound</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: A stab wound is caused by a sharp object (e.g., knife or scissors), producing a wound that is <strong>deeper than it is wide</strong> with clean, inverted edges.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Contusions</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> are caused by blunt force trauma, leading to subcutaneous bleeding (bruising) without breaking the skin. The <strong>delayed appearance</strong> of bruises is common, and their progression provides clues to the timing and severity of the injury.</span></span></p>",
      "correct_choice_id": 200188,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50048,
      "choices": [
        {
          "id": 200192,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Inj. Amphotericin B for 4-8 weeks, followed by oral itraconazole</span></span></span></span></span></p>"
        },
        {
          "id": 200193,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Inj. Amphotericin B for 8 weeks, followed by oral posaconazole</span></span></span></span></span></p>"
        },
        {
          "id": 200194,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Inj. Fluconazole, followed by oral fluconazole</span></span></span></span></span></p>"
        },
        {
          "id": 200195,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Inj. Amphotericin B, followed by flucytosine</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient presented with periorbital pain and nasal discharge. On examination, the findings shown in the image below. She is an immunocompromised patient currently on HAART. Which of the following antifungal regimen should be prescribed to this patient along with HAART? (</span></span></span></span>INICET Nov 2022)</p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/759.jpg\" style=\"height:338px; width:300px\" /></span></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/759.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9229295",
      "question_audio": null,
      "question_video": null,
      "map_id": 34881545,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Inj. Amphotericin B for 8 weeks, followed by oral posaconazole</span></strong></span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">An immunocompromised patient presenting with peri-orbital swelling and black necrosed lesion is suggestive of mucormycosis, an opportunistic fungal infection.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Amphotericin B is the first-line treatment for mucormycosis due to its broad-spectrum antifungal activity. Posaconazole is used for consolidation therapy following initial treatment with Amphotericin B, especially in cases of severe infection or in immunocompromised patients.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Treatment of the underlying immunodeficiency along with surgical debridement might be needed.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Inj. Amphotericin B for 4-8 weeks, followed by oral itraconazole: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This regimen is not the most recommended for mucormycosis. Itraconazole is less effective compared to posaconazole for mucormycosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Inj. Fluconazole, followed by oral fluconazole: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Fluconazole is not effective against mucormycosis. It is primarily used for infections caused by Candida and Cryptococcus species.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Inj. Amphotericin B, followed by flucytosine: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Flucytosine is used in combination with Amphotericin B for the treatment of cryptococcal meningitis, not mucormycosis.</span></span></span></p>\r\n\r\n<h3> </h3>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Mucormycosis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> requires aggressive treatment with Amphotericin B followed by consolidation therapy with posaconazole, particularly in immunocompromised patients. This combination helps ensure both initial and sustained control of the fungal infection.</span></span></span></p>",
      "correct_choice_id": 200193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50049,
      "choices": [
        {
          "id": 200196,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Muscarinic action of acetyIcholine</span></span></span></span></span></p>"
        },
        {
          "id": 200197,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Potentiation of acetylcholine</span></span></span></span></span></p>"
        },
        {
          "id": 200198,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Antagonism of acetylcholine</span></span></span></span></span></p>"
        },
        {
          "id": 200199,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Nicotinic action of acetylcholine</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">An experiment is being conducted on a dog blood pressure to study the effect of acetylcholine. The blood pressure is recorded at each intervention and is shown below. What does phase 4 in the graph indicate? (</span></span></span></span></span>INICET Nov 2022)</p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-9.jpg\" style=\"height:190px; width:300px\" /></span></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-9.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7684321",
      "question_audio": null,
      "question_video": null,
      "map_id": 34031009,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D.</span></span></strong></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Nicotinic action of acetylcholine</span></strong></span></span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">For demonstrating nicotinic actions (on ganglia) of acetylcholine, two criteria are required:</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">High dose of acetylcholine (around 5 mg).</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Muscarinic receptors must be blocked by giving atropine (to avoid death of the animal due to overactivity of muscarinic receptors)</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">About the given graph:</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture1_2v4u1Uh.jpg\" style=\"height:316px; width:500px\" /></span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In phases 1 and 2, Acetylcholine is given at doses of 2 mcg and 50 mcg. This leads to a drop in the BP due to its action in the muscarinic receptors.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In phase 3 when its muscarinic action is blocked by atropine, administration of 50 mcg of Acetylcholine does not cause a fall in BP.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">But in phase 4, when Ach is administered at higher dose of 5 mg, it acts on the Neuronal Nicotinic receptors located in CNS, ganglia and adrenals, leading to their stimulation and release of norepinephrine, which causes the BP to shoot up. Thus, Phase 4 in the graph indicates the nicotinic action of acetylcholine at higher doses.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. Muscarinic action of acetylcholine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Muscarinic actions are demonstrated in Phases 1 and 2, where acetylcholine causes a drop in blood pressure. This option is incorrect for Phase 4.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Potentiation of acetylcholine: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Potentiation would suggest an increased effect due to repeated or combined actions, which is not the primary mechanism demonstrated in Phase 4.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Antagonism of acetylcholine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Antagonism would imply inhibition of acetylcholine’s effects. Phase 3 demonstrates antagonism (by atropine) but not Phase 4.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 4 in the graph indicates the nicotinic action of acetylcholine, characterized by a rise in blood pressure due to the stimulation of neuronal nicotinic receptors after administering a high dose of acetylcholine (5 mg) following the blockade of muscarinic receptors with atropine.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture1_2v4u1Uh.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200199,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50050,
      "choices": [
        {
          "id": 200200,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        },
        {
          "id": 200201,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 200202,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 200203,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A persistent alcoholic patient presents with convulsions and impaired sensorium. He has been drinking for ten years and consumes 24 units every day. His most recent drink was two days ago. He is discovered to have auditory hallucinations as well as secondary delusions. What method will you employ to manage this patient?</span></p><p style=\"text-align:justify;\"> </p><ol><li><span style=\"font-size:12.0pt;\">Diazepam</span></li><li><span style=\"font-size:12.0pt;\">Thiamine</span></li><li><span style=\"font-size:12.0pt;\">Naltrexone</span></li><li><span style=\"font-size:12.0pt;\">Flupenthixol depot injection</span></li></ol>",
      "unique_key": "Q4085187",
      "question_audio": null,
      "question_video": null,
      "map_id": 34559875,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 2</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The patient is presenting with symptoms of alcohol withdrawal, specifically delirium tremens, characterized by tremors, altered sensorium, hallucinations, seizures, and agitation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. Diazepam:</strong> Benzodiazepines, like diazepam, are the first line of treatment for alcohol withdrawal symptoms and can help reduce the severity of symptoms, prevent seizures, and can be titrated based on the severity of withdrawal.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2. Thiamine</strong>: Chronic alcoholics are at risk for thiamine (Vitamin B1) deficiency, leading to Wernicke's encephalopathy. It is important to administer thiamine before or with the first dose of glucose-containing fluids or foods to prevent precipitating or exacerbating Wernicke's encephalopathy.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3. Naltrexone:</strong> This is an opioid antagonist that is used to decrease alcohol cravings. It is not directly useful in treating acute withdrawal symptoms.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4. Flupenthixol depot injection:</strong> This is an antipsychotic medication. It is not the primary treatment for alcohol withdrawal.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\">Alcohol withdrawal delirium (DTs) typically presents 48-72 hours after the last drink and is characterized by disturbances of consciousness, disorientation to time, place, and person, hallucinations (especially visual), agitation, coarse tremors and autonomic hyperactivity. Risk factors include surgery, infections or other medical conditions. It is a medical emergency requiring prompt intervention. Treatment includes intravenous lorazepam or diazepam with thiamine supplementation to prevent Wernicke encephalopathy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 472-473.</strong></span></p>",
      "correct_choice_id": 200203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50051,
      "choices": [
        {
          "id": 200204,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 200205,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 4</span></p>"
        },
        {
          "id": 200206,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
        },
        {
          "id": 200207,
          "text": "<p><span style=\"font-size:12.0pt;\">3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify true statements about familial adenomatous polyposis? (INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Autosomal recessive inheritance</span></li><li><span style=\"font-size:12.0pt;\">If not treated, all cases progress to adenocarcinoma colon.</span></li><li><span style=\"font-size:12.0pt;\">KRAS mutations cause familial adenomatous polyposis</span></li><li><span style=\"font-size:12.0pt;\">It is associated with congenital hypertrophy of the retinal pigment epithelium.</span></li></ol>",
      "unique_key": "Q1126799",
      "question_audio": null,
      "question_video": null,
      "map_id": 34400520,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 2 and 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Familial adenomatous polyposis (FAP) is a hereditary condition characterized by the development of numerous adenomatous polyps in the colon and rectum, often numbering in the hundreds to thousands. The condition is caused by mutations in the <strong>APC gene (chromosome 5q)</strong>, leading to autosomal dominant inheritance.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>True Statements:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Statement 2</strong>: If not treated, all cases of FAP will progress to colorectal adenocarcinoma. This is because the polyps have a high potential to become malignant if not removed or if the patient does not undergo a prophylactic colectomy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Statement 4</strong>: FAP is associated with congenital hypertrophy of the retinal pigment epithelium, which is often used as a marker for the condition, especially in screening family members.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Statement 1</strong>: FAP is inherited in an <strong>autosomal dominant</strong> pattern, not autosomal recessive. This means that a single copy of the mutated APC gene can cause the disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Statement 3</strong>: FAP is primarily caused by mutations in the <strong>APC gene</strong>, not KRAS. While KRAS mutations are involved in colorectal cancer progression, they are not the cause of FAP.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-123524.jpg\" alt=\"\" width=\"1000\" height=\"727\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-123524.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50052,
      "choices": [
        {
          "id": 200208,
          "text": "<p><span style=\"font-size:12.0pt;\">Roenne's nasal step</span></p>"
        },
        {
          "id": 200209,
          "text": "<p><span style=\"font-size:12.0pt;\">Bayonetting</span></p>"
        },
        {
          "id": 200210,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased cup-disc ratio</span></p>"
        },
        {
          "id": 200211,
          "text": "<p><span style=\"font-size:12.0pt;\">Baring of nasal arteries</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a feature of the optic disc in glaucoma? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2022)</span></p>",
      "unique_key": "Q4849366",
      "question_audio": null,
      "question_video": null,
      "map_id": 34700600,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Roenne's nasal step</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Roenne's nasal step is not a feature of the optic disc in glaucoma.</span></li><li><span style=\"font-size:12.0pt;\">Roenne's nasal step is a visual field defect. It is the result of two arcuate scotomas running in different arcs and meeting at the horizontal meridian. This forms a right-angled defect in the nasal side of the visual field.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture2_LziWdrm.jpg\" alt=\"\" width=\"400\" height=\"425\"></span></p><p><span style=\"color:black;font-size:12.0pt;\"><i><strong>Roenne’s nasal step</strong></i></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-182049.png\" alt=\"\" width=\"1000\" height=\"569\"></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Early glaucomatous changes:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Increase in cup-disc ratio (C/D ratio) to >0.4</span></li><li><span style=\"font-size:12.0pt;\">Splinter hemorrhages near the optic disc margin</span></li><li><span style=\"font-size:12.0pt;\">Atrophy of the retinal nerve fiber layer</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Advanced glaucomatous changes:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Marked increase in C/D ratio (0.7 or more)</span></li><li><span style=\"font-size:12.0pt;\">Thinning of the neuroretinal rim</span></li><li><span style=\"font-size:12.0pt;\">Nasal shifting of the retinal vessels or bayonetting</span></li><li><span style=\"font-size:12.0pt;\">Pulsations of retinal arterioles at the disc margin.</span></li><li><span style=\"font-size:12.0pt;\">If the damage progresses, all neural tissue is destroyed and the optic nerve appears white and deeply excavated.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Bayonetting:</strong> This refers to the appearance of blood vessels on the optic disc where the vessels appear to sharply bend or 'bayonet' due to the structural changes in the optic disc from glaucomatous damage, particularly as the neuroretinal rim thins and the cup enlarges.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increased cup-disc ratio:</strong> A hallmark of glaucomatous damage to the optic nerve, where the optic cup enlarges relative to the overall disc, often exceeding a ratio of 0.5, which is considered abnormal and suggestive of glaucoma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Baring of nasal arteries:</strong> This describes the exposure or baring of the nasal retinal arteries as a result of thinning of the nerve fiber layer in glaucoma. It is a less commonly described feature compared to others but can occur as part of the broader pattern of optic nerve head changes in glaucoma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Roenne's nasal step, while indicative of the functional impact of glaucoma, does not represent a direct observation of the optic disc but is rather a manifestation of the disease's effect on the visual field.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture2_LziWdrm.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200208,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50053,
      "choices": [
        {
          "id": 200212,
          "text": "<p><span style=\"font-size:12.0pt;\">2 only</span></p>"
        },
        {
          "id": 200213,
          "text": "<p><span style=\"font-size:12.0pt;\">3 only</span></p>"
        },
        {
          "id": 200214,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 4</span></p>"
        },
        {
          "id": 200215,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true about proto-oncogenes? (INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">KIT has decreased expression in GIST.</span></li><li><span style=\"font-size:12.0pt;\">KRAS mutation is more commonly associated with small-cell lung carcinoma.</span></li><li><span style=\"font-size:12.0pt;\">ERBB2 over-expression is associated with breast carcinomas.</span></li><li><span style=\"font-size:12.0pt;\">PDGFR-β has suppressed expression in colorectal cancers.</span></li></ol>",
      "unique_key": "Q3039580",
      "question_audio": null,
      "question_video": null,
      "map_id": 34139308,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 3 Only</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">ERBB2, also known as HER2, is a proto-oncogene that encodes a receptor tyrosine kinase. Overexpression of HER2 is strongly associated with breast carcinomas, specifically HER2-positive breast cancers. HER2 is a significant marker in breast cancer, as its overexpression or amplification can lead to more aggressive tumor growth and is a target for specific therapies like trastuzumab.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-121654.jpg\" alt=\"\" width=\"1000\" height=\"788\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-121749.jpg\" alt=\"\" width=\"1000\" height=\"662\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. KIT has decreased expression in GIST (Gastrointestinal Stromal Tumors)</strong>: This statement is incorrect. KIT, also known as CD117, is commonly overexpressed in GISTs. The detection of KIT is often used diagnostically to confirm GIST.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2. KRAS mutation is more commonly associated with small-cell lung carcinoma</strong>: This statement is incorrect. KRAS mutations are more commonly associated with non-small cell lung carcinoma (NSCLC), particularly adenocarcinoma of the lung, as well as colorectal and pancreatic cancers. </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4. PDGFR-β has suppressed expression in colorectal cancers</strong>: This statement is incorrect. PDGFR-β (Platelet-derived growth factor receptor beta) is generally overexpressed in gliomas and leukemias, rather than being suppressed in colorectal cancers.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">ERBB2 encodes for HER2, which is involved in Breast carcinoma. ERBB1 encodes for EGFR, which is involved in Adenocarcinoma of lung.</span></li><li><span style=\"font-size:12.0pt;\">Genes involved in GIST are → DOG1 > CD117 (cKIT) > CD34</span></li><li><span style=\"font-size:12.0pt;\">KRAS mutations are cause of Lung, colorectal and pancreatic carcinoma. Gain of function mutation is seen in Adenocarcinoma of lung.</span></li><li><span style=\"font-size:12.0pt;\">PDGFR-β over-expression is seen in Glioma and Leukemia.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-121654.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50054,
      "choices": [
        {
          "id": 200216,
          "text": "<p><span style=\"font-size:12pt;\">8</span></p>"
        },
        {
          "id": 200217,
          "text": "<p><span style=\"font-size:12pt;\">4</span></p>"
        },
        {
          "id": 200218,
          "text": "<p><span style=\"font-size:12pt;\">6</span></p>"
        },
        {
          "id": 200219,
          "text": "<p><span style=\"font-size:12pt;\">10</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">According to new WHO guidelines, what is the minimum number of antenatal visits recommended to have a positive pregnancy outcome?</span><span style=\"font-size:12.0pt;\"> </span>(INICET NOV 2022)</p>",
      "unique_key": "Q2818279",
      "question_audio": null,
      "question_video": null,
      "map_id": 34776940,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) 8</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The World Health Organization (WHO) updated its guidelines in 2016, recommending a minimum of 8 antenatal visits to improve pregnancy outcomes and reduce perinatal mortality. This guideline is structured to ensure comprehensive monitoring and support throughout the pregnancy:</span></p><p> </p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:12pt;\"><strong>1st Trimester:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Contact 1: up to 12 weeks</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>2nd Trimester:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Contact 2: at 20 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 3: at 26 weeks</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>3rd Trimester:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Contact 4: at 30 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 5: at 34 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 6: at 36 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 7: at 38 weeks</span></li><li><span style=\"font-size:12pt;\">Contact 8: at 40 weeks</span></li></ul></li></ol><p> </p><p><span style=\"font-size:12pt;\">These visits are designed to monitor the health of the mother and fetus, provide timely interventions, and offer essential health education.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The WHO recommends a minimum of 8 antenatal visits to improve pregnancy outcomes and reduce perinatal mortality.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: The 2016 WHO model for positive pregnancy experience, MOHFW guidelines for antenatal care, ACOG guidelines for antenatal care (2017).</strong></span></p>",
      "correct_choice_id": 200216,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50055,
      "choices": [
        {
          "id": 200220,
          "text": "<p><span style=\"font-size:12.0pt;\">Wolman’s Disease</span></p>"
        },
        {
          "id": 200221,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaucher’s Disease</span></p>"
        },
        {
          "id": 200222,
          "text": "<p><span style=\"font-size:12.0pt;\">Tangier’s disease</span></p>"
        },
        {
          "id": 200223,
          "text": "<p><span style=\"font-size:12.0pt;\">Tay Sach’s disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young male with a H/o dyslipidemia having ABC-A1 mutation shows the following. See the image and tell the diagnosis. (</span>INICET Nov 2022)</p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#212529;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture2_XX4nmXu.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture2_XX4nmXu.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6988404",
      "question_audio": null,
      "question_video": null,
      "map_id": 34371411,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C)</strong> </span><span style=\"font-size:12.0pt;\"><strong>Tangier’s disease</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Tangier's disease is an inherited disorder characterized by significantly reduced levels of high-density lipoprotein (HDL) in the blood. This condition can lead to the accumulation of cholesterol in various tissues and organs. Individuals with Tangier's disease may have enlarged orange tonsils and an increased risk of cardiovascular disease as shown in the picture.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Wolman's Disease</strong>: Wolman's disease is a severe form of lysosomal acid lipase (LAL) deficiency, a rare genetic disorder. It is characterized by the complete absence of the enzyme lysosomal acid lipase, leading to the buildup of fats in various tissues and organs. Symptoms typically appear in infancy and may include hepatomegaly (enlarged liver), splenomegaly (enlarged spleen), diarrhea/steatorrhea (fatty stools), and vomiting. This condition can be life-threatening.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Gaucher's Disease</strong>: Gaucher's disease is another genetic disorder caused by the deficiency of the enzyme glucocerebrosidase. It results in the accumulation of harmful quantities of glucocerebroside in various organs and tissues, particularly the spleen, liver, and bone marrow. Common symptoms include an enlarged spleen and liver, anemia, low platelet counts, and bone abnormalities. There are different types of Gaucher's disease, and the severity can vary.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tay-Sachs Disease</strong>: Tay-Sachs disease is a genetic disorder that primarily affects the nervous system. It is caused by the absence or deficiency of an enzyme called hexosaminidase A, which leads to the buildup of a fatty substance called GM2 ganglioside in the brain and nerve cells. Symptoms typically appear in early childhood and include developmental regression, loss of motor skills, and a cherry-red spot in the eye. Tay-Sachs disease is progressive and ultimately fatal.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Tangier’s disease / Hypo alpha lipoproteinemia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">ABC-A1 transporters are required for efflux of intracellular free cholesterol and phospholipids across the plasma membrane to combine with apolipoproteins, forming nascent high-density lipoprotein-cholesterol (HDL-C) particles (see fig).</span></p><p> </p><p><span style=\"background-color:white;color:#212529;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture3_bCUeUCB.jpg\" alt=\"\" width=\"400\" height=\"400\"></span></p><ul><li><span style=\"font-size:12.0pt;\">So, in case of defective ABC-A1, HDL cholesterol and PL are not exported, and HDL is not properly formed causing HDL↓ (Hypo alpha-lipoproteinemia).</span></li><li><span style=\"font-size:12.0pt;\">Cholesterol accumulates in reticuloendothelial system causing:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Hepatosplenomegaly</span></li><li><span style=\"font-size:12.0pt;\">Enlarged lymph nodes</span></li><li><span style=\"font-size:12.0pt;\">Large orange/ yellow tonsils (due to fat deposition)</span></li></ul></li><li><span style=\"font-size:12.0pt;\">The characteristic feature of Wolman’s disease is <strong>calcification of adrenals</strong>. It is also known as cholesterol ester storage disease and occurs due to deficiency of enzyme acid lipase</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture3_bCUeUCB.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50056,
      "choices": [
        {
          "id": 200224,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Klima needle</span></span></p>"
        },
        {
          "id": 200225,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Salah’s needle</span></span></p>"
        },
        {
          "id": 200226,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Jamshidi needle</span></span></p>"
        },
        {
          "id": 200227,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Islam needle</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Identify the given bone marrow biopsy instrument. (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/07/screenshot-2024-10-07-183006.jpg\" style=\"height:135px; width:400px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/07/screenshot-2024-10-07-183006.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1966982",
      "question_audio": null,
      "question_video": null,
      "map_id": 34517467,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Klima needle</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The instrument shown is a <strong>Klima needle</strong>, which is used for <strong>bone marrow aspiration and biopsy</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Klima and Salah’s needles</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> are both reusable bone marrow aspiration and biopsy needles made of stainless steel.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The <strong>Klima needle</strong> is distinguished by having a <strong>guard</strong> that screws along the length of the needle, but <strong>it does not have a side screw</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Salah’s needle</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> also has a guard, but it is situated <strong>2 cm from the tip</strong> and has a <strong>side screw</strong> for added stability.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Salah's needle</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">While similar to the Klima needle, Salah’s needle has a distinct <strong>side screw</strong> and guard located closer to the tip, which helps differentiate it from the Klima needle.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/07/screenshot-2024-10-07-183523.jpg\" style=\"height:167px; width:400px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Jamshidi needle</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The <strong>Jamshidi needle</strong> has a <strong>tapered end</strong>, which helps reduce crush artifacts when obtaining bone marrow samples. It is often used for both diagnostic biopsy and aspiration.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/07/screenshot-2024-10-07-183659.jpg\" style=\"height:272px; width:300px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Islam needle</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The <strong>Islam needle</strong> has a <strong>core securing device</strong> at the tip to hold the core of bone during the biopsy procedure.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/07/screenshot-2024-10-07-183815.jpg\" style=\"height:226px; width:300px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The <strong>Klima needle</strong> is used for <strong>bone marrow biopsy</strong> and is characterized by its guard without a side screw. It is crucial to differentiate between biopsy needles like Klima, Salah, Jamshidi, and Islam based on their structural features and specific use in medical procedures.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/07/screenshot-2024-10-07-183523.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50057,
      "choices": [
        {
          "id": 200228,
          "text": "<p><span style=\"font-size:12.0pt;\">Phase contrast microscopy</span></p>"
        },
        {
          "id": 200229,
          "text": "<p><span style=\"font-size:12.0pt;\">Dark field microscopy</span></p>"
        },
        {
          "id": 200230,
          "text": "<p><span style=\"font-size:12.0pt;\">Electron microscopy</span></p>"
        },
        {
          "id": 200231,
          "text": "<p><span style=\"font-size:12.0pt;\">Polarized microscopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the microscopy technique to produce high contrast image of transparent, live bacteria? (INICET MAY 2022)</span></p>",
      "unique_key": "Q6329926",
      "question_audio": null,
      "question_video": null,
      "map_id": 34787929,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Phase contrast microscopy</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Phase-contrast microscopy (PCM) is an optical microscopy technique that <strong>converts phase shifts in light passing through a transparent specimen to brightness changes in the image</strong>. Phase shifts themselves are invisible, but become visible when shown as brightness variations.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Contrast is improved by using the difference in thickness or refractive index of structures within and around the cell. Difference in intensity of light is created as rays pass through varied refractive indices and produces contrast thus <strong>making the structures within the cells and its surroundings clearly visible.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Dark-field microscopy </strong>(also called dark-ground microscopy) describes microscopy methods, in <u>both light and electron microscopy</u>, which <strong>exclude the unscattered beam from the image</strong>. As a result, the field around the specimen (i.e., where there is no specimen to scatter the beam) is generally dark.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. </strong>The <strong>electron microscope</strong> uses a beam of electrons and their wave-like characteristics to magnify an object's image, unlike the optical microscope that uses visible light to magnify images.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Polarized microscopy</strong> is used to visualize the intracellular structures using differences in birefringence.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Phase contrast microscopy is the technique used to produce high contrast images of transparent, live bacteria by converting phase shifts into brightness changes.</span></p>",
      "correct_choice_id": 200228,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50058,
      "choices": [
        {
          "id": 200232,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trichodysplasia spinulosa</span></span></span></p>"
        },
        {
          "id": 200233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Condyloma accuminata</span></span></span></p>"
        },
        {
          "id": 200234,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Molluscum contagiosum</span></span></span></p>"
        },
        {
          "id": 200235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Donovanosis</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A woman presents with lesions on the inner thighs and peri-anal region. They are nodular, 4-6 mm in size, and appear pale. The histopathological image shows multiple intracytoplasmic inclusion bodies consistent with Henderson-Patterson bodies. The diagnosis is: (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture14.jpg\" style=\"height:265px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture14.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9742995",
      "question_audio": null,
      "question_video": null,
      "map_id": 34168424,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Molluscum contagiosum</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical history along with histological image showing <strong>intracytoplasmic inclusion bodies suggests a diagnosis of Molluscum contagiosum.</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Molluscum contagiosum <strong>is a poxvirus infection</strong> of the skin and the mucous membranes. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There are four types of molluscum contagiosum viruses (MCVs), MCV-1 to -4, with <strong>MCV-1 being the most prevalent and MCV-2 being most often sexually transmitted. </strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The infections are common in young children between 2 and 12 years of age and are transmitted through direct contact or shared articles (e.g., towels). </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Molluscum may affect any area of the skin but is most common on the trunk, arms, and legs. In adults, molluscum infections are typically sexually transmitted and affect the genitals, lower abdomen, buttocks, and inner thighs. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The average incubation period is 6 weeks. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diagnosis is based on the characteristic clinical appearance of pearly, <strong>domeshaped papules with a dimpled center</strong>. The papules measure 1 to 5 mm in diameter, and their central waxy core contains cells with intracytoplasmic viral inclusions called as <strong>Molluscum bodies or Henderson Patterson bodies.</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture15.jpg\" style=\"height:122px; width:600px\" /></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Trichodysplasia spinulosa</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a rare viral infection associated with immunosuppression and does not typically present with the described clinical or histopathological features.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Condyloma accuminata</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Caused by human papillomavirus (HPV), this condition presents as warty growths, typically on the genital and perianal regions, but it does not produce Henderson-Patterson bodies.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Donovanosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Also known as granuloma inguinale, this sexually transmitted infection caused by <em>Klebsiella granulomatis</em> presents with ulcerative lesions rather than nodular papules and does not show the characteristic Henderson-Patterson bodies.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Molluscum contagiosum</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a viral skin infection that presents with dome-shaped papules containing Henderson-Patterson bodies, which are diagnostic of this condition.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture15.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50059,
      "choices": [
        {
          "id": 200236,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MRI showing < 1/3rd of MCA territorial infarct</span></span></span></p>"
        },
        {
          "id": 200237,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood pressure of > 185/110 mmHg</span></span></span></p>"
        },
        {
          "id": 200238,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ischemia < 2 hours</span></span></span></p>"
        },
        {
          "id": 200239,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Onset of symptoms < 4 hours</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis can be considered in all of these conditions, except:</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q7249518",
      "question_audio": null,
      "question_video": null,
      "map_id": 34935075,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Blood pressure of > 185/110 mmHg</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood pressure of > 185/110 mmHg: This is a contraindication for thrombolysis. Elevated blood pressure increases the risk of hemorrhagic complications during thrombolysis. Therefore, blood pressure must be controlled to below 185/110 mmHg before initiating thrombolytic therapy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis is a treatment used to dissolve blood clots in certain types of stroke patients. It is most effective when administered within a specific time window from the onset of symptoms and under certain conditions to ensure patient safety and efficacy of the treatment.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. MRI showing < 1/3rd of MCA territorial infarct:</span></strong><span style=\"font-size:12.0pt\"> This indicates that the infarct size is within a range that is generally considered safe for thrombolysis. More extensive infarcts (> 1/3rd of the middle cerebral artery territory) are a contraindication due to the higher risk of hemorrhagic transformation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><span style=\"font-size:12.0pt\"> <strong>C. Ischemia < 2 hours and D. Onset of symptoms < 4 hours</strong>: Both of these options fall within the critical time window for thrombolysis, which is generally considered up to 4.5 hours from symptom onset. Treatment within this time frame can significantly improve outcomes in stroke patients.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis is contraindicated in patients with blood pressure higher than 185/110 mmHg at the time of treatment.</span></span></span></p>",
      "correct_choice_id": 200237,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50060,
      "choices": [
        {
          "id": 200240,
          "text": "<p><span style=\"font-size:12.0pt;\">Use of cochlear implant</span></p>"
        },
        {
          "id": 200241,
          "text": "<p><span style=\"font-size:12.0pt;\">LMP</span></p>"
        },
        {
          "id": 200242,
          "text": "<p><span style=\"font-size:12.0pt;\">History of fall</span></p>"
        },
        {
          "id": 200243,
          "text": "<p><span style=\"font-size:12.0pt;\">History of hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman with a severe headache is scheduled to undergo a CT scan. During history taking, which of the following will you definitely ask for before the commencement of the scan? (INICET MAY 2022)</span></p>",
      "unique_key": "Q8870764",
      "question_audio": null,
      "question_video": null,
      "map_id": 34756574,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) LMP</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The most important information to obtain during a history in a 28-year-old woman of reproductive age who has been referred for a CT scan is the last menstrual period (LMP). Since it is imperative to rule out pregnancy before taking a CT scan, last menstrual period is the most appropriate answer to this question.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Use of cochlear implant: </strong>While important in MRI to prevent damage to the implant from the magnetic field, it is not typically a concern in CT scans which use X-rays.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. History of fall: </strong>Although relevant to the medical history, it is not critical specifically before a CT scan unless symptoms suggest complications that a CT scan could exacerbate.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. History of hypertension: </strong>Important in overall patient assessment but does not directly influence the decision to perform a CT scan as critically as confirming pregnancy status does.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Inquiring about the Last Menstrual Period (LMP) is essential for any woman of childbearing age before undergoing diagnostic procedures involving radiation, such as a CT scan, to avoid potential harm to an unborn baby.</span></p>",
      "correct_choice_id": 200241,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50061,
      "choices": [
        {
          "id": 200244,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 3</span></span></span></p>"
        },
        {
          "id": 200245,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
        },
        {
          "id": 200246,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2, 3</span></span></span></p>"
        },
        {
          "id": 200247,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2, 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following statements are true regarding sirtuins? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases insulin sensitivity and thus glucose metabolism.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Promotes genes that increase longevity.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are of 7 types.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are one of the types of histone deacetylases. </span></span></span></li>\r\n</ol>",
      "unique_key": "Q5051200",
      "question_audio": null,
      "question_video": null,
      "map_id": 34195454,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) 1, 2, 3, 4</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sirtuins</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> are a family of proteins that have been widely studied for their role in regulating various cellular processes, including aging, metabolism, and stress responses. Here's a detailed breakdown of each statement:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases insulin sensitivity and thus glucose metabolism:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sirtuins, particularly SIRT1, have been shown to enhance insulin sensitivity and promote glucose metabolism, which is crucial for maintaining energy homeostasis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Promotes genes that increase longevity:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sirtuins are known to regulate gene expression in ways that promote longevity. They are involved in the deacetylation of proteins that contribute to cell survival, repair, and metabolism, which are associated with extended lifespan in various organisms.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are of 7 types:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> There are seven known sirtuins in humans, designated SIRT1 through SIRT7, each with specific functions in different cellular compartments.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are one of the types of histone deacetylases:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sirtuins function as NAD+-dependent deacetylases, a class of enzymes that remove acetyl groups from histone and non-histone proteins, influencing gene expression and protein activity.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sirtuins </span></strong><span style=\"font-size:12.0pt\">are a family of seven histone deacetylases involved in increasing insulin sensitivity, glucose metabolism, promoting genes associated with longevity, and playing a significant role in various cellular processes.</span></span></span></p>",
      "correct_choice_id": 200245,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50062,
      "choices": [
        {
          "id": 200248,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-4, B-1, C-3, D-2</span></span></p>"
        },
        {
          "id": 200249,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-4, B-1, C-2, D-3</span></span></p>"
        },
        {
          "id": 200250,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-4, B-2, C-3, D-1</span></span></p>"
        },
        {
          "id": 200251,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-2, B-1, C-3, D-4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following: </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h4><span style=\"font-size:12pt\"><span style=\"font-family:\"Calibri Light\",sans-serif\"><em><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Column A:</span></em></span></span></h4>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">A. Malaria<br />\r\nB. Tuberculosis<br />\r\nC. Leprosy<br />\r\nD. Actinomycosis</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h4><span style=\"font-size:12pt\"><span style=\"font-family:\"Calibri Light\",sans-serif\"><em><span style=\"font-family:\"Calibri\",sans-serif\">Column B:</span></em></span></span></h4>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1. ZN stain</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2. Fite-Faraco stain</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">3. Gram stain</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">4. Giemsa stain</span></span></span></p>",
      "unique_key": "Q9934908",
      "question_audio": null,
      "question_video": null,
      "map_id": 34659634,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans.</span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\"> B) A-4, B-1, C-2, D-3</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">The correct pairs are as follows:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. Malaria</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> – <strong><span style=\"font-family:\"Calibri\",sans-serif\">Giemsa stain (4)</span></strong>: Giemsa stain is the gold standard for <strong><span style=\"font-family:\"Calibri\",sans-serif\">malaria diagnosis</span></strong>. It helps visualize <strong><span style=\"font-family:\"Calibri\",sans-serif\">Maurer's clefts</span></strong> (seen in <em><span style=\"font-family:\"Calibri\",sans-serif\">Plasmodium falciparum</span></em>) and <strong><span style=\"font-family:\"Calibri\",sans-serif\">Schüffner's dots</span></strong> (seen in <em><span style=\"font-family:\"Calibri\",sans-serif\">Plasmodium vivax</span></em> and <em><span style=\"font-family:\"Calibri\",sans-serif\">Plasmodium ovale</span></em>).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Tuberculosis</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> – <strong><span style=\"font-family:\"Calibri\",sans-serif\">ZN stain (1)</span></strong>: <strong><span style=\"font-family:\"Calibri\",sans-serif\">Ziehl-Neelsen (ZN) stain</span></strong> is used to detect <strong><span style=\"font-family:\"Calibri\",sans-serif\">Mycobacterium tuberculosis</span></strong>, as it helps identify <strong><span style=\"font-family:\"Calibri\",sans-serif\">acid-fast bacilli</span></strong> in sputum samples.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Leprosy</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> – <strong><span style=\"font-family:\"Calibri\",sans-serif\">Fite-Faraco stain (2)</span></strong>: The <strong><span style=\"font-family:\"Calibri\",sans-serif\">Fite-Faraco stain</span></strong> is used to visualize <strong><span style=\"font-family:\"Calibri\",sans-serif\">Mycobacterium leprae</span></strong>, which causes <strong><span style=\"font-family:\"Calibri\",sans-serif\">leprosy</span></strong>. This stain highlights the acid-fastness of the bacillus with better sensitivity than the ZN stain for this organism.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Actinomycosis</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> – <strong><span style=\"font-family:\"Calibri\",sans-serif\">Gram stain (3)</span></strong>: <strong><span style=\"font-family:\"Calibri\",sans-serif\">Gram stain</span></strong> is typically used to identify <strong><span style=\"font-family:\"Calibri\",sans-serif\">Actinomyces</span></strong>, which are <strong><span style=\"font-family:\"Calibri\",sans-serif\">Gram-positive filamentous bacteria</span></strong> involved in <strong><span style=\"font-family:\"Calibri\",sans-serif\">actinomycosis</span></strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Each pathogen has a preferred staining method for its detection:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Giemsa stain</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> for <strong><span style=\"font-family:\"Calibri\",sans-serif\">malaria</span></strong> (Plasmodium species).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ziehl-Neelsen stain</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> for <strong><span style=\"font-family:\"Calibri\",sans-serif\">tuberculosis</span></strong> (Mycobacterium tuberculosis).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Fite-Faraco stain</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> for <strong><span style=\"font-family:\"Calibri\",sans-serif\">leprosy</span></strong> (Mycobacterium leprae).</span></span></span></li>\r\n\t<li><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Gram stain</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> for <strong><span style=\"font-family:\"Calibri\",sans-serif\">actinomycosis</span></strong> (Actinomyces species).</span></span></li>\r\n</ul>",
      "correct_choice_id": 200249,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50063,
      "choices": [
        {
          "id": 200252,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcified valve</span></p>"
        },
        {
          "id": 200253,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic regurgitation</span></p>"
        },
        {
          "id": 200254,
          "text": "<p><span style=\"font-size:12.0pt;\">First degree heart block</span></p>"
        },
        {
          "id": 200255,
          "text": "<p><span style=\"font-size:12.0pt;\">Mild mitral stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The absence of loud S1 in mitral stenosis would indicate all of the following, except:</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q7979585",
      "question_audio": null,
      "question_video": null,
      "map_id": 34639315,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong> </span><span style=\"font-size:12.0pt;\"><strong>D) Mild mitral stenosis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The first heart sound (S1) is produced by the closure of the mitral and tricuspid valves at the beginning of systole. In mitral stenosis, the loudness of S1 can vary depending on several factors. A loud S1 is typically associated with the early stages of mitral stenosis when the valve leaflets are still relatively mobile. However, in certain conditions, S1 can become softer.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In mild mitral stenosis without significant calcification usually results in a loud S1. This is because the mitral valve leaflets are still relatively mobile and can close forcefully. Therefore, mild mitral stenosis is the correct exception in this context, as it does not typically cause a soft S1.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Calcified valve:</strong> When the mitral valve becomes calcified, it loses its mobility. This results in a softer S1 because the valve leaflets are not able to close rapidly or forcefully.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Aortic regurgitation:</strong> Aortic regurgitation can lead to an increased preload in the left ventricle, which can in turn affect the closure of the mitral valve, making S1 softer. Additionally, mitral regurgitation, which often coexists with mitral stenosis, can also soften S1.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. First degree heart block:</strong> In first degree AV block, there is a prolonged PR interval. This delayed conduction can lead to a less forceful closure of the mitral valve, resulting in a softer S1.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In mitral stenosis, a loud S1 is typically seen in the early stages with mobile valves, while a soft S1 can indicate valve calcification, aortic regurgitation, or first degree heart block. Mild mitral stenosis without calcification usually results in a loud S1</span></p>",
      "correct_choice_id": 200255,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50064,
      "choices": [
        {
          "id": 200256,
          "text": "<p><span style=\"font-size:12pt;\">Vulval dystrophy</span></p>"
        },
        {
          "id": 200257,
          "text": "<p><span style=\"font-size:12pt;\">Vulval hamartoma</span></p>"
        },
        {
          "id": 200258,
          "text": "<p><span style=\"font-size:12pt;\">Smoking</span></p>"
        },
        {
          "id": 200259,
          "text": "<p><span style=\"font-size:12pt;\">Vulval warts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">All of the following are risk factors of vulval cancer except? </span>(INICET NOV 2022)</p>",
      "unique_key": "Q2996792",
      "question_audio": null,
      "question_video": null,
      "map_id": 34038313,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Vulval hamartoma</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Vulval cancer has several known risk factors, which include:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Chronic vulval irritation</strong>: Persistent irritation and inflammation can contribute to the development of vulval cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>Immunosuppressive conditions</strong>: Conditions such as pregnancy and HIV infection can compromise the immune system, increasing the risk of vulval cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>HPV (Human Papillomavirus)</strong>: Infection with HPV, particularly strains 16 and 18, is a significant risk factor.</span></li><li><span style=\"font-size:12pt;\"><strong>Smoking</strong>: Smoking is a known risk factor for various cancers, including vulval cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>Condyloma (anogenital warts)</strong>: Caused by HPV, these warts can lead to changes in vulval cells that may progress to cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>Sexually transmitted diseases (STDs)</strong>: History of STDs can increase the risk due to the association with HPV and chronic inflammation.</span></li><li><span style=\"font-size:12pt;\"><strong>Vulvar dystrophies</strong>: Conditions like lichen sclerosus can predispose individuals to vulval cancer.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Vulval hamartoma</strong> is not a risk factor for vulval cancer. Hamartomas are benign, disorganized clusters of tissue that do not typically transform into malignant tumors.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Vulval dystrophy</strong>: Vulval dystrophies, such as lichen sclerosus, are risk factors for vulval cancer due to chronic irritation and inflammation.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Smoking</strong>: Smoking is a well-documented risk factor for many cancers, including vulval cancer.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Vulval warts</strong>: Vulval warts, often caused by HPV, can lead to cellular changes that increase the risk of vulval cancer.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Vulval hamartomas are not a risk factor for vulval cancer, while chronic irritation, immunosuppressive conditions, HPV infection, smoking, anogenital warts, STDs, and vulvar dystrophies are known risk factors.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg 680, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 334</strong></span></p>",
      "correct_choice_id": 200257,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50065,
      "choices": [
        {
          "id": 200260,
          "text": "<p><span style=\"font-size:12.0pt;\">B, A, C, D</span></p>"
        },
        {
          "id": 200261,
          "text": "<p><span style=\"font-size:12.0pt;\">D, C, B, A</span></p>"
        },
        {
          "id": 200262,
          "text": "<p><span style=\"font-size:12.0pt;\">C, D, A, B</span></p>"
        },
        {
          "id": 200263,
          "text": "<p><span style=\"font-size:12.0pt;\">A, B, C, D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Arrange the following steps of ventricular action potential in the correct order: (</span>INICET Nov 2022)</p><p> </p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Opening of voltage-gated calcium channels</span></li><li><span style=\"font-size:12.0pt;\">Repolarizing K+ currents</span></li><li><span style=\"font-size:12.0pt;\">Opening of voltage-gated sodium channels</span></li><li><span style=\"font-size:12.0pt;\">Transient outward flow of potassium</span></li></ol>",
      "unique_key": "Q9716498",
      "question_audio": null,
      "question_video": null,
      "map_id": 34080373,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>C) C, D, A, B</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The ventricular action potential is characterized by a sequence of changes in membrane potential and ionic currents. The correct sequence is as follows:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>C. Opening of voltage-gated sodium channels:</strong> This is the initial depolarization phase (Phase 0). When the membrane potential reaches the threshold, voltage-gated sodium channels open, leading to a rapid influx of Na+ ions and a sharp rise in membrane potential.</span></li><li><span style=\"font-size:12.0pt;\"><strong>D. Transient outward flow of potassium:</strong> This corresponds to Phase 1. Shortly after the peak of the action potential, transient outward K+ channels open, causing a brief efflux of K+ ions which results in a slight repolarization.</span></li><li><span style=\"font-size:12.0pt;\"><strong>A. Opening of voltage-gated calcium channels:</strong> This is Phase 2, the plateau phase. Voltage-gated L-type calcium channels open, allowing Ca2+ to enter the cell. The influx of Ca2+ is balanced by the efflux of K+ through delayed rectifier K+ channels, maintaining a plateau in the membrane potential.</span></li><li><span style=\"font-size:12.0pt;\"><strong>B. Repolarizing K+ currents:</strong> This is Phase 3. The Ca2+ channels close, but the delayed rectifier K+ channels remain open, leading to a net efflux of K+ and returning the membrane potential to its resting value.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/physiology-5_1-5.jpg\" alt=\"\" width=\"600\" height=\"467\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The correct sequence for ventricular action potential is as follows:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">C. Opening of voltage-gated sodium channels</span></p><p><span style=\"font-size:12.0pt;\">D. Transient outward flow of potassium</span></p><p><span style=\"font-size:12.0pt;\">A. Opening of voltage-gated calcium channels</span></p><p><span style=\"font-size:12.0pt;\">B. Repolarizing K+ currents</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/physiology-5_1-5.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50066,
      "choices": [
        {
          "id": 200264,
          "text": "<p><span style=\"font-size:12.0pt;\">Voluminous and ballooned out lungs</span></p>"
        },
        {
          "id": 200265,
          "text": "<p><span style=\"font-size:12.0pt;\">High concentration of arsenic from shaft of hair</span></p>"
        },
        {
          "id": 200266,
          "text": "<p><span style=\"font-size:12.0pt;\">Paltauf's hemorrhage in sub pleura</span></p>"
        },
        {
          "id": 200267,
          "text": "<p><span style=\"font-size:12.0pt;\">Cadaveric spasm with mud in closed fist</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The dead body of a 4-year-old child who was playing around the riverside and accidentally drowned in the river is recovered. There is frothing seen from his mouth and nose. Which of the below postmortem findings is not seen in a case of drowning? (INICET NOV 2022)</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-25_4Q29tq1.jpg\" alt=\"\" width=\"300\" height=\"227\"></span></p><p style=\"text-align:justify;\"> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-25_4Q29tq1.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4789419",
      "question_audio": null,
      "question_video": null,
      "map_id": 34021620,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. High concentration of arsenic from shaft of hair</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image shows frothing from nostrils which is likely to be due to antemortem drowning.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">This finding is unrelated to drowning and would suggest chronic arsenic poisoning rather than an acute drowning incident.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Postmortem changes of drowning:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Bloody froth in the airway</span></li><li><span style=\"font-size:12.0pt;\">Water in the stomach and small intestine</span></li><li><span style=\"font-size:12.0pt;\">Water in middle ear</span></li><li><span style=\"font-size:12.0pt;\">Cerebral edema</span></li><li><span style=\"font-size:12.0pt;\">Bloated and cyanosed face</span></li><li><span style=\"font-size:12.0pt;\">Petrous or mastoid hemorrhage.</span></li><li><span style=\"font-size:12.0pt;\">Voluminous / ballooned out lungs</span></li><li><span style=\"font-size:12.0pt;\">Suffused conjunctive, dilated pupils</span></li><li><span style=\"font-size:12.0pt;\"><strong>\"Washerwoman\"</strong> changes of the hands (shriveling of the skin) develop when submerged in water for several hours</span></li><li><span style=\"font-size:12.0pt;\">Cadaveric spasm with mud in closed fist </span></li><li><span style=\"font-size:12.0pt;\"><strong>Cutis anserina</strong> / goose skin- The contraction of the erector pilorum muscles causes puckering and a grainy appearance of the skin.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cadaveric spasm</strong> - Gravel, weed, soil, grass, etc. is firmly held in the clenched hands due to cadaveric spasm. This is a vital sign of antemortem drowning.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Rigor mortis -</strong> This appears early in cases of a violent antemortem struggle.</span></li><li><span style=\"font-size:12.0pt;\">Diatom test</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Gettler test</strong> can be done to estimate the chloride content in the right and left sides of the heart to differentiate between freshwater and saltwater drowning.</span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Voluminous and ballooned out lungs:</strong> Seen in drowning due to the inhalation of water.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Paltauf's hemorrhage in sub pleura:</strong> Hemorrhages found beneath the pleura, associated with drowning.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cadaveric spasm with mud in closed fist:</strong> Indicates a struggle and is a sign of antemortem drowning.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In cases of drowning, typical findings include frothing from the mouth and nose, voluminous lungs, and cadaveric spasm with debris. High arsenic concentration in hair shafts is not associated with drowning.</span></p>",
      "correct_choice_id": 200265,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50067,
      "choices": [
        {
          "id": 200268,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">3 and 4 </span></span></span></p>"
        },
        {
          "id": 200269,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 2 and 3 </span></span></span></p>"
        },
        {
          "id": 200270,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2, 3 and 4 </span></span></span></p>"
        },
        {
          "id": 200271,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Only 4 </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Consider the causes of alopecia. Which among the following cause(s) non-scarring alopecia? (INICET NOV 2022) </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Alopecia areata</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Telogen effluvium</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Androgenic alopecia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Frontal fibrosing alopecia</span></span></span></li>\r\n</ol>",
      "unique_key": "Q4366343",
      "question_audio": null,
      "question_video": null,
      "map_id": 34308525,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) 1, 2 and 3</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Non-scarring alopecia is caused by </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">androgenic alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">alopecia areata</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">telogen effluvium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (1, 2, and 3). </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Frontal fibrosing alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is a type of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">primary cicatricial (scarring) alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Alopecia areata</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is a chronic inflammatory disease causing </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">non-scarring hair loss</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. It is a </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">T-cell-mediated inflammatory disease</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> associated with several autoimmune conditions, including </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">thyroiditis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">lupus erythematosus</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">vitiligo</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">psoriasis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. It mainly affects the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">scalp</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, but may also involve the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">beard, eyebrows, and eyelashes</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. In some cases, it can lead to total hair loss on the scalp (</span><strong><span style=\"font-family:\"Calibri\",sans-serif\">alopecia totalis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">) or the entire body (</span><strong><span style=\"font-family:\"Calibri\",sans-serif\">alopecia universalis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Telogen effluvium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is a type of non-scarring alopecia marked by </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">diffuse shedding</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> of normal hair due to the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">premature termination</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> of the anagen phase of the hair cycle. It can be either acute or chronic:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Acute telogen effluvium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> typically occurs 2–3 months after stressful events such as high fever, surgery, or postpartum hormonal changes (</span><strong><span style=\"font-family:\"Calibri\",sans-serif\">telogen gravidarum</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">). This condition often resolves spontaneously.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Chronic telogen effluvium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> persists for more than six months and is often associated with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">thyroid disorders</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">iron-deficiency anemia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, or </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">malnutrition</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Androgenetic alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is a non-scarring alopecia characterized by a reduction in hair fiber production and follicle miniaturization. It is related to </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">dihydrotestosterone (DHT)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, an androgenic metabolite, and has two forms:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Male-pattern hair loss</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> typically causes frontal hairline recession and vertex thinning.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Female-pattern hair loss</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> results in mid-frontal scalp thinning with minimal involvement of the temporal region.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Frontal fibrosing alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, on the other hand, is a type of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">scarring (cicatricial) alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, leading to permanent hair loss due to follicular destruction.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. 3 and 4: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">While </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">androgenic alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (option 3) causes non-scarring alopecia, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">frontal fibrosing alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (option 4) is a scarring form of alopecia, making this option incorrect.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. 2, 3, and 4: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Although </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">telogen effluvium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (option 2) and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">androgenic alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (option 3) are types of non-scarring alopecia, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">frontal fibrosing alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (option 4) is scarring, which makes this option incorrect.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Only 4: Frontal fibrosing alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is a scarring type of alopecia, so it cannot be classified as non-scarring, making this option incorrect.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Non-scarring alopecia includes </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">androgenic alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">alopecia areata</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">telogen effluvium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. These conditions result in hair loss that does not involve permanent destruction of the hair follicles, distinguishing them from scarring types of alopecia like </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">frontal fibrosing alopecia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>",
      "correct_choice_id": 200269,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50068,
      "choices": [
        {
          "id": 200272,
          "text": "<p><span style=\"font-size:12.0pt;\">Common peroneal nerve</span></p>"
        },
        {
          "id": 200273,
          "text": "<p><span style=\"font-size:12.0pt;\">Sural nerve</span></p>"
        },
        {
          "id": 200274,
          "text": "<p><span style=\"font-size:12.0pt;\">Tibial nerve</span></p>"
        },
        {
          "id": 200275,
          "text": "<p><span style=\"font-size:12.0pt;\">Femoral nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the nerve passing around the marked structure: (INICET MAY 2022</span>)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture7_JnVEIDn.jpg\" alt=\"\" width=\"100\" height=\"347\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture7_JnVEIDn.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4741224",
      "question_audio": null,
      "question_video": null,
      "map_id": 34478482,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Common peroneal nerve</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The structure marked in the image is the fibula's neck.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The common peroneal nerve supplies motor fibers to the muscles of the lateral compartment of the leg, including the fibularis longus and fibularis brevis muscles, which evert the foot and plantarflex the ankle joint. It also provides sensory fibers to the skin over the lateral aspect of the leg and dorsum of the foot.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Injuries to the common peroneal nerve can occur due to trauma or compression, and can result in weakness or paralysis of the muscles it innervates, as well as sensory loss over the affected area. Common peroneal nerve injuries can be treated with conservative measures such as physiotherapy or surgery in severe cases.</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/09/ia-5.jpg\" alt=\"\" width=\"600\" height=\"328\"></span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-191113.jpg\" alt=\"\" width=\"1000\" height=\"419\"></span></p><p style=\"text-align:justify;\"> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sural nerve:</strong> The sural nerve is a sensory nerve in the calf region. It is formed by branches from both the common peroneal and tibial nerves. The sural nerve provides sensation to the posterolateral aspect of the lower leg and the lateral side of the foot. It runs more distally in the leg and is not closely associated with the neck of the fibula.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tibial nerve:</strong> The tibial nerve is another major branch of the sciatic nerve. After the division of the sciatic nerve, the tibial nerve continues its course in the posterior compartment of the leg, supplying muscles there and then continuing into the foot. It is primarily responsible for plantar flexion of the foot and toe flexion. The tibial nerve does not have a close relation with the neck of the fibula as it runs more medially in the leg.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Femoral nerve:</strong> The femoral nerve originates from the lumbar plexus and supplies the anterior compartment of the thigh. It is responsible for hip flexion and knee extension. This nerve is located in the anterior aspect of the thigh, far away from the neck of the fibula, and has no direct relation with it.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The Common peroneal nerve (also known as common fibular nerve)</strong>, a significant branch of the sciatic nerve, follows a course along the thigh's posterior compartment and wraps around the fibula's neck, making it susceptible to injury. After encircling the fibula, it splits into the superficial and deep peroneal nerves, which innervate the leg's lateral and anterior compartments and contribute sensory functions to parts of the foot.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/09/ia-5.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200272,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50069,
      "choices": [
        {
          "id": 200276,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rocky mountain spotted fever</span></span></span></p>"
        },
        {
          "id": 200277,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malaria</span></span></span></p>"
        },
        {
          "id": 200278,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">COVID-19</span></span></span></p>"
        },
        {
          "id": 200279,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scrub typhus</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which disease causes the lesion shown in the image below?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">INICET NOV 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/picture5_y6cRShi.jpg\" style=\"height:216px; width:300px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/picture5_y6cRShi.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1622949",
      "question_audio": null,
      "question_video": null,
      "map_id": 34740291,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Scrub typhus</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The lesion shown in the image is eschar. It is seen in scrub typhus.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scrub typhus</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is an infectious disease caused by the rickettsial bacterium Orientia tsutsugamushi.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is transmitted to humans by the bite of the <strong>larva of trombiculid mites</strong>. Later it causes disseminated vasculitis and perivascular inflammation ultimately leading to significant vascular leakage leading to end-organ injury.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical features usually arise after an incubation period of 6-21 days and manifest as fever, headache, myalgia, and gastrointestinal symptoms. An eschar which usually begins as a primary papular lesion later crusts to form a <strong>black ulcer with central necrosis</strong> is a distinct feature of scrub typhus although its presence varies in different regions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A classic case of </span></span></span><strong><span dir=\"ltr\" lang=\"EN-US\"><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">Rocky mountain spotted fever (RMSF)</span><span style=\"font-style:normal\"> </span></span></strong><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">involves a rash that appears 2-4 days after the onset of fever as small, flat, pink, macules on the wrists, forearms, and ankles and spreads to include the trunk and sometimes the <strong>palms of hands and soles of feet</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option B:</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Malaria</strong> is a protozoal disease caused by Plasmodium species characterized by periodic bouts of fever with chills and rigors, followed by anemia, splenomegaly, and hepatomegaly.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D: COVID-19</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a highly contagious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). </span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scrub typhus, caused by Orientia tsutsugamushi, is characterized by an eschar at the site of the mite bite, along with fever and systemic symptoms.</span></span></span></p>",
      "correct_choice_id": 200279,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50070,
      "choices": [
        {
          "id": 200280,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">E1, E2, E5</span></span></span></p>"
        },
        {
          "id": 200281,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">E6, E7</span></span></span></p>"
        },
        {
          "id": 200282,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">L1, L2</span></span></span></p>"
        },
        {
          "id": 200283,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E1, E2</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The image below shows the life cycle of a virus. Which of the proteins of the virus act as oncogenes? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">INICET NOV 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-83.jpg\" style=\"height:459px; width:400px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-83.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1214566",
      "question_audio": null,
      "question_video": null,
      "map_id": 34024835,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) E6, E7</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The image shows the life cycle of the human papilloma virus, and the E6 and E7 proteins act as oncogenes</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-84.jpg\" style=\"height:556px; width:728px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HPV oncogenes <strong>E6 and E7 deregulate host cell cycle by binding and inactivating tumor suppressor genes p53 and pRb</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Binding of E6 gene to p53 causes degradation of p53. </span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E7 gene binds to pRb and disrupts the complex between pRb and E2F leading to uncontrolled proliferation. HPV, human papilloma virus.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-85.jpg\" style=\"height:486px; width:783px\" /></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E6 and E7 proteins of HPV are the primary oncogenes responsible for the virus's ability to cause cancer. They do this by inactivating key tumor suppressor proteins, p53 and pRb, leading to uncontrolled cell growth and proliferation.</span></span></span></li>\r\n</ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-84.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50071,
      "choices": [
        {
          "id": 200284,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In children, equally among males and females.</span></span></p>"
        },
        {
          "id": 200285,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In adults, equally among males and females.</span></span></p>"
        },
        {
          "id": 200286,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In adults, occurs more in males than in females.</span></span></p>"
        },
        {
          "id": 200287,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In children, occurs more in females than in males.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 14-year-old girl presented with sudden-onset blindness for the past 4 hours. However, on history taking, it is noted that she is not concerned about it. However, she is concerned that her mother passed away recently and that she should have spent more time with her. Physical examination findings are normal. Which of the following is true about the condition? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q9661278",
      "question_audio": null,
      "question_video": null,
      "map_id": 34709553,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D) In children, occurs more in females than in males.</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The clinical presentation described is suggestive of <strong>conversion disorder</strong> (also called functional neurological symptom disorder). This condition is characterized by neurological symptoms that are not consistent with known neurological or medical conditions. In this case, the sudden-onset blindness with normal physical examination results and a lack of concern about the blindness (referred to as <strong>la belle indifférence</strong>) is a classic presentation of conversion disorder.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Conversion disorder frequently follows psychosocial stressors, as seen in this girl who recently experienced the death of her mother. These symptoms are thought to represent unconscious psychological conflict manifesting in physical symptoms. There is no underlying physical cause for the symptoms, and the symptoms are not deliberately produced.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct answer, <strong>D. In children, occurs more in females than in males</strong>, is accurate because conversion disorder is more common in females, particularly during childhood and adolescence. This gender disparity is especially evident in children and young adults, where females are disproportionately affected.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. In children, equally among males and females</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is incorrect. Conversion disorder is not equally distributed among males and females. It is significantly more common in females, especially during childhood and adolescence.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. In adults, equally among males and females</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is incorrect. Conversion disorder is more common in females in both children and adults. The disorder does not show equal prevalence between the sexes at any age.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. In adults, occurs more in males than in females</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is incorrect. Conversion disorder is more prevalent in females across all age groups, including adults. There is no evidence to suggest it occurs more in males at any stage.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Conversion disorder</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> often follows psychological stress and is characterized by sudden neurological symptoms without a medical explanation. It commonly presents with motor or sensory deficits and is more prevalent in <strong>females, especially in children and adolescents</strong>.</span></span></p>",
      "correct_choice_id": 200287,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50072,
      "choices": [
        {
          "id": 200288,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">ER +, PR +, HER2 – </span></span></span></p>"
        },
        {
          "id": 200289,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">ER +, PR -, HER2 – </span></span></span></p>"
        },
        {
          "id": 200290,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">ER -, PR -, HER2 – </span></span></span></p>"
        },
        {
          "id": 200291,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">ER -, PR -, HER2 +</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">What finding on immunohistochemical staining is consistent with basal-like breast cancer in a 59-year-old female presenting with a breast lump?</span></span></span></p>",
      "unique_key": "Q2013749",
      "question_audio": null,
      "question_video": null,
      "map_id": 34136548,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) ER-, PR-, HER2- </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">ER -, PR -, HER2 –: Basal-like breast cancer is characterized by being negative for estrogen receptor (ER -), progesterone receptor (PR -), and HER2 (HER2 –). This profile is consistent with basal-like breast cancer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> <strong>A. ER +, PR +, HER2 –:</strong> This profile indicates that the tumor is estrogen receptor-positive (ER +) and progesterone receptor-positive (PR +) but HER2-negative (HER2 –). This profile is not consistent with basal-like breast cancer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. ER +, PR -, HER2 –: This profile suggests that the tumor is estrogen receptor-positive (ER +) but progesterone receptor-negative (PR -) and HER2-negative (HER2 –). This is not consistent with basal-like breast cancer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> <strong>D</strong>. <strong>ER -, PR -, HER2 +:</strong> This profile indicates that the tumor is negative for estrogen receptor (ER -) and progesterone receptor (PR -) but HER2-positive (HER2 +). This profile is not consistent with basal-like breast cancer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Basal-like or triple-negative breast cancer is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor type 2 (HER2) on immunohistochemical staining. Positive staining is indicated by the presence of brown-coloured tissue, with ER and PR staining the nucleus brown, while HER2 staining the cell membrane brown.</span></span></span></p>",
      "correct_choice_id": 200290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50073,
      "choices": [
        {
          "id": 200292,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Putamen</span></span></p>"
        },
        {
          "id": 200293,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Subthalamic nucleus</span></span></p>"
        },
        {
          "id": 200294,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Caudate nucleus</span></span></p>"
        },
        {
          "id": 200295,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Globus pallidus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presented with violent, flinging movements. Where is the lesion causing the hemiballismus seen? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q2305073",
      "question_audio": null,
      "question_video": null,
      "map_id": 34619819,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Subthalamic nucleus</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemiballismus is characterized by involuntary, violent, flinging movements, typically on one side of the body. This condition is most commonly associated with a lesion in the subthalamic nucleus. The subthalamic nucleus plays a crucial role in regulating movements, and damage to this area can lead to the excessive, uncontrolled movements seen in hemiballismus. This differentiates it from lesions in other parts of the basal ganglia, which are associated with different movement disorders.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Putamen:</span></strong><span style=\"font-size:12.0pt\"> Lesions in the putamen are more commonly associated with chorea, which involves rapid, involuntary, and irregular movements, rather than the violent flinging movements of hemiballismus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Caudate nucleus:</span></strong><span style=\"font-size:12.0pt\"> Similar to the putamen, lesions in the caudate nucleus typically result in chorea. The caudate nucleus is part of the striatum, and its dysfunction does not usually present with the violent movements characteristic of hemiballismus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Globus pallidus:</span></strong><span style=\"font-size:12.0pt\"> Lesions in the globus pallidus often result in athetosis, which involves slow, writhing movements. This is different from the abrupt and forceful movements seen in hemiballismus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemiballismus, characterized by violent, flinging movements, is most commonly caused by a lesion in the subthalamic nucleus.</span></span></span></p>",
      "correct_choice_id": 200293,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50074,
      "choices": [
        {
          "id": 200296,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Denervation</span></span></span></p>"
        },
        {
          "id": 200297,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decreased nutrition</span></span></span></p>"
        },
        {
          "id": 200298,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decreased workload</span></span></span></p>"
        },
        {
          "id": 200299,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reduced blood supply</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What is the reason behind Senile Atrophy? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(INICET NOV 2022)</span></span></p>",
      "unique_key": "Q2220223",
      "question_audio": null,
      "question_video": null,
      "map_id": 34467402,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Reduced blood supply</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Senile atrophy is seen when there is a reduced blood supply to a tissue. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atrophy is decrease in cell size and/or number due to decreased demand or functional loss.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 pathways responsible for it: Ubiquitin Pathway (via Proteasomes) and Autophagy (Defense mechanism).</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-125722.jpg\" style=\"height:308px; width:1000px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">A. Denervation</span></strong><span style=\"font-size:12.0pt\">: Atrophy due to loss of nerve supply is known as denervation atrophy, commonly seen in conditions like poliomyelitis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">B. Decreased nutrition</span></strong><span style=\"font-size:12.0pt\">: This refers to atrophy due to inadequate nutrient supply, leading to cachexia.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">C. Decreased workload</span></strong><span style=\"font-size:12.0pt\">: This refers to disuse atrophy, where tissues reduce in size due to inactivity, such as muscle wasting in immobilized limbs.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Senile atrophy is primarily due to reduced blood supply, leading to tissue shrinkage and loss of function with aging.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-125722.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200299,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50075,
      "choices": [
        {
          "id": 200300,
          "text": "<p><span style=\"font-size:12.0pt;\">Laparoscopic surgeries result in lesser post-operative pain.</span></p>"
        },
        {
          "id": 200301,
          "text": "<p><span style=\"font-size:12.0pt;\">Laparoscopic surgeries are cosmetically better as they result in smaller incisions.</span></p>"
        },
        {
          "id": 200302,
          "text": "<p><span style=\"font-size:12.0pt;\">Laparoscopic surgeries result in an earlier return to normal physiological function.</span></p>"
        },
        {
          "id": 200303,
          "text": "<p><span style=\"font-size:12.0pt;\">Laparoscopic surgeries result in a longer duration of stay in the hospital</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old female patient is scheduled for a laparoscopic cholecystectomy, which of the following is not an advantage of laparoscopic surgery? (INICET NOV 2022)</span></p>",
      "unique_key": "Q8796601",
      "question_audio": null,
      "question_video": null,
      "map_id": 34688276,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Laparoscopic surgeries result in a longer duration of stay in the hospital</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Laparoscopic surgeries have become popular as they result in lesser post-operative pain, are cosmetically better, and result in an earlier return to normal physiological function (Options A, B, and C). Patients are discharged from the hospital earlier, with a lower incidence of complications, as compared to open surgeries. Therefore, Option D is the correct answer, as it is not an advantage of laparoscopic surgery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">This statement is incorrect. Laparoscopic surgery is associated with shorter hospital stays compared to traditional open surgery. Patients typically spend less time in the hospital and recover faster, which is one of the key advantages of this approach.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Laparoscopic surgeries result in lesser post-operative pain</strong>: Smaller incisions and less tissue trauma typically result in less post-operative pain compared to traditional open surgery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Laparoscopic surgeries are cosmetically better as they result in smaller</strong> <strong>incisions</strong>: This is an advantage of laparoscopic surgery. The smaller incisions are not only cosmetically appealing but also result in reduced scarring and a lower risk of wound infections.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Laparoscopic surgeries result in an earlier return to normal physiological</strong> <strong>function</strong>: Patients often recover more quickly and can resume their normal activities sooner due to the minimally invasive nature of the procedure.</span></p>",
      "correct_choice_id": 200303,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50076,
      "choices": [
        {
          "id": 200304,
          "text": "<p><span style=\"font-size:12.0pt;\">Piperacillin + tazobactam</span></p>"
        },
        {
          "id": 200305,
          "text": "<p><span style=\"font-size:12.0pt;\">Amphotericin + flucytosine</span></p>"
        },
        {
          "id": 200306,
          "text": "<p><span style=\"font-size:12.0pt;\">Vancomycin + ceftriaxone</span></p>"
        },
        {
          "id": 200307,
          "text": "<p><span style=\"font-size:12.0pt;\">Antitubercular therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young man is brought to the hospital with high-grade fever and altered consciousness. On examination, the patient had neck rigidity and pain when bending the neck. A lumbar puncture was performed and it showed a WBC count of 1500 cells/ L, majority being neutrophils, elevated pressure with protein of 120 mg/dL, and a CSF glucose level of 70 mg dL & blood glucose level - 300 mg dL). How will you manage the index case? (INICET MAY 2022)</span></p>",
      "unique_key": "Q4471897",
      "question_audio": null,
      "question_video": null,
      "map_id": 34695849,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Vancomycin + ceftriaxone</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The clinical scenario and the laboratory results provided strongly suggest a diagnosis of bacterial meningitis. The CSF analysis shows significant findings including a high WBC count predominantly composed of neutrophils, elevated protein, and a relatively low CSF glucose level considering the elevated blood glucose. The CSF glucose level, when compared to the blood glucose, gives a ratio that is suggestive of bacterial meningitis (a ratio of 0.4 or less is highly indicative).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Meningitis can present with symptoms such as high-grade fever, altered consciousness, neck rigidity, and positive meningeal signs like Kernig's and Brudzinski's signs. The diagnosis is confirmed by CSF analysis, which typically shows:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Neutrophilic pleocytosis</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Increased protein levels</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Decreased glucose concentrations</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Presence of microorganisms on Gram stain and culture</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">The initial treatment of bacterial meningitis should include broad-spectrum antibiotics that cover the most common pathogens. A combination of a third-generation cephalosporin like ceftriaxone and vancomycin is recommended to cover for <strong>Streptococcus pneumoniae</strong> and <strong>Neisseria meningitidis</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Piperacillin + tazobactam</strong>: Piperacillin + tazobactam is used in certain situations such as hospital-acquired infections or when there is no response to ceftriaxone. However, it is not the first-line treatment for community-acquired bacterial meningitis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Amphotericin + flucytosine</strong>: Amphotericin + flucytosine are antifungal agents used to treat fungal meningitis, not bacterial meningitis. Fungal meningitis presents differently and typically in immunocompromised individuals.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Antitubercular therapy</strong>: Antitubercular therapy is considered when the CSF profile shows low glucose, high protein, and lymphocytic predominance, which is typical for tuberculous meningitis. The provided CSF findings do not match those of tuberculous meningitis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Vancomycin combined with a third-generation cephalosporin like ceftriaxone is the recommended initial treatment for suspected bacterial meningitis.</span></p>",
      "correct_choice_id": 200306,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50077,
      "choices": [
        {
          "id": 200308,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">High fetal head station</span></span></span></p>"
        },
        {
          "id": 200309,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Multiparity</span></span></span></p>"
        },
        {
          "id": 200310,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Neuraxial block</span></span></span></p>"
        },
        {
          "id": 200311,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Chorioamnionitis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">All are causes of uterine dysfunction, except: </span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q2658241",
      "question_audio": null,
      "question_video": null,
      "map_id": 34207250,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Multiparity</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Multiparity is not a cause of uterine dysfunction; rather, nulliparity (the condition of a woman who has never given birth) is a recognized cause. Uterine dysfunction, particularly hypotonic uterine dysfunction, is associated with several factors, but multiparity is generally associated with a more efficient labor process due to the body's previous experience with childbirth.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Causes of hypotonic uterine dysfunction:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Neuraxial analgesia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The use of epidural or spinal anesthesia can interfere with uterine contractions.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Chorioamnionitis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is an infection of the amniotic fluid and membranes, which can lead to inflammation and impaired uterine contractility.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Nulliparity</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: First-time mothers (nulliparous women) are more likely to experience uterine dysfunction due to the unconditioned nature of the uterine muscles.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other factors</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Mechanical disruption of myometrial function by a fibroid or pelvic tumor</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Maternal obesity</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Uterine mullerian anomaly</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Increased maternal age</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Malposition and malpresentation of the fetus</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Contracted pelvis</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. High fetal head station</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: High fetal head station can be associated with labor dystocia and uterine dysfunction as it may indicate issues with the descent of the baby.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Multiparity</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Neuraxial block (e.g., epidural) can interfere with effective uterine contractions, leading to uterine dysfunction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Chorioamnionitis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Chorioamnionitis, an infection, can impair uterine contractions and lead to dysfunctional labor.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Nulliparity, not multiparity, is a cause of uterine dysfunction. Causes of hypotonic uterine dysfunction include neuraxial analgesia, chorioamnionitis, nulliparity, and mechanical factors such as fibroids or pelvic tumors.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg459, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 416</span></strong></span></span></p>",
      "correct_choice_id": 200309,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50078,
      "choices": [
        {
          "id": 200312,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary vasoconstriction</span></p>"
        },
        {
          "id": 200313,
          "text": "<p><span style=\"font-size:12.0pt;\">Polycythemia</span></p>"
        },
        {
          "id": 200314,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        },
        {
          "id": 200315,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoxia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following physiological adaptations is generally not observed at high altitudes? (INICET NOV 2022)</span></p>",
      "unique_key": "Q6502168",
      "question_audio": null,
      "question_video": null,
      "map_id": 34259774,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Respiratory acidosis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The physiological adaptation that does not happen at high altitudes is respiratory acidosis. Respiratory alkalosis is the physiological adaptation seen at high altitudes due to hyperventilation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pulmonary vasoconstriction</strong>: Correct, as it is a physiological response to low oxygen levels to improve gas exchange.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Polycythemia</strong>: Correct, as it increases the blood's oxygen-carrying capacity.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hypoxia</strong>: Correct, as it is the primary condition caused by low oxygen levels at high altitudes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The principal means by which acclimatization to high altitude comes about are</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">A great increase in pulmonary ventilation - increase in pulmonary ventilation on rising to a high altitude blows off large quantities of carbon dioxide, reducing the Pco2 and increasing the ph of the body fluids.</span></li><li><span style=\"font-size:12.0pt;\">Increased numbers of red blood cells,</span></li><li><span style=\"font-size:12.0pt;\">Increased diffusing capacity of the lungs,</span></li><li><span style=\"font-size:12.0pt;\">Increased vascularity of the peripheral tissues</span></li><li><span style=\"font-size:12.0pt;\">Increased ability of the tissue cells to use oxygen despite low Po2.</span></li><li><span style=\"font-size:12.0pt;\">Cellular Acclimatization - cell mitochondria and cellular oxidative enzyme systems are slightly more plentiful than in sea-level inhabitants</span></li></ol>",
      "correct_choice_id": 200314,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50079,
      "choices": [
        {
          "id": 200316,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 2, 4</span></span></p>"
        },
        {
          "id": 200317,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 3, 4</span></span></p>"
        },
        {
          "id": 200318,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 2, 3 </span></span></p>"
        },
        {
          "id": 200319,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">2, 3, 4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following findings are seen in a high-resolution CT scan of fungal pneumonia? (INICET NOV 2022) </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Interlobular septations</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Peripheral wedge-shaped consolidation</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Pleural effusion</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cavitary lesions with surrounding ground glass opacities</span></span></span></li>\r\n</ol>",
      "unique_key": "Q2172177",
      "question_audio": null,
      "question_video": null,
      "map_id": 34730850,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) 1, 2, 3</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">High-resolution computed tomography (HRCT) of fungal pneumonia shows interlobular septations, peripheral wedge-shaped consolidation, and pleural effusion. HRCT of fungal pneumonia shows a nodule (not a cavity) with surrounding ground-glass opacities.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A nodule surrounded by ground-glass attenuation on HRCT imaging is seen in aspergillosis, candidiasis, <em>Pneumocystis jirovecii</em> pneumonia, coccidioidomycosis, and paracoccidioidomycosis. Cavitation on HRCT is seen in cases of community-acquired pneumonia due to <em>Mycobacterium tuberculosis</em>, <em>S. aureus</em>, and gram-negative bacilli.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Aspergillosis is a fungal disease caused by <em>Aspergillus</em> species. Pulmonary aspergillosis has been categorized into saprophytic, allergic, and invasive forms.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">HRCT findings of various types of aspergillosis are as follows:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Aspergilloma</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (saprophytic) shows a mass with soft-tissue attenuation, which is separated from the thoracic wall by airspace called the air crescent sign. Multiple nodules and bilateral involvement may be seen.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Allergic bronchopulmonary aspergillosis (ABPA-allergic)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> shows hypodense mucous plugs.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Angioinvasive aspergillosis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> shows multiple nodules surrounded by a halo of ground-glass attenuation (<em>halo sign</em>) or pleural-based wedge-shaped areas of consolidation.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. 1, 2, 4:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Cavitary lesions with surrounding ground-glass opacities are more often associated with bacterial pneumonia or other causes of lung abscesses, not typically fungal pneumonia like aspergillosis or <em>Pneumocystis jirovecii</em> pneumonia.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. 1, 3, 4:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> While pleural effusion and interlobular septations are seen in fungal infections, cavitary lesions are more commonly associated with bacterial infections rather than fungal.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. 2, 3, 4:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This option includes cavitary lesions and pleural effusion but excludes interlobular septations, which are typically seen in fungal pneumonia.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Fungal pneumonia on HRCT typically shows interlobular septations, peripheral wedge-shaped consolidation, and pleural effusion with a nodule surrounded by ground-glass attenuation.</span></span></span></p>",
      "correct_choice_id": 200318,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50080,
      "choices": [
        {
          "id": 200320,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-2, B-3, C-1, D-4</span></span></span></span></span></p>"
        },
        {
          "id": 200321,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿A-3, B-4, C-2, D-1</span></span></span></span></span></p>"
        },
        {
          "id": 200322,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿A-1, B-2, C-4, D-3</span></span></span></span></span></p>"
        },
        {
          "id": 200323,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-4, B-1, C-3, D-2</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following drugs in column A to their site of action in column B?</span></span></span></span></span>(INICET NOV 2022)</p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-184118.jpg\" style=\"height:235px; width:700px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-184118.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7174730",
      "question_audio": null,
      "question_video": null,
      "map_id": 34312399,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D. A-4, B-1, C-3, D-2</span></span></strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct match is as follows:</span></span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/screenshot-2024-10-14-180359.jpg\" style=\"height:236px; width:700px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Acetazolamide is a carbonic anhydrase inhibitor that acts at the proximal convoluted tubules.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Torsemide is a loop diuretic that acts by inhibiting Na+-K+-2Cl channel at the thick ascending limb of the Loop of Henle.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Chlorthalidone, a thiazide-like diuretic, inhibits the Na-CI symporter in the distal convoluted tubule. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Vasopressin, or ADH, is secreted by the posterior pituitary and mainly acts on the collecting duct, and increases the reabsorption of free water. </span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Acetazolamide acts on the proximal convoluted tubule, Torsemide on the thick ascending limb of the loop of Henle, Chlorothiazide on the distal convoluted tubule, and Vasopressin on the collecting duct.</span></span></span></p>\r\n\r\n<p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/14/screenshot-2024-10-14-180359.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200323,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50081,
      "choices": [
        {
          "id": 200324,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gaucher’s disease</span></span></span></p>"
        },
        {
          "id": 200325,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Wolman's disease</span></span></span></p>"
        },
        {
          "id": 200326,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Niemann pick disease</span></span></span></p>"
        },
        {
          "id": 200327,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fish eye disease</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the given image: (</span></span></span>INICET Nov 2022)</p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture15.jpg\" style=\"height:254px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture15.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1835551",
      "question_audio": null,
      "question_video": null,
      "map_id": 34645225,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Gaucher’s disease</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gaucher's disease is an inherited genetic disorder characterized by the accumulation of a fatty substance called glucocerebroside in various organs, particularly the liver, spleen, and bone marrow.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Symptoms include bone pain, anemia, enlarged organs (hepatosplenomegaly), a swollen and painful belly, easy bruising, and fatigue.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gaucher's disease is most common in Jewish people of Eastern and Central European descent (Ashkenazi).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is caused by a deficiency of the enzyme glucocerebrosidase, which is responsible for breaking down glucocerebroside.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options</span></strong></span></span><strong>:</strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong> </strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Wolman's disease:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Wolman's disease is a rare autosomal recessive lipid storage disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is caused by mutations in the LIPA gene, which encodes lysosomal acid lipase, an enzyme responsible for breaking down lipids.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Individuals with Wolman's disease have a deficiency of lysosomal acid lipase, leading to the accumulation of cholesterol and triglycerides in various organs, including the liver, spleen, and intestines.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Symptoms often appear in infancy and may include enlarged liver and spleen, abdominal distension, diarrhea, and failure to thrive.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Niemann-Pick disease:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Niemann-Pick disease is a rare inherited disorder that affects the body's ability to metabolize fat (cholesterol and lipids) within cells.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">There are several subtypes of Niemann-Pick disease, including types A, B, and C, each caused by different genetic mutations.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Symptoms can vary depending on the subtype but may include hepatosplenomegaly (enlarged liver and spleen), neurological problems, and respiratory difficulties.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Type C Niemann-Pick disease, in particular, can lead to cognitive and motor impairment.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Fish eye disease:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fish eye disease is a rare genetic disorder and is a variant of familial lecithin-cholesterol acyltransferase (LCAT) deficiency.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is characterized by a deficiency of the LCAT enzyme, which plays a role in cholesterol metabolism.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fish eye disease leads to the accumulation of cholesterol in various tissues and can cause eye problems, including corneal opacities and vision impairment.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Unlike the more severe form of LCAT deficiency, known as LCAT deficiency, Fish eye disease typically has milder symptoms.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given image shows crumpled tissue paper appearance of macrophage cells (see images below) which is a characteristic feature of Gaucher’s disease. This disease is a type of sphingolipidoses and occurs due to deficiency of enzyme β-glucosyl ceramidase.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:#212529\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/screenshot-2024-01-01-132209.jpg\" style=\"height:176px; width:600px\" /></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:#212529\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture16.jpg\" style=\"height:255px; width:300px\" /></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/screenshot-2024-01-01-132209.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200324,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50082,
      "choices": [
        {
          "id": 200328,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Systolic BP <90 mmHg</span></span></p>"
        },
        {
          "id": 200329,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Temperature >38 degrees Celsius or <36 degrees Celsius</span></span></p>"
        },
        {
          "id": 200330,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Respiratory rate >20 bpm</span></span></p>"
        },
        {
          "id": 200331,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Heart rate >90/min</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">All the following are criteria for SIRS, except ______. (INICET NOV 2022)<span style=\"color:#00b050\"> </span></span></span></p>",
      "unique_key": "Q2912865",
      "question_audio": null,
      "question_video": null,
      "map_id": 34806635,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Systolic BP <90 mmHg </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Systolic BP <90 mmHg</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is <strong><span style=\"font-family:\"Calibri\",sans-serif\">not</span></strong> a criterion for <strong><span style=\"font-family:\"Calibri\",sans-serif\">SIRS</span></strong> (Systemic Inflammatory Response Syndrome).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">SIRS is diagnosed when <strong><span style=\"font-family:\"Calibri\",sans-serif\">two</span></strong> of the following criteria are present:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Hyperthermia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (>38°C) or <strong><span style=\"font-family:\"Calibri\",sans-serif\">hypothermia</span></strong> (<36°C)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Tachypnea</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (respiratory rate >20 breaths per minute) or arterial carbon dioxide tension (PaCO₂) <32 mmHg</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Tachycardia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (heart rate >90 beats per minute)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">White blood cell count >12 × 10⁹/L or <4 × 10⁹/L, or >10% band forms (immature neutrophils)</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Sepsis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is SIRS with a documented infection.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Temperature >38°C or <36°C:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Is a part of the SIRS criteria.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Respiratory rate >20 breaths/min:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Is a criterion for SIRS (tachypnea).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Heart rate >90/min:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (tachycardia) is also one of the criteria for SIRS.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">SIRS criteria include hyperthermia/hypothermia, tachycardia, tachypnea, and abnormal white blood cell count. Systolic BP is <strong><span style=\"font-family:\"Calibri\",sans-serif\">not</span></strong> included as a direct diagnostic criterion for SIRS.</span></span></span></p>",
      "correct_choice_id": 200328,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50083,
      "choices": [
        {
          "id": 200332,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline 100 mg intravenously for 7 days</span></p>"
        },
        {
          "id": 200333,
          "text": "<p><span style=\"font-size:12.0pt;\">Clindamycin 600 mg intravenously 8 hourly for 7 days</span></p>"
        },
        {
          "id": 200334,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate 2.4 mg/kg intravenously at 12 and 24 hours, followed by daily once</span></p>"
        },
        {
          "id": 200335,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine intramuscularly 8 hourly for 3 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient comes with a history of high fever for 5 days and altered sensorium. On further probing, it was found that he had two seizures one day ago. Peripheral smear shows the following findings. How will you manage this patient?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/27.jpg\" alt=\"\" width=\"400\" height=\"236\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/27.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9199408",
      "question_audio": null,
      "question_video": null,
      "map_id": 34757216,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Artesunate 2.4 mg/kg intravenously at 12 and 24 hours, followed by daily once</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A Giemsa-stained peripheral blood smear shows many red blood cells (RBCs) infected with classic, <strong>ring-shaped and headphone-shaped trophozoites of Plasmodium falciparum parasite</strong>. High degree of parasitemia and RBCs infected with two or more trophozoites were seen, a finding typical of P. falciparum malaria.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cerebral malaria is a complicated form of malaria associated with multisystem organ dysfunction and high degree of morbidity and mortality. These patients often present with impaired consciousness, delirium and convulsions. It is a medical emergency where prompt diagnosis and early institution of treatment can be lifesaving. Intravenous quinine or artesunate are the mainstays of treatment in cerebral malaria.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Management of Cerebral Malaria:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Artesunate</strong>: Administered intravenously at a dose of 2.4 mg/kg immediately, followed by 2.4 mg/kg at 12 and 24 hours, and then once daily if necessary.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Alternative Treatment</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Artemether</strong>: 3.2 mg/kg intramuscularly initially, followed by 1.6 mg/kg once daily.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Quinine dihydrochloride</strong>: 20 mg of salt/kg infused over 4 hours, followed by 10 mg of salt/kg infused over 2-8 hours.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Doxycycline 100 mg intravenously for 7 days</strong>: Doxycycline is not the first-line treatment for severe malaria. It is typically used as a secondary prophylactic measure or in combination with other antimalarial drugs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Clindamycin 600 mg intravenously 8 hourly for 7 days: </strong>Clindamycin is not used for the treatment of malaria. It is an antibiotic that is used for bacterial infections.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chloroquine intramuscularly 8 hourly for 3 days</strong>: Chloroquine is ineffective against Plasmodium falciparum due to widespread resistance. It is also not suitable for treating severe or cerebral malaria.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cerebral malaria caused by Plasmodium falciparum is a medical emergency requiring prompt treatment with intravenous artesunate, which is the most effective and rapid-acting medication for severe malaria.</span></p>",
      "correct_choice_id": 200334,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50084,
      "choices": [
        {
          "id": 200336,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1 → 3 →2 → 4</span></span></p>"
        },
        {
          "id": 200337,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">3 → 1 → 2 → 4</span></span></p>"
        },
        {
          "id": 200338,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">3 →<span style=\"font-family:\"Calibri\",sans-serif\"> 1 </span>→<span style=\"font-family:\"Calibri\",sans-serif\"> 4 </span>→<span style=\"font-family:\"Calibri\",sans-serif\"> 2</span></span></span></p>"
        },
        {
          "id": 200339,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1 → 3 → 4 → 2</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Which is the correct sequence for the correction of hypospadias? (INICET NOV 2022) </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Urethroplasty</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Meatoplasty</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Orthoplasty</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Glanuloplasty</span></span></span></li>\r\n</ol>",
      "unique_key": "Q8881043",
      "question_audio": null,
      "question_video": null,
      "map_id": 34985044,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. <span style=\"font-family:\"Calibri\",sans-serif\">C) 3 </span>→<span style=\"font-family:\"Calibri\",sans-serif\"> 1 </span>→<span style=\"font-family:\"Calibri\",sans-serif\"> 4 </span>→<span style=\"font-family:\"Calibri\",sans-serif\"> 2</span> </span></span></span></strong></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct sequence for the correction of hypospadias is <strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. 3 </span></strong>→<strong><span style=\"font-family:\"Calibri\",sans-serif\"> 1 </span></strong>→<strong><span style=\"font-family:\"Calibri\",sans-serif\"> 4 </span></strong>→<strong><span style=\"font-family:\"Calibri\",sans-serif\"> 2</span></strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The main principles of surgery in hypospadias, in sequence, include:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Orthoplasty</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Corrects chordee (the abnormal curvature of the penis), which is the first step in the procedure to ensure proper straightening of the penis.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Urethroplasty</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Repositioning and tubularization of the urethra to ensure the proper opening at the distal end of the penis.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Glanuloplasty</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Reconstruction of the glans, forming the tip of the penis and covering the urethral opening.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Meatoplasty</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Reconstruction of the distal urethral meatus, which is the final step to ensure a functional and anatomically correct urethral opening.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypospadias is the most common <strong><span style=\"font-family:\"Calibri\",sans-serif\">congenital abnormality of the urethra</span></strong>. It is characterized by a <strong><span style=\"font-family:\"Calibri\",sans-serif\">ventrally placed urethral meatus</span></strong>, a hooded foreskin, and ventral chordee (bending of the penis). The correction aims to restore both functional and cosmetic normality.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This sequence places urethroplasty first, which is incorrect because chordee (orthoplasty) needs to be corrected first to ensure proper straightening before other steps.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This is a common but incorrect option, as it places urethroplasty before glanuloplasty, while glans reconstruction should be done before distal urethral meatoplasty.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> The sequence is incorrect, placing urethroplasty and orthoplasty in the wrong order.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct sequence for hypospadias repair is <strong><span style=\"font-family:\"Calibri\",sans-serif\">orthoplasty</span></strong> first (to correct chordee), followed by <strong><span style=\"font-family:\"Calibri\",sans-serif\">urethroplasty</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">glanuloplasty</span></strong>, and finally <strong><span style=\"font-family:\"Calibri\",sans-serif\">meatoplasty</span></strong> to reconstruct the urethral opening.</span></span></p>",
      "correct_choice_id": 200338,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50085,
      "choices": [
        {
          "id": 200340,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyphema</span></p>"
        },
        {
          "id": 200341,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Aqueous flare</span></p>"
        },
        {
          "id": 200342,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Arlt line</span></p>"
        },
        {
          "id": 200343,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Hypopyon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A farmer presents with pain and discharge in his left eye. He says that he sustained an injury caused by a leaf a few days back. What is the finding seen in the image? (</span>INICET Nov 2022)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture3_9GuvF0u.jpg\" alt=\"\" width=\"400\" height=\"285\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture3_9GuvF0u.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9050834",
      "question_audio": null,
      "question_video": null,
      "map_id": 34929876,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Hypopyon </strong></span><span style=\"font-size:10.5pt;\"> </span></p><p> </p><p><span style=\"font-size:12.0pt;\">The finding seen in the image is hypopyon.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Hypopyon is an accumulation of inflammatory cells in the anterior chamber of the eye, typically seen in the lower part of the chamber as a whitish exudate.</span></li><li><span style=\"font-size:12.0pt;\">In fungal corneal ulcers, the hypopyon may not be sterile as the fungus can penetrate into the anterior chamber without causing a perforation.</span></li><li><span style=\"font-size:12.0pt;\">Hypopyon associated with anterior uveitis is immobile because of the high fibrin content in the exudate.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A: Hyphema</strong> is a hemorrhage in the anterior chamber. It commonly occurs after a blunt ocular injury. The bleeding is from the iris root or ciliary body face. The blood settles inferiorly forming a fluid level.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture4_Y2WCgfK.jpg\" alt=\"\" width=\"300\" height=\"197\"></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong> </span><span style=\"font-size:12.0pt;\"><strong>Aqueous flare</strong> refers to the haziness of the normally clear fluid in the anterior chamber. It reflects the presence of protein due to the breakdown of the blood-aqueous barrier. The presence of flare indicates active inflammation.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong> </span><span style=\"font-size:12.0pt;\"><strong>Arlt line</strong> is the scarring on the conjunctiva in the area of sulcus subtarsalis. It can be a single line, irregularly shaped, or star-shaped. Common causes are trachoma, healed traumatic wounds, or surgical scars.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture5_eRZ1892.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Hypopyon </strong>is points to severe intraocular inflammation needing prompt treatment to preserve eye function and prevent potential complications. The presence of hypopyon after an injury with organic material highly suggests a fungal etiology, requiring specific antifungal treatment alongside broad-spectrum antibacterial coverage.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture4_Y2WCgfK.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200343,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50086,
      "choices": [
        {
          "id": 200344,
          "text": "<p><span style=\"font-size:12pt;\">Progestin injection</span></p>"
        },
        {
          "id": 200345,
          "text": "<p><span style=\"font-size:12pt;\">Progestin implants</span></p>"
        },
        {
          "id": 200346,
          "text": "<p><span style=\"font-size:12pt;\">Female sterilization</span></p>"
        },
        {
          "id": 200347,
          "text": "<p><span style=\"font-size:12pt;\">Levonorgestrel-releasing and copper-containing intrauterine devices</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are long acting reversible methods of contraception, except: (INICET NOV 2022)</span></p>",
      "unique_key": "Q5995506",
      "question_audio": null,
      "question_video": null,
      "map_id": 34869625,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Female sterilization</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Long-Acting Reversible Contraceptives (LARC) are those which are administered at a frequency of less than once per month. LARC methods include:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Intrauterine devices (IUDs):</strong> Such as CuT 380A with a lifespan of 10 years, and the Levonorgestrel-releasing IUD (LNG IUD) with a lifespan of 5 years.</span></li><li><span style=\"font-size:12pt;\"><strong>Implants:</strong> Implanon, which contains etonorgestrel, has a lifespan of 3 years, and Norplant II, which contains LNG, also has a lifespan of 3 years.</span></li><li><span style=\"font-size:12pt;\"><strong>Injectable contraceptives:</strong> Including Depo-Provera (DMPA) which is administered as 150 mg every 3 months, and Norethisterone enanthate (NET-EN) which is administered as 200 mg every 2 months.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Progestin injection:</strong> This is a form of LARC. Injectable contraceptives like DMPA and NET-EN are given at intervals of 2 to 3 months.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Progestin implants:</strong> These are also considered LARC. Implanon and Norplant II are examples of progestin implants with a duration of action up to 3 years.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Levonorgestrel-releasing and copper-containing intrauterine devices:</strong> Both types of IUDs are classified as LARC. The CuT 380A lasts for up to 10 years, and the LNG IUD lasts for up to 5 years.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Long-acting reversible contraceptives (LARC) include intrauterine devices (IUDs), progestin implants, and injectable contraceptives, but do not include permanent methods like female sterilization.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg 107,112, 127, Dutta’s textbook of Gynecology 6<sup>th</sup> edition pg 491-492,479,</strong></span></p>",
      "correct_choice_id": 200346,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50087,
      "choices": [
        {
          "id": 200348,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1-c, 2-b, 3-a, 4-d </span></span></span></p>"
        },
        {
          "id": 200349,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1-c, 2-a, 3-b, 4-d </span></span></span></p>"
        },
        {
          "id": 200350,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1-b, 2-d, 3-c, 4-a </span></span></span></p>"
        },
        {
          "id": 200351,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1-b, 2-c, 3-a, 4-d </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following therapeutic methods used in the management of psoriasis with their possible side effects. (INICET NOV 2022) </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Column A</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1. PUVA</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2. Cyclosporine</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">3. Methotrexate</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">4. Acitretin</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Column B</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">a. Abortifacient</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">b. Effective but is highly nephrotoxic</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">c. Long-term use increases the risk of skin cancer</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">d. Mucositis, teratogenic</span></span></span></p>",
      "unique_key": "Q1144114",
      "question_audio": null,
      "question_video": null,
      "map_id": 34675161,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) 1-c, 2-b, 3-a, 4-d </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correctly matched pairs are as follows:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">PUVA</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (Psoralen + UVA):</span><br />\r\n\t<strong><span style=\"font-family:\"Calibri\",sans-serif\">Long-term use increases the risk of skin cancer</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.<br />\r\n\tPUVA is highly effective in treating psoriasis but has the potential for both acute and chronic side effects. Chronic use is associated with an increased risk of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">non-melanoma skin cancer</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (such as squamous cell carcinoma and basal cell carcinoma).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Cyclosporine</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span><br />\r\n\t<strong><span style=\"font-family:\"Calibri\",sans-serif\">Effective but is highly nephrotoxic</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.<br />\r\n\tCyclosporine is an immunosuppressant primarily associated with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">renal impairment</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (nephrotoxicity), metabolic disturbances, and an increased risk of malignancies. It is less frequently used now due to these side effects.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Methotrexate</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span><br />\r\n\t<strong><span style=\"font-family:\"Calibri\",sans-serif\">Abortifacient</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.<br />\r\n\tMethotrexate is a folic acid antagonist used to treat psoriasis and other autoimmune conditions. It has abortifacient properties and is used in the management of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">molar pregnancies</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Methotrexate is also associated with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">mucositis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">teratogenicity</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">hepatotoxicity</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Acitretin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span><br />\r\n\t<strong><span style=\"font-family:\"Calibri\",sans-serif\">Mucositis, teratogenic</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.<br />\r\n\tAcitretin, a systemic retinoid, is highly teratogenic and causes mucocutaneous side effects such as </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">mucositis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">hyperlipidemia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Women are advised to avoid conception for </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">3 years after stopping</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> acitretin due to its teratogenic effects.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. 1-c, 2-a, 3-b, 4-d: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This incorrectly matches </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Cyclosporine (a)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> with abortifacient properties, which is incorrect as this applies to </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Methotrexate</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Methotrexate (3) should be associated with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">a</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, not Cyclosporine (2).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. 1-b, 2-d, 3-c, 4-a: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This mismatches </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">PUVA</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Cyclosporine</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. PUVA should be associated with the risk of skin cancer (</span><strong><span style=\"font-family:\"Calibri\",sans-serif\">c</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">), not nephrotoxicity (</span><strong><span style=\"font-family:\"Calibri\",sans-serif\">b</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">), and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Cyclosporine</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is nephrotoxic, not linked to mucositis (</span><strong><span style=\"font-family:\"Calibri\",sans-serif\">d</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. 1-b, 2-c, 3-a, 4-d: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">PUVA is associated with skin cancer risk, not nephrotoxicity, and Cyclosporine is nephrotoxic, not associated with skin cancer. This option misplaces the side effects for both PUVA and Cyclosporine.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In psoriasis treatment, be aware of the side effects of key therapies:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">PUVA</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> increases the risk of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">skin cancer</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> with long-term use.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Cyclosporine</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is highly </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">nephrotoxic</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Methotrexate</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> has </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">abortifacient</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> properties.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Acitretin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> causes </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">mucositis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and is highly </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">teratogenic</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200348,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50088,
      "choices": [
        {
          "id": 200352,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">3, 4</span></span></span></p>"
        },
        {
          "id": 200353,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">1, 2</span></span></span></p>"
        },
        {
          "id": 200354,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">1, 2, 3, 4, 5</span></span></span></p>"
        },
        {
          "id": 200355,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">5, 6</span></span></span></p>"
        }
      ],
      "text": "<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A healthcare worker in a remote primary healthcare clinic is reviewing the Vaccine Vial Monitor (VVM) on a vial of a vaccine that has been stored in the clinic for some time. Which of the following statements regarding the utility and interpretation of the VVM is/are correct?\" (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is used for monitoring heat exposure of the vaccine by healthcare workers in primary healthcare.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It shows cumulative exposure of the vaccine to the heat.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It can be used to assess the potential efficacy of the vaccine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calculation of the expiry date can be done using VVM.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The expiry date of the vaccine can be relaxed if VVM is in an acceptable range.</span></span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">If the square and the circle are the same in color, then the vaccine can be safely used.</span></span></li>\r\n</ol>",
      "unique_key": "Q4710246",
      "question_audio": null,
      "question_video": null,
      "map_id": 34121592,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">Ans. B) 1, 2</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vaccine vial monitors (VVM) are heat-sensitive indicators routinely used to monitor heat exposure of the vaccine and determine vaccine viability as the vaccine vial moves across the supply chain. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">VVMs change color as the vaccine is exposed to cumulative heat. If the color of inner square is similar or darker than the outer circle, the vaccine vial should be discarded.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3. A VVM can be used to assess vaccine potency and not vaccine efficacy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">4 & 5. Expiry date can’t be determined by VVM and has no relation to extend the expiry date.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6. If the square and the circle are the same in color, then the vaccine should be discarded.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture3555.jpg\" style=\"height:319px; width:500px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/screenshot-2023-10-27-130342.jpg\" style=\"height:643px; width:900px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture3555.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200353,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50089,
      "choices": [
        {
          "id": 200356,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">New drug application is filed after phase 4</span></span></span></p>"
        },
        {
          "id": 200357,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 4 is also called post-marketing surveillance</span></span></span></p>"
        },
        {
          "id": 200358,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 3 are open label studies without any blinding</span></span></span></p>"
        },
        {
          "id": 200359,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 2 is done on healthy individuals</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following statements is correct regarding clinical trials? </span></span></span>(INICET NOVEMBER 2022)</p>",
      "unique_key": "Q5401985",
      "question_audio": null,
      "question_video": null,
      "map_id": 34554304,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B. Phase 4 is also called post-marketing surveillance</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 4 clinical trials are also called post-marketing surveillance. This statement is correct. Phase 4 trials are conducted after a drug has been approved and marketed to monitor its long-term effectiveness and safety.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. New drug application is filed after phase 4: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This statement is incorrect. The New Drug Application (NDA) is filed after successful completion of Phase 3 clinical trials, not Phase 4. Phase 4 occurs after the drug has been approved and marketed.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Phase 3 are open label studies without any blinding: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This statement is incorrect. Phase 3 clinical trials are typically randomized and double-blinded to eliminate bias and ensure robust results. Open label studies, where both the participants and investigators know which treatment is being administered, are less common in Phase 3 trials.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Phase 2 is done on healthy individuals: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This statement is incorrect. Phase 2 clinical trials are conducted on patients who have the condition that the drug is intended to treat. Phase 1 trials, on the other hand, are usually done on healthy volunteers to assess safety and dosage.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong>Educational Objective:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-181342.jpg\" style=\"height:717px; width:1000px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-181342.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200357,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50090,
      "choices": [
        {
          "id": 200360,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Nelfinavir</span></span></span></p>"
        },
        {
          "id": 200361,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Emtricitabine</span></span></span></p>"
        },
        {
          "id": 200362,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Abacavir</span></span></span></p>"
        },
        {
          "id": 200363,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Zidovudine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient who is a known case of HIV is started on combined active antiretroviral therapy (cART). After 5 months of treatment, he develops hyperpigmentation in the palms and soles. What is the most likely drug causing this? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q4547627",
      "question_audio": null,
      "question_video": null,
      "map_id": 34309845,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Emtricitabine</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The most likely drug causing hyperpigmentation of the hands and soles is </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">emtricitabine</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Emtricitabine is an </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">anti-retroviral drug</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> that acts by inhibiting nucleoside reverse transcriptase (NRTI). It is generally well-tolerated and has minimal toxic effects. One of the known adverse effects is </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">hyperpigmentation of the skin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, particularly in sun-exposed areas, as well as the palms and soles. Other side effects may include headache, vomiting, and nausea.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Nelfinavir: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Nelfinavir is a </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">protease inhibitor</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> that is more commonly associated with causing </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">diarrhea or loose stools</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, which usually resolves within a month of starting treatment. It does not commonly cause hyperpigmentation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Abacavir: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Abacavir is another NRTI but is known for its potential to cause a </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">life-threatening hypersensitivity syndrome</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, which typically presents with fever, abdominal pain, and maculopapular rash. This reaction occurs within 6 weeks of starting the drug and requires immediate discontinuation. Hyperpigmentation is not a known side effect of Abacavir.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Zidovudine: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Zidovudine is an NRTI associated with side effects like </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">malaise, fatigue, myalgia, anorexia, and insomnia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. It can also cause </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">nail hyperpigmentation</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">bone marrow suppression</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, but it is not as strongly associated with hyperpigmentation of the palms and soles as emtricitabine.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Emtricitabine</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> is an NRTI that can cause </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">hyperpigmentation of the palms and soles</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">, especially in individuals on long-term antiretroviral therapy. It is essential to monitor patients for this side effect, although it is typically benign.</span></span></p>",
      "correct_choice_id": 200361,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50091,
      "choices": [
        {
          "id": 200364,
          "text": "<p><span style=\"font-size:12.0pt;\">Nocardia</span></p>"
        },
        {
          "id": 200365,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycobacterium tuberculosis</span></p>"
        },
        {
          "id": 200366,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycobacterium leprae</span></p>"
        },
        {
          "id": 200367,
          "text": "<p><span style=\"font-size:12.0pt;\">Actinomyces</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a gram-positive organism that shows the following appearance on Ziehl-Neelsen staining?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/30.jpg\" alt=\"\" width=\"300\" height=\"193\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/30.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1731298",
      "question_audio": null,
      "question_video": null,
      "map_id": 34781287,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Nocardia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The characteristic morphology of Nocardia is a <strong>branching, filamentous, gram-positive rod</strong> when observed under the microscope. Nocardia can resemble Actinomyces species on gram stain.  However, <strong>Nocardia is an obligate aerobe</strong> that stains weakly positive on acid-fast staining.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Nocardia is typically <strong>weakly acid-fast</strong> after traditional carbol-fuchsin staining and positive on modified acid-fast staining due to the presence of mycolic acid in the cell wall. Unlike mycobacteria (also acid-fast positive), <strong>Nocardia has a “beaded” appearance on acid-fast staining</strong>. Nocardia is <strong>catalase-positive and urease positive</strong>.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-114237.png\" alt=\"\" width=\"300\" height=\"228\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Mycobacterium tuberculosis</strong> bacilli are acid fast but non-branching</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/31.jpg\" alt=\"\" width=\"500\" height=\"356\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mycobacterium leprae</strong> bacilli are less acid and alcohol fast than the tubercle bacillus; therefore, 10% sulphuric acid is used as a decolorizer in place of acid/alcohol solution.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/32.jpg\" alt=\"\" width=\"400\" height=\"300\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Actinomyces</strong> are gram-positive but non-acid-fast in contrast to Nocardia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The following image shows the filamentous gram-positive stained actinomyces:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/33.jpg\" alt=\"\" width=\"400\" height=\"266\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Nocardia can be identified by its branching filamentous structure on gram stain and weak acid-fast positivity due to the presence of mycolic acid in its cell wall, distinguishing it from other gram-positive and acid-fast organisms.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-114237.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200364,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50092,
      "choices": [
        {
          "id": 200368,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-1, B-3, C-2, D-4</span></span></span></span></span></p>"
        },
        {
          "id": 200369,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-4, B-1, C-3, D-2</span></span></span></span></span></p>"
        },
        {
          "id": 200370,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿A-2, B-4, C-1, D-3</span></span></span></span></span></p>"
        },
        {
          "id": 200371,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-3, B-2, C-4, D-1</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following drugs in Column A with their contraindications in Column B? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-180006.jpg\" style=\"height:312px; width:700px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-180006.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9016163",
      "question_audio": null,
      "question_video": null,
      "map_id": 34865075,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B. <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">A-4, B-1, C-3, D-2</span></strong></span></span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Morphine is contraindicated in head injury due to the following reasons:</span></span></strong></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">It causes miosis and in patients with head injury who are in a comatose state, the progress of the patient after giving drugs is assessed by pupillary reaction. So, if the pupil already remains constricted due to morphine, the assessment of progress cannot be done.</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Morphine leads to respiratory depression and if in the patients with head injury, if the respiratory rate is already depressed, it will get aggravated.</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Respiratory depression will lead to accumulation of CO2, leading to vasodilatation and increased intracranial pressure.</span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Amiodarone can cause QT prolongation and even precipitate Torsade de pointes.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Vigabatrin is contraindicated in pregnancy as it is teratogenic.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Estrogen preparations are known to increase the risk of thromboembolism.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Morphine is contraindicated in head injury due to its effects on pupil size and respiratory depression. Amiodarone is associated with QT prolongation and potential arrhythmias. Vigabatrin is teratogenic and contraindicated in pregnancy. Estrogen increases the risk of thromboembolic events.</span></span></span></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200369,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50093,
      "choices": [
        {
          "id": 200372,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Loss of knee jerk</span></span></span></p>"
        },
        {
          "id": 200373,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypotension</span></span></span></p>"
        },
        {
          "id": 200374,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Respiratory depression</span></span></span></p>"
        },
        {
          "id": 200375,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Reduced muscle tone</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A woman with eclampsia is started on magnesium sulfate. What is the first sign of magnesium sulfate toxicity?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q1539901",
      "question_audio": null,
      "question_video": null,
      "map_id": 34783729,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Loss of knee jerk</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Therapeutic range</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The therapeutic range of magnesium for the prevention of seizures in eclampsia is 4-7 mEq/L.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Loss of Deep Tendon Reflexes (DTRs)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The first sign of magnesium sulfate toxicity is the loss of DTRs, specifically the knee jerk reflex. This occurs when plasma magnesium levels reach 7-10 mEq/L.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Respiratory depression</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: When plasma magnesium levels reach 10-12 mEq/L, respiratory depression occurs. Beyond 12 mEq/L, respiratory paralysis and respiratory arrest can occur.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Cardiac arrest</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Cardiac arrest can happen if serum magnesium levels exceed 25 mEq/L.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Monitoring</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: A patient on magnesium sulfate is monitored for toxicity by checking clinical signs, including DTRs, urine output, and respiratory rate.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Treatment of toxicity</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Treatment for magnesium sulfate toxicity involves administering calcium gluconate or calcium chloride (1g intravenously) and discontinuing magnesium sulfate, which usually reverses mild to moderate respiratory depression.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Hypotension</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Hypotension is not the first sign of magnesium sulfate toxicity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Respiratory depression</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Respiratory depression occurs at higher magnesium levels (10-12 mEq/L), after the loss of knee jerk reflex.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Reduced muscle tone</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Reduced muscle tone is not the first sign of magnesium sulfate toxicity and is less specific than the loss of DTRs.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The first sign of magnesium sulfate toxicity is the loss of deep tendon reflexes (knee jerk).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of obstetrics 24<sup>th</sup> edition page 759</span></strong></span></span></p>",
      "correct_choice_id": 200372,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50094,
      "choices": [
        {
          "id": 200376,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Topically applied sulfonamide antibacterial</span></span></span></p>"
        },
        {
          "id": 200377,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Topical ocular carbonic anhydrase inhibitor</span></span></span></p>"
        },
        {
          "id": 200378,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Second-generation sulfonylurea</span></span></span></p>"
        },
        {
          "id": 200379,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Opioid receptor agonist</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Dorzolamide is a: </span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q7437724",
      "question_audio": null,
      "question_video": null,
      "map_id": 34566935,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> </span><span style=\"font-family:\"Calibri\",sans-serif\"><strong>B. Topical ocular carbonic anhydrase inhibitor</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Dorzolamide is a topical ocular carbonic anhydrase inhibitor. It helps in decreasing the rate of formation of aqueous humor in the eye, therefore useful in the management of glaucoma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong>Option A. Topically applied sulfonamide antibacterial</strong> agents include silver sulfadiazine, Mafenide acetate, sulfacetamide etc.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong>Option C. Second-Generation Sulfonylureas</strong> are oral antidiabetic agents which act via increasing sensitivity of the insulin receptors and stimulate the release of insulin from the pancreas. It is used to manage type-2 diabetes mellitus. It includes Glipizide, Glyburide etc.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong>Option D. Opioid receptor agonist</strong> is the class of drugs which bind to the opioid receptors in the body. It includes Morphine, Pethidine, Fentanyl etc.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Dorzolamide is a topical ocular carbonic anhydrase inhibitor used to reduce intraocular pressure by decreasing the production of aqueous humor, making it effective in the treatment of glaucoma. This distinguishes it from sulfonamide antibacterials, second-generation sulfonylureas, and opioid receptor agonists, which are used for different medical conditions.</span></span></span></p>",
      "correct_choice_id": 200377,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50095,
      "choices": [
        {
          "id": 200380,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sporothrix schenckii</span></span></span></p>"
        },
        {
          "id": 200381,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Staphylococcus aureus</span></span></span></p>"
        },
        {
          "id": 200382,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Nocardia asteroides</span></span></span></p>"
        },
        {
          "id": 200383,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Mycobacterium marinum</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A young man presents with skin lesions as shown in the image below. All of the following organisms can spread through dermal and subcutaneous lymphatics, except?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">INICET NOV 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/26.jpg\" style=\"height:170px; width:300px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/26.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6142901",
      "question_audio": null,
      "question_video": null,
      "map_id": 34795349,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B) Staphylococcus aureus</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Although Staphylococcus aureus can cause various skin infections, including cellulitis, abscesses, and impetigo, it does not typically spread through dermal and subcutaneous lymphatics in the characteristic pattern of lymphocutaneous spread. Staphylococcus aureus usually causes localized infections.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Organisms that can spread through dermal and subcutaneous lymphatics:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Sporothrix schenckii:</span></strong><span style=\"font-size:12.0pt\"> Causes sporotrichosis, also known as \"rose gardener's disease,\" which presents with nodular lymphangitis, characterized by lesions following the lymphatic drainage.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Nocardia asteroides:</span></strong><span style=\"font-size:12.0pt\"> Nocardiosis can present with cutaneous and subcutaneous lesions that spread along lymphatics, particularly in immunocompromised individuals.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Mycobacterium marinum:</span></strong><span style=\"font-size:12.0pt\"> Causes swimming pool granuloma or fish tank granuloma, presenting with skin lesions that spread along lymphatic channels.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">While Sporothrix schenckii, Nocardia asteroides, and Mycobacterium marinum are known to spread through dermal and subcutaneous lymphatics, causing lymphocutaneous lesions, Staphylococcus aureus typically causes localized skin infections and does not exhibit this pattern of spread.</span></span></span></p>",
      "correct_choice_id": 200381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50096,
      "choices": [
        {
          "id": 200384,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Antihistone antibodies</span></span></p>"
        },
        {
          "id": 200385,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Anti-dsDNA antibodies</span></span></p>"
        },
        {
          "id": 200386,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Anticentromere antibodies</span></span></p>"
        },
        {
          "id": 200387,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Antinuclear antibodies</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A young patient presents to the clinic with erythematous lesions over the exposed areas of the skin like hands, arms, chest, etc. She also complains of arthralgia and breathlessness. Which among the following antibodies will be useful in diagnosing this condition? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103830-am.jpeg\" style=\"height:257px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103830-am.jpeg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6968177",
      "question_audio": null,
      "question_video": null,
      "map_id": 34825928,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Anti-dsDNA antibodies</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient exhibits symptoms including erythematous lesions on sun-exposed areas of the skin, arthralgia, and breathlessness, which are characteristic of Systemic Lupus Erythematosus (SLE). The rash described is typical of an SLE rash and not dermatomyositis, which presents with rashes over the knuckles known as Gottron's papules.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For diagnosing SLE, anti-dsDNA antibodies are very useful due to their high specificity. Although their sensitivity is relatively low (30-50%), the specificity is very high (>90-95%), making them reliable markers for confirming the diagnosis of SLE. Anti-dsDNA antibodies are also associated with disease activity in SLE.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Antihistone antibodies:</span></strong><span style=\"font-size:12.0pt\"> These are primarily associated with drug-induced lupus erythematosus, not classic SLE.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Anticentromere antibodies:</span></strong><span style=\"font-size:12.0pt\"> These are typically seen in limited forms of scleroderma, particularly CREST syndrome, and are not associated with SLE.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Antinuclear antibodies (ANA):</span></strong><span style=\"font-size:12.0pt\"> While ANA is a good initial screening test for SLE due to its high sensitivity, it lacks specificity. ANA can be positive in a variety of autoimmune conditions, thus it is not as specific as anti-dsDNA antibodies for diagnosing SLE.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-dsDNA antibodies are highly specific for diagnosing Systemic Lupus Erythematosus (SLE), despite their moderate sensitivity.</span></span></span></p>",
      "correct_choice_id": 200385,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50097,
      "choices": [
        {
          "id": 200388,
          "text": "<p><span style=\"font-size:12.0pt;\">1,5,4,2,3</span></p>"
        },
        {
          "id": 200389,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4,5</span></p>"
        },
        {
          "id": 200390,
          "text": "<p><span style=\"font-size:12.0pt;\">5,4,3,2,1</span></p>"
        },
        {
          "id": 200391,
          "text": "<p><span style=\"font-size:12.0pt;\">5,1,2,3,4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Arrange the cells according to their positions from the basal layer towards the lumen in the seminiferous tubules? (</span>INICET Nov 2022)</p><p> </p><p><span style=\"font-size:12.0pt;\">1. Spermatogonia</span></p><p><span style=\"font-size:12.0pt;\">2. Primary spermatocyte</span></p><p><span style=\"font-size:12.0pt;\">3. Spermatid</span></p><p><span style=\"font-size:12.0pt;\">4. Spermatozoa</span></p><p><span style=\"font-size:12.0pt;\">5. Myoepithelial cell</span></p>",
      "unique_key": "Q2775439",
      "question_audio": null,
      "question_video": null,
      "map_id": 34430655,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. 5,1,2,3,4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">From the basal layer towards the lumen in the seminiferous tubules, the cells are arranged in the order of:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Myoepithelial cells</span></li><li><span style=\"font-size:12.0pt;\">Spermatogonia</span></li><li><span style=\"font-size:12.0pt;\">Primary spermatocyte</span></li><li><span style=\"font-size:12.0pt;\">Spermatid</span></li><li><span style=\"font-size:12.0pt;\">Spermatozoa</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">In the seminiferous tubules, cells are organized in a specific sequence from the basal layer towards the lumen as part of the spermatogenesis process. The order reflects the developmental stages of sperm cells:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">5. Myoepithelial cells: These cells, located at the basal layer, support the structure and function of the seminiferous tubules.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">1. Spermatogonia: These are the stem cells located just above the basal membrane, which undergo mitotic divisions to produce more spermatogonia or differentiate into primary spermatocytes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">2. Primary spermatocytes:  Situated above the spermatogonia, these cells undergo meiosis I to form secondary spermatocytes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">3. Spermatid: Derived from the secondary spermatocytes after meiosis II, these cells are closer to the lumen and undergo spermiogenesis to become spermatozoa.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">4. Spermatozoa: These are the final, mature male gametes that are nearest to the lumen of the tubule, ready to be released into the reproductive tract.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">From the basal layer towards the lumen in the seminiferous tubules, the cells are arranged in the order of:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Myoepithelial cells</span></li><li><span style=\"font-size:12.0pt;\">Spermatogonia</span></li><li><span style=\"font-size:12.0pt;\">Primary spermatocyte</span></li><li><span style=\"font-size:12.0pt;\">Spermatid</span></li><li><span style=\"font-size:12.0pt;\">Spermatozoa</span></li></ul>",
      "correct_choice_id": 200391,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50098,
      "choices": [
        {
          "id": 200392,
          "text": "<p><span style=\"font-size:12pt;\">Squamous cell carcinoma</span></p>"
        },
        {
          "id": 200393,
          "text": "<p><span style=\"font-size:12pt;\">Basal cell carcinoma</span></p>"
        },
        {
          "id": 200394,
          "text": "<p><span style=\"font-size:12pt;\">Melasma</span></p>"
        },
        {
          "id": 200395,
          "text": "<p><span style=\"font-size:12pt;\">Discoid lupus erythematosus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Based on the image, a 60-year-old male patient with diabetes presents with progressive skin lesions. What could be the likely diagnosis? </span>(INICET NOVEMBER 2022)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture4_QYIjZ0G.jpg\" alt=\"\" width=\"300\" height=\"255\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture4_QYIjZ0G.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9881535",
      "question_audio": null,
      "question_video": null,
      "map_id": 34090508,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Basal cell carcinoma</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The image above displays a <strong>central rodent ulcer</strong>, which <strong>indicates basal cell carcinoma.</strong> This malignant tumor exhibits characteristics of <strong>slow local invasion and mainly affects the pilosebaceous skin.</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Basal Cell Carcinoma (BCC):</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The <strong>most significant predisposing factor</strong> for basal cell carcinoma is <strong>exposure to ultraviolet radiation</strong>. Other risk factors include ionizing radiation, coal tar, aromatic hydrocarbons, and arsenic exposure.</span></li><li><span style=\"font-size:12pt;\">Basal cell carcinoma predominantly affects <strong>middle-aged</strong> or <strong>elderly men</strong> with a history of excessive <strong>sun exposure</strong>, often among individuals with <strong>white skin, aged between 40 to 80 years.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Morphologically</strong>, basal cell carcinoma can be of 2 types:</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>1. Localized types</strong>: These are more common and include:</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12pt;\"><strong>Nodular and nodulocystic BCC</strong>: Representing the <strong>majority of cases</strong>, these appear as <strong>pearly, waxy nodules with rolled borders</strong> and sometimes central <strong>ulceration or depression</strong>, known as <strong>umbilication</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture16.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12pt;\"><strong>Pigmented BCC</strong>: These are similar to nodular BCC but contain <strong>melanin,</strong> giving them a <strong>darker appearance</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Nevoid BCC</strong>: This type is rarer and can <strong>resemble benign moles</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>2. Generalized types</strong>: These are <strong>less common</strong> and can be <strong>more challenging</strong> to treat due to their growth patterns:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Superficial multifocal and spreading BCC</strong>: Often appearing as <strong>scaly, erythematous patches</strong> that can be <strong>mistaken for eczema or psoriasis</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Infiltrative BCC</strong>: These grow more aggressively and can <strong>invade deeper</strong> tissues.</span></li><li><span style=\"font-size:12pt;\"><strong>Cicatrizing (or sclerosing) BCC</strong>: This type can cause <strong>scarring</strong> as it grows.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\">While <strong>nodular BCC</strong> is the <strong>most common</strong> form, it is important for <strong>medical practitioners</strong> to recognize the less common types due to their <strong>growth patterns</strong> and <strong>potential for tissue destruction.</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Squamous cell carcinoma (SCC)</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It typically presents as a <strong>firm, red nodule</strong> or a <strong>flat sore</strong> with a <strong>scaly crust </strong>as seen in the image below.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture17.jpg\" alt=\"\" width=\"500\" height=\"246\"></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">While it's possible for diabetic patients to develop SCC, the description provided fits BCC more closely.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Melasma</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It is characterized by <strong>brown to gray-brown</strong> patches as seen in the image below.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture18.jpg\" alt=\"\" width=\"300\" height=\"400\"></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It is usually seen on the <strong>face.</strong></span></li><li><span style=\"font-size:12pt;\">It is more common in <strong>women</strong>, especially during <strong>pregnancy,</strong> and is not typically associated with progressive lesions.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Discoid lupus erythematosus</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It often presents as a <strong>chronic rash</strong> with <strong>red, inflamed, and scaly patches</strong> that can cause <strong>scarring</strong>, usually on the <strong>face, ears, and scalp</strong>, as seen in the image below.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture19.jpg\" alt=\"\" width=\"300\" height=\"162\"></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It is an <strong>autoimmune condition</strong> and not directly linked to diabetes.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">In an <strong>elderly patient</strong>, progressive <strong>pearly or waxy skin</strong> lesions, especially if located on <strong>sun-exposed</strong> areas, are likely indicative of <strong>basal cell carcinoma</strong>.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology -9th Edition Page no 4.15, 51.3, 88.10-12, 141.1-16</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Robbins basic pathology 10<sup>th</sup> edition page no 1148</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Bailey & Loves short practice of surgery 27<sup>th</sup> edition Page no 599, 604-6011</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture16.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200393,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50099,
      "choices": [
        {
          "id": 200396,
          "text": "<p><span style=\"font-size:12.0pt;\">Nylon</span></p>"
        },
        {
          "id": 200397,
          "text": "<p><span style=\"font-size:12.0pt;\">Polyglactin</span></p>"
        },
        {
          "id": 200398,
          "text": "<p><span style=\"font-size:12.0pt;\">Polypropylene 1-0</span></p>"
        },
        {
          "id": 200399,
          "text": "<p><span style=\"font-size:12.0pt;\">Polypropylene 2-0</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following suture materials is commonly used in neurosurgery and microsurgery? (INICET NOV 2022)</span></p>",
      "unique_key": "Q8366671",
      "question_audio": null,
      "question_video": null,
      "map_id": 34305159,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Nylon</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Nylon is a non-absorbable suture material and is commonly used in neurosurgery, microsurgery, and ophthalmic surgery due to its low tissue reaction and high tensile strength.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Polyglactin:</strong> Polyglactin (Vicryl) is an absorbable braided suture material and is commonly used in general surgical practices for gut anastomoses, vascular ligatures, subcuticular wound closures, and ophthalmic surgery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Polypropylene 1-0 & Option D. Polypropylene 2-0: </strong>Polypropylene is a non-absorbable suture material and is used in plastic surgery, cardiovascular surgery, hernia repair. Polypropylene 1-0 and 2-0 refer to the size or diameter of the suture, with 1-0 being larger than 2-0. These sutures are too thick to be used in microsurgery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Therefore, options B, C, and D are incorrect as they do not match the given description.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-153525.jpg\" alt=\"\" width=\"1000\" height=\"526\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-153525.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200396,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50100,
      "choices": [
        {
          "id": 200400,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute lymphoblastic leukemia</span></span></span></p>"
        },
        {
          "id": 200401,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic lymphocytic leukemia</span></span></span></p>"
        },
        {
          "id": 200402,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute myeloid leukemia</span></span></span></p>"
        },
        {
          "id": 200403,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic myelogenous leukemia</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The given peripheral smear is associated with which of the following leukemias? (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture2.jpg\" style=\"height:209px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture2.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7035322",
      "question_audio": null,
      "question_video": null,
      "map_id": 34030211,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Chronic lymphocytic leukemia</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"> </span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The peripheral smear findings point toward a diagnosis of chronic lymphocytic leukemia.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The blood contains large numbers of small round lymphocytes with scant cytoplasm. Some of these cells are usually disrupted in the process of making smears, producing <strong>so-called smudge cells</strong>. Lymphocytes are of same size and configuration with a uniform appearance <strong>called as \"convent-girl\" appearance.</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Acute lymphoblastic leukemia (ALL)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The peripheral smear in ALL typically shows a high number of lymphoblasts, which are larger than normal lymphocytes and have a high nuclear-cytoplasmic ratio. There would be an absence of smudge cells, which are characteristic of CLL.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Acute myeloid leukemia (AML)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: AML is characterized by the presence of myeloblasts in the peripheral blood smear. These cells are larger, have more cytoplasm, and may contain Auer rods. Again, smudge cells are not a feature of AML.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Chronic myelogenous leukemia (CML)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The peripheral smear in CML shows a full spectrum of myeloid cells, from myeloblasts to mature neutrophils, often with an increase in basophils and eosinophils. Smudge cells are not a characteristic finding in CML.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-122634_v2GVwX7.jpg\" style=\"height:370px; width:1000px\" /></strong></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-122634_v2GVwX7.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200401,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50101,
      "choices": [
        {
          "id": 200404,
          "text": "<p><span style=\"font-size:12.0pt;\">It decreases ATP production and hence breaks the links between globin chains</span></p>"
        },
        {
          "id": 200405,
          "text": "<p><span style=\"font-size:12.0pt;\">It increases ATP production</span></p>"
        },
        {
          "id": 200406,
          "text": "<p><span style=\"font-size:12.0pt;\">Binds to the central cavity of hemoglobin surrounded by histidine and lysine and favours salt bridge formation</span></p>"
        },
        {
          "id": 200407,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits Taut structure formation</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">2,3 BPG causes unloading of oxygen to tissues because:</span></p>",
      "unique_key": "Q9388763",
      "question_audio": null,
      "question_video": null,
      "map_id": 34954900,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Binds to the central cavity of hemoglobin surrounded by histidine and lysine and favors salt bridge formation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Binds to the central cavity of hemoglobin surrounded by histidine and lysine and favors salt bridge formation:</strong> This is the correct explanation. 2,3 BPG binds to a specific site in hemoglobin's central cavity, which is surrounded by histidine and lysine residues. This binding reduces hemoglobin's affinity for oxygen, favoring the release of oxygen molecules from hemoglobin into the surrounding tissues. The formation of salt bridges as a result of this binding contributes to the release of oxygen.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>It decreases ATP production and hence breaks the links between globin chains:</strong> This statement is not accurate. 2,3 BPG does not directly affect ATP production or break links between globin chains.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>It increases ATP production:</strong> This statement is not correct. 2,3 BPG is not involved in ATP production.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Inhibits Taut structure formation:</strong> This statement is not accurate. 2,3 BPG does not inhibit the formation of the Taut structure.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">2,3 BPG is formed in RL shunt which has no net ATP production</span></li><li><span style=\"font-size:12.0pt;\">2,3-Bisphosphoglycerate (2,3-BPG) plays a crucial role in regulating oxygen delivery by binding to deoxyhemoglobin and stabilizing the T (taut) state, which has a lower affinity for oxygen, thereby promoting oxygen unloading to tissues.</span></li></ul><p> </p><p><span style=\"color:#212529;font-size:12.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:500/500;width:97.9%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture5_Zb3dzLZ.jpg\" alt=\"\" width=\"500\" height=\"500\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">When 2,3 BPG levels gets decreased, it promotes relaxed confirmation of Hb resulting in oxygen loading.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture5_Zb3dzLZ.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200406,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50102,
      "choices": [
        {
          "id": 200408,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">CAMP</span></span></span></p>"
        },
        {
          "id": 200409,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">cGMP</span></span></span></p>"
        },
        {
          "id": 200410,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Calcium</span></span></span></p>"
        },
        {
          "id": 200411,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phosphatidyl glycerol and inositol phosphate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient with erectile dysfunction is given sildenafil. Which of the following mediates the action of sildenafil? (</span></span>INICET Nov 2022)</p>",
      "unique_key": "Q4400311",
      "question_audio": null,
      "question_video": null,
      "map_id": 34327036,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B. cGMP</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Sildenafil is a phosphodiesterase 5 inhibitor.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The corpus cavernosum produces nitric oxide during arousal that stimulates the formation of cGMP. cGMP causes relaxation of the smooth muscle of the corpus cavernosum and penile arteries, engorgement of the corpus cavernosum, and erection.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">By inhibiting PDE 5, the hydrolysis if cGMP is prevented, thus leading to erection.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. cAMP</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: cAMP (cyclic adenosine monophosphate) is another second messenger involved in various biological processes, but it is not the primary mediator in the mechanism of action of sildenafil for erectile dysfunction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Calcium</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Calcium plays a critical role in muscle contraction and various cellular functions, but it is not directly involved in the mechanism of action of sildenafil for treating erectile dysfunction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Phosphatidyl glycerol and inositol phosphate</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: These molecules are involved in different signaling pathways, such as the phosphatidylinositol pathway, but they are not relevant to the action of sildenafil.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Sildenafil, a PDE5 inhibitor, enhances and prolongs erections by preventing the breakdown of cGMP, which is the primary mediator responsible for smooth muscle relaxation and increased blood flow in the corpus cavernosum of the penis during arousal.</span></span></span></p>",
      "correct_choice_id": 200409,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50103,
      "choices": [
        {
          "id": 200412,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1-a, 2-b, 3-c, 4-d</span></span></span></span></span></p>"
        },
        {
          "id": 200413,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿1-c, 2-d, 3-a, 4-b</span></span></span></span></span></p>"
        },
        {
          "id": 200414,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿1-d, 2-a, 3-d, 4-c</span></span></span></span></span></p>"
        },
        {
          "id": 200415,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿1-d, 2-c, 3-b, 4-a</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following teratogenic drugs with their teratogenic effects: (</span></span></span>INICET Nov 2022)</p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-181740.jpg\" style=\"height:290px; width:1000px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-181740.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9209614",
      "question_audio": null,
      "question_video": null,
      "map_id": 34679047,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">1-d, 2-c, 3-b, 4-a</span></strong></span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The correctly matched pairs of teratogenic drugs and their effects is 1-d, 2-c, 3-b, 4-a.</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Lithium is used in the treatment of bipolar disorders and prophylaxis of mania. It is c/I in pregnancy as it leads to Ebstein’s anomaly in the fetus, which is characterised by arterialization of the right ventricle and a box shaped heart.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Warfarin leads to defect in the growth of the cartilage (chondrodysplasia punctata) characterized by depressed nasal bridge, stippled epiphyses etc. Warfarin embryopathy is maximally seen when it is used between 6-9 weeks.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Thalidomide causes proximal limb defect or Phocomelia. Thalidomide acts via inhibiting angio-genesis, inhibiting cereblon and suppressing immune responses. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Chloramphenicol inhibits peptidyl transferase. It causes Bone Marrow suppression and leads to grey baby syndrome.</span></span></span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The teratogenic effects of certain drugs is crucial for managing medication use during pregnancy. Lithium can cause Ebstein’s anomaly, Warfarin is associated with saddle nose and growth retardation, Thalidomide causes limb malformations, and Chloramphenicol can lead to Grey Baby Syndrome.</span></span></span></p>",
      "correct_choice_id": 200415,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50104,
      "choices": [
        {
          "id": 200416,
          "text": "<p><span style=\"font-size:12.0pt;\">Iliolumbar artery</span></p>"
        },
        {
          "id": 200417,
          "text": "<p><span style=\"font-size:12.0pt;\">Lateral sacral artery</span></p>"
        },
        {
          "id": 200418,
          "text": "<p><span style=\"font-size:12.0pt;\">Inferior gluteal artery</span></p>"
        },
        {
          "id": 200419,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior gluteal artery</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is not a branch of the posterior division of the internal iliac artery?</span><span style=\"font-size:14px;\"> (INICET MAY 2022)</span></p>",
      "unique_key": "Q5318106",
      "question_audio": null,
      "question_video": null,
      "map_id": 34432169,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Inferior gluteal artery</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: The inferior gluteal artery is typically a branch of the anterior division of the internal iliac artery.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Course & Supply</strong>: It exits the pelvis through the greater sciatic foramen, usually below the piriformis muscle. It supplies the gluteal muscles (mainly gluteus maximus), and also gives off branches that participate in anastomoses around the hip joint.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Iliolumbar Artery</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: This arises from the posterior division of the internal iliac artery.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Course & Supply</strong>: It ascends posteriorly to supply the iliacus muscle, the iliac bone, and the lumbosacral region. Its branches also participate in anastomoses with the lumbar arteries.</span></li></ul><p style=\"margin-left:48px;\"> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lateral Sacral Artery</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: This too arises from the posterior division of the internal iliac artery.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Course & Supply</strong>: Generally, there are two lateral sacral arteries (superior and inferior) that descend to supply the sacrum and coccyx. They anastomose with the median sacral artery and with each other. Some branches of the lateral sacral arteries also supply the meninges of the sacral part of the spinal cord.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Superior Gluteal Artery</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: This artery arises from the posterior division of the internal iliac artery.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Course & Supply</strong>: It leaves the pelvis through the greater sciatic foramen, usually above the piriformis muscle. It supplies the gluteal muscles and also contributes to the anastomotic network around the hip joint.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Branches of the anterior trunk of the internal iliac artery:</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Vaginal artery (in females)</span></li><li><span style=\"font-size:12.0pt;\">Uterine artery (in females)</span></li><li><span style=\"font-size:12.0pt;\">Inferior vesical artery (in males) or vaginal artery (in females): supplies the urinary bladder and reproductive organs.</span></li><li><span style=\"font-size:12.0pt;\">Middle rectal artery: supplies the rectum and anal canal.</span></li><li><span style=\"font-size:12.0pt;\">Internal pudendal artery: supplies the perineum, external genitalia, and the lower anal canal.</span></li><li><span style=\"font-size:12.0pt;\">Obturator artery: supplies the adductor muscles of the thigh, external genitalia, and the hip joint.</span></li><li><span style=\"font-size:12.0pt;\">Inferior gluteal artery: supplies the muscles of the gluteal region.</span></li><li><span style=\"font-size:12.0pt;\">Superior vesical artery: supplies the urinary bladder and the vas deferens.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/09/ia-13.jpg\" alt=\"\" width=\"700\" height=\"563\"></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/09/ia-13.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200418,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50105,
      "choices": [
        {
          "id": 200420,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">This action can be reversed by phenylephrine.</span></span></span></span></span></p>"
        },
        {
          "id": 200421,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿It cannot be reversed by levallorphan.</span></span></span></span></span></p>"
        },
        {
          "id": 200422,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">It is caused by activation of the Edinger-Westphal nucleus.</span></span></span></span></span></p>"
        },
        {
          "id": 200423,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Tolerance develops to this adverse effect on long-term use.</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient with a history of substance addiction is admitted to the hospital due to the overdose of the addictive substance. The patient has slow heart rate, respiratory depression, and low blood pressure. His ocular findings are shown below. Which of the following statements is true regarding this condition? (INICET NOV 2022)</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/750.jpg\" style=\"height:202px; width:300px\" /></span></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/750.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1693124",
      "question_audio": null,
      "question_video": null,
      "map_id": 34518083,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C.<span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\"> It is caused by activation of the Edinger-Westphal nucleus.</span></strong></span></span></span></strong></span></span><br />\r\n </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The pupil is constricted in the given image and as the history describes the patient to be an addict, who is brought to the hospital in an intoxicated state. The clinical features like pin-point pupils, bradycardia, hypotension, respiratory depression suggests that this is a case of opioid intoxication.</span></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong>Opioid induced miosis:</strong></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The pupillary constriction caused by opioids result due to the activation of the Edinger Westphal Nucleus. Therefore, topical use of opioids in the eye does not induce miosis. It will be seen only on systemic administration of opioids. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The miosis induced by opioids cannot be reversed by mydriatic drugs like phenylephrine or anticholinergic drugs. Rather it can be reversed by opioid antagonists like naloxone and levallorphan.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Tolerance does not develop to opioid induced miosis even on long term use. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. This action can be reversed by phenylephrine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Phenylephrine is a mydriatic agent that causes dilation of the pupil by stimulating alpha-1 adrenergic receptors. It would not reverse opioid-induced miosis, which is due to central nervous system effects rather than direct effects on the iris muscles.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. It cannot be reversed by levallorphan</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Levallorphan is an opioid antagonist that can reverse the effects of opioid toxicity, including miosis. Therefore, this statement is incorrect.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Tolerance develops to this adverse effect on long-term use:</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Tolerance to opioid-induced miosis does not typically develop, even with long-term use of opioids. Therefore, this statement is incorrect.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Opioid-induced miosis is caused by activation of the Edinger-Westphal nucleus, and it is a characteristic sign of opioid intoxication. This effect cannot be reversed by phenylephrine, and tolerance does not develop to this effect with long-term opioid use. Opioid antagonists like naloxone and levallorphan can reverse the miosis caused by opioid overdose</span></span></span></p>",
      "correct_choice_id": 200422,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50106,
      "choices": [
        {
          "id": 200424,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">iv, v</span></span></span></p>"
        },
        {
          "id": 200425,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ii</span></span></span></p>"
        },
        {
          "id": 200426,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">v</span></span></span></p>"
        },
        {
          "id": 200427,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ii, iii</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the incorrectly matched pair(s) of pharyngeal arch and its artery?</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol style=\"list-style-type:lower-roman\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1st arch - Maxillary artery</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2nd arch - Hyoid and stapedial artery</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3rd arch - Common carotid and proximal internal carotid artery</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4th arch - Subclavian artery</span></span></span></li>\r\n\t<li><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">6th arch - Aorta on the left side</span></span></li>\r\n</ol>\r\n\r\n<p> </p>",
      "unique_key": "Q2956973",
      "question_audio": null,
      "question_video": null,
      "map_id": 34557083,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\"> C. v</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All the given pairs of pharyngeal arteries and their arteries are correctly matched except for 'v' (option C).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The 6th pharyngeal arch has its blood supply on the left side from the left pulmonary artery and ductus arteriosus, not from the aorta.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol style=\"list-style-type:lower-roman\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1st arch - Maxillary artery</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Correct. The maxillary artery is indeed a derivative of the first pharyngeal arch.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2nd arch - Hyoid and stapedial artery:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Correct. The hyoid artery (or the stapedial artery in its embryonic context) is derived from the second pharyngeal arch.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3rd arch - Common carotid and proximal internal carotid artery</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Correct. The third pharyngeal arch gives rise to portions of the common carotid artery and the proximal part of the internal carotid artery.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4th arch - Subclavian artery:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Correct on the right side. The fourth pharyngeal arch is associated with the development of the right subclavian artery and part of the aortic arch on the left side.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/17.jpg\" style=\"height:284px; width:500px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/17.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200426,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50107,
      "choices": [
        {
          "id": 200428,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adenocarcinoma</span></span></span></p>"
        },
        {
          "id": 200429,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Squamous cell carcinoma</span></span></span></p>"
        },
        {
          "id": 200430,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Large cell carcinoma</span></span></span></p>"
        },
        {
          "id": 200431,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Small cell carcinoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 55-year-old male, with a smoking history of 20 pack years, presented in OPD with breathlessness and chest pain. Further investigations revealed a lung tumor. On staining, cells are positive for chromogranin. What is the likely diagnosis? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(INICET NOV 2022)</span></span></p>",
      "unique_key": "Q3282704",
      "question_audio": null,
      "question_video": null,
      "map_id": 34173449,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Small cell carcinoma  </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">History of chronic smoking and lung tumor cells staining positive for chromogranin suggests small cell carcinoma of the lung.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SMALL CELL CARCINOMAS:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This highly malignant tumor has a distinctive cell type. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Strongly associated with cigarette smoking</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This lung cancer type is most commonly associated with ectopic hormone production</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Electron microscopy shows </span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dense-core neurosecretory granules are present along the bronchial epithelium which can secrete polypeptide hormones</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Presence of neuroendocrine markers such as chromogranin, synaptophysin, and CD57 (in 75% of cases) and parathormone-like and other hormonally active products suggest derivation of this tumor from neuroendocrine progenitor cells of the lining bronchial epithelium. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Adenocarcinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is the most common subtype of lung cancer, especially in non-smokers, and it typically involves peripheral lung lesions. It is characterized by markers like TTF-1, NAPSIN-A, and CEA, rather than chromogranin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Squamous cell carcinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This type is also associated with smoking but is more likely to present centrally in the lungs. It shows keratinization and intercellular bridges on histology and is associated with markers like p40 and p63, not chromogranin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Large cell carcinoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This diagnosis is typically a diagnosis of exclusion and does not have a specific marker like chromogranin. It is also more common in non-smokers and presents as a peripheral tumor.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-115311.jpg\" style=\"height:733px; width:800px\" /></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-144842.jpg\" style=\"height:658px; width:1000px\" /></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-115311.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200431,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50108,
      "choices": [
        {
          "id": 200432,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 200433,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 200434,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 200435,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following tests can be used if otoacoustic emissions is absent for screening?</span>(INICET NOV 2022)</p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Pure tone audiometry</span></li><li><span style=\"font-size:12.0pt;\">Tympanometry</span></li><li><span style=\"font-size:12.0pt;\">Free field audiometry</span></li><li><span style=\"font-size:12.0pt;\">Speech audiometry</span></li></ol>",
      "unique_key": "Q4961282",
      "question_audio": null,
      "question_video": null,
      "map_id": 34861815,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 2 and 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">When otoacoustic emissions (OAE) are absent, it indicates a potential cochlear pathology, specifically affecting the outer hair cells. Further testing is required to assess the extent and nature of hearing loss, as well as to rule out any retrocochlear pathology.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2. Tympanometry</strong>: This test assesses the condition of the middle ear and tympanic membrane mobility by creating variations in air pressure in the ear canal. It is useful to determine if the absence of OAEs might be related to middle ear issues, such as fluid, which can mask cochlear function.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4. Speech Audiometry</strong>: This test evaluates the ability to understand speech and also provides information about the clarity of speech perception. It helps to determine the speech recognition threshold and is crucial for diagnosing the degree and type of hearing loss when OAEs are absent.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. Pure Tone Audiometry</strong>: While this test is crucial for determining the threshold levels of hearing and the degree of hearing loss across different frequencies, it was not specified as one of the correct responses in this context.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3. Free Field Audiometry</strong>: Generally used for young children or individuals who cannot reliably use headphones, this test measures hearing sensitivity to sounds presented in an open field. However, it requires a controlled sound field, which is not always practical for immediate follow-up when OAEs are absent.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-110337.png\" alt=\"\" width=\"1000\" height=\"642\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 29</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-110337.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200432,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50109,
      "choices": [
        {
          "id": 200436,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Multi-infarct dementia</span></span></p>"
        },
        {
          "id": 200437,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Frontal lobe meningioma</span></span></p>"
        },
        {
          "id": 200438,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Korsakoff disease </span></span></p>"
        },
        {
          "id": 200439,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Subdural hematoma</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">An old lady sustained a fall and developed a headache and neurological symptoms a few days later. What is your diagnosis? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q8554242",
      "question_audio": null,
      "question_video": null,
      "map_id": 34608941,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D) Subdural hematoma</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The given clinical scenario of an elderly individual experiencing a headache and neurological symptoms following a fall is highly suggestive of <strong>subdural hematoma (SDH)</strong>. Subdural hematomas occur due to bleeding between the arachnoid membrane and the dura mater, which typically results from the rupture of bridging veins. These veins are more prone to injury in elderly patients due to brain atrophy, which increases the distance the veins need to traverse.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Elderly individuals, alcoholics, and patients on anticoagulant therapy</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> are at higher risk for developing subdural hematomas. Often, these injuries are triggered by even minor or trivial trauma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A <strong>non-contrast CT scan</strong> is the preferred diagnostic modality for detecting a subdural hematoma. On CT imaging, acute SDH appears <strong>hyperdense</strong> (bright), while chronic SDH appears <strong>hypodense</strong> (dark).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Key features of subdural hematomas on CT include:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Crescent-shaped</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (concavo-convex) appearance.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hemorrhage may spread across suture lines (unlike epidural hematomas).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Typically unilateral (85% of cases).</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">If the subdural hematoma is large (>1 cm), causes a midline shift >5 mm, or there is a neurological decline (e.g., a drop in Glasgow Coma Scale by two or more points), <strong>surgical intervention (craniotomy)</strong> is indicated for evacuation of the hematoma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Multi-infarct dementia (MID)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: MID is a type of <strong>vascular dementia</strong> that occurs due to multiple small infarctions or strokes, often leading to cognitive decline and memory loss. This type of dementia is common in the elderly, but it is not associated with trauma or sudden neurological symptoms.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Frontal lobe meningioma</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Meningiomas are <strong>benign brain tumors</strong> that arise from the meninges. They usually grow slowly and can cause progressive symptoms depending on their location. Frontal lobe tumors may result in <strong>personality changes</strong> and cognitive decline but are not related to trauma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Korsakoff syndrome</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Korsakoff syndrome is a <strong>memory disorder</strong> caused by <strong>thiamine (vitamin B1) deficiency</strong>, most commonly seen in alcoholics. It primarily affects the ability to form new memories (anterograde amnesia) and may be accompanied by confabulation. However, this condition is not typically linked to traumatic injuries.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Subdural hematoma</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is caused by the rupture of bridging veins between the dura and arachnoid mater, often due to minor trauma in the elderly or patients on anticoagulants. Diagnosis is confirmed through a <strong>non-contrast CT scan</strong>, and surgical intervention is required in severe cases with significant mass effect.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200439,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50110,
      "choices": [
        {
          "id": 200440,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium iodide</span></p>"
        },
        {
          "id": 200441,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 200442,
          "text": "<p><span style=\"font-size:12.0pt;\">Propylthiouracil</span></p>"
        },
        {
          "id": 200443,
          "text": "<p><span style=\"font-size:12.0pt;\">Betamethasone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male patient with Graves' disease with eye signs and enlarged thyroid is scheduled for a total thyroidectomy. What medication can be administered in the preoperative period to minimize intraoperative bleeding in this patient? (INICET NOV 2022)</span></p>",
      "unique_key": "Q9154000",
      "question_audio": null,
      "question_video": null,
      "map_id": 34688491,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Potassium iodide</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Potassium iodide, which can be given 10 days before the surgery to reduce intraoperative bleeding during total thyroidectomy. This is because iodide alone produces transient remission and may reduce vascularity, thereby marginally improving safety.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Propranolol: </strong>Propranolol is a beta-blocker that can be used to prepare the patient for surgery by inhibiting the peripheral conversion of T4 to T3 and causing beta-adrenergic blockade. However, it is not specifically used to reduce intraoperative bleeding during thyroidectomy. It is beneficial in thyroid storm.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Propylthiouracil</strong>: Propylthiouracil is an antithyroid drug that inhibits thyroid synthesis and peripheral conversion of T4 to T3. It is used to render the patient euthyroid before surgery, but it is not specifically used to reduce intraoperative bleeding.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Betamethasone</strong>: Betamethasone is a glucocorticoid that reduces the peripheral conversion of T4 to T3. However, it is not used preoperatively in thyroidectomy to reduce intraoperative bleeding.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Graves' disease is an autoimmune disorder that results in an overactive thyroid gland, known as hyperthyroidism. In this condition, the immune system attacks the thyroid gland, causing it to produce more thyroid hormone than the body needs. As a result, the thyroid gland becomes hyperactive, leading to various symptoms associated with hyperthyroidism. Graves' disease is the most prevalent cause of hyperthyroidism.</span></p>",
      "correct_choice_id": 200440,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50111,
      "choices": [
        {
          "id": 200444,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Uveitis</span></span></span></p>"
        },
        {
          "id": 200445,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Mucormycosis</span></span></span></p>"
        },
        {
          "id": 200446,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Follicular conjunctivitis</span></span></span></p>"
        },
        {
          "id": 200447,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Papillary conjunctivitis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The most common ocular manifestation of COVID-19 is _______. (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q5453166",
      "question_audio": null,
      "question_video": null,
      "map_id": 34325398,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) Follicular conjunctivitis</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The most common ocular manifestation of COVID-19 is </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">follicular conjunctivitis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Other ocular symptoms associated with COVID-19 include:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Hemorrhagic conjunctivitis</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Dry eye disease</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Episcleritis</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Chemosis</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Photophobia</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">However, these occur less frequently. The most prevalent ocular symptoms reported by COVID-19 patients are </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">dry eye</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> or </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">foreign body sensation</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, along with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">redness</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">tearing</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">itching</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">eye pain</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">discharge</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Severe intraocular complications can include:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Retinal artery occlusions</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Hemorrhages</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Cotton-wool spots</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (caused by complement-mediated thrombotic angiopathy)</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">ACE-2 receptors</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> present in the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">cornea</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">conjunctiva</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> make the ocular surface a potential target tissue for SARS-CoV-2 infection.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Sometimes, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">conjunctivitis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> may be the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">only symptom</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> of COVID-19, highlighting the need for patients with these signs to undergo nasopharyngeal RT-PCR testing.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Uveitis: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Uveitis is an inflammation of the uveal tract and is not a common manifestation in COVID-19 patients. While viral infections can cause uveitis, it is much less common than conjunctivitis in COVID-19 cases.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Mucormycosis: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Mucormycosis (commonly referred to as \"black fungus\") is a </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">secondary fungal infection</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> seen in immunocompromised COVID-19 patients, particularly those with uncontrolled diabetes or those treated with steroids. It is not considered a primary ocular manifestation of COVID-19 itself.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Papillary conjunctivitis: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Papillary conjunctivitis, characterized by large papillae in the conjunctiva, is not the most common type of conjunctivitis seen in COVID-19. </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Follicular conjunctivitis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is more frequently associated with viral infections like COVID-19.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">most common ocular manifestation</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> of COVID-19 is </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">follicular conjunctivitis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Patients with conjunctivitis as the sole symptom of COVID-19 should be tested with nasopharyngeal RT-PCR, as ocular involvement can be an early or even sole indicator of SARS-CoV-2 infection.</span></span></span></p>",
      "correct_choice_id": 200446,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50112,
      "choices": [
        {
          "id": 200448,
          "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">1,3,4,5</span></p>"
        },
        {
          "id": 200449,
          "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">2,3,4,5</span></p>"
        },
        {
          "id": 200450,
          "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">2,4</span></p>"
        },
        {
          "id": 200451,
          "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">1,4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following equipment is required for putting intravenous cannula in a newborn?</span>(INICET NOV 2022)</p><p> </p><ol><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">22G cannula</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">24G IV cannula</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">5-mL syringe</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Adhesive tape</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Normal saline</span></p></li></ol>",
      "unique_key": "Q2147542",
      "question_audio": null,
      "question_video": null,
      "map_id": 34569058,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-left:1px;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. 2,3,4,5</strong></span></p><p style=\"margin-left:1px;\"> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>2. 24G IV cannula:</strong> This refers to a 24-gauge (24G) cannula, which is typically used for neonates and infants due to its smaller diameter, making it suitable for their small and fragile veins.</span></p><p><span style=\"font-size:12pt;\"><strong>3. 5-mL syringe:</strong> While placing an IV cannula, it's essential to have a syringe attached. The syringe helps to test the patency of the cannula once it's in the vein (flashback of blood can be seen), and it also assists in gently flushing the cannula with normal saline to ensure it's correctly positioned.</span></p><p><span style=\"font-size:12pt;\"><strong>4. Adhesive tape:</strong> Once the cannula is in position, adhesive tape or a securement device is necessary to stabilize and fix the cannula in place, preventing it from dislodging.</span></p><p><span style=\"font-size:12pt;\"><strong>5. Normal saline:</strong> Normal saline is used for flushing the cannula once it's in place to ensure patency. It's also utilized to keep the cannula patent if it's not immediately hooked up to an IV line.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Option:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>1. 22G IV cannula:</strong> A 22-gauge (22G) cannula is larger and may be used for older infants or children but is often too large for a newborn's tiny veins. Hence, it is not typically used for neonates.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">For placing an IV cannula in a newborn, the equipment required includes a 24G needle, a 5-mL syringe, adhesive tape, and normal saline.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/06/screenshot-2024-07-06-160732.png\" alt=\"\" width=\"450\" height=\"300\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/06/screenshot-2024-07-06-160732.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200449,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50113,
      "choices": [
        {
          "id": 200452,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-2, B-3, C-1, D-4</span></span></span></span></span></p>"
        },
        {
          "id": 200453,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿A-4, B-3, C-1, D-2</span></span></span></span></span></p>"
        },
        {
          "id": 200454,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿A-3, B-4, C-2, D-1</span></span></span></span></span></p>"
        },
        {
          "id": 200455,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-4, B-3, C-2, D-1</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following drugs with the targets of their actions: (</span></span></span></span></span>INICET Nov 2022)</p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-185018.jpg\" style=\"height:311px; width:700px\" /></span></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-185018.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9937058",
      "question_audio": null,
      "question_video": null,
      "map_id": 34402902,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D. </span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-4, B-3, C-2, D-1</span></span></strong></span></span></span><br />\r\n </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Trastuzumab is used in HER2/neu positive breast cancers.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Infliximab is anti-TNFα monoclonal antibody used in the management of Rheumatoid arthritis.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Sirolimus acts by inhibiting the progression of cell cycle from G1 to S phase by blocking mTOR. It is used in the prevention of transplant rejection.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Imatinib is a BCR-ABL inhibitor that is used in the treatment of CML.</span></span></span></span></span><br />\r\n\t </li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-185152.jpg\" style=\"height:488px; width:1000px\" /></span></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-185152.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200455,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50114,
      "choices": [
        {
          "id": 200456,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Retrolentiform</span></span></p>"
        },
        {
          "id": 200457,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Sublentiform</span></span></p>"
        },
        {
          "id": 200458,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Anterior limb</span></span></p>"
        },
        {
          "id": 200459,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Posterior limb</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 50-year-old male patient presented with left-sided hemiparesis. Damage to which part of the internal capsule leads to this presentation?</span></span><span style=\"font-size:11.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> (</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">INICET MAY 2022)</span></span></p>",
      "unique_key": "Q7915364",
      "question_audio": null,
      "question_video": null,
      "map_id": 34078141,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Posterior limb</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The internal capsule is a white matter structure in the brain that contains many important tracts, including those for motor and sensory functions. Damage to specific parts of the internal capsule can result in different clinical presentations based on the fibers that are affected.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Posterior limb</span></strong><span style=\"font-size:12.0pt\"> is the part of the internal capsule that carries corticospinal and corticobulbar tracts, which are responsible for motor and sensory functions. Damage to the posterior limb can result in contralateral hemiparesis (weakness on the opposite side of the body). Therefore, a lesion in the posterior limb of the right internal capsule would lead to left-sided hemiparesis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Retrolentiform</span></strong><span style=\"font-size:12.0pt\">: This part of the internal capsule contains optic radiations, which are involved in visual processing. Damage here would lead to <strong>visual deficits</strong> rather than motor or sensory deficits.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Sublentiform</span></strong><span style=\"font-size:12.0pt\">: This part carries auditory radiations and is involved in hearing. Damage to this part would result in <strong>auditory deficits,</strong> not motor weakness.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Anterior limb</span></strong><span style=\"font-size:12.0pt\">: This part of the internal capsule contains frontopontine fibers and thalamocortical radiations, which are involved in <strong>cognitive and executive functions</strong>. Damage here might affect cognition but not typically result in hemiparesis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Damage to the posterior limb of the internal capsule can lead to contralateral hemiparesis due to the involvement of motor and sensory pathways.</span></span></span></p>",
      "correct_choice_id": 200459,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50115,
      "choices": [
        {
          "id": 200460,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Tocainide</span></span></span></span></span></p>"
        },
        {
          "id": 200461,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Propranolol</span></span></span></span></span></p>"
        },
        {
          "id": 200462,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Quinidine</span></span></span></span></span></p>"
        },
        {
          "id": 200463,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Lignocaine</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:\"Calibri\",sans-serif\">An anti-arrhythmic drug, which is effective in both atrial and ventricular arrhythmias, is shown to have the following effect on action potential. Which of the following is the most likely drug? (</span></span></span></span>INICET Nov 2022)</p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:Helvetica\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-10.jpg\" style=\"height:150px; width:300px\" /></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-10.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3181707",
      "question_audio": null,
      "question_video": null,
      "map_id": 34883892,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans.  C. Quinidine</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Quinidine and procainamide are class IA anti-arrhythmic agents. These blocks Na+ channel along with potassium channel as well. This increases action potential duration (APD), which leads to QT prolongation.</span></span></span></span></span><br />\r\n\t<br />\r\n\t </li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-11.jpg\" style=\"height:201px; width:400px\" /></span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. Tocainide</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Tocainide is a Class IB anti-arrhythmic drug. These drugs block Na+ channels and open K+ channels, reducing the slope of phase 4 of the action potential. This effect shortens the action potential duration.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-180023.png\" style=\"height:241px; width:400px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Propranolol</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Propranolol is a beta-receptor blocker and a Class II anti-arrhythmic. It works primarily by inhibiting sympathetic input to the heart, reducing heart rate, and decreasing the force of contraction. It does not directly affect the action potential duration in the same way as Class I drugs.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Lignocaine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Lignocaine (Lidocaine) is a Class IB anti-arrhythmic drug. It shortens the action potential duration by blocking Na+ channels and opening K+ channels. This effect is the opposite of what is shown in the graph.</span></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-180053.png\" style=\"height:246px; width:400px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Note – </span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Class 1c agents like Flecainide and Encainide block sodium channels with no action on potassium channel. The image below illustrates the action potential changes when a class 1c anti-arrhythmic is used.</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-180124.png\" style=\"height:240px; width:400px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Class IA anti-arrhythmic agents like Quinidine prolong the action potential duration by blocking sodium and potassium channels, making them effective in treating both atrial and ventricular arrhythmias. This effect is clearly reflected in the graph provided, distinguishing it from other classes of anti-arrhythmic drugs.</span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-11.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200462,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50116,
      "choices": [
        {
          "id": 200464,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosine at 508</span></p>"
        },
        {
          "id": 200465,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine at 508</span></p>"
        },
        {
          "id": 200466,
          "text": "<p><span style=\"font-size:12.0pt;\">Tryptophan at 508</span></p>"
        },
        {
          "id": 200467,
          "text": "<p><span style=\"font-size:12.0pt;\">Lysine at 805</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Cystic fibrosis is caused by which of the following deletion? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q7412171",
      "question_audio": null,
      "question_video": null,
      "map_id": 34326287,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Phenylalanine at 508</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Correct. Cystic fibrosis is primarily caused by the deletion of Phenylalanine at position 508 in the CFTR gene. This mutation leads to a malfunctioning CFTR protein, which results in the characteristic symptoms of cystic fibrosis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Tyrosine at 508: </strong>Cystic fibrosis is not caused by the deletion of Tyrosine at position 508. The critical deletion is of Phenylalanine at this position.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tryptophan at 508: </strong>Cystic fibrosis is not caused by the deletion of Tryptophan at position 508. The deletion of Phenylalanine at this position is the key mutation associated with cystic fibrosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lysine at 805: </strong>Cystic fibrosis is not caused by the deletion of Lysine at position 805. The F508del mutation is the most common and well-known mutation in cystic fibrosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cystic fibrosis is due to mutation in cystic fibrosis transmembrane conductance regulator (CFTR) protein by deletion of one codon which give rise to phenylalanine at position 508 of this protein. Mnemonic: F-fibrosis, F- Phenylalaine</span></p><p> </p><p><span style=\"font-size:12.0pt;\">This protein helps in movement of H<sub>2</sub>O and chloride ion in and out of cell and helps in the formation of mucus secretion and saliva.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In normal conditions, the channel allows the formation of thin layer of mucus. But in cystic fibrosis, a thick layer of mucus is formed (see fig) causing airway obstruction leading to infection and ultimately scarring of lung tissue.</span></p><p><span style=\"background-color:white;color:#212529;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture4_CFFYSB0.jpg\" alt=\"\" width=\"500\" height=\"500\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture4_CFFYSB0.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200465,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50117,
      "choices": [
        {
          "id": 200468,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 200469,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 200470,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
        },
        {
          "id": 200471,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man presented in OPD with complaints of fever, night sweats, and weight loss for 2 months. On examination, lymphadenopathy was present. They were non-tender, rubbery in consistency, located in the supraclavicular and inguinal regions on both sides. Peripheral smear showed the presence of bi-nucleated cells. Which markers can be identified in this condition? (INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">CD15</span></li><li><span style=\"font-size:12.0pt;\">CD30</span></li><li><span style=\"font-size:12.0pt;\">CD19</span></li><li><span style=\"font-size:12.0pt;\">CD3</span></li></ol>",
      "unique_key": "Q8635375",
      "question_audio": null,
      "question_video": null,
      "map_id": 34649279,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1 and 2</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Clinical history and the histopathological examination showing bi-nucleated cells, called Reed Sternberg cells points to a diagnosis of Hodgkins lymphoma. RS cells are CD 15+ and CD30+.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Reed-Sternberg cells marker –</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">CDI5</span></li><li><span style=\"font-size:12.0pt;\">CD30 (most sensitive)</span></li><li><span style=\"font-size:12.0pt;\">PAX-5 (most SPECIFIC)</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-121049.png\" alt=\"\" width=\"400\" height=\"253\"></p><p> </p><p><span style=\"font-size:12.0pt;\">Reed Sternberg Cells are non-specific since it is seen in conditions like:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Hodgkin’s Lymphoma</span></li><li><span style=\"font-size:12.0pt;\">Non- Hodgkin’s Lymphoma</span></li><li><span style=\"font-size:12.0pt;\">Infection Mononucleosis</span></li><li><span style=\"font-size:12.0pt;\">Sarcoma.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>CD19 (3) </strong>and <strong>CD3 (4):</strong> These markers are associated with B and T cells, respectively. CD19 is a B-cell marker, and CD3 is a T-cell marker. They are not typically associated with Reed-Sternberg cells in Hodgkin's lymphoma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In Hodgkin's lymphoma, Reed-Sternberg cells characteristically express CD15 and CD30, making these markers essential for diagnosis.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-121049.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200471,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50118,
      "choices": [
        {
          "id": 200472,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 2</span></span></span></p>"
        },
        {
          "id": 200473,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 3</span></span></span></p>"
        },
        {
          "id": 200474,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2, 4</span></span></span></p>"
        },
        {
          "id": 200475,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2, 3</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following cells are present in the molecular layer of the cerebellum? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Stellate cells</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Basket cells</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Purkinje cells</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Granular cells</span></span></span></li>\r\n</ol>",
      "unique_key": "Q5514873",
      "question_audio": null,
      "question_video": null,
      "map_id": 34331814,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) 1, 2</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">molecular layer</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> of the cerebellum contains </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">stellate</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">basket cells</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The molecular layer is the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">outermost layer</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> of the cerebellar cortex. It includes:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Stellate cells</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">basket cells</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: These cells receive excitatory input from parallel fibers and form </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">inhibitory synapses</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> on Purkinje cells.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">dendrites of Purkinje cells</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Although Purkinje cells themselves are not in this layer, their dendrites extend into the molecular layer.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This layer contains many myelinated and unmyelinated nerve fibers, giving it a pale appearance on H&E staining.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. 1, 3: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Purkinje cells are located in the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Purkinje layer</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, not the molecular layer. The dendrites of Purkinje cells extend into the molecular layer, but the cell bodies reside in the middle layer of the cerebellum.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. 2, 4: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Granular cells are located in the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">granular layer</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (innermost layer), not the molecular layer. The granular layer contains the cell bodies of granular cells and Golgi cells.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. 2, 3: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Purkinje cells are in the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Purkinje layer</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, while basket cells are in the molecular layer. Therefore, this combination is incorrect because Purkinje cells are not present in the molecular layer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">molecular layer</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> of the cerebellum contains </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">stellate cells</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">basket cells</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> that form inhibitory synapses on Purkinje cells. Purkinje cells are located in their own middle layer, and granular cells reside in the innermost granular layer.</span></span></span></p>",
      "correct_choice_id": 200472,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50119,
      "choices": [
        {
          "id": 200476,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Isospora</span></span></span></p>"
        },
        {
          "id": 200477,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Cryptosporidium</span></span></span></p>"
        },
        {
          "id": 200478,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Cyclospora</span></span></span></p>"
        },
        {
          "id": 200479,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Microspora</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">On Ziehl-Neelsen (ZN) staining oocysts of size 8-10 µm cysts are visible. Identify the organism?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">INICET NOV 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-120408.png\" style=\"height:324px; width:400px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-120408.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q6014726",
      "question_audio": null,
      "question_video": null,
      "map_id": 34772986,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. C) Cyclospora</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cyclospora cayetanensis is a coccidian parasite that causes the gastrointestinal disease cyclosporiasis. The organism produces oocysts that are 8-10 µm in diameter, which can be detected by Ziehl-Neelsen staining. The oocysts exhibit a variable acid-fast staining property and can also autofluoresce under ultraviolet light.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cyclospora oocysts have the following characteristics:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Size</span></strong><span style=\"font-size:12.0pt\">: 8-10 µm in diameter.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Staining</span></strong><span style=\"font-size:12.0pt\">: They show variable acid-fast staining.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Autofluorescence</span></strong><span style=\"font-size:12.0pt\">: They exhibit blue-green autofluorescence under ultraviolet light.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-120540.png\" style=\"height:787px; width:600px\" /></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Isospora</span></strong><span style=\"font-size:12.0pt\">: Isospora (now known as Cystoisospora) produces larger oocysts, typically 20-30 µm in size, and contains two sporocysts with four sporozoites each. It does not match the 8-10 µm size described.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Cryptosporidium</span></strong><span style=\"font-size:12.0pt\">: Cryptosporidium oocysts are smaller, measuring 4-6 µm in diameter, and consistently exhibit acid-fast staining and bright auramine fluorescence. They do not match the size range described.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Microspora</span></strong><span style=\"font-size:12.0pt\">: Microspora are a group of spore-forming unicellular parasites that do not fit the description of having 8-10 µm oocysts visible with Ziehl-Neelsen staining.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/06-1.jpg\" style=\"height:323px; width:600px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-120540.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200478,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50120,
      "choices": [
        {
          "id": 200480,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        },
        {
          "id": 200481,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 200482,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        },
        {
          "id": 200483,
          "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following are parvovirus-related manifestations. Identify the incorrect pair?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Pure red cell aplasia - chronic hemolytic anemia</span></li><li><span style=\"font-size:12.0pt;\">Polymyalgia rheumatica - young women</span></li><li><span style=\"font-size:12.0pt;\">Hydrops fetalis - pregnant women</span></li><li><span style=\"font-size:12.0pt;\">Erythema infectiosum - infants</span></li></ol>",
      "unique_key": "Q9436508",
      "question_audio": null,
      "question_video": null,
      "map_id": 34517547,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 2</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Polymyalgia rheumatica is closely associated with giant cell arteritis in women above 50yrs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. Pure red cell aplasia - chronic hemolytic anemia: </strong>Parvovirus B19 can cause pure red cell aplasia, particularly in patients with chronic hemolytic anemia. The virus affects erythroid precursors in the bone marrow, leading to severe anemia in these patients.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3. Hydrops fetalis - pregnant women: </strong>Parvovirus B19 infection during pregnancy can lead to severe fetal complications, including hydrops fetalis, which is a life-threatening condition characterized by severe edema in the fetus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4. Erythema infectiosum - infants: </strong>Erythema infectiosum, also known as fifth disease or slapped-cheek disease, is a common manifestation of parvovirus B19 infection in young children, not just infants. It presents with a characteristic \"slapped cheek\" rash.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Polymyalgia rheumatica is typically seen in women above 50 years old and is not related to parvovirus infection in young women. Parvovirus B19 is more commonly associated with conditions such as erythema infectiosum in children, pure red cell aplasia in patients with chronic hemolytic anemia, and hydrops fetalis in pregnant women.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Parvo virus infection -</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Common symptoms of parvovirus B19 (B19V) infection include a mild nonspecific prodromal illness that may consist of fever (15-30% of patients), malaise, headache, myalgia, nausea, and rhinorrhea; typically beginning 5-7 days after initial infection</span></p><p> </p><p><span style=\"font-size:12.0pt;\">A diffuse maculopapular rash can appear 1-4 days later and fades to a <strong>lacy erythematous rash,</strong> which may be pruritic and may spread gradually toward the distal extremities. Most seropositive patients have no history of this classic biphasic illness. The clinical symptoms widely vary, and the classic <strong>\"slapped cheek\" rash</strong> is much more common in young children called as erythema infectiosum, also known as fifth disease or slapped-cheek disease,</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/picture3_yezpQKZ.jpg\" alt=\"\" width=\"400\" height=\"210\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Alternatively, parvovirus B19 infection may manifest with purpuric rash, erythema multiforme, or pruritus of the soles of the feet. Parvovirus B19 may cause a <strong>papular-purpuric \"gloves-and-socks\" syndrome (PPGSS</strong>), which manifests as an erythematous exanthem of the hands and feet with a distinct margin at the wrist and ankle joints.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Transient <strong>small joint arthropathy</strong> may be the main clinical presentation of parvovirus B19 in adults.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Pure red cell aplasia and chronic hemolytic anemia</strong> is seen  in patients with immunosuppression.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Patients with severe anemia due to <strong>transient aplastic crisis (TAC</strong>) may present with pallor, fatigue, or signs of an aplastic crisis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Parvovirus B19V infection during pregnancy can lead to <strong>hydrops fetalis and/or fetal loss</strong>.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/picture3_yezpQKZ.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200483,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50121,
      "choices": [
        {
          "id": 200484,
          "text": "<p><span style=\"font-size:12.0pt;\">Residual volume</span></p>"
        },
        {
          "id": 200485,
          "text": "<p><span style=\"font-size:12.0pt;\">Functional residual capacity</span></p>"
        },
        {
          "id": 200486,
          "text": "<p><span style=\"font-size:12.0pt;\">Tidal volume</span></p>"
        },
        {
          "id": 200487,
          "text": "<p><span style=\"font-size:12.0pt;\">Inspiratory reserve volume</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What does the zero pressure indicate in the pressure-volume curve? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q4979142",
      "question_audio": null,
      "question_video": null,
      "map_id": 34432954,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Functional residual capacity</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The pressure-volume curve represents the relationship between the lung volumes and the transpulmonary pressures. Zero pressure in this context usually refers to the point where the pressure inside the lungs is equal to the atmospheric pressure, indicating a state of no net airflow. This point corresponds to the functional residual capacity (FRC), which is the volume of air remaining in the lungs after a normal, passive exhalation.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Functional Residual Capacity (FRC):</strong> It is the volume of air present in the lungs at the end of passive expiration. This capacity includes the expiratory reserve volume (ERV) and the residual volume (RV). FRC is an important measure because it represents the balance point between the elastic recoil forces of the lungs and the chest wall.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/physiology-5_1-7.jpg\" alt=\"\" width=\"700\" height=\"411\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The functional residual capacity is the volume of the air that remains in the lungs after normal expiration. The normal value is about 2.5 liters.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong> Residual volume is the air left in the lungs after a maximal expiratory effort.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> Tidal volume is the amount of air that moves in during each inspiration or the amount of air that moves out with each expiration, during quiet breathing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Inspiratory reserve volume is the air inspired with a maximal inspiratory effort in addition to the tidal volume.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The zero pressure in the pressure-volume curve indicates the functional residual capacity, which is the volume of air remaining in the lungs after a normal exhalation.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/physiology-5_1-7.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200485,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50122,
      "choices": [
        {
          "id": 200488,
          "text": "<p><span style=\"font-size:12.0pt;\">Interferon gamma</span></p>"
        },
        {
          "id": 200489,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-2</span></p>"
        },
        {
          "id": 200490,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-12</span></p>"
        },
        {
          "id": 200491,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Delayed hypersensitivity is due to?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOVEMBER 2022)</span></p>",
      "unique_key": "Q6108759",
      "question_audio": null,
      "question_video": null,
      "map_id": 34129041,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Interferon gamma</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Delayed-type hypersensitivity (DTH) is a form of cell-mediated immune response that occurs typically 24-72 hours after exposure to the antigen. This response is primarily mediated by T-helper 1 (Th1) cells which secrete a variety of cytokines, including Interferon gamma (IFN-γ). IFN-γ is crucial in activating macrophages and enhancing their microbicidal activity, which is a key component of the DTH response. This type of hypersensitivity is important in defense against intracellular pathogens such as Mycobacterium tuberculosis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-105707.png\" alt=\"\" width=\"500\" height=\"439\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-87.jpg\" alt=\"\" width=\"500\" height=\"376\"></strong></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Interleukin-2 (IL-2)</strong> - IL-2 is primarily involved in the activation and proliferation of T cells but is not the primary mediator of delayed hypersensitivity reactions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Interleukin-12 (IL-12)</strong> - IL-12 plays a role in the differentiation of naive T cells into Th1 cells and can promote IFN-γ production, but it is not the direct mediator of DTH.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Interleukin-4 (IL-4)</strong> - IL-4 is associated with the differentiation of naive T cells into Th2 cells and promotes humoral immunity, which is not involved in delayed-type hypersensitivity reactions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Interferon gamma is the key cytokine responsible for mediating delayed hypersensitivity reactions by activating macrophages and enhancing their pathogen-killing capabilities.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-105707.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200488,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50123,
      "choices": [
        {
          "id": 200492,
          "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-c, 3-d, 4-a</span></p>"
        },
        {
          "id": 200493,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-b, 3-c 4-d</span></p>"
        },
        {
          "id": 200494,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-d, 3-b 4-c</span></p>"
        },
        {
          "id": 200495,
          "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-c, 3-a, 4-d</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following molecules with their carriers in plasma: (</span>INICET Nov 2022)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/29/12.jpg\" alt=\"\" width=\"1000\" height=\"590\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/29/12.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9191141",
      "question_audio": null,
      "question_video": null,
      "map_id": 34701127,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 1-b, 2-c, 3-d, 4-a</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Plasma contains various components like ions, inorganic and organic molecules that help in the transport of substances across various parts of the body, such as Albumin, globulin, and fibrinogen fractions.</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Thyroxine</strong> is carried by transthyretin, also called thyroid-binding pre-albumin.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Fatty acids</strong> are carried by albumin, which is a major carrier protein and osmotic regulator. It also transports hormones, amino acids, vitamins, and steroids.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hemoglobin</strong> binds to haptoglobin, which prevents free hemoglobin from being excreted in the urine.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Heme</strong> binds with hemopexin for heme recycling.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Plasma transporters like prealbumin, albumin, haptoglobin, and hemopexin play crucial roles in the transport and recycling of thyroxine, fatty acids, hemoglobin, and heme respectively.</span></p>",
      "correct_choice_id": 200492,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50124,
      "choices": [
        {
          "id": 200496,
          "text": "<p><span style=\"font-size:12.0pt;\">Brain</span></p>"
        },
        {
          "id": 200497,
          "text": "<p><span style=\"font-size:12.0pt;\">Kidney</span></p>"
        },
        {
          "id": 200498,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin</span></p>"
        },
        {
          "id": 200499,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following organs has the least arteriovenous oxygen difference? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q8515435",
      "question_audio": null,
      "question_video": null,
      "map_id": 34414381,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Kidney</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The arteriovenous oxygen difference (A-V O2 difference) is a measure of the amount of oxygen extracted by the tissues from the blood. The greater the oxygen utilization by the tissues, the larger the A-V O2 difference.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Kidney:</strong> The kidney has the least arteriovenous oxygen difference. This is because the primary function of the kidneys is to filter large volumes of blood through the glomeruli rather than to metabolize oxygen extensively. As a result, the oxygen extracted by the renal tissues is relatively low compared to the amount of blood flow, resulting in a low A-V O2 difference.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Brain:</strong> The brain has a higher arteriovenous oxygen difference due to its significant metabolic activity and oxygen consumption to support its functions. The brain requires a constant and substantial supply of oxygen for neuronal activity, resulting in a higher A-V O2 difference compared to the kidney.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Skin:</strong> The skin also has a relatively low oxygen consumption compared to organs like the brain and liver, but its arteriovenous oxygen difference is still higher than that of the kidney. The skin is primarily involved in protective functions and thermoregulation, requiring less oxygen.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Liver:</strong> The liver has a moderate to high arteriovenous oxygen difference due to its metabolic functions, including detoxification, synthesis of proteins, and other vital activities that require substantial oxygen consumption. The liver's metabolic demands make its A-V O2 difference higher than that of the kidney.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The kidney has the least arteriovenous oxygen difference among the given organs due to its primary function of blood filtration, which requires relatively low oxygen extraction. This results in a low A-V O2 difference compared to organs like the brain and liver that have higher metabolic and oxygen consumption demands.</span></p>",
      "correct_choice_id": 200497,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50125,
      "choices": [
        {
          "id": 200500,
          "text": "<p><span style=\"font-size:12pt;\">Mifepristone + misoprostol</span></p>"
        },
        {
          "id": 200501,
          "text": "<p><span style=\"font-size:12pt;\">Manual vacuum aspiration</span></p>"
        },
        {
          "id": 200502,
          "text": "<p><span style=\"font-size:12pt;\">Dilatation and evacuation</span></p>"
        },
        {
          "id": 200503,
          "text": "<p><span style=\"font-size:12pt;\">Extra-amniotic instillation of ethacridine lactate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following can be used in first-trimester medical termination of pregnancy (MTP), except: </span>(INICET NOV 2022)</p>",
      "unique_key": "Q8443410",
      "question_audio": null,
      "question_video": null,
      "map_id": 34795739,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Extra-amniotic instillation of ethacridine lactate</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Extra-amniotic instillation of ethacridine lactate</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">This method is typically used for second-trimester abortions. It involves the instillation of ethacridine lactate into the extra-amniotic space to induce abortion. However, it is rarely used nowadays due to advancements in other safer and more effective methods.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Medical methods of first-trimester abortion</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Mifepristone + misoprostol</strong>: A combination of mifepristone (a progesterone receptor antagonist) and misoprostol (a prostaglandin analog) is a common and effective method for first-trimester medical termination of pregnancy.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Surgical methods of first-trimester abortion</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Manual vacuum aspiration</strong>: This is a safe and effective method for terminating a pregnancy in the first trimester.</span></li><li><span style=\"font-size:12pt;\"><strong>Dilatation and curettage</strong>: Another surgical method used to evacuate the contents of the uterus in the first trimester.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Mifepristone + misoprostol</strong>: Mifepristone + misoprostol is a commonly used combination for medical termination in the first trimester.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Manual vacuum aspiration</strong>: Manual vacuum aspiration is a standard procedure for first-trimester abortion.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Dilatation and evacuation</strong>: Dilatation and evacuation is another method used in the first trimester to terminate a pregnancy.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Extra-amniotic instillation of ethacridine lactate is not used for first-trimester medical termination of pregnancy (MTP).</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg364,369, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg203</strong></span></p>",
      "correct_choice_id": 200503,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50126,
      "choices": [
        {
          "id": 200504,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Renal failure</span></span></span></p>"
        },
        {
          "id": 200505,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Accumulation of calcium phosphate</span></span></span></p>"
        },
        {
          "id": 200506,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin D deficiency</span></span></span></p>"
        },
        {
          "id": 200507,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Parathyroid activation secretion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">All of the following conditions are associated with Metastatic calcification except: (INICET Nov 2022)</span></span></p>",
      "unique_key": "Q1871687",
      "question_audio": null,
      "question_video": null,
      "map_id": 34734526,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Vitamin D deficiency</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metastatic calcification is associated with Hypercalcemia (Vitamin D toxicity), not Vitamin D deficiency.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-131920.jpg\" style=\"height:403px; width:1000px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tumors having Dystrophic calcification: Psammoma bodies present</span></u></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">M – M</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">eningioma, <strong>M</strong>esothelioma</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">O – O</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">vary (Serous cystadenoma)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">S – S</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">alivary gland tumor</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">T – T</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">hyroid (Papillary thyroid cancer)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P – P</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">rolactinoma</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">G – G</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">lucagonoma</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Renal failure</span></strong><span style=\"font-size:12.0pt\">: Chronic kidney disease can lead to secondary hyperparathyroidism and hyperphosphatemia, both of which contribute to hypercalcemia and subsequent metastatic calcification.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Accumulation of calcium phosphate</span></strong><span style=\"font-size:12.0pt\">: This typically occurs in the context of renal failure or parathyroid hormone-related issues, leading to metastatic calcification.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D Parathyroid activation secretion</span></strong><span style=\"font-size:12.0pt\">: Hyperparathyroidism, whether primary or secondary, causes an increase in serum calcium, leading to metastatic calcification.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metastatic calcification is associated with conditions that lead to hypercalcemia, not with conditions that result in normal or low calcium levels, such as Vitamin D deficiency.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-131920.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200506,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50127,
      "choices": [
        {
          "id": 200508,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3</span></p>"
        },
        {
          "id": 200509,
          "text": "<p><span style=\"font-size:12.0pt;\">1,3</span></p>"
        },
        {
          "id": 200510,
          "text": "<p><span style=\"font-size:12.0pt;\">3,4</span></p>"
        },
        {
          "id": 200511,
          "text": "<p><span style=\"font-size:12.0pt;\">1,4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following statements is true regarding the course of the mandibular nerve? </span>(INICET NOV 2022)</p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Auriculotemporal nerve is a branch from the anterior division of the mandibular nerve, and it emerges from behind the temporomandibular joint.</span></li><li><span style=\"font-size:12.0pt;\">Buccal branch is a branch from the anterior division of the mandibular nerve, and it emerges from behind the mandibular ramus.</span></li><li><span style=\"font-size:12.0pt;\">Lingual nerve is a branch from the posterior division of the mandibular nerve, and it arcs around the submandibular duct.</span></li><li><span style=\"font-size:12.0pt;\">Ophthalmic nerve is a branch from the anterior division of the mandibular nerve, and it arises in the middle cranial fossa.</span></li></ol>",
      "unique_key": "Q5971522",
      "question_audio": null,
      "question_video": null,
      "map_id": 34627776,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. 2,3</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Correct Statements:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Statement 2</strong>: True. The buccal branch, which is indeed a branch of the anterior division of the mandibular nerve, emerges from behind the mandibular ramus. This nerve primarily supplies sensory innervation to the skin over the cheek and buccal mucosa.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Statement 3:</strong> True. The lingual nerve, a branch from the posterior division of the mandibular nerve, is responsible for providing sensory innervation to the anterior two-thirds of the tongue. It famously arcs around the submandibular duct, a notable anatomical feature.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/16.jpg\" alt=\"\" width=\"500\" height=\"442\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Statement 1</strong>: Incorrect. The auriculotemporal nerve actually arises from the posterior division of the mandibular nerve, not the anterior division, and it does indeed emerge from behind the temporomandibular joint.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Statement 4:</strong> Incorrect. The ophthalmic nerve is not a branch of the mandibular nerve. Instead, it is an independent division of the trigeminal nerve (V1), originating from the trigeminal ganglion located in the middle cranial fossa. It is responsible for providing sensory innervation to the forehead, scalp, and parts of the eye.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The mandibular nerve's complex branching includes both sensory and motor components that are essential for facial sensation and movements. Understanding its branches, such as the buccal and lingual nerves, and their courses, is critical in dental, surgical, and diagnostic practices.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/16.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200508,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50128,
      "choices": [
        {
          "id": 200512,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        },
        {
          "id": 200513,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
        },
        {
          "id": 200514,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4</span></p>"
        },
        {
          "id": 200515,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following cyanotic heart diseases causes increased pulmonary blood flow? (INICET MAY 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Ebstein anomaly</span></li><li><span style=\"font-size:12.0pt;\">Tetralogy of Fallot</span></li><li><span style=\"font-size:12.0pt;\">Transposition of the great arteries (TGA)</span></li><li><span style=\"font-size:12.0pt;\">Total anomalous pulmonary venous communication (TAPVC)</span></li></ol>",
      "unique_key": "Q5562441",
      "question_audio": null,
      "question_video": null,
      "map_id": 34762481,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 3, 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Transposition of the great arteries (TGA) and total anomalous pulmonary venous communication (TAPVC) are both cyanotic congenital heart diseases that cause increased pulmonary blood flow.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3. Transposition of the Great Arteries (TGA): </strong>In TGA, the positions of the pulmonary artery and the aorta are switched, which results in deoxygenated blood being circulated throughout the body. The mixing of oxygenated and deoxygenated blood occurs, leading to increased pulmonary blood flow because the deoxygenated blood is directed to the lungs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4. Total Anomalous Pulmonary Venous Communication (TAPVC): </strong>In TAPVC, the pulmonary veins do not connect normally to the left atrium. Instead, they connect to the right atrium or systemic veins, causing a mixing of oxygenated and deoxygenated blood. This also leads to increased blood flow to the lungs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1, 4: </strong>Ebstein anomaly does not cause increased pulmonary blood flow. Ebstein anomaly involves downward displacement of the tricuspid valve, leading to decreased pulmonary blood flow.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 1, 2: </strong>Both Ebstein anomaly and Tetralogy of Fallot cause decreased pulmonary blood flow. Tetralogy of Fallot includes pulmonary stenosis, which limits blood flow to the lungs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 2, 4: </strong>Tetralogy of Fallot causes decreased pulmonary blood flow due to the presence of pulmonary stenosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cyanotic congenital heart diseases such as Transposition of the Great Arteries (TGA) and Total Anomalous Pulmonary Venous Communication (TAPVC) cause increased pulmonary blood flow.</span></p>",
      "correct_choice_id": 200514,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50129,
      "choices": [
        {
          "id": 200516,
          "text": "<p><span style=\"font-size:12.0pt;\">Unburnt particles</span></p>"
        },
        {
          "id": 200517,
          "text": "<p><span style=\"font-size:12.0pt;\">Smoke</span></p>"
        },
        {
          "id": 200518,
          "text": "<p><span style=\"font-size:12.0pt;\">Impact</span></p>"
        },
        {
          "id": 200519,
          "text": "<p><span style=\"font-size:12.0pt;\">Muzzle impression</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the cause of tattooing around the entry wound of a bullet? </span>(INICET NOVEMBER 2022)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-39.jpg\" alt=\"\" width=\"300\" height=\"439\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-39.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1362242",
      "question_audio": null,
      "question_video": null,
      "map_id": 34335047,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A. Unburnt particles </strong> </span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Tattooing is a term used to describe the punctate abrasions observed when skin comes into contact with partially burned or unburned grains of gunpowder.</span></li><li><span style=\"font-size:12.0pt;\">They are also called stippling or peppering. This is seen up to 50 cm of firing</span></li><li><span style=\"font-size:12.0pt;\">They are seen in near (30-50cm) to mid-range of shooting</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Firearm injuries:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-40.jpg\" alt=\"\" width=\"400\" height=\"400\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Blackening – </strong>due to deposit of smoke</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-41.jpg\" alt=\"\" width=\"500\" height=\"218\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Grease collar</strong> - due to the deposition of the lubricant of the bullet in the tissues</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Burn injuries</strong> - occur due to flame released during the firing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Smoke:</strong> Causes blackening, not tattooing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Impact:</strong> Refers to the force of the bullet causing tissue damage but does not explain tattooing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Muzzle impression:</strong> Occurs when the muzzle of the firearm makes contact with the skin, leaving an impression, but does not cause tattooing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Tattooing around the entry wound of a bullet is caused by unburnt particles of gunpowder embedding into the skin.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-40.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200516,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50130,
      "choices": [
        {
          "id": 200520,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1</span></span></p>"
        },
        {
          "id": 200521,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">2</span></span></p>"
        },
        {
          "id": 200522,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">3</span></span></p>"
        },
        {
          "id": 200523,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A female patient was clinically diagnosed to have hypothyroidism. Measurements of the following parameters were obtained: TSH; combined protein levels; and total and free T3, T4, and rT3. Which one of the following options represents her condition? (INICET NOV 2022) </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/07/screenshot-2024-10-07-175439.jpg\" style=\"height:176px; width:700px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/07/screenshot-2024-10-07-175439.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3271833",
      "question_audio": null,
      "question_video": null,
      "map_id": 34905097,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D) 4</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Laboratory investigations in a patient with <strong>hypothyroidism</strong> would show <strong>low levels of total and free T3, T4, and rT3</strong> with <strong>high TSH levels</strong>, and <strong>normal combined protein levels</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Normally, the hypothalamus releases thyrotropin-releasing hormone (TRH), which stimulates the pituitary gland to release thyroid-stimulating hormone (TSH). TSH then stimulates the thyroid gland to produce T3 and T4. When thyroid hormone production is deficient (hypothyroidism), TSH levels rise in an attempt to stimulate the gland further.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Elevated TSH</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> with <strong>low free T4</strong> levels is indicative of <strong>primary hypothyroidism</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In contrast, <strong>secondary hypothyroidism</strong> (due to pituitary failure) would show <strong>low TSH</strong> and <strong>low T3/T4</strong> levels.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Tertiary hypothyroidism</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (due to hypothalamic dysfunction) also results in <strong>low TSH</strong> and <strong>low T3/T4</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Patients with hypothyroidism typically present with <strong>fatigue</strong>, <strong>dry skin</strong>, <strong>weight gain</strong>, <strong>constipation</strong>, <strong>cold intolerance</strong>, <strong>bradycardia</strong>, and <strong>depression</strong>. Physical findings may include <strong>cool extremities</strong>, <strong>puffy face</strong>, and <strong>periorbital edema</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. 1 (High T3, T4, and Low TSH)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This combination suggests <strong>hyperthyroidism</strong>, not hypothyroidism.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. 2 (Low T3, T4, Normal TSH)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This could indicate <strong>euthyroid sick syndrome</strong> rather than primary hypothyroidism.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. 3 (High T3, T4, Normal TSH)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This may represent conditions with <strong>normal thyroid function</strong> or thyroid hormone resistance.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In <strong>primary hypothyroidism</strong>, you typically see <strong>low free T3 and T4</strong> levels with <strong>elevated TSH</strong>. Proper diagnosis and management are crucial, and hypothyroidism is often treated with <strong>levothyroxine</strong> to normalize hormone levels.</span></span></span></p>",
      "correct_choice_id": 200523,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50131,
      "choices": [
        {
          "id": 200524,
          "text": "<p><span style=\"font-size:12.0pt;\">IV fluids</span></p>"
        },
        {
          "id": 200525,
          "text": "<p><span style=\"font-size:12.0pt;\">CECT abdomen</span></p>"
        },
        {
          "id": 200526,
          "text": "<p><span style=\"font-size:12.0pt;\">Exploratory laparotomy</span></p>"
        },
        {
          "id": 200527,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37-year-old male patient presents to the surgical emergency with a history of peptic ulcer disease and pain in abdomen, bloating, and obstipation for 3 days. What is the next line in management? (INICET NOV 2022)</span></p>",
      "unique_key": "Q3749081",
      "question_audio": null,
      "question_video": null,
      "map_id": 34296819,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) All of the above</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Given scenario of history of peptic ulcer disease with acute abdomen suggests a peptic ulcer perforation.</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>IV fluids</strong>: Administering intravenous (IV) fluids is essential to address potential dehydration or peritonitis, to stabilise the patient.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>CECT abdomen (Contrast-enhanced computed tomography of the abdomen)</strong>: Performing a CECT abdomen is a diagnostic step that can help identify the cause of the patient's symptoms, such as complications related to peptic ulcer disease, including perforation or other abdominal pathologies.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Exploratory laparotomy</strong>: An exploratory laparotomy may be necessary if the patient's condition deteriorates or if there are signs of a surgical emergency, such as peritonitis or suspected perforation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In summary, option D is correct because it covers the initial steps in managing this patient comprehensively, including addressing fluid balance (IV fluids), diagnostic imaging (CECT abdomen), and considering surgical intervention (exploratory laparotomy) if indicated by the clinical presentation and imaging findings</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Perforation of a hollow viscus is a life-threatening condition caused by the rupture of the alimentary tract.</span></li><li><span style=\"font-size:12.0pt;\">This results in the leakage of enteric contents, leading to acute bacterial peritonitis.</span></li><li><span style=\"font-size:12.0pt;\">Clinical features include abdominal pain and distension, nausea, vomiting, tachycardia, tenderness, rebound tenderness, decreased or absent bowel sounds, and guarding on palpation.</span></li><li><span style=\"font-size:12.0pt;\">Investigations include estimating the white blood cell count, urea, serum electrolytes, and an erect abdominal radiograph showing free gas under the diaphragm.</span></li><li><span style=\"font-size:12.0pt;\">CECT is the most sensitive investigation to detect minimal/suspected pneumoperitoneum.</span></li><li><span style=\"font-size:12.0pt;\">Management includes IV fluids and exploratory laparotomy.</span></li></ul>",
      "correct_choice_id": 200527,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50132,
      "choices": [
        {
          "id": 200528,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Nelfinavir</span></span></span></p>"
        },
        {
          "id": 200529,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Emtricitabine</span></span></span></p>"
        },
        {
          "id": 200530,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Abacavir</span></span></span></p>"
        },
        {
          "id": 200531,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Zidovudine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient who is a known case of HIV is started on combined active antiretroviral therapy (cART). After few months of treatment, he develops palmo-plantar hyperpigmentation. What is the most likely drug implicated in this scenario?</span></span></p>",
      "unique_key": "Q8313185",
      "question_audio": null,
      "question_video": null,
      "map_id": 34602299,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B. Emtricitabine</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Emtricitabine is an NRTI (Nucleoside Reverse Transcriptase Inhibitor) which can lead to hyperpigmentation of the palms and soles.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong>Option A</strong>. Nelfinavir is a protease inhibitor. It can cause diarrhea or loose stools, dyslipidemia, lipodystrophy and hyperlipidemia.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong>Option C</strong>. Abacavir is an NRTI that can lead to Steven Johnson Syndrome.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong>Option D</strong>. Zidovudine is an NRTI that can cause nail hyperpigmentation, bone marrow suppression, myopathy, hepatotoxicity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Emtricitabine, an NRTI used in the treatment of HIV, is known to cause palmo-plantar hyperpigmentation as a side effect. This differentiates it from other antiretroviral medications such as nelfinavir, abacavir, and zidovudine, which have different side effect profiles.</span></span></span></p>",
      "correct_choice_id": 200529,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50133,
      "choices": [
        {
          "id": 200532,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-d, 3-a, 4-d</span></p>"
        },
        {
          "id": 200533,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-b, 3-a, 4-c</span></p>"
        },
        {
          "id": 200534,
          "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-d, 3-c, 4-d</span></p>"
        },
        {
          "id": 200535,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-c, 3-d, 4-b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man from Mumbai presents to a clinic with fatigue and weakness. His family has a history of chronic diseases, but he himself has been asymptomatic until recently. The physician explains the different stages of disease progression and the interventions required. Which of the following best matches the stages with their relevant descriptions? (INICET NOV 2022)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-123815.png\" alt=\"\" width=\"700\" height=\"142\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-123815.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q2870417",
      "question_audio": null,
      "question_video": null,
      "map_id": 34866363,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1-d, 2-b, 3-a, 4-c</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Natural history of disease refers to the progression of a disease in an individual over time, in the absence of treatment. It has two phases, a period of pre-pathogenesis and a period of pathogenesis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip48.jpg\" alt=\"\" width=\"700\" height=\"344\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The period of pre-pathogenesis is before the onset of disease in humans.</span></li><li><span style=\"font-size:12.0pt;\">An interaction between the agent, host and the environment occurs in this phase before the pathogenesis.</span></li><li><span style=\"font-size:12.0pt;\">It starts with appropriate exposure to or accumulation of factors sufficient for the disease process to begin in a susceptible host.</span></li><li><span style=\"font-size:12.0pt;\">The exposure is a microorganism in an infectious disease. For lung cancer, it is any factor that initiates the process, such as asbestos fibres or components in tobacco smoke.</span></li><li><span style=\"font-size:12.0pt;\">Primary prevention (health promotion and specific protection) is applicable in this period.</span></li><li><span style=\"font-size:12.0pt;\">The period of pathogenesis starts after the disease process has been triggered and pathological changes occur without the individual being aware of it.</span></li><li><span style=\"font-size:12.0pt;\">It begins with the entry of the organism till recovery, death, or disability.</span></li><li><span style=\"font-size:12.0pt;\">The subclinical or asymptomatic period between exposure and onset of symptoms is called the incubation period for infectious diseases, and the latency period for chronic diseases.</span></li><li><span style=\"font-size:12.0pt;\">The onset of clinical symptoms is the beginning of the clinical stage of the disease.</span></li><li><span style=\"font-size:12.0pt;\">Secondary (halting of the disease process) and tertiary prevention (measures to limit disability) are applicable in this period.</span></li><li><span style=\"font-size:12.0pt;\">Rehabilitation has been defined as the use of medical, social, educational, and vocational measures for training the individual to the highest possible level of functional ability.</span></li><li><span style=\"font-size:12.0pt;\">It is a part of tertiary prevention like providing callipers for walking patients and arranging schooling after being affected by polio.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture6555.jpg\" alt=\"\" width=\"900\" height=\"495\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip48.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200533,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50134,
      "choices": [
        {
          "id": 200536,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemoperitoneum leads to reddish discoloration of the flanks of the abdomen.</span></p>"
        },
        {
          "id": 200537,
          "text": "<p><span style=\"font-size:12.0pt;\">Cullen’s sign refers to discoloration around the umbilicus.</span></p>"
        },
        {
          "id": 200538,
          "text": "<p><span style=\"font-size:12.0pt;\">Palpation begins at the site of pain.</span></p>"
        },
        {
          "id": 200539,
          "text": "<p><span style=\"font-size:12.0pt;\">Guarding and rigidity indicate peritoneal irritation.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with severe abdominal pain. Identify the false statement given about the examination of the abdomen: (INICET NOV 2022)</span></p>",
      "unique_key": "Q2505299",
      "question_audio": null,
      "question_video": null,
      "map_id": 34813643,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Palpation begins at the site of pain.</strong></span></p><p><span style=\"font-size:11pt;\"><strong> </strong></span></p><p><span style=\"font-size:12.0pt;\">Palpation in the examination of a patient with abdominal pain should never start at the site of pain. Instead, it should begin away from the painful area to avoid causing the patient unnecessary discomfort and to prevent muscle guarding that might obscure findings. This approach allows the examiner to gather information about the non-painful areas first and approach the painful site last, ensuring a more accurate and less distressing examination.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hemoperitoneum leads to reddish discoloration of the flanks of the abdomen: </strong>This statement is correct. Hemoperitoneum, which is bleeding into the peritoneal cavity, can cause reddish or purplish discoloration on the flanks, known as Grey Turner’s sign. This is a significant indicator of internal bleeding, particularly in cases of acute pancreatitis or trauma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cullen’s sign refers to discoloration around the umbilicus: </strong>This statement is correct. Cullen’s sign is the appearance of bluish discoloration around the umbilicus, which indicates intraperitoneal hemorrhage. It is often associated with conditions such as ruptured ectopic pregnancy or acute pancreatitis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Guarding and rigidity indicate peritoneal irritation: </strong>This statement is correct. Guarding (voluntary or involuntary muscle contraction) and rigidity (a constant, board-like hardness of the abdominal muscles) are classic signs of peritoneal irritation or inflammation, such as that seen in peritonitis. These signs suggest that there may be an underlying acute inflammatory or infectious process in the abdomen.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">When examining a patient with abdominal pain, always begin palpation away from the site of pain to ensure a more accurate and less distressing assessment.</span></p>",
      "correct_choice_id": 200538,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50135,
      "choices": [
        {
          "id": 200540,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Polyneuropathy</span></span></span></p>"
        },
        {
          "id": 200541,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Radiculopathy</span></span></span></p>"
        },
        {
          "id": 200542,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Upper motor neuron</span></span></span></p>"
        },
        {
          "id": 200543,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lower motor neuron</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The following clinical examination was performed. What lesion would cause an exaggerated reflex?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/07/screenshot-2024-09-07-154119.png\" style=\"height:141px; width:300px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/07/screenshot-2024-09-07-154119.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q9438114",
      "question_audio": null,
      "question_video": null,
      "map_id": 34858979,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Upper motor neuron</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical examination shown in the image involves testing the ankle jerk reflex, which is a deep tendon reflex. Exaggerated or hyperactive reflexes are typically a sign of an upper motor neuron (UMN) lesion. UMN lesions occur in the neural pathways above the level of the anterior horn cell in the spinal cord, which includes the brain and the spinal cord itself. When these pathways are damaged, there is a loss of inhibitory control over the lower motor neurons, leading to hyperreflexia (exaggerated reflexes).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Upper motor neuron lesions</span></strong><span style=\"font-size:12.0pt\"> are characterized by:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyperreflexia (exaggerated reflexes)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spasticity</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Positive Babinski sign</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Weakness without significant muscle atrophy</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt\"><strong>Polyneuropathy</strong>: This condition affects multiple peripheral nerves and is typically associated with diminished or absent reflexes rather than exaggerated reflexes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt\"><strong>Radiculopathy</strong>: Damage to the nerve roots also results in lower motor neuron signs, including reduced reflexes and weakness in the distribution of the affected nerve root.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt\"><strong>Lower motor neuron</strong>: Lesions here cause diminished or absent reflexes due to direct damage to the anterior horn cells or peripheral nerves that innervate muscles.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Exaggerated reflexes, such as an exaggerated ankle jerk reflex, are indicative of an upper motor neuron lesion. Lower motor neuron lesions, including those caused by polyneuropathy and radiculopathy, typically result in diminished or absent reflexes.</span></span></span></p>",
      "correct_choice_id": 200542,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50136,
      "choices": [
        {
          "id": 200544,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glutathione reductase</span></span></span></p>"
        },
        {
          "id": 200545,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glutathione peroxidase</span></span></span></p>"
        },
        {
          "id": 200546,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thioredoxine peroxidase</span></span></span></p>"
        },
        {
          "id": 200547,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thioredoxine oxidase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Selenocysteine is present in which of the following enzymes?</span></span></p>",
      "unique_key": "Q2545390",
      "question_audio": null,
      "question_video": null,
      "map_id": 34103304,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Glutathione peroxidase</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option B.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Glutathione peroxidase:</strong> Glutathione peroxidase is an enzyme that contains selenocysteine in its active site. It plays a vital role in protecting cells from oxidative damage by catalyzing the reduction of hydrogen peroxide and lipid hydroperoxides using glutathione as a cofactor.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option A.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Glutathione reductase:</strong> Glutathione reductase is an enzyme involved in the reduction of oxidized glutathione (GSSG) back to its reduced form (GSH). It does not contain selenocysteine.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option C.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Thioredoxin peroxidase:</strong> Thioredoxin peroxidase (also known as peroxiredoxins) is a group of thiol-containing proteins involved in breaking down hydrogen peroxide during oxidative stress. It does not contain selenocysteine.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option D.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Thioredoxin oxidase:</strong> Thioredoxin oxidase is not a known enzyme. There is an enzyme called thioredoxin reductase, which is involved in maintaining the redox state of thioredoxin, but it does not contain selenocysteine.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enzymes which require amino acid selenocysteine at their catalytic site are:</span></span></span></li>\r\n</ul>\r\n\r\n<ol style=\"margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glutathione Peroxidase</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thioredoxin Reductase</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Iodothyronine deiodinase</span></span></span></li>\r\n</ol>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Codon for selenocysteine: UGA</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This AA is formed by co–translational (during translation) modification (not by post-translational modification).</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200545,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50137,
      "choices": [
        {
          "id": 200548,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">NYHA 3</span></span></span></p>"
        },
        {
          "id": 200549,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">NYHA 4</span></span></span></p>"
        },
        {
          "id": 200550,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">MMRC 4</span></span></span></p>"
        },
        {
          "id": 200551,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">MMRC 5</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient with heart disease has breathlessness on going to the bathroom. What grade does he belong to? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q3036489",
      "question_audio": null,
      "question_video": null,
      "map_id": 34216552,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) NYHA 3</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This patient with heart disease experiences dyspnea while performing an </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">activity of daily living</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (going to the bathroom), which classifies him as </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">NYHA Class 3</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">New York Heart Association (NYHA)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> classification system is used to classify patients with heart disease based on their </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">functional disability</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">NYHA Class I</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: No limitation of physical activity; ordinary activity does not cause symptoms.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">NYHA Class II</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Slight limitation of physical activity; comfortable at rest, but ordinary activity causes symptoms.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">NYHA Class III</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Marked limitation of physical activity; comfortable at rest, but </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">less than ordinary activity</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (e.g., walking to the bathroom) causes symptoms.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">NYHA Class IV</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Unable to carry out any physical activity without symptoms, or symptoms at rest.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In this case, the patient's breathlessness when going to the bathroom indicates a significant limitation, making him fall under </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Class III</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. NYHA 4: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Class 4 indicates severe limitations, where the patient is unable to perform any activity without symptoms or experiences symptoms even at rest, which is more severe than this patient’s current condition.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. MMRC 4 and D. MMRC 5: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Modified Medical Research Council (MMRC) Dyspnea Scale</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is used to assess dyspnea in </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">chronic obstructive pulmonary disease (COPD)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. This classification scale does not apply to patients with heart disease. The MMRC scale is used to assess the degree of breathlessness in COPD, ranging from 0 to 4, where higher numbers indicate more severe breathlessness.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">NYHA classification</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is commonly used to evaluate patients with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">heart failure</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> based on their level of physical activity and symptom severity. Class III patients experience significant limitations in activity, where even mild exertion (such as going to the bathroom) causes symptoms like breathlessness.</span></span></span></p>",
      "correct_choice_id": 200548,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50138,
      "choices": [
        {
          "id": 200552,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatocellular carcinoma</span></p>"
        },
        {
          "id": 200553,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibronodular hyperplasia</span></p>"
        },
        {
          "id": 200554,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver abscess</span></p>"
        },
        {
          "id": 200555,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydatid cyst</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old male underwent NCCT abdomen for suspected renal calculi. An incidental finding was noted in the liver. What is the likely diagnosis? (INCET MAY 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-177.jpg\" alt=\"\" width=\"336\" height=\"271\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-177.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6653683",
      "question_audio": null,
      "question_video": null,
      "map_id": 34581152,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Hydatid cyst</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The above CT image showing a calcified lesion in the liver with a lamellar wall which indicates hydatid disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Caused by Echinococcus granulosus → Humans – accidental host</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-178.jpg\" alt=\"\" width=\"866\" height=\"311\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hepatocellular carcinoma:</strong> Typically presents as a solid tumor with irregular borders and might show vascular invasion or enhancement after contrast administration, not typically calcified.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fibronodular hyperplasia:</strong> Refers to a benign liver lesion that generally does not demonstrate the clear, calcified, and layered appearance of a hydatid cyst.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Liver abscess:</strong> Would more likely present as a fluid-filled lesion with possible air-fluid levels and peripheral enhancement after contrast, not the lamellar calcification seen here.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hydatid cysts in the liver are recognized on CT scans by their calcified, lamellar structure and are an important differential when considering cystic liver lesions, particularly in regions where Echinococcus is endemic.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-178.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200555,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50139,
      "choices": [
        {
          "id": 200556,
          "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-d, 3-a, 4-c</span></p>"
        },
        {
          "id": 200557,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-a, 3-b, 4-d</span></p>"
        },
        {
          "id": 200558,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-b, 3-a, 4-c</span></p>"
        },
        {
          "id": 200559,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-a, 3-b, 4-c</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following: (INCET NOV 2022)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-27%20183230.jpg\" width=\"1151\" height=\"337\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-27%20183230.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9813624",
      "question_audio": null,
      "question_video": null,
      "map_id": 34567196,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C</strong>) <strong>1-d, 2-b, 3-a, 4-c</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. Football sign:</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"background-color:white;color:#0d0d0d;font-size:10.5pt;\">This sign is associated with pneumoperitoneum, where an accumulation of gas in the peritoneal cavity gives a silhouette resembling a football on X-ray images.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-163521_sTAjDlR.png\" alt=\"\" width=\"200\" height=\"286\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2. Rat tail sign:</strong> Typically seen in carcinoma of the esophagus, this sign describes the tapering of the esophageal lumen due to the tumor, resembling a rat’s tail.</span><span style=\"background-color:white;color:#0d0d0d;font-size:10.5pt;\">.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-163534_8I0o2Kl.png\" alt=\"\" width=\"200\" height=\"288\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3. String sign:</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"background-color:white;color:#0d0d0d;font-size:10.5pt;\">Found in CHPS (Congenital Hypertrophic Pyloric Stenosis), it refers to the appearance of a narrowed, elongated channel through the pylorus.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-163547_HQrbrqm.png\" alt=\"\" width=\"200\" height=\"173\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4. Inverted umbrella sign:</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"background-color:white;color:#0d0d0d;font-size:10.5pt;\">This is seen in cases of TB (tuberculosis), particularly referring to the appearance of a contracted cecum and narrow ileocecal junction</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-163602_nOdKJAL.png\" alt=\"\" width=\"200\" height=\"261\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-27%20183612.jpg\" width=\"893\" height=\"273\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-163521_sTAjDlR.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200558,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50140,
      "choices": [
        {
          "id": 200560,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis with high anion gap</span></p>"
        },
        {
          "id": 200561,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis with high anion gap</span></p>"
        },
        {
          "id": 200562,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis with normal anion gap</span></p>"
        },
        {
          "id": 200563,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis with normal anion gap</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following electrolyte abnormalities is seen in methanol intoxication? (INICET NOV 2022)</span></p>",
      "unique_key": "Q1981031",
      "question_audio": null,
      "question_video": null,
      "map_id": 34155186,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Metabolic acidosis with high anion gap</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Methanol intoxication leads to metabolic acidosis with a high anion gap & high osmolal gap. Methanol is metabolized in the body to formic acid, which is a strong acid. The accumulation of formic acid in the bloodstream results in an increase in hydrogen ion concentration, leading to acidosis. The high anion gap indicates that there are unmeasured anions (such as formate) contributing to the acidosis. In addition to causing a high anion gap, methanol intoxication also leads to a high osmolal gap, which is another diagnostic clue in cases of toxic alcohol ingestion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Metabolic alkalosis with high anion gap: </strong>This statement is incorrect because methanol intoxication does not cause alkalosis. Instead, it causes acidosis due to the production of formic acid.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Metabolic acidosis with normal anion gap: </strong>This statement is incorrect because the acidosis caused by methanol intoxication is characterized by a high anion gap due to the accumulation of formate, a byproduct of methanol metabolism.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Metabolic alkalosis with normal anion gap: </strong>This statement is incorrect because methanol intoxication leads to acidosis, not alkalosis, and the anion gap is elevated, not normal.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Methanol intoxication causes metabolic acidosis with a high anion gap due to the accumulation of formic acid.</span></p>",
      "correct_choice_id": 200561,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50141,
      "choices": [
        {
          "id": 200564,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 200565,
          "text": "<p><span style=\"font-size:12pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 200566,
          "text": "<p><span style=\"font-size:12pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 200567,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Chemoprophylaxis for leprosy should be given to which of the following persons?</span>(INICET NOVEMBER 2022)</p><p> </p><ol><li><span style=\"font-size:12pt;\">Sharing the same clothes, towels</span></li><li><span style=\"font-size:12pt;\">Living with a patient with leprosy for > 6 month</span></li><li><span style=\"font-size:12pt;\">Contact of age more than 2 years</span></li><li><span style=\"font-size:12pt;\">Contact for more than 20 hours per week. </span></li></ol><p> </p>",
      "unique_key": "Q1557907",
      "question_audio": null,
      "question_video": null,
      "map_id": 34916220,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 2, 3, 4</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Chemoprophylaxis for leprosy should be given to contacts 2, 3 and 4.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Chemoprophylaxis for leprosy should be given to the following contacts:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Being identified as a contact, i.e., a person who has been in close contact with the index case for <strong>20 hours (option 4) or more per week for more than 3 months</strong> <strong>(option 2)</strong> (Exception is <strong>blanket approach</strong> where no link with an index case needs to be established.)</span></li><li><span style=\"font-size:12pt;\"><strong>Age:</strong> <strong>More than 2 years (option 3);</strong> if younger than 2 years, the child can be given SDR at the age of 2, in follow up visits of contacts (if meeting all other inclusion criteria.)</span></li><li><span style=\"font-size:12pt;\"><strong>Consent of the contact obtained</strong>. Depending on the country situation, this can be <strong>written</strong> or a <strong>verbal consent</strong>. In case of children, consent should be obtained from the <strong>parent</strong> or <strong>guardian,</strong> and sometimes an <strong>assent</strong> from the <strong>grown-up</strong> <strong>children.</strong></span></li><li><span style=\"color:#0f0f0f;font-size:12pt;\"><strong>Sharing </strong>the same <strong>clothes and</strong> <strong>towels (Option 1),</strong> while a potential <strong>route of transmission</strong>, is <strong>not</strong> generally considered a primary <strong>criterion</strong> for <strong>chemoprophylaxis.</strong></span></li></ul><p> </p><p><span style=\"color:black;font-size:12pt;\"><strong>Exclusion criteria</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12pt;\">Persons with possible signs and/or symptoms of <strong>leprosy;</strong></span></li><li><span style=\"color:black;font-size:12pt;\">Persons with possible signs and/or symptoms of <strong>TB</strong> <strong>or confirmed with TB;</strong></span></li><li><span style=\"color:black;font-size:12pt;\">Persons with a history of <strong>liver or kidney disorders</strong>;</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Pregnancy</strong>; SDR can be <strong>given after the delivery</strong>;</span></li><li><span style=\"color:black;font-size:12pt;\">Persons who have received <strong>rifampicin in the last two years</strong> e.g. as treatment of TB, leprosy or as prophylaxis (e.g. contact of another index case);</span></li><li><span style=\"color:black;font-size:12pt;\">Persons with history of <strong>allergy to rifampicin</strong>;</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Refusal to take SDR.</strong></span></li></ul><p> </p><p><span style=\"color:black;font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Chemoprophylaxis for leprosy is crucial for contacts who have had significant exposure to an individual with leprosy, particularly those living in the same household or in close contact for extended periods.</span></p><p> </p><p><span style=\"color:black;font-size:12pt;\"><strong>Rifampicin:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">A <strong>single dose of 600 mg</strong> kills more than <strong>99%</strong> of the <strong>susceptible organisms</strong> present at the start of treatment, that is as much as <strong>3 to 6 months</strong> of daily treatment with the combination <strong>dapsone plus Clofazimine.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Rifampicin </strong>has become established as a <strong>highly potent bactericidal drug</strong>, and it acts by <strong>inhibiting</strong> the <strong>bacterial DNA dependent RNA polymerase</strong>.</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Single Dose of Rifampicin </strong>(SDR) is used in <strong>chemoprophylaxis.</strong></span></li><li><span style=\"color:black;font-size:12pt;\">Chemoprophylaxis must be initiated only <strong>4 weeks after treatment for leprosy</strong> has begun in the <strong>patient</strong> so as to ensure the <strong>patient is non-infectious</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><i><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-22-160933.jpg\" alt=\"\" width=\"1000\" height=\"405\"></i></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref - </strong></span><span style=\"color:black;font-size:12pt;\"><strong>Jopling’s Handbook of Leprosy 6<sup>th</sup> Edition Page no 242</strong></span></p><p><span style=\"color:#3c4245;font-size:12pt;\"><strong>Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis</strong></span></p><p><a href=\"https://www.who.int/publications/i/item/9789290228073\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/publications/i/item/9789290228073</u></strong></span></a><span style=\"font-size:12pt;\"><strong> (page 23, 24)</strong></span></p><p><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051288/\"><span style=\"font-size:12pt;\"><strong><u>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051288/</u></strong></span></a></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-22-160933.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200566,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50142,
      "choices": [
        {
          "id": 200568,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-3, D-4</span></p>"
        },
        {
          "id": 200569,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-4, C-1, D-3</span></p>"
        },
        {
          "id": 200570,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-2, C-1, D-4</span></p>"
        },
        {
          "id": 200571,
          "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-2, C-3, D-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following cancers with their corresponding criteria for the minimum number of lymph nodes required for pathological staging: (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-162903.jpg\" alt=\"\" width=\"600\" height=\"241\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-162903.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5392930",
      "question_audio": null,
      "question_video": null,
      "map_id": 34138198,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) A-1, B-2, C-3, D-4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The minimum number of lymph nodes required for accurate staging are 16 for stomach carcinoma, 12 for colon carcinoma, 6 for gall bladder carcinoma, and 10 for breast carcinoma.</span></p>",
      "correct_choice_id": 200568,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50143,
      "choices": [
        {
          "id": 200572,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1st trimester USG is the best assessment</span></span></span></p>"
        },
        {
          "id": 200573,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Calculated from the last day of the last menstrual period</span></span></span></p>"
        },
        {
          "id": 200574,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In an IVF pregnancy, day of embryo transfer/day of fertilization is needed to calculate POG</span></span></span></p>"
        },
        {
          "id": 200575,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Crown-rump length is the best measure of period of gestation in the first trimester</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Identify the wrong statement regarding the period of gestation calculation:</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q4806227",
      "question_audio": null,
      "question_video": null,
      "map_id": 34518658,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Calculated from the last day of the last menstrual period</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Gestational age or period of gestation (POG) refers to the duration of pregnancy calculated from the first day of last menstrual period </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Calculating the EDD: </span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Normal duration of pregnancy: 280 days (40 weeks)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Calculating the EDD: <strong>Naegele’s formula</strong>. To the LMP (1<sup>st</sup> day of the last menstrual day) </span></span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Add 9 months + 7 days</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Subtract 3 months and add 7 days</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Dating the pregnancy:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND</span></span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1st trimester CRL: most accurate (till 14 weeks)</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">BPD in the 2nd trimester</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. 1st trimester USG is the best assessment</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Correct, because the 1st trimester USG provides the most accurate dating method.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. In an IVF pregnancy, day of embryo transfer/day of fertilization is needed to calculate POG</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Correct, because calculating gestational age in IVF pregnancies relies on the day of embryo transfer or fertilization.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. <strong>Crown-rump length is the best measure of period of gestation in the first trimester</strong>: Correct, because CRL is the best measure for assessing the period of gestation in the first trimester.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Gestational age is calculated from the first day of the last menstrual period (LMP), not the last day.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg, Dutta’s 108, 109, textbook of obstetrics 8<sup>th</sup> edition pg127</span></strong></span></span></p>",
      "correct_choice_id": 200573,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50144,
      "choices": [
        {
          "id": 200576,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medullary cancer of thyroid</span></span></span></p>"
        },
        {
          "id": 200577,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Follicular cancer of thyroid</span></span></span></p>"
        },
        {
          "id": 200578,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thyroglossal cyst</span></span></span></p>"
        },
        {
          "id": 200579,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Papillary cancer of thyroid</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 19-year-old girl presents with a midline neck swelling that moves on deglutition. Ultrasound revealed a 2 cm x 2 cm nodule on the left lobe of the thyroid, extending into the strap muscles. The histopathology image is given below. What is the most likely diagnosis? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/5_PlzqSOh.jpg\" style=\"height:147px; width:300px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/5_PlzqSOh.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2413983",
      "question_audio": null,
      "question_video": null,
      "map_id": 34035665,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Papillary cancer of thyroid</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical scenario and the image showing papillae lined by cells with overlapping nuclei and Orphan Annie eye nuclei indicate a diagnosis of papillary carcinoma of thyroid.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histologically, the following features are present</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Papillary pattern - Papillae composed of fibrovascular stalk and covered by single layer of tumor cells is the predominant feature. Papillae are often accompanied by follicles.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tumor cells. The tumor cells have characteristic nuclear features due to dispersed nuclear chromatin imparting it ground glass or optically clear appearance and clear or oxyphilic cytoplasm also called Orphan Annie nuclei. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Invasion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Invade the capsule and intra-thyroid lymphatics</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Psammoma bodies</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Small, concentric, calcified spherules called psammoma bodies in the stroma.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Papillary carcinoma thyroid microscopy shows branching papillae having fibrovascular stalk covered by a single layer of cuboidal cells having ground nuclei. Colloid-filled follicles and sloid sheets of tumor cells are present.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Medullary cancer of thyroid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This cancer arises from the parafollicular C-cells of the thyroid and is associated with elevated calcitonin levels. Histologically, it shows a solid growth pattern with amyloid deposits, which is not seen in the provided image.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Follicular cancer of thyroid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This type of thyroid cancer typically shows a follicular growth pattern with invasion into blood vessels or the capsule. The cells do not have the distinct nuclear features (Orphan Annie nuclei) seen in papillary carcinoma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Thyroglossal cyst</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a benign cystic lesion that usually presents as a midline neck mass that moves with swallowing or tongue protrusion. It does not present with a nodule in the thyroid gland or the histological features described in this case.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Papillary carcinoma of the thyroid is characterized by Orphan Annie nuclei, psammoma bodies, and a papillary architecture, which are key diagnostic features.</span></span></span></p>",
      "correct_choice_id": 200579,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50145,
      "choices": [
        {
          "id": 200580,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoprolol</span></p>"
        },
        {
          "id": 200581,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 200582,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
        },
        {
          "id": 200583,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Based on the ECG given below, which of the following drugs is NOT used in the management of the condition? (INICET NOV 2022)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103835-am.jpeg\" alt=\"\" width=\"300\" height=\"164\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103835-am.jpeg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4099464",
      "question_audio": null,
      "question_video": null,
      "map_id": 34534504,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Adenosine</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The ECG shows a case of <strong>atrial fibrillation</strong>, characterized by an irregularly irregular rhythm and the absence of distinct P waves. Instead, there are fibrillatory waves that can be seen in the baseline. Atrial fibrillation is a common type of irregular heart rhythm where the atria beat chaotically and irregularly.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Adenosine is not used in the management of atrial fibrillation. It is primarily indicated for the treatment of regular narrow complex tachycardias, such as supraventricular tachycardia (SVT). Adenosine works by temporarily blocking the atrioventricular (AV) node, which can help reset the heart rhythm in cases of regular tachycardias. However, in irregular rhythms like atrial fibrillation, adenosine is contraindicated because it can induce atrial fibrillation or exacerbate the condition.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Metoprolol:</strong> Metoprolol is a beta-blocker used in the management of atrial fibrillation. It helps control the heart rate by slowing down the conduction through the AV node.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Amiodarone:</strong> Amiodarone is an antiarrhythmic medication used for rhythm control in atrial fibrillation. It can help to convert atrial fibrillation to a normal sinus rhythm and maintain it.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diltiazem:</strong> Diltiazem is a calcium channel blocker used to control the ventricular rate in atrial fibrillation by slowing conduction through the AV node.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Adenosine should not be used in the management of atrial fibrillation due to its potential to induce or worsen the condition.</span></p>",
      "correct_choice_id": 200582,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50146,
      "choices": [
        {
          "id": 200584,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amoxicillin-clavulanic acid + Azithromycin</span></span></span></p>"
        },
        {
          "id": 200585,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Co-trimoxazole + steroids</span></span></span></p>"
        },
        {
          "id": 200586,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Co-trimoxazole only</span></span></span></p>"
        },
        {
          "id": 200587,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antitubercular treatment</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient, who is a known case of HIV with a CD4 count of 200 cells/cu.mm, presents with 5 days of cough and high-grade fever without chills and rigors. There is no history of diarrhea, vomiting, or nuchal rigidity. Chest x-ray is normal. What treatment will you give?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q3159810",
      "question_audio": null,
      "question_video": null,
      "map_id": 34284695,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Co-trimoxazole only</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In a patient with HIV and a CD4 count of 200 cells/cu.mm presenting with symptoms such as cough and fever, but with a normal chest x-ray, <strong>Pneumocystis jirovecii pneumonia (PCP)</strong> is a likely diagnosis. PCP is a common opportunistic infection in HIV patients, especially when the CD4 count is below 200 cells/cu.mm.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The treatment of choice for PCP is co-trimoxazole (trimethoprim-sulfamethoxazole). It is essential to start treatment empirically in suspected cases of PCP because delayed treatment can lead to significant morbidity and mortality. The dose of co-trimoxazole is typically higher for treating PCP than for prophylaxis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Steroids are indicated in severe cases of PCP to reduce inflammation, specifically if the patient has hypoxemia (PaO2 < 70 mmHg) or an alveolar-arterial (A-a) gradient > 35 mmHg. In this scenario, there is no data indicating severe disease, so co-trimoxazole alone is appropriate.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Amoxicillin-clavulanic acid + Azithromycin: </span></strong><span style=\"font-size:12.0pt\">This combination is used for bacterial pneumonia, not PCP. Given the normal chest x-ray and the patient's clinical presentation, bacterial pneumonia is less likely.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Co-trimoxazole + steroids: </span></strong><span style=\"font-size:12.0pt\">Steroids are added in severe cases of PCP. However, there is no evidence in this case of severe hypoxemia or an increased A-a gradient to justify the use of steroids along with co-trimoxazole.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Antitubercular treatment: </span></strong><span style=\"font-size:12.0pt\">There is no indication from the clinical presentation or the normal chest x-ray that the patient has tuberculosis. Antitubercular treatment is therefore not appropriate in this scenario.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For HIV patients with a CD4 count below 200 cells/cu.mm and presenting with cough and fever but a normal chest x-ray, co-trimoxazole is the first-line treatment for suspected PCP</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note - For a patient with a CD4 count of 200 and lower respiratory tract symptoms:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">PCP Pneumonia</span></strong><span style=\"font-size:12.0pt\">: Suspect if the chest X-ray is normal or negative.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bacterial Pneumonia</span></strong><span style=\"font-size:12.0pt\">: Suspect if the chest X-ray shows consolidation or examination reveals bronchial breath sounds.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200586,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50147,
      "choices": [
        {
          "id": 200588,
          "text": "<p><span style=\"font-size:12.0pt;\">a-1, b-2, c-3, d-4</span></p>"
        },
        {
          "id": 200589,
          "text": "<p><span style=\"font-size:12.0pt;\">a-2, b-3, c-4, d-1</span></p>"
        },
        {
          "id": 200590,
          "text": "<p><span style=\"font-size:12.0pt;\">a-2, b-4, c-3, d-1</span></p>"
        },
        {
          "id": 200591,
          "text": "<p><span style=\"font-size:12.0pt;\">a-1, b-3, c-4, d-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following: </span>(INICET NOVEMBER 2021)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/untitled-21.jpg\" alt=\"\" width=\"600\" height=\"229\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/untitled-21.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5954222",
      "question_audio": null,
      "question_video": null,
      "map_id": 34390353,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) a-2, b-4, c-3, d-1</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The correct match for Wullstein’s classification is a-2, b-4, c-3, d-1</span></p><p> </p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Type II – 2. graft placed over the incus</span></li><li><span style=\"font-size:12.0pt;\">Type III – 4. columella tympanoplasty</span></li><li><span style=\"font-size:12.0pt;\">Type IV – 3. Cavum minor</span></li><li><span style=\"font-size:12.0pt;\">Type V – 1. Fenestration tympanoplasty</span></li></ol><p> </p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>Type II (Ossiculoplasty)</strong>: Malleus partially eroded; ossicular chain reconstruction involves placing a graft over the incus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Type III (Columella Effect)</strong>: Malleus and incus eroded; new TM coupled to the stapes head, referred to as columella tympanoplasty.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Type IV (Cavum Minor)</strong>: Stapedial head also eroded; new TM and new ossicular coupling to the stapes footplate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Type V (Fenestration Operation)</strong>: Creating a fenestra and coupling the ossicular chain to the scala vestibuli.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Wullstein’s classification of tympanoplasty provides a systematic approach to different types of middle ear reconstructions based on the extent of ossicular damage and required surgical repair.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_m0R8vHp.png\" width=\"781\" height=\"552\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-115802.png\" alt=\"\" width=\"1000\" height=\"480\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_m0R8vHp.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200590,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50148,
      "choices": [
        {
          "id": 200592,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 1</span></span></span></p>"
        },
        {
          "id": 200593,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 3</span></span></span></p>"
        },
        {
          "id": 200594,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 2</span></span></span></p>"
        },
        {
          "id": 200595,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 4</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A hospital is investigating the effectiveness of statins in a multiple-centric clinical trial. The study involves 4000-5000 patients and half of them have received the drug while the other half was given a placebo. Both the subjects and the investigators are unaware of which group is getting the drug and which group is being administered the placebo. Which of the following phases of clinical trial corresponds to this scenario? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q4307111",
      "question_audio": null,
      "question_video": null,
      "map_id": 34775505,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B. Phase 3 </span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">As the study is being conducted in multiple centers in a double blinded manner, where neither the physician nor the patients know what they are receiving, therefore this trial is in Phase 3.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The phases of clinical trials are as follows: -</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-103816.png\" style=\"height:426px; width:1000px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase Zero trials are called micro-dosing studies. It is an optional trial done by some companies on small number of healthy volunteers to know the pharmacokinetics of the drug. Dose used is one-hundredth of the final human dose or 100 microgram (whichever is lower).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Pre-clinical trials are animal studies. The drugs are first tested on the small animals like rats, guinea pig etc. to know the complete pharmacokinetics.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The described clinical trial, with its large sample size, multiple centers, double-blind design, and focus on confirming the efficacy of statins, corresponds to a <strong><span style=\"font-family:\"Calibri\",sans-serif\">Phase 3</span></strong> clinical trial. This phase is crucial for determining whether the drug is effective and safe for widespread use.</span></span></span></p>\r\n\r\n<p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-103816.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200593,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50149,
      "choices": [
        {
          "id": 200596,
          "text": "<p><span style=\"font-size:12.0pt;\">20, 22 desmolase, 3β-hydroxysteroid dehydrogenase 17 alpha hydroxylase, 17,20 lyase</span></p>"
        },
        {
          "id": 200597,
          "text": "<p><span style=\"font-size:12.0pt;\">3β-hydroxysteroid dehydrogenase 17 alpha hydroxylase, 17,20 lyase, 20, 22 desmolase,</span></p>"
        },
        {
          "id": 200598,
          "text": "<p><span style=\"font-size:12.0pt;\">20, 22 desmolase, 17,20 lyase, 17 alpha hydroxylase, 3β-hydroxysteroid dehydrogenase</span></p>"
        },
        {
          "id": 200599,
          "text": "<p><span style=\"font-size:12.0pt;\">17 alpha hydroxylase, 3β-hydroxysteroid dehydrogenase, 20, 22 desmolase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Choose the right sequence of steps in the conversion of cholesterol to testosterone (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2022)</span></p>",
      "unique_key": "Q1218054",
      "question_audio": null,
      "question_video": null,
      "map_id": 34078740,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 20, 22 desmolase, 3β-hydroxysteroid dehydrogenase 17 alpha hydroxylase, 17,20 lyase</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">For the sequence of reactions for cholesterol to testosterone conversion, refer to pathway below:</span></p><p> </p><p><span style=\"color:#212529;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture9_mbYtURI.jpg\" alt=\"\" width=\"500\" height=\"313\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">For change in number of carbons refer to diagram below:</span></p><p> </p><p><span style=\"color:#212529;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture10_GsePGR0.jpg\" alt=\"\" width=\"500\" height=\"256\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The correct sequence for the conversion of cholesterol to testosterone involves the enzymes 20, 22 desmolase, 3β-hydroxysteroid dehydrogenase, 17 alpha hydroxylase, and 17,20 lyase in that specific order.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture9_mbYtURI.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200596,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50150,
      "choices": [
        {
          "id": 200600,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treatment completion rate</span></span></span></p>"
        },
        {
          "id": 200601,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Annual new case detection rate per lac</span></span></span></p>"
        },
        {
          "id": 200602,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treatment initiation rate</span></span></span></p>"
        },
        {
          "id": 200603,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Proportion of newly diagnosed patients with grade-2 disability</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A public health official is evaluating the effectiveness of a health system in emphasizing early detection of leprosy in a community setting. Which of the following metrics would be most indicative of the system's commitment to early identification?\" (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q9435686",
      "question_audio": null,
      "question_video": null,
      "map_id": 34542084,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Proportion of newly diagnosed patients with grade-2 disability</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The proportion of newly diagnosed patients with grade 2 disability is useful in determining whether the health system is giving importance to identifying leprosy in the community.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/untitled-1.jpg\" style=\"height:881px; width:1000px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Treatment completion rate</span></strong><span style=\"font-size:12.0pt\">: This measures the effectiveness of treatment adherence and success but does not directly reflect the system's ability to detect cases early.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Annual new case detection rate per lac</span></strong><span style=\"font-size:12.0pt\">: While it shows the number of new cases detected, it doesn't indicate how early these cases are being detected.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Treatment initiation rate</span></strong><span style=\"font-size:12.0pt\">: This measures how quickly diagnosed patients begin treatment but does not indicate how early the cases are being detected.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The proportion of newly diagnosed patients with grade-2 disability is a key indicator of the effectiveness of a health system in detecting leprosy early. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lower proportions suggest better early detection efforts</span></span></span></li>\r\n</ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/untitled-1.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200603,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50151,
      "choices": [
        {
          "id": 200604,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet</span></p>"
        },
        {
          "id": 200605,
          "text": "<p><span style=\"font-size:12.0pt;\">Intrinsic</span></p>"
        },
        {
          "id": 200606,
          "text": "<p><span style=\"font-size:12.0pt;\">Extrinsic</span></p>"
        },
        {
          "id": 200607,
          "text": "<p><span style=\"font-size:12.0pt;\">vWD</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following represents maximum amplitude in Thromboelastography? (INICET NOV 2022)</span></p>",
      "unique_key": "Q7294339",
      "question_audio": null,
      "question_video": null,
      "map_id": 34120214,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Platelet</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Thromboelastography (TEG) is a test that measures the viscoelastic properties of blood as it clots under low shear conditions, mimicking sluggish venous flow. The <strong>maximum amplitude (MA)</strong> on a TEG tracing represents the final strength of the clot and is predominantly determined by the number and function of platelets and fibrin interaction.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Platelets</strong> play a crucial role in forming the solid clot structure, which is reflected by the MA. Thus, the maximum amplitude in TEG is directly associated with platelet function and quantity.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture3.jpg\" alt=\"\" width=\"250\" height=\"419\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture4.jpg\" alt=\"\" width=\"500\" height=\"225\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Intrinsic and Option C. Extrinsic</strong>: These terms refer to different pathways of the coagulation cascade, not directly to the maximum amplitude in TEG.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. vWD</strong>: von Willebrand Disease affects platelet adhesion due to deficiency or dysfunction of von Willebrand factor, but the maximum amplitude is a function of platelet interaction with fibrin, not directly of vWD.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The maximum amplitude in Thromboelastography represents platelets. TEG is a non-invasive test that quantitatively measures the ability of whole blood to form a clot.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture3.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200604,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50152,
      "choices": [
        {
          "id": 200608,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypotension</span></span></span></p>"
        },
        {
          "id": 200609,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hyponatremia</span></span></span></p>"
        },
        {
          "id": 200610,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Rash</span></span></span></p>"
        },
        {
          "id": 200611,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Elevated levels of gamma glutamyl transpeptidas</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">All of the following side effects are more commonly seen with carbamazepine than oxcarbazepine, except: (</span></span>INICET Nov 2022)</p>",
      "unique_key": "Q8124470",
      "question_audio": null,
      "question_video": null,
      "map_id": 34013946,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B. Hyponatremia</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hyponatremia is more commonly observed in individuals taking oxcarbazepine compared to those taking carbamazepine. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Both of these antiepileptic drugs can contribute to hyponatremia by enhancing the effects of ADH (antidiuretic hormone), leading to increased retention of water, which in turn reduces the osmolarity and causes hyponatremia. However, the incidence of hyponatremia appears to be higher with oxcarbazepine when compared to carbamazepine.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. Hypotension</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Hypotension is more commonly seen with carbamazepine. It can affect cardiovascular function and lead to decreased blood pressure.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Rash</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Rash is a common side effect of both drugs, but it is more frequently seen with carbamazepine. Skin reactions can range from mild to severe, including Stevens-Johnson syndrome and toxic epidermal necrolysis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Elevated levels of gamma glutamyl transpeptidases (GGT)</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Elevated GGT levels are more commonly associated with carbamazepine use. GGT is an enzyme found in the liver, and its elevated levels can indicate liver enzyme induction or liver injury, which is more common with carbamazepine.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hyponatremia is more commonly associated with oxcarbazepine than carbamazepine. While both drugs can cause similar side effects due to their similar mechanisms of action, certain adverse effects, such as hypotension, rash, and elevated GGT levels, are more frequently seen with carbamazepine.</span></span></span></p>",
      "correct_choice_id": 200609,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50153,
      "choices": [
        {
          "id": 200612,
          "text": "<p>1</p>"
        },
        {
          "id": 200613,
          "text": "<p>2</p>"
        },
        {
          "id": 200614,
          "text": "<p>3</p>"
        },
        {
          "id": 200615,
          "text": "<p>4</p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which marked structure causes lateral rotation, flexion, and abduction at the hip joint, along with flexion at the knee joint?</span>(INICET NOV 2022)</p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/14.jpg\" alt=\"\" width=\"150\" height=\"336\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/14.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5779611",
      "question_audio": null,
      "question_video": null,
      "map_id": 34740031,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The muscle marked in the image are:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> 1- Rectus femoris</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B.</strong> 2- Vastus lateralis</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. 3- Adductor longus</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. 4- Sartorius</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Sartorius is involved in lateral rotation, flexion, and abduction at the hip joint, and flexion at the knee. The structure marked '4' is sartorius.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The sartorius muscle is a long, thin muscle that runs down the front of the thigh. It is the body's longest muscle and is sometimes referred to as the tailor muscle because of the position that tailors often adopt while working. The sartorius muscle originates from the anterior superior iliac spine and the upper half of the notch below it, and runs obliquely across the thigh to insert into the superior aspect of the medial surface of the tibial shaft near the tibial tuberosity. It joins the aponeurosis of the gracilis and semitendinosus muscles to form the pes anserinus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The sartorius muscle is responsible for several actions, including flexion, abduction, and lateral rotation of the thigh, as well as flexion of the leg. Because of its location and actions, it is involved in many activities that require movement of the lower limb, such as walking, running, and climbing stairs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/15.jpg\" alt=\"\" width=\"500\" height=\"522\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Muscles of the anterior compartment of thigh (spinal segments in bold are the major segments innervating the muscle)</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/16/muscle.jpg\" alt=\"\" width=\"1000\" height=\"1229\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/15.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200615,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50154,
      "choices": [
        {
          "id": 200616,
          "text": "<p><span style=\"font-size:12.0pt;\">Anemia of chronic disorder</span></p>"
        },
        {
          "id": 200617,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
        },
        {
          "id": 200618,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron-deficiency anemia</span></p>"
        },
        {
          "id": 200619,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickle cell anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 12-year-old boy was brought to OPD with complaint of fatigue. Serum investigations revealed findings as given below. What is the likely diagnosis? (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hemoglobin – 9 g/dl</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Mean cell volume (MCV) – 60 fL</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Mean cell Hb (MCH) – 20 pg</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Serum Ferritin – 185 mcg/L</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Total leukocyte count – Elevated lymphocyte and Neutrophils</span></p><p> </p><p><span style=\"font-size:12.0pt;\">[Reference normal values for this question: Serum Ferritin: 50-200 mcg/L; Mean cell volume (MCV) - 80-100 fL; Mean cell Hb (MCH) - 27-31 pg]</span></p>",
      "unique_key": "Q5063491",
      "question_audio": null,
      "question_video": null,
      "map_id": 34111685,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Thalassemia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The clinical presentation of fatigue, along with laboratory findings, strongly suggests <strong>thalassemia</strong>.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>MCV of 60 fL </strong>and <strong>MCH of 20 pg</strong> are both very low, indicating microcytic hypochromic anemia, which is typical in thalassemia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Serum ferritin</strong> is within the normal range (185 mcg/L), which rules out iron-deficiency anemia, as that condition would typically present with low ferritin levels.</span></li><li><span style=\"font-size:12.0pt;\">The elevated lymphocyte and neutrophil counts could be a secondary response but are not specific to thalassemia.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Thalassemia is characterized by a reduction in the synthesis of globin chains (alpha or beta), leading to ineffective erythropoiesis and anemia. The microcytosis and hypochromia (low MCV and MCH) are hallmarks of this condition.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anemia of chronic disorder</strong>: Typically presents with normal to reduced MCV and low serum iron, but ferritin is usually raised, not within the normal range.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Iron-deficiency anemia</strong>: Would show low serum ferritin, low MCV, and low MCH, but the serum ferritin here is normal.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sickle cell anemia</strong>: Would not typically present with low MCV and MCH, as sickle cells tend to be normocytic or macrocytic.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-125253.jpg\" alt=\"\" width=\"1000\" height=\"410\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-125253.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200617,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50155,
      "choices": [
        {
          "id": 200620,
          "text": "<p><span style=\"font-size:12.0pt;\">RT PCR</span></p>"
        },
        {
          "id": 200621,
          "text": "<p><span style=\"font-size:12.0pt;\">Real time PCR</span></p>"
        },
        {
          "id": 200622,
          "text": "<p><span style=\"font-size:12.0pt;\">Southern blotting</span></p>"
        },
        {
          "id": 200623,
          "text": "<p><span style=\"font-size:12.0pt;\">Immunoassays</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">SARS CoV-2 diagnosis is done by all except?</span></p>",
      "unique_key": "Q4817924",
      "question_audio": null,
      "question_video": null,
      "map_id": 34037942,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Southern blotting</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Southern blotting is not a standard method for SARS-CoV-2 diagnosis. It is a technique primarily used for the detection and analysis of DNA fragments, not RNA viruses like SARS-CoV-2. </span></li><li><span style=\"font-size:12.0pt;\">Diagnosis of SARS-CoV-2 (COVID-19) primarily involves detecting viral RNA or immune response markers. Let's break down the options:</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. RT-PCR (Reverse Transcription PCR) —Used</strong></span></p><ul><li><span style=\"font-size:12pt;\">Gold standard for detecting viral RNA.</span></li><li><span style=\"font-size:12pt;\">RNA is reverse-transcribed to DNA, then amplified.</span></li><li><span style=\"font-size:12pt;\">High sensitivity and specificity.</span><br> </li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Real-Time PCR —Used</strong></span></p><ul><li><span style=\"font-size:12pt;\">Often used in combination with RT (i.e., RT-qPCR).</span></li><li><span style=\"font-size:12pt;\">Provides quantitative data and real-time amplification curves.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Southern Blotting —Not used</strong></span></p><ul><li><span style=\"font-size:12pt;\">Southern blotting is used to detect DNA, not RNA.</span></li><li><span style=\"font-size:12pt;\">It is not suitable for viral RNA detection.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Immunoassays — Used</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Used for antibody detection (IgM, IgG) or antigen detection.</span></li><li><span style=\"font-size:12.0pt;\">Examples: ELISA, lateral flow assays (like rapid tests).</span></li><li><span style=\"font-size:12.0pt;\">Useful for screening, epidemiological surveillance, and past infection confirmation.</span><br> </li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_PbXBhOt.png\" width=\"1382\" height=\"315\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_PbXBhOt.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200622,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50156,
      "choices": [
        {
          "id": 200624,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine hydroxylase</span></p>"
        },
        {
          "id": 200625,
          "text": "<p><span style=\"font-size:12.0pt;\">Isovaleryl CoA dehydrogenase</span></p>"
        },
        {
          "id": 200626,
          "text": "<p><span style=\"font-size:12.0pt;\">Fumarylacetoacetate hydrolase</span></p>"
        },
        {
          "id": 200627,
          "text": "<p><span style=\"font-size:12.0pt;\">Branched chain keto acid dehydrogenase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Brunt sugar smell of urine is due to the defect of? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q3097435",
      "question_audio": null,
      "question_video": null,
      "map_id": 34310249,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Branched chain keto acid dehydrogenase</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Burnt sugar-like odour is a characteristic feature of Maple Syrup Urine Disease (MSUD) which occurs due to the inherited deficiency of branched chain Keto-acid dehydrogenase/decarboxylase.</span></li><li><span style=\"font-size:12.0pt;\">It results in a defect in oxidative phosphorylation and catabolism of branched-chain amino acids (BCAA) Valine/Isoleucine/leucine. As a result, these amino acids are excreted in urine. There is also mental retardation.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Phenylalanine hydroxylase: </strong>Deficiency of phenylalanine hydroxylase leads to phenylketonuria (PKU), which is characterized by a mousy or musty odor due to the accumulation of phenylalanine and its metabolites.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Isovaleryl CoA dehydrogenase: </strong>Deficiency of isovaleryl CoA dehydrogenase causes isovaleric acidemia, which is associated with a rancid, cheesy, or sweaty feet odor due to the accumulation of isovaleric acid.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fumarylacetoacetate hydrolase: </strong>Deficiency of fumarylacetoacetate hydrolase leads to tyrosinemia type I, which is characterized by a boiled cabbage or rotten mushrooms odor due to the accumulation of tyrosine and its metabolites.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-115715.jpg\" alt=\"\" width=\"1000\" height=\"459\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-115715.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200627,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50157,
      "choices": [
        {
          "id": 200628,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium</span></p>"
        },
        {
          "id": 200629,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose 6 Phosphate</span></p>"
        },
        {
          "id": 200630,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin</span></p>"
        },
        {
          "id": 200631,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Glycogen phosphorylase is activated by? (INICET Nov 2022)</span></p>",
      "unique_key": "Q2029718",
      "question_audio": null,
      "question_video": null,
      "map_id": 34819823,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Calcium</strong></span></p><p> </p><ul><li><span style=\"font-size:16px;\">Glycogen phosphorylase is primarily activated indirectly by calcium ions. An increase in intracellular calcium levels triggers the activation of phosphorylase kinase, which, in turn, activates glycogen phosphorylase. Calcium acts as a secondary messenger to stimulate this cascade of enzymatic reactions.</span></li></ul><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B.</strong> <strong>Glucose 6 Phosphate</strong>: Glucose 6-phosphate, a product of glycogenolysis (glycogen breakdown), actually inhibits glycogen phosphorylase. It is part of a negative feedback mechanism to prevent excessive glycogen breakdown when glucose levels are sufficient.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C.</strong> <strong>Insulin</strong>: Insulin does not directly activate glycogen phosphorylase. Instead, insulin plays a role in promoting glycogen synthesis by activating glycogen synthase and inhibiting glycogen phosphorylase.</span></p><p> </p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D.</strong> <strong>Glucose</strong>: Glucose itself does not directly activate glycogen phosphorylase. In fact, high levels of glucose signal that glucose is available for energy production, leading to the inhibition of glycogenolysis and glycogen phosphorylase.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:16px;\">Glycogen phosphorylase is activated indirectly through the calcium signaling pathway, which initiates a series of enzymatic reactions ultimately leading to the activation of glycogen phosphorylase. This mechanism allows the regulation of glycogen breakdown in response to cellular energy needs.</span></p><p> </p><p><span style=\"color:#374151;font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/01.jpg\" alt=\"\" width=\"700\" height=\"439\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/01.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200628,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50158,
      "choices": [
        {
          "id": 200632,
          "text": "<p><span style=\"font-size:12pt;\">Squamous cell carcinoma</span></p>"
        },
        {
          "id": 200633,
          "text": "<p><span style=\"font-size:12pt;\">Clear cell adenocarcinoma</span></p>"
        },
        {
          "id": 200634,
          "text": "<p><span style=\"font-size:12pt;\">Adenocarcinoma</span></p>"
        },
        {
          "id": 200635,
          "text": "<p><span style=\"font-size:12pt;\">Sarcoma botryoides</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The daughter of a woman who received diethylstilbestrol during her pregnancy is at higher risk for? </span>(INICET NOV 2022)</p>",
      "unique_key": "Q4098080",
      "question_audio": null,
      "question_video": null,
      "map_id": 34890416,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Clear cell adenocarcinoma</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Diethylstilbestrol (DES)</strong> is a synthetic estrogen that was previously prescribed to pregnant women to prevent miscarriages and other pregnancy complications. It was later discovered to be a teratogen and is no longer used.</span></li><li><span style=\"font-size:12pt;\">Exposure to DES in utero is known to cause the following conditions:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>In girls</strong>:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">T-shaped uterus</span></li><li><span style=\"font-size:12pt;\">Cockscomb cervix</span></li><li><span style=\"font-size:12pt;\">Vaginal and cervical clear cell adenocarcinoma</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>In boys</strong>:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Micropenis</span></li><li><span style=\"font-size:12pt;\">Hypospadias</span></li><li><span style=\"font-size:12pt;\">Undescended testes</span></li></ul></li></ul></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Squamous cell carcinoma</strong>: Squamous cell carcinoma is the most common type of cervical cancer. It arises from the ectocervix, at the squamocolumnar junction. This type of cancer is not specifically associated with DES exposure.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Adenocarcinoma</strong>: Adenocarcinoma arises from the endocervix and is not specifically linked to DES exposure.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Sarcoma botryoides</strong>: Sarcoma botryoides is a type of rhabdomyosarcoma that arises from the cervix. It presents as a pinkish polypoidal growth filling up the vagina completely and causes blood-tinged watery discharge. It is not associated with DES exposure.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">DES exposure in utero is specifically associated with an increased risk of clear cell adenocarcinoma of the vagina and cervix.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg42</strong></span></p>",
      "correct_choice_id": 200633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50159,
      "choices": [
        {
          "id": 200636,
          "text": "<p><span style=\"font-size:12pt;\">Herpes zoster infection</span></p>"
        },
        {
          "id": 200637,
          "text": "<p><span style=\"font-size:12pt;\">Irritant contact dermatitis</span></p>"
        },
        {
          "id": 200638,
          "text": "<p><span style=\"font-size:12pt;\">Allergic contact dermatitis</span></p>"
        },
        {
          "id": 200639,
          "text": "<p><span style=\"font-size:12pt;\">Herpes simplex infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The patient, aged 60, shows a lesion as depicted in the image below. Additionally, he reports that he felt a spider crawling in the area of the lesion when he woke up. What is the most probable diagnosis based on this information? </span>(INICET NOVEMBER 2022)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture3_vuB7XiA.jpg\" alt=\"\" width=\"300\" height=\"192\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture3_vuB7XiA.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6566700",
      "question_audio": null,
      "question_video": null,
      "map_id": 34797975,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Herpes zoster infection</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The above image shows <strong>confluent, red, vesicular</strong> lesions in a <strong>single dermatome</strong> along with <strong>spider</strong> <strong>crawling sensation (paraesthesia)</strong> is highly suggestive of <strong>Herpes zoster infection</strong>.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Varicella-zoster virus (VZV) </strong>is a human <strong>herpesvirus</strong> that causes <strong>varicella (chickenpox)</strong> as a <strong>primary</strong> infection and then remains in a <strong>latent</strong> form in the <strong>dorsal root ganglia</strong> for a variable period after which it can <strong>reactivate</strong> to cause herpes zoster (<strong>shingles</strong>) which leads to vesicular lesions that are grouped together in a <strong>dermatomal / Segmental distribution</strong>.</span></li><li><span style=\"font-size:12pt;\">The <strong>mucous membranes</strong> within the affected dermatomes are involved.</span></li><li><span style=\"font-size:12pt;\">The <strong>first symptom of zoster is usually pain</strong>, <strong>1-3 days</strong> after which the lesions appear. The patients are <strong>infectious</strong>, both from the virus in the <strong>lesions</strong> and <strong>nasopharynx.</strong></span></li><li><span style=\"font-size:12pt;\">The dermatomes of <strong>T3 to L3 </strong>spinal segments are <strong>most affected </strong>in all ages. The <strong>posterior nerve roots and ganglia</strong> show inflammatory changes.</span></li><li><span style=\"font-size:12pt;\">Zoster is a <strong>self-limiting </strong>infection, but it is <strong>painful</strong> and carries a risk of secondary infection and <strong>post-herpetic neuralgia</strong>. <strong>Analgesia</strong> and treatment of secondary infections are sufficient for mild infections.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Indications for antivirals in VZV (Acyclovir 800 mg):</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Painful zoster infections in adults</span></li><li><span style=\"font-size:12pt;\">Facial zoster at any age</span></li><li><span style=\"font-size:12pt;\">Immunocompromised</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>The commonest and most intractable complication of zoster is post-herpetic neuralgia</strong>. It is generally defined as persistence or recurrence of pain more than 1-3 months after the onset of zoster. <strong>Post-herpetic neuralgia is most frequent when the trigeminal nerve is involved</strong>.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Irritant contact dermatitis</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">It typically presents with <strong>erythema</strong> and <strong>scaling</strong> and can include bl<strong>istering</strong>, but it is <strong>not </strong>usually <strong>unilateral </strong>or confined to a <strong>dermatomal pattern </strong>as seen in the image.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Allergic contact dermatitis</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">This causes an <strong>itchy, red rash</strong> and may lead to <strong>blisters</strong>. The distribution is typically at the <strong>site of contact</strong> with the <strong>allergen</strong> and <strong>not dermatomal</strong>.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Herpes Simplex infection</strong>: It presents as <strong>grouped vesicles </strong>on an erythematous base, usually around the <strong>lips or genital </strong>region as shown in the image below. It does <strong>not </strong>follow a <strong>dermatomal </strong>pattern.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/whatsapp-image-2023-11-22-at-50843-pm.jpeg\" alt=\"\" width=\"303\" height=\"202\"></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">In a <strong>60-year-old</strong> patient presenting with a <strong>unilateral vesicular rash</strong> in a <strong>dermatomal</strong> distribution, the most likely diagnosis is <strong>herpes zoster infection</strong>.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology 9th edition, Page nos 4.13, 25.27-25.28</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrison's Principles of Internal Medicine 20th Edition, Page no 106</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/whatsapp-image-2023-11-22-at-50843-pm.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200636,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50160,
      "choices": [
        {
          "id": 200640,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Anaerobic respiration produces carbon dioxide </span></span></span></p>"
        },
        {
          "id": 200641,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Low pH mainly activates lysosomal enzymes </span></span></span></p>"
        },
        {
          "id": 200642,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Peripheral vasodilation </span></span></span></p>"
        },
        {
          "id": 200643,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Renal perfusion is enhanced</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">A 56-year-old male presents to the emergency department with signs and symptoms of shock. Which of the following statements regarding shock is true?</span></span></p>",
      "unique_key": "Q5696752",
      "question_audio": null,
      "question_video": null,
      "map_id": 34637449,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Low pH mainly activates lysosomal enzymes</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Low pH mainly activates lysosomal enzymes: In cases of shock, reduced tissue perfusion and oxygen supply can lead to cellular hypoxia and acidosis (low pH). Low pH can activate lysosomal enzymes within cells, leading to cellular damage and tissue injury. This is one of the mechanisms contributing to organ dysfunction in shock.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Anaerobic respiration produces carbon dioxide:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Anaerobic respiration occurs in cells when there is insufficient oxygen to support aerobic respiration. It produces lactic acid as a metabolic byproduct, not carbon dioxide. Carbon dioxide is primarily produced during <strong>aerobic respiration</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Peripheral vasodilation:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Shock often involves systemic vasodilation, but it's not limited to peripheral vasodilation. In distributive shock, like septic shock, there is widespread vasodilation, including peripheral and central blood vessels, which can result in decreased blood pressure and poor tissue perfusion.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Renal perfusion is enhanced:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> In shock, including various types of shock such as hypovolemic, distributive, or cardiogenic shock, renal perfusion is typically compromised due to decreased cardiac output or blood volume. The kidneys receive less blood flow in an attempt to redirect blood to vital organs like the brain and heart. This reduction in renal perfusion can lead to <strong>acute kidney injury (AKI).</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Shock is a state of circulatory failure resulting in tissue hypoperfusion and hypoxia. Prolonged shock eventually leads to irreversible tissue damage. In cases of shock, there is inadequate oxygenation. Thus, cells switch from aerobic to anaerobic respiration where lactic acid, not carbon dioxide, is produced. The accumulation of lactic acid in the blood leads to systemic acidosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Lysosomes are membraned organelles that enclose all the hydrolysing enzymes capable of breaking down biological polymers. The lysosomal enzymes are only active in acidic pH (low pH value) and this pH is maintained within the organelle. Hypoxic tissue injury during shock causes membrane damage, and extravasation of the enzymes from lysosomes. Thus, leading to tissue death.</span></span></span></p>",
      "correct_choice_id": 200641,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50161,
      "choices": [
        {
          "id": 200644,
          "text": "<p><span style=\"font-size:12pt;\">Metoprolol</span></p>"
        },
        {
          "id": 200645,
          "text": "<p><span style=\"font-size:12pt;\">Ivabradine</span></p>"
        },
        {
          "id": 200646,
          "text": "<p><span style=\"font-size:12pt;\">Prazosin</span></p>"
        },
        {
          "id": 200647,
          "text": "<p><span style=\"font-size:12pt;\">Frusemide</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young man sustained a scorpion sting 2 hours ago. On examination, his blood pressure is 154/94 mm Hg; Heart Rate 72 beats/minute, and respiratory rate 32 breaths/minute. He also complains of breathlessness. Which of the following is the preferred drug for management of this patient? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q5523301",
      "question_audio": null,
      "question_video": null,
      "map_id": 34473090,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Prazosin</strong></span></p><p><br><span style=\"font-size:12pt;\">Scorpion venom causes release of a large amounts of catecholamines from the adrenals which can lead to hypertension, tachycardia, breathlessness due to pulmonary edema etc. These effects are counteracted by using Prazosin, which is a selective α1 blocker.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Metoprolol: </strong>This is a beta-blocker used primarily for managing hypertension, heart rate control, and other cardiovascular conditions. It is not typically used in the management of scorpion stings, as it doesn't directly address the pathophysiological effects of the venom.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Ivabradine: </strong>This drug is used to reduce heart rate in certain conditions such as chronic heart failure and angina. It is not indicated for treating symptoms of scorpion sting.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Frusemide: </strong>This is a diuretic, primarily used to treat conditions like hypertension and edema. It does not have a direct role in managing the effects of a scorpion sting.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Prazosin is the preferred drug for managing the symptoms of a scorpion sting, as it counteracts the effects of catecholamines released due to the venom, providing relief from hypertension and pulmonary edema. Other drugs listed do not directly address the primary pathophysiological effects of a scorpion sting.</span></p>",
      "correct_choice_id": 200646,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50162,
      "choices": [
        {
          "id": 200648,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Weakly basic drugs</span></span></span></p>"
        },
        {
          "id": 200649,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Strong acids</span></span></span></p>"
        },
        {
          "id": 200650,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Strong bases</span></span></span></p>"
        },
        {
          "id": 200651,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Weakly acidic drugs</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Alkalinization of urine will be helpful in the treatment of poisoning due to?</span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q4838854",
      "question_audio": null,
      "question_video": null,
      "map_id": 34874466,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D. Weakly acidic drugs</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Alkalinization of urine is effective in treating overdoses of weakly acidic drugs. By increasing the pH of the urine, it promotes the ionization of these drugs. Ionized drugs are less likely to be reabsorbed in the kidney tubules and are more readily excreted. This principle is particularly applied in cases of aspirin (salicylate) poisoning.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Weakly basic drugs:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Urinary alkalinization is not typically used for weakly basic drugs. Basic drugs are more likely to be reabsorbed in an alkaline environment, making this approach counterproductive.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Strong acids:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Strong acids are not significantly affected by urinary pH, so alkalinization would not be particularly beneficial.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Strong bases:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Similar to strong acids, strong bases are not significantly impacted by changes in urinary pH.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Alkalinization of urine is an effective strategy to enhance the excretion of weakly acidic drugs by increasing their ionization and reducing their reabsorption in the renal tubules, thus promoting their elimination from the body. This method is particularly useful in cases of poisoning with weak acids, such as aspirin (salicylates).</span></span></span></p>",
      "correct_choice_id": 200651,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50163,
      "choices": [
        {
          "id": 200652,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Midazolam</span></span></span></p>"
        },
        {
          "id": 200653,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Diazepam</span></span></span></p>"
        },
        {
          "id": 200654,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Alprazolam</span></span></span></p>"
        },
        {
          "id": 200655,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Oxazepam</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient is brought with altered sensorium and seizures. Attendant shows the laboratory report which reveals elevated transaminases. Which of the following can be used in this condition? (</span></span>INICET Nov 2022)</p>",
      "unique_key": "Q3185071",
      "question_audio": null,
      "question_video": null,
      "map_id": 34589570,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D. Oxazepam</span></strong></span></span><br />\r\n </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Oxazepam is a short acting Benzodiazepine, which has no active metabolites and can be used safely in a patient with active liver disease. Other BZDs that can be used include Temazepam, Lorazepam, Estazolam.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. Midazolam</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Midazolam is metabolized in the liver through oxidative pathways and produces active metabolites. It is not the best choice for patients with liver impairment.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Diazepam</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Diazepam is metabolized in the liver to active metabolites, which can accumulate in patients with liver dysfunction, potentially leading to prolonged sedation and toxicity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Alprazolam</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Alprazolam is also metabolized in the liver through oxidative processes and has active metabolites. It is not recommended for patients with significant liver disease.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In patients with liver impairment, such as those with elevated transaminases, it is crucial to use medications that are not heavily reliant on hepatic metabolism and do not produce active metabolites. Oxazepam, being metabolized via conjugation, is a safer option in such scenarios compared to other benzodiazepines like midazolam, diazepam, and alprazolam.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Remember with mnemonic ‘<span style=\"color:red\">STOLE’</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:red\">S</span></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">hort-acting Benzodiazepines</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:red\">T</span></span><span style=\"font-family:\"Calibri\",sans-serif\">emazepam</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:red\">O</span></span><span style=\"font-family:\"Calibri\",sans-serif\">xazepam</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:red\">L</span></span><span style=\"font-family:\"Calibri\",sans-serif\">orazepam</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:red\">E</span></span><span style=\"font-family:\"Calibri\",sans-serif\">stazolam</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200655,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50164,
      "choices": [
        {
          "id": 200656,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Inhibits HMG Co reductase</span></span></span></p>"
        },
        {
          "id": 200657,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Activates PPAR alpha</span></span></span></p>"
        },
        {
          "id": 200658,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Binds to deoxycholic acid</span></span></span></p>"
        },
        {
          "id": 200659,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Inhibit intestinal absorption of cholesterol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient who is on treatment for hyperlipidemia develops gallstones. What is the mechanism of action of the causative drug that was given to this patient? (</span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q9743537",
      "question_audio": null,
      "question_video": null,
      "map_id": 34100147,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B. Activates PPAR alpha</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Fibrates, such as clofibrate, fenofibrate, and gemfibrozil, are used to treat hyperlipidemia. These drugs work by activating peroxisome proliferator-activated receptor alpha (PPARα). The activation of PPARα leads to:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Increased synthesis of lipoprotein lipase, which accelerates the clearance of triglyceride-rich lipoproteins.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Reduced production of VLDL and chylomicrons.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Lower levels of triglycerides.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Statins inhibit HMG CoA reductase. These drugs are used as lipid-lowering agents in dyslipidemia and are associated with statin-induced myopathy. These drugs do not lead to development of gallstones.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Bile Acid Sequestrants<strong> </strong>bind<strong> </strong>to deoxycholic acid and prevent its reabsorption in the intestine. It may result in deficiency of fat-soluble vitamins.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Ezetimibe is a drug that acts by inhibiting intestinal absorption of cholesterol</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Fibrates are lipid-lowering agents that work by activating PPARα. While effective at reducing triglycerides and VLDL, they can increase the risk of gallstone formation due to increased cholesterol content in bile. This is an important consideration when choosing lipid-lowering therapy, especially in patients at risk for cholelithiasis.</span></span></span></p>",
      "correct_choice_id": 200657,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50165,
      "choices": [
        {
          "id": 200660,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Fenofibrate 160 mg</span></span></p>"
        },
        {
          "id": 200661,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Rosuvastatin + Fenofibrate</span></span></p>"
        },
        {
          "id": 200662,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Rosuvastatin 10 mg</span></span></p>"
        },
        {
          "id": 200663,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Atorvastatin 80 mg </span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The lipid profile of a patient who suffered from acute coronary syndrome is given below. What drug can be used to treat this condition? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Serum low-density lipoprotein: 127 g/dL</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Serum high-density lipoprotein: 32 mg/dL</span></span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Serum triglycerides: 278 mg/dL</span></span></li>\r\n</ul>",
      "unique_key": "Q7816884",
      "question_audio": null,
      "question_video": null,
      "map_id": 34229863,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D) Atorvastatin 80 mg</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Atorvastatin 80 mg</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> can be used to treat this condition. The first line of therapy in controlling cholesterol in patients with atherosclerotic cardiovascular disease (ASCVD) is starting a high-intensity statin. <strong><span style=\"font-family:\"Calibri\",sans-serif\">High-intensity statins</span></strong> include atorvastatin (40–80 mg) and rosuvastatin (20–40 mg).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Statins are <strong><span style=\"font-family:\"Calibri\",sans-serif\">competitive inhibitors of HMG-CoA reductase</span></strong>, which leads to a decrease in cholesterol biosynthesis. This mechanism effectively reduces low-density lipoprotein (LDL) cholesterol and triglyceride levels, both of which are elevated in this patient’s lipid profile.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Fenofibrate</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Fenofibrate reduces lipoprotein levels by interacting with peroxisome proliferator-activated receptor (PPAR-α) and stimulating lipoprotein lipase. Fenofibrate is typically used for treating hyperlipoproteinemia and severe hypertriglyceridemia (>1000 mg/dL), which is not the case in this patient, as the triglycerides are elevated but not that high.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Rosuvastatin + Fenofibrate</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The combination of rosuvastatin and fenofibrate was previously used to reduce atherosclerotic cardiovascular disease risk. However, recent studies have indicated no added benefit from combining these two drugs, leading to the recommendation against this combination therapy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Rosuvastatin 10 mg</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Rosuvastatin 10 mg is considered a low-intensity statin and is mainly used for <strong><span style=\"font-family:\"Calibri\",sans-serif\">primary prevention</span></strong> in patients who are at risk for atherosclerotic cardiovascular disease but have not yet developed significant coronary events. For secondary prevention, as in this patient with acute coronary syndrome, a high-intensity statin like atorvastatin 80 mg or rosuvastatin 20–40 mg is recommended.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Patients with atherosclerotic cardiovascular disease, such as those who have experienced an acute coronary syndrome, should be treated with <strong><span style=\"font-family:\"Calibri\",sans-serif\">high-intensity statins</span></strong> to reduce LDL cholesterol and prevent further cardiovascular events. Atorvastatin (40–80 mg) and rosuvastatin (20–40 mg) are the main options in this category.</span></span></span></p>",
      "correct_choice_id": 200663,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50166,
      "choices": [
        {
          "id": 200664,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Somatic hypermutation</span></span></span></p>"
        },
        {
          "id": 200665,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alternative RNA splicing</span></span></span></p>"
        },
        {
          "id": 200666,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Affinity maturation</span></span></span></p>"
        },
        {
          "id": 200667,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Allelic exclusion</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Due to which phenomenon, B cells express IgM and IgD antibodies at the same time?</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q5974232",
      "question_audio": null,
      "question_video": null,
      "map_id": 34879451,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Alternative RNA splicing</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B cells express IgM and IgD antibodies at the same time due to <strong>alternative RNA splicing.</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alternative splicing is the process that selectively removes introns or exons, or parts thereof, to generate multiple messenger RNAs (mRNAs) from a single precursor mRNA (pre-mRNA).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Humoral immunity is mediated by antibodies, which are produced by B lymphocytes. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Upon maturation, B lymphocytes produce IgM as the first type of immunoglobulin, followed by immunoglobulin IgG, IgE, and IgA, as a result of irreversible rearrangement of the immunoglobulin gene after activation. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In contrast, the IgM-to-IgD transition is produced through alternative splicing of a long primary mRNA transcript from the Ig heavy chain gene, IGH. The nuclear RNA-binding protein, <strong>HuR</strong>, is well known for its function in mRNA splicing and nuclear export. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Options A. Somatic hypermutation and C. Affinity maturation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Affinity maturation is the process by which antibodies gain increased affinity, avidity, and anti-pathogen activity and is the result of somatic hypermutation (SHM) of immunoglobulin genes in B cells, coupled to selection for antigen binding.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Allelic exclusion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Allelic exclusion is a process by which only one allele of a gene is expressed while the other allele is silenced.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong> </strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B cells express both IgM and IgD through alternative RNA splicing, allowing the simultaneous expression of these two immunoglobulins.</span></span></span></p>",
      "correct_choice_id": 200665,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50167,
      "choices": [
        {
          "id": 200668,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Starts after peak of uterine contraction and ends after uterine contraction ends</span></span></p>"
        },
        {
          "id": 200669,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">They are smooth and gradual</span></span></p>"
        },
        {
          "id": 200670,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">At least 10 beats, 2 times in a 20 min period above baseline</span></span></p>"
        },
        {
          "id": 200671,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Not associated with accelerations</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which statement is false regarding late decelerations? (INICET NOV 2022) </span></span></p>",
      "unique_key": "Q9421658",
      "question_audio": null,
      "question_video": null,
      "map_id": 34833813,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) At least 10 beats, 2 times in a 20 min period above baseline</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The false statement about <strong>late decelerations</strong> among the given options is <strong>option C - At least 10 beats, 2 times in a 20 min period above baseline</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Typically, a late deceleration causes a <strong>fall in the fetal heart rate (FHR)</strong> by a depth of <strong><10 to 20 bpm below the baseline</strong>. It is usually not accompanied by accelerations (<strong>Option D</strong>).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Late decelerations</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> are <strong>smooth, gradual</strong> (<strong>Option B</strong>) symmetrical declines in the FHR that <strong>begin at or after the peak of uterine contraction and end only after the contraction has ended</strong> (<strong>Option A</strong>).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Late decelerations are usually indicative of <strong>uteroplacental insufficiency and fetal hypoxia</strong>. Other causes of late decelerations include hypotension from epidural anesthesia, excessive use of oxytocin, maternal hypertension, diabetes, and placental abruption.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A late deceleration plus <strong>decreased variability</strong> in FHR is predictive of <strong>fetal acidemia</strong> and neonatal morbidity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The given <strong>CTG</strong> shows <strong>late decelerations</strong> and their relationship with the uterine contraction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Starts after peak of uterine contraction and ends after uterine contraction ends</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is correct. Late decelerations typically begin after the peak of the uterine contraction and persist beyond the end of the contraction. This is due to uteroplacental insufficiency and the delay in oxygen delivery to the fetus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. They are smooth and gradual</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is correct. Late decelerations show a smooth and gradual decrease in fetal heart rate, usually due to reduced oxygenation of the fetus caused by impaired placental function.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Not associated with accelerations</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is correct. Late decelerations are typically not associated with accelerations, which are indicative of fetal well-being. The absence of accelerations alongside late decelerations can suggest fetal distress.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Late decelerations</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> are characterized by a gradual, symmetrical decrease in fetal heart rate that begins after the peak of uterine contractions and persists beyond their end. They are typically caused by <strong>uteroplacental insufficiency</strong> and are a concerning sign for <strong>fetal hypoxia</strong>.</span></span></span></p>",
      "correct_choice_id": 200670,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50168,
      "choices": [
        {
          "id": 200672,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Complement deficiency</span></span></p>"
        },
        {
          "id": 200673,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Deficiency of CD4 T lymphocytes</span></span></p>"
        },
        {
          "id": 200674,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">MHC class II deficiency on lymphocytes</span></span></p>"
        },
        {
          "id": 200675,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">MHC class I deficiency on lymphocytes</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In a patient with bare lymphocytic disease, graft vs host reaction does not occur due to: (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q7871778",
      "question_audio": null,
      "question_video": null,
      "map_id": 34672553,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) MHC class II deficiency on lymphocytes</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In a patient with <strong>bare lymphocytic disease</strong>, graft vs host reaction does not occur due to <strong>MHC class II deficiency</strong> on the lymphocytes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Bare lymphocyte disease</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> occurs due to mutations in transcription factors that are required for the expression of <strong>class II MHC molecules</strong>. This leads to the <strong>absence of class II MHC molecules</strong>, which in turn results in the <strong>impaired development of CD4+ T cells</strong>. Since CD4+ T cells are essential for both cellular immunity and assisting B cells, the absence of MHC class II results in a combined immunodeficiency.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Without functional <strong>CD4+ T cells</strong>, the immune system cannot mount the typical response required for graft vs host disease (GVHD), which is the reason GVHD does not occur in these patients. <strong>MHC class II deficiency</strong> leads to a failure in antigen presentation to CD4+ helper T cells, crucial for initiating and propagating immune responses.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Complement deficiency</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Complement deficiency affects the ability of the immune system to lyse pathogens and participate in immune complex clearance. It does not directly affect the occurrence of GVHD, which is primarily mediated by T cells recognizing foreign MHC molecules.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Deficiency of CD4 T lymphocytes</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: While this is related to the condition, the root cause is not directly a CD4 deficiency but rather a <strong>MHC class II deficiency</strong>, which leads to the impaired development of CD4+ T cells. The problem lies in the lack of MHC class II expression, not the lymphocytes themselves.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. MHC class I deficiency on lymphocytes</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: <strong>MHC class I</strong> is involved in presenting antigens to <strong>CD8+ cytotoxic T cells</strong>, not CD4+ T cells. Deficiency of MHC class I affects cellular immunity against viral infections but does not explain the lack of GVHD in <strong>bare lymphocytic disease</strong>, which is primarily related to <strong>MHC class II</strong> deficiency.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Bare lymphocytic disease</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> results from a deficiency in <strong>MHC class II molecules</strong>, leading to the impaired development of <strong>CD4+ T lymphocytes</strong>, and thereby causing a combined immunodeficiency. The lack of MHC class II prevents graft vs host disease from occurring in these patients.</span></span></span></p>",
      "correct_choice_id": 200674,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50169,
      "choices": [
        {
          "id": 200676,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1-D, 2-B, 3-A, 4-C</span></span></p>"
        },
        {
          "id": 200677,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1-C, 2-B, 3-D, 4-A</span></span></p>"
        },
        {
          "id": 200678,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1-C, 2-D, 3-B, 4-A</span></span></p>"
        },
        {
          "id": 200679,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1-D, 2-C, 3-B, 4-A</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following: (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1 - Kleptomania<br />\r\n2 - Pyromania<br />\r\n3 - Mutilomania<br />\r\n4 - Dipsomania</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A - Intense desire to drink alcoholic drinks<br />\r\nB - Intense desire to mutilate<br />\r\nC - Intense desire to steal items of trivial value<br />\r\nD - Intense desire to burn things</span></span></span></p>",
      "unique_key": "Q1909538",
      "question_audio": null,
      "question_video": null,
      "map_id": 34700135,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) 1-C, 2-D, 3-B, 4-A</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct option is <strong>1-C, 2-D, 3-B, 4-A</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Impulse control disorders are characterized by the <strong>repeated failure to resist an impulse, drive, or urge</strong> to perform an act that is rewarding to the person, at least in the short term, despite the long-term harm either to the individual or to others. These disorders involve marked distress about the behavior pattern or impairment in personal, family, social, educational, or other important areas of functioning.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">These disorders include:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Pyromania</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The deliberate setting of fires on more than one occasion.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Kleptomania</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The recurrent inability to resist urges to steal objects that are of little or no personal use.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Compulsive sexual behavior disorder</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (not directly in this question but part of impulse control disorders).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Intermittent explosive disorder</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Repeated episodes of impulsive, aggressive, violent behavior.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Kleptomania</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is the repeated failure to resist impulses to steal objects of trivial value, and the act is not driven by personal need. The stolen items are typically returned, given away, or kept hidden.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Pyromania</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> involves the intentional setting of fires, and is associated with disorders like <strong>substance abuse</strong>, <strong>depression</strong>, and <strong>personality disturbances</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Dipsomania</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> refers to an irresistible impulse to consume alcoholic beverages at periodic intervals.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Mutilomania</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is the irresistible urge to mutilate animals.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Impulse control disorders include <strong>kleptomania</strong> (urge to steal), <strong>pyromania</strong> (urge to set fires), <strong>dipsomania</strong> (urge to drink alcohol), and <strong>mutilomania</strong> (urge to mutilate). These behaviors are driven by compulsions and often result in distress or impairment despite their immediate rewarding nature.</span></span></span></p>",
      "correct_choice_id": 200678,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50170,
      "choices": [
        {
          "id": 200680,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 3, 4</span></span></p>"
        },
        {
          "id": 200681,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">2, 4</span></span></p>"
        },
        {
          "id": 200682,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">2, 3, 4</span></span></p>"
        },
        {
          "id": 200683,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Regarding urinary tract infection (UTI) in children, which of the following is true? (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Most common cause of UTI is <em>Streptococcus pneumoniae</em>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Bowel, bladder dysfunction increases the risk of recurrence.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cotrimoxazole is not given.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Micturating cysto-urethrogram (MCU) is done in children with recurrence of UTI.</span></span></span></li>\r\n</ol>",
      "unique_key": "Q1536380",
      "question_audio": null,
      "question_video": null,
      "map_id": 34250728,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) 2, 4</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The true statements regarding UTI in children are:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Bowel and bladder dysfunction</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> increases the risk of recurrence.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Micturating cysto-urethrogram (MCU)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is performed in children with recurrent UTIs.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The <strong>most common cause</strong> of UTI in children is <strong>Escherichia coli</strong> (<em>E. coli</em>), not <em>Streptococcus pneumoniae</em> (hence, statement 1 is incorrect). <strong>Bowel and bladder dysfunction</strong> can lead to incomplete emptying of the bladder, increasing the risk of bacterial infections and subsequent UTI recurrence.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Cotrimoxazole</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is used as both treatment and prophylaxis for UTI in children, particularly to prevent recurrent infections (making statement 3 incorrect).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">MCU</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is performed in cases of recurrent UTI to evaluate structural abnormalities, such as <strong>vesicoureteral reflux (VUR)</strong>, which can contribute to infection risk.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. 1, 3, 4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is incorrect as <em>Streptococcus pneumoniae</em> is not the most common cause of UTI in children, and cotrimoxazole is indeed used for UTI treatment and prevention.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. 2, 3, 4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This option is partially correct, but cotrimoxazole is used for UTI treatment, so statement 3 is incorrect.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. 1, 4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Incorrect because <em>Streptococcus pneumoniae</em> is not the most common cause of UTI in children.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In pediatric patients, <strong>Escherichia coli</strong> is the most common pathogen causing UTIs. Risk factors for recurrent UTIs include <strong>bladder and bowel dysfunction</strong>. Evaluation of recurrent UTIs typically involves a <strong>micturating cysto-urethrogram (MCU)</strong> to assess for structural issues like <strong>vesicoureteral reflux (VUR)</strong>. <strong>Cotrimoxazole</strong> is commonly used for treatment and as prophylaxis to prevent recurrent infections.</span></span></span></p>",
      "correct_choice_id": 200681,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50171,
      "choices": [
        {
          "id": 200684,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Cadherins</span></span></p>"
        },
        {
          "id": 200685,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Platelet endothelial cell adhesion molecule-1 (PECAM-1)</span></span></p>"
        },
        {
          "id": 200686,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">E-selectin</span></span></p>"
        },
        {
          "id": 200687,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Cd11a</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following molecules helps the leukocytes roll over the endothelial cells in the vessels? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q1440706",
      "question_audio": null,
      "question_video": null,
      "map_id": 34006470,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) E-selectin</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">E-selectin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, present on the endothelial cells, is responsible for helping <strong>leukocytes roll</strong> over the endothelium during the initial stages of inflammation. This rolling is a weak interaction that allows leukocytes to slow down and prepare for stronger adhesion mediated by integrins, followed by transmigration across the endothelium into tissues.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Selectins</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> are adhesion molecules that play a critical role in leukocyte-endothelium interactions:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">L-selectin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Found on leukocytes.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">E-selectin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Expressed on the endothelial cells.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">P-selectin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Found in platelets and endothelial cells.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Rolling</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is the first step in the recruitment of leukocytes to the site of injury or infection, followed by <strong>firm adhesion</strong>, <strong>transmigration</strong>, and <strong>migration</strong> through the endothelial layer to the site of tissue damage.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Cadherins</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Cadherins are adhesion molecules, but they are primarily involved in <strong>cell-cell adhesion</strong> within tissues and are not directly involved in leukocyte rolling.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Platelet endothelial cell adhesion molecule-1 (PECAM-1)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: PECAM-1 plays a role in <strong>diapedesis</strong> (the movement of leukocytes through the endothelium) rather than in the rolling process.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Cd11a</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: <strong>CD11a</strong>, part of the integrin family, is involved in <strong>firm adhesion</strong> of leukocytes to the endothelium, not the rolling process.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">E-selectin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> facilitates the <strong>rolling</strong> of leukocytes on the endothelium, which is the first step in the process of leukocyte extravasation during inflammation. This is followed by stronger adhesion through <strong>integrins</strong> and migration to the site of tissue injury.</span></span></span></p>",
      "correct_choice_id": 200686,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50172,
      "choices": [
        {
          "id": 200688,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Refractive error</span></span></p>"
        },
        {
          "id": 200689,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Untreated cataract</span></span></p>"
        },
        {
          "id": 200690,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Glaucoma</span></span></p>"
        },
        {
          "id": 200691,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Diabetic retinopathy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What is the most common cause of moderate-severe visual impairment according to the National Blindness and Visual Impairment Survey 2015-19? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q6350907",
      "question_audio": null,
      "question_video": null,
      "map_id": 34314661,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Untreated cataract</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">According to the <strong>National Blindness and Visual Impairment Survey (2015-19)</strong>, the <strong>most common cause</strong> of <strong>moderate-severe visual impairment (MSVI)</strong> is <strong>untreated cataract</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">MSVI</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is defined as visual acuity of <strong><6/18 to 3/60</strong> in the better eye, even with available correction. Cataracts are a leading cause of vision loss globally, particularly in individuals over the age of 50 years, due to the clouding of the lens that can occur with aging.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Refractive error</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Refractive errors are a common cause of visual impairment but are more prevalent in patients <strong>under 49 years</strong> and are generally correctable with glasses or other corrective measures.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Glaucoma</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Glaucoma, although a significant cause of visual impairment, accounts for a smaller proportion of cases compared to cataracts, especially in older populations.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Diabetic retinopathy</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Diabetic retinopathy can lead to visual impairment, but its prevalence as a cause of moderate-severe visual impairment is lower compared to cataracts.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Untreated cataracts</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> are the most common cause of <strong>moderate-severe visual impairment</strong> in individuals over the age of 50, according to the <strong>National Blindness and Visual Impairment Survey 2015-19</strong>. Cataracts are a treatable cause of blindness and emphasize the need for timely surgical intervention to restore vision.</span></span></p>",
      "correct_choice_id": 200689,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50173,
      "choices": [
        {
          "id": 200692,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypertension + tachycardia</span></span></p>"
        },
        {
          "id": 200693,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypotension + tachycardia</span></span></p>"
        },
        {
          "id": 200694,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypotension + bradycardia</span></span></p>"
        },
        {
          "id": 200695,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hypertension + bradycardia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Neurogenic shock is associated with _______. (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q2104114",
      "question_audio": null,
      "question_video": null,
      "map_id": 34214207,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) Hypotension + bradycardia</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Neurogenic shock</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is associated with <strong>hypotension</strong> and <strong>bradycardia</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This type of shock occurs due to a <strong>loss of sympathetic tone</strong> in the peripheral vascular system, which leads to <strong>vasodilation</strong> and <strong>decreased vascular resistance</strong>. The result is <strong>hypotension</strong>. In contrast to other types of shock (which often involve compensatory <strong>tachycardia</strong>), neurogenic shock is unique because of <strong>bradycardia</strong>, due to the disruption of sympathetic innervation to the heart and <strong>unopposed vagal (parasympathetic) activity</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Neurogenic shock</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is most commonly caused by <strong>spinal cord injuries</strong>, particularly injuries to the cervical or upper thoracic regions, which disrupt the autonomic nervous system's ability to regulate blood pressure and heart rate.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Hypertension + tachycardia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: These findings are not typical of neurogenic shock. Hypertension and tachycardia may be seen in other conditions, such as adrenergic crises or hypertensive emergencies.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Hypotension + tachycardia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is more characteristic of <strong>other types of shock</strong>, like hypovolemic or septic shock, where compensatory tachycardia is seen as a response to low blood pressure.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Hypertension + bradycardia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: While bradycardia can occur in neurogenic shock, hypertension is not typically associated with this condition. Instead, hypotension is the hallmark due to peripheral vasodilation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Neurogenic shock</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is a type of <strong>distributive shock</strong> associated with <strong>hypotension</strong> and <strong>bradycardia</strong> due to the loss of sympathetic tone following <strong>spinal cord injuries</strong>, leading to vasodilation, decreased cardiac output, and unopposed vagal activity.</span></span></span></p>",
      "correct_choice_id": 200694,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50174,
      "choices": [
        {
          "id": 200696,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Placenta weight at term is 470 g</span></span></p>"
        },
        {
          "id": 200697,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Round-oval with 22 cm diameter</span></span></p>"
        },
        {
          "id": 200698,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Extraplacental membranes and 2-vesseled umbilical cord present</span></span></p>"
        },
        {
          "id": 200699,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Central thickness >2.5 cm</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The following are correct regarding normal placenta, except _______. (INICET NOV 2022) (OBG)</span></span></p>",
      "unique_key": "Q8417388",
      "question_audio": null,
      "question_video": null,
      "map_id": 34964341,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) Extraplacental membranes and 2-vesseled umbilical cord present</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Among the options, <strong>Extraplacental membranes and 2-vesseled umbilical cord present</strong> (option C) is the <strong>incorrect statement</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In a <strong>normal placenta</strong>:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The placenta at term <strong>weighs about 470 g</strong> (option A).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">It is <strong>round to oval in shape</strong> with a diameter of approximately <strong>22 cm</strong> (option B).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The <strong>central thickness</strong> of the placenta is generally <strong>greater than 2.5 cm</strong> (option D).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The <strong>umbilical cord</strong> in a normal placenta has <strong>three vessels</strong>—<strong>two arteries and one vein</strong>. A <strong>two-vessel cord</strong> is abnormal and can be associated with congenital anomalies.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Thus, <strong>option C</strong> is incorrect because the <strong>normal umbilical cord</strong> has three vessels, not two.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Information:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The placenta is a <strong>discoid, deciduate, and hemochorial</strong> structure:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Deciduate</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> means that the placenta is shed at the time of parturition.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Hemochorial</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> indicates that maternal blood comes into direct contact with the fetal trophoblasts.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The placenta consists of two plates:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Chorionic plate</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The fetal surface of the placenta, lined by the amniotic membrane, to which the umbilical cord is attached.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Basal plate</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The maternal side, which is attached to the uterine wall, divided into clefts known as <strong>cotyledons</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The <strong>normal placenta</strong> at term weighs around <strong>470 g</strong>, is <strong>round-oval</strong> with a diameter of <strong>22 cm</strong>, and has a <strong>three-vessel umbilical cord</strong>. A <strong>two-vessel cord</strong> is an abnormal finding.</span></span></span></p>",
      "correct_choice_id": 200698,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50175,
      "choices": [
        {
          "id": 200700,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Saccharine test</span></span></p>"
        },
        {
          "id": 200701,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Electron microscopy</span></span></p>"
        },
        {
          "id": 200702,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Charcoal powder method</span></span></p>"
        },
        {
          "id": 200703,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Scintigraphy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following tests cannot be used to assess nasal mucociliary clearance? </span></span></p>",
      "unique_key": "Q2931235",
      "question_audio": null,
      "question_video": null,
      "map_id": 34031146,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Electron microscopy</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Among the given options, <strong>electron microscopy</strong> will be the least useful in assessing <strong>nasal mucociliary clearance</strong>. Other tests, such as the saccharine test, charcoal powder method, and scintigraphy, are commonly used to measure <strong>mucociliary transit time</strong> and <strong>total nasal clearance</strong> in humans.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Electron microscopy</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is used to study the <strong>structure and function</strong> of <strong>cilia</strong>. It can help detect <strong>structural abnormalities</strong> in the cilia, which could impair mucociliary clearance. However, it cannot measure the <strong>actual clearance function</strong> or detect <strong>functional obstructions</strong> in the nasal passage.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Tests typically used for assessing mucociliary clearance include:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Saccharine test</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: A simple test that measures the time it takes for a patient to taste a small amount of saccharine placed in the nasal cavity.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Scintigraphy</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Uses radioactive tracers to assess <strong>mucociliary transport</strong> by measuring how long it takes for radioactive particles to be cleared from the nasal cavity.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Charcoal powder method</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: A small amount of charcoal is placed on the nasal lining, and clearance is assessed by detecting the presence of charcoal in the pharynx.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Saccharine test</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is a commonly used, simple, and non-invasive method to assess <strong>mucociliary clearance</strong>. It measures how long it takes for the patient to taste the sweet saccharine placed in their nasal cavity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Charcoal powder method</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This method involves placing a small amount of charcoal in the nasal cavity and observing its clearance by detecting the charcoal in the pharynx. It is another method for measuring <strong>mucociliary clearance</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Scintigraphy</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Scintigraphy uses <strong>radioisotopes</strong> to track the clearance of particles from the nasal cavity. It is an effective tool for measuring mucociliary function.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Electron microscopy</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is used to study the <strong>structure</strong> of cilia but cannot measure <strong>mucociliary clearance</strong>. Other tests, such as the <strong>saccharine test</strong>, <strong>scintigraphy</strong>, and the <strong>charcoal powder method</strong>, are used to directly assess <strong>nasal mucociliary clearance</strong> in clinical practice.</span></span></span></p>",
      "correct_choice_id": 200701,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50176,
      "choices": [
        {
          "id": 200704,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-1, B-3, C-2, D-4</span></span></p>"
        },
        {
          "id": 200705,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-3, B-4, C-1, D-2</span></span></p>"
        },
        {
          "id": 200706,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-3, B-2, C-1, D-4</span></span></p>"
        },
        {
          "id": 200707,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-2, B-3, C-4, D-1</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following: (INICET NOV 2022) </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Tooth</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A. Canine</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">B. Lateral incisor</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">C. First molar</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">D. Third molar</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Age of eruption </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1. 6-7 years</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2. 8-9 years</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">3. 11-12 years</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">4. 17-25 yearss</span></span></span></p>",
      "unique_key": "Q4850421",
      "question_audio": null,
      "question_video": null,
      "map_id": 34921326,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) A-3, B-2, C-1, D-4</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct option is <strong>Option C. A-3, B-2, C-1, D-4.</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The time of emergence of secondary dentition or permanent teeth is crucial in pediatric and forensic medicine. For the given teeth:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">First molar</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The first molar typically erupts around 6-7 years of age.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Lateral incisor</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Lateral incisors emerge around 7-9 years of age.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Canine</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Canines usually emerge between 11-12 years of age.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Third molar</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The third molars (also known as wisdom teeth) usually appear between 17-25 years of age.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This matches the arrangement in Option C, which makes it the correct answer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. A-1, B-3, C-2, D-4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Incorrect. The lateral incisor is assigned to an incorrect age range, as lateral incisors erupt between 7-9 years, not 11-12 years as implied here.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. A-3, B-4, C-1, D-2</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Incorrect. The third molar has an incorrect assigned range of 8-9 years, which is too early for its eruption, typically occurring much later (17-25 years).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. A-2, B-3, C-4, D-1</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Incorrect. The sequence places the first molar too late at 17-25 years, which is actually the time for the third molar's eruption, making this option invalid.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct timeline of tooth eruption for different types of permanent teeth is essential for understanding developmental milestones, particularly in pediatrics and forensic medicine. Key timings include:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">First molar: 6-7 years</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Lateral incisor: 7-9 years</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Canine: 11-12 years</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Third molar: 17-25 years</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200706,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50177,
      "choices": [
        {
          "id": 200708,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1 year</span></span></p>"
        },
        {
          "id": 200709,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">2 years</span></span></p>"
        },
        {
          "id": 200710,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">3 years</span></span></p>"
        },
        {
          "id": 200711,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">4 years</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Handedness is seen at the age of ______. (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q4108266",
      "question_audio": null,
      "question_video": null,
      "map_id": 34422103,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">C) 3 years</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Handedness is typically established at the age of <strong><span style=\"font-family:\"Calibri\",sans-serif\">3 years</span></strong>. This refers to a child's preference for using one hand over the other, which usually becomes noticeable around this age. It is a part of the developmental milestones that children go through, and at this age, a child is expected to have a clear preference for either the right or left hand. Trying to change a child’s hand preference after this age may result in frustration or confusion for the child.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. 1 year:</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> At 1 year, children are developing motor skills, such as walking with support or independently. However, their hand preference is not firmly established at this stage, and both hands are typically used interchangeably.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. 2 years:</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> By 2 years, children have better motor control and can perform simple tasks, such as making a tower of blocks, but hand preference (handedness) is still not clearly defined or permanent at this stage.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. 4 years:</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Although children can perform more complex tasks by 4 years of age, such as drawing shapes or hopping, their handedness is already established by this time, which typically happens around 3 years of age.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Handedness is typically seen and established by the age of 3 years. This is a crucial developmental milestone and should be recognized as part of normal child development.</span></span></span></p>",
      "correct_choice_id": 200710,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50178,
      "choices": [
        {
          "id": 200712,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">First degree heart block</span></span></p>"
        },
        {
          "id": 200713,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ventricular tachycardia</span></span></p>"
        },
        {
          "id": 200714,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Third degree heart block</span></span></p>"
        },
        {
          "id": 200715,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Second degree heart block</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Identify the conduction abnormality from the ECG given below. (INICET NOV 2022) </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-110723.jpg\" style=\"height:132px; width:500px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-110723.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2544019",
      "question_audio": null,
      "question_video": null,
      "map_id": 34142225,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> <strong><span style=\"font-family:\"Calibri\",sans-serif\">Second degree heart block</span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The ECG shown above is the second-degree atrioventricular block type 1 - Wenckebach phenomenon.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Second Degree Heart Block</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> occurs due to the intermittent failure of electrical impulse conduction from the atrium to the ventricle. It is characterized by a missed QRS complex. There are two types:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Mobitz type 1/Wenckebach</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This occurs due to the decremental conduction of electrical impulses in the AV node. The hallmark of this block is the progressive elongation of the PR interval, leading to an eventual drop of the QRS complex. It is commonly seen in young athletes.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Mobitz type 2</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: It occurs in the distal or infra-His conduction system. Unlike Mobitz type 1, the PR interval remains constant, but some P waves fail to conduct, leading to missed QRS complexes. Mobitz type 2 is more serious and may require a pacemaker.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. First degree heart block</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This block is characterized by a prolonged but consistent PR interval (greater than 200 milliseconds), with every P wave followed by a QRS complex. There is no dropped QRS in first-degree heart block, unlike the second-degree heart block, which shows intermittent dropped QRS complexes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Ventricular tachycardia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Ventricular tachycardia appears on the ECG as a wide QRS complex tachycardia with a rate of over 100 beats per minute. This is distinct from the block patterns, which primarily affect the PR interval and conduction between the atria and ventricles.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Third degree heart block</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: In third-degree (complete) heart block, there is no conduction between the atria and ventricles, leading to independent beating of the atria (P waves) and ventricles (QRS complexes). The PR intervals are variable and unrelated to the QRS complexes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Second-degree heart block type 1 (Wenckebach) is characterized by progressive prolongation of the PR interval until a QRS complex is dropped.</span></span></p>",
      "correct_choice_id": 200715,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50179,
      "choices": [
        {
          "id": 200716,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">4-3-2-1</span></span></p>"
        },
        {
          "id": 200717,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">4-2-3-1</span></span></p>"
        },
        {
          "id": 200718,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">4-3-1-2 </span></span></p>"
        },
        {
          "id": 200719,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">4-1-2-3</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Arrange the following steps of dilation and curettage in sequence. (INICET NOV 2022) </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Serial dilation</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Curettage</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Uterine sound</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Assessment of uterine size and direction</span></span></span></li>\r\n</ol>",
      "unique_key": "Q4741178",
      "question_audio": null,
      "question_video": null,
      "map_id": 34991928,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) 4-3-1-2 </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct sequence of dilation and curettage (D&C) is <strong><span style=\"font-family:\"Calibri\",sans-serif\">4-3-1-2</span></strong>:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Assessment of uterine size and direction:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This ensures that the uterine position is understood before further intervention.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Uterine sound:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This is used to determine the length and angle of the uterine cavity.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Serial dilation:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Gradual dilation of the cervical canal is done using graduated dilators to prepare for the curettage procedure.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Curettage:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> A curette is used to scrape the endometrial lining or remove tissue from the uterine cavity.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The steps of the procedure ensure the safe and proper removal of uterine contents, while minimizing trauma to the cervix and uterine wall.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct sequence for performing a dilation and curettage is <strong><span style=\"font-family:\"Calibri\",sans-serif\">4-3-1-2</span></strong>, starting with assessing the uterine size and direction, followed by uterine sounding, dilation, and finally curettage. This order is crucial to ensure safe and effective treatment.</span></span></span></p>",
      "correct_choice_id": 200718,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50180,
      "choices": [
        {
          "id": 200720,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Wilson’s disease</span></span></p>"
        },
        {
          "id": 200721,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Huntington’s chorea</span></span></p>"
        },
        {
          "id": 200722,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Glutaric aciduria</span></span></p>"
        },
        {
          "id": 200723,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hepatitis A</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">An 11-year-old boy was brought to the outpatient clinic with intentional tremors, and poor scholastic performance. His sister has similar complaints. On examination, hepatomegaly is seen. The eye finding is shown in the image. What is the probable diagnosis? (INICET NOV 2022) </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-111446.jpg\" style=\"height:273px; width:400px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-111446.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1448365",
      "question_audio": null,
      "question_video": null,
      "map_id": 34839705,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Wilson's disease</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The probable diagnosis in the given case, based on the clinical scenario and the image, which shows <strong><span style=\"font-family:\"Calibri\",sans-serif\">icterus</span></strong> in the eyes, is <strong><span style=\"font-family:\"Calibri\",sans-serif\">Wilson’s disease</span></strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Wilson’s disease is an <strong><span style=\"font-family:\"Calibri\",sans-serif\">autosomal-recessive condition</span></strong> caused by mutations in the <strong><span style=\"font-family:\"Calibri\",sans-serif\">ATP7B gene</span></strong>, which encodes for the ATPase that removes copper, preventing its accumulation in the liver and brain.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Clinical features include <strong><span style=\"font-family:\"Calibri\",sans-serif\">jaundice</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">ascites</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">hepatomegaly</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">dysarthria</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">dystonia</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">wing-beating tremor</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">a decline in school performance</span></strong>, and <strong><span style=\"font-family:\"Calibri\",sans-serif\">personality change</span></strong>. Deposition of copper in the eyes results in <strong><span style=\"font-family:\"Calibri\",sans-serif\">Kayser-Fleischer (KF) rings</span></strong> seen in the cornea, along with symptoms such as sunflower cataracts.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Diagnosis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is confirmed by:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">KF rings</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and decreased levels of <strong><span style=\"font-family:\"Calibri\",sans-serif\">serum copper</span></strong> and <strong><span style=\"font-family:\"Calibri\",sans-serif\">ceruloplasmin</span></strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Increased <strong><span style=\"font-family:\"Calibri\",sans-serif\">24-hour urine copper excretion</span></strong> is another diagnostic marker.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Liver biopsy</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> with measurement of <strong><span style=\"font-family:\"Calibri\",sans-serif\">hepatic copper levels</span></strong> is considered the <strong><span style=\"font-family:\"Calibri\",sans-serif\">gold standard</span></strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Treatment</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">British anti-lewisite</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (intramuscular) or <strong><span style=\"font-family:\"Calibri\",sans-serif\">D-penicillamine</span></strong> (oral), which enhance copper excretion.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Zinc acetate</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> helps reduce copper absorption.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Trientine hydrochloride</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is used as an alternative in patients intolerant to penicillamine.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Liver transplantation is reserved for advanced stages of the disease.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Huntington's chorea</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is a <strong><span style=\"font-family:\"Calibri\",sans-serif\">CAG repeat disorder</span></strong> with an <strong><span style=\"font-family:\"Calibri\",sans-serif\">autosomal dominant</span></strong> inheritance pattern. It is characterized by <strong><span style=\"font-family:\"Calibri\",sans-serif\">involuntary movements</span></strong> known as chorea. The clinical presentation of Huntington’s disease typically involves progressive motor dysfunction, psychiatric disturbances, and cognitive decline, which does not fit the symptoms of this patient.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Glutaric aciduria</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Glutaric aciduria is an <strong><span style=\"font-family:\"Calibri\",sans-serif\">autosomal recessive disorder</span></strong> typically presenting in the <strong><span style=\"font-family:\"Calibri\",sans-serif\">first 6 months of life</span></strong>. Symptoms include <strong><span style=\"font-family:\"Calibri\",sans-serif\">hypotonia</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">jitteriness</span></strong>, and <strong><span style=\"font-family:\"Calibri\",sans-serif\">hyperkinetic movements</span></strong> like dystonia or choreoathetosis. This condition usually presents earlier in infancy and lacks the copper metabolism issues found in Wilson’s disease.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Hepatitis A</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Hepatitis A is caused by the <strong><span style=\"font-family:\"Calibri\",sans-serif\">fecal-oral transmission</span></strong> of the Hepatitis A virus. It typically presents with <strong><span style=\"font-family:\"Calibri\",sans-serif\">nausea</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">vomiting</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">mild fever</span></strong>, and <strong><span style=\"font-family:\"Calibri\",sans-serif\">jaundice</span></strong>. However, it is acute and resolves without causing the neurological symptoms or chronic liver disease seen in Wilson’s disease.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Wilson’s disease</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is an autosomal-recessive disorder caused by mutations in the <strong><span style=\"font-family:\"Calibri\",sans-serif\">ATP7B gene</span></strong>, leading to abnormal copper accumulation in organs, most notably the liver and brain. Symptoms include neurological decline and hepatic dysfunction, along with characteristic <strong><span style=\"font-family:\"Calibri\",sans-serif\">Kayser-Fleischer rings</span></strong> in the eyes.</span></span></span></p>",
      "correct_choice_id": 200720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50181,
      "choices": [
        {
          "id": 200724,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Control of hemorrhage</span></span></p>"
        },
        {
          "id": 200725,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Resuscitation</span></span></p>"
        },
        {
          "id": 200726,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Decontamination</span></span></p>"
        },
        {
          "id": 200727,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Vascular anastomosis </span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is not a part of damage control surgery? (INICET NOV 2022)<span style=\"color:#00b050\"> </span></span></span></p>",
      "unique_key": "Q1887781",
      "question_audio": null,
      "question_video": null,
      "map_id": 34567405,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Ans. D) Vascular anastomosis </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Vascular anastomosis is undertaken as a part of definitive surgery, not damage control surgery (DCS).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Damage Control Surgery (DCS)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is minimal intervention done to stabilize the patient initially and is followed by definitive surgery later. It coordinates staged operative interventions with periods of <strong><span style=\"font-family:\"Calibri\",sans-serif\">aggressive resuscitation</span></strong> to salvage trauma patients who have sustained major injuries.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The initial focus is <strong><span style=\"font-family:\"Calibri\",sans-serif\">hemorrhage control</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">resuscitation</span></strong>, and <strong><span style=\"font-family:\"Calibri\",sans-serif\">contamination control</span></strong>. It includes an abbreviated laparotomy, temporary packing, and closure of the abdomen to manage the physiologic response to shock and hemorrhage.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">After the initial steps of DCS, <strong><span style=\"font-family:\"Calibri\",sans-serif\">vascular anastomosis</span></strong> may be done in a later stage, tailored to the patient's condition, and is preferred to be completed within 24–72 hours.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Note: Vascular anastomosis is less likely to be part of the initial stages of DCS, making it the best option as the correct answer for this question.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Control of hemorrhage:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Is one of the primary steps of DCS to prevent ongoing blood loss.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Resuscitation:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Is critical and is performed aggressively throughout DCS to stabilize the patient’s hemodynamic condition.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Decontamination:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Is necessary in DCS to reduce infection risk, particularly in the case of bowel perforation or other contaminating injuries.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Vascular anastomosis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> is not a part of <strong><span style=\"font-family:\"Calibri\",sans-serif\">damage control surgery</span></strong> but is performed in later stages as part of <strong><span style=\"font-family:\"Calibri\",sans-serif\">definitive surgery</span></strong>. Damage control surgery is aimed at stabilizing patients with life-threatening conditions through steps like hemorrhage control, resuscitation, and contamination limitation.</span></span></p>",
      "correct_choice_id": 200727,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50182,
      "choices": [
        {
          "id": 200728,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Large bowel obstruction due to sigmoid volvulus</span></span></p>"
        },
        {
          "id": 200729,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Large bowel obstruction due to fecolith</span></span></p>"
        },
        {
          "id": 200730,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Cecal volvulus</span></span></p>"
        },
        {
          "id": 200731,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Small bowel obstruction due to bowel perforation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">An elderly lady presents with abdominal pain and distension. She has a history of scoliosis. Given below is the erect X-ray abdomen radiograph of the lady. What is the most likely diagnosis? (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-112259.jpg\" style=\"height:371px; width:300px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-112259.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9857126",
      "question_audio": null,
      "question_video": null,
      "map_id": 34309425,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. <strong><span style=\"font-family:\"Calibri\",sans-serif\">A) Large bowel obstruction due to sigmoid volvulus</span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The given clinical scenario with an elderly woman and the radiograph showing characteristic <strong><span style=\"font-family:\"Calibri\",sans-serif\">coffee bean appearance</span></strong> are highly suggestive of <strong><span style=\"font-family:\"Calibri\",sans-serif\">sigmoid volvulus</span></strong> causing a <strong><span style=\"font-family:\"Calibri\",sans-serif\">large bowel obstruction</span></strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Sigmoid volvulus</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is a cause of large bowel obstruction and occurs when the sigmoid colon <strong><span style=\"font-family:\"Calibri\",sans-serif\">twists</span></strong> on the sigmoid mesocolon. Symptoms include constipation, abdominal bloating, nausea, and/or vomiting. The onset may be acute or chronic. It occurs more commonly in patients with a history of mental illness and chronic constipation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">X-ray abdomen</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> shows a large, dilated loop of the colon, often with a few air-fluid levels. Specific signs include the <strong><span style=\"font-family:\"Calibri\",sans-serif\">coffee bean sign</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">Frimann-Dahl sign</span></strong> (three dense lines converge towards the site of obstruction), and the <strong><span style=\"font-family:\"Calibri\",sans-serif\">absence of rectal gas</span></strong>. <strong><span style=\"font-family:\"Calibri\",sans-serif\">CT</span></strong> may reveal a large gas-filled loop <strong><span style=\"font-family:\"Calibri\",sans-serif\">without haustral markings</span></strong>, forming a <strong><span style=\"font-family:\"Calibri\",sans-serif\">closed-loop obstruction</span></strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Large bowel obstruction due to fecolith</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Fecolith (a hardened mass of stool) is more likely to cause appendicitis or obstruction at the ileocecal valve rather than in the sigmoid colon. Fecolith obstruction does not commonly result in the characteristic \"coffee bean\" appearance on imaging.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Cecal volvulus</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: While this is another form of volvulus, it is less common than sigmoid volvulus. Cecal volvulus typically occurs in younger patients and presents with a different radiological appearance, including haustral markings and a different orientation of the twisted bowel.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Small bowel obstruction due to bowel perforation</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Small bowel obstruction does not typically show the \"coffee bean\" sign seen in sigmoid volvulus. Additionally, perforation would likely show free air under the diaphragm, which is not indicated in this case.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The \"coffee bean sign\" seen on X-ray is a characteristic feature of <strong><span style=\"font-family:\"Calibri\",sans-serif\">sigmoid volvulus</span></strong>, a condition where the sigmoid colon twists on itself, causing large bowel obstruction.</span></span></span></p>",
      "correct_choice_id": 200728,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50183,
      "choices": [
        {
          "id": 200732,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Tetralogy of Fallot (TOF)</span></span></p>"
        },
        {
          "id": 200733,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ebstein's anomaly</span></span></p>"
        },
        {
          "id": 200734,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Transposition of great arteries (TGA)</span></span></p>"
        },
        {
          "id": 200735,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Total anomalous pulmonary venous return (TAPVC)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A child presents with cyanosis. His chest radiograph is shown below. What is the diagnosis?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-112556.jpg\" style=\"height:260px; width:300px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-112556.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2385154",
      "question_audio": null,
      "question_video": null,
      "map_id": 34102366,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">A) Tetralogy of Fallot (TOF)</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The given clinical scenario and chest X-ray showing a \"coeur en sabot\" or boot-shaped heart are highly suggestive of <em><span style=\"font-family:\"Calibri\",sans-serif\">Tetralogy of Fallot (TOF)</span></em>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">TOF is a cyanotic congenital heart disease with the following four components:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Obstruction to right ventricular outflow (pulmonary stenosis)</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Malalignment type of ventricular septal defect (VSD)</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Dextroposition of the aorta so that it overrides the ventricular septum (overriding of the aorta)</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Right ventricular hypertrophy (RVH)</span></strong></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In TOF, the hypertrophied right ventricle causes the rounded apical shadow to be uplifted so that it is situated higher above the diaphragm than normal. On X-ray, this appears as a boot-shaped heart or <em><span style=\"font-family:\"Calibri\",sans-serif\">coeur en sabot</span></em>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Ebstein's anomaly:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Is a rare cyanotic congenital heart disease characterized by diminished pulmonary blood flow due to abnormality of the tricuspid valve. In this condition, severe right-sided cardiomegaly due to an elongated and enlarged right atrium leads to an elevated apex, giving a <strong><span style=\"font-family:\"Calibri\",sans-serif\">box-shaped heart</span></strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Transposition of great arteries (TGA):</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Is a congenital heart condition where the great arteries are transposed. The chest radiograph in TGA often shows an <strong><span style=\"font-family:\"Calibri\",sans-serif\">egg-on-a-string</span></strong> appearance due to the narrow superior mediastinum and enlarged cardiac silhouette. It is the most specific congenital heart defect in infants of diabetic mothers.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Total anomalous pulmonary venous return (TAPVC):</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Occurs when pulmonary veins drain into the right atrium instead of the left atrium. The chest X-ray shows a <strong><span style=\"font-family:\"Calibri\",sans-serif\">snowman-shaped heart</span></strong> due to the supracardiac type of TAPVC, where the heart and superior mediastinal structures resemble a snowman.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><em><span style=\"font-family:\"Calibri\",sans-serif\">Tetralogy of Fallot (TOF)</span></em><span style=\"font-family:\"Calibri\",sans-serif\"> is a cyanotic congenital heart disease that shows a <strong><span style=\"font-family:\"Calibri\",sans-serif\">boot-shaped heart</span></strong> (coeur en sabot) on chest radiograph due to right ventricular hypertrophy. The condition is characterized by pulmonary stenosis, ventricular septal defect, overriding aorta, and right ventricular hypertrophy.</span></span></span></p>",
      "correct_choice_id": 200732,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50184,
      "choices": [
        {
          "id": 200736,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hand, foot, and mouth disease</span></span></p>"
        },
        {
          "id": 200737,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Dengue</span></span></p>"
        },
        {
          "id": 200738,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Zika fever</span></span></p>"
        },
        {
          "id": 200739,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Roseola infantum</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Vesicular rash is seen in __________. (INICET NOV 2022) </span></span></p>",
      "unique_key": "Q8527185",
      "question_audio": null,
      "question_video": null,
      "map_id": 34412573,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Hand, foot, and mouth disease </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Vesicular rash is seen in <em><span style=\"font-family:\"Calibri\",sans-serif\">hand, foot, and mouth disease</span></em>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">It is a mild exanthematous fever usually occurring in children but may also occur in adults. It is characterized by <em><span style=\"font-family:\"Calibri\",sans-serif\">papulovesicular rashes</span></em> that involve the oral mucosa, palms, and soles.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The virus is shed in the stool and is transmitted by the fecal-oral route. It is a <em><span style=\"font-family:\"Calibri\",sans-serif\">self-limiting disease</span></em> and subsides in 1-2 weeks. Treatment is symptomatic as the rash heals spontaneously.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Coxsackieviruses are enteroviruses and belong to the <em><span style=\"font-family:\"Calibri\",sans-serif\">Picornaviridae family</span></em>. They are classified into groups A and B. Group A viruses are classified into 24 types, and group B viruses are classified into 6 types.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Diseases caused by Coxsackie A viruses include:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><em><span style=\"font-family:\"Calibri\",sans-serif\">Hand, foot, and mouth disease (HFMD)</span></em></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><em><span style=\"font-family:\"Calibri\",sans-serif\">Herpangina</span></em><span style=\"font-family:\"Calibri\",sans-serif\"> – Characterized by ulcerating small vesicles on the oral fauces, or palate or uvula, and the posterior pharyngeal wall.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><em><span style=\"font-family:\"Calibri\",sans-serif\">Aseptic meningitis</span></em></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Dengue</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Cutaneous and mucosal findings in dengue are erythema, morbilliform eruptions, and <em><span style=\"font-family:\"Calibri\",sans-serif\">hemorrhagic lesions</span></em>. The rash in dengue is not typically vesicular.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Zika fever:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Zika fever is characterized by fever, <em><span style=\"font-family:\"Calibri\",sans-serif\">maculopapular rash</span></em>, arthralgia, and conjunctivitis, but not by vesicular rashes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Roseola infantum</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Presents as a nonpruritic, <em><span style=\"font-family:\"Calibri\",sans-serif\">pink papular rash</span></em> that begins on the trunk, not as a vesicular rash.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The key point to remember from this question is that vesicular rashes, especially involving the palms, soles, and oral mucosa, are characteristic of <em><span style=\"font-family:\"Calibri\",sans-serif\">hand, foot, and mouth disease</span></em> caused by Coxsackie A virus.</span></span></span></p>",
      "correct_choice_id": 200736,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50185,
      "choices": [
        {
          "id": 200740,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1-b, 2-c ,3-d, 4-a.</span></span></p>"
        },
        {
          "id": 200741,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1-a, 2-c, 3-b, 4-d. </span></span></p>"
        },
        {
          "id": 200742,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1-a, 2-b, 3-c, 4-d.</span></span></p>"
        },
        {
          "id": 200743,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1-c, 2-b, 3-a, 4-d.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following plant poisons with their active principles. (INICET NOV 2022) </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Column:1</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1. Datura</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2. Opium</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">3. Abrus precatorius</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">4. Nux vomica</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Column:2</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">a. Atropine<br />\r\nb. Abrin<br />\r\nc. Thebaine<br />\r\nd. Strychnine</span></span></span></p>",
      "unique_key": "Q7240331",
      "question_audio": null,
      "question_video": null,
      "map_id": 34934817,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) 1-a, 2-c, 3-b, 4-d. </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct match is <strong><span style=\"font-family:\"Calibri\",sans-serif\">1-a, 2-c, 3-b, 4-d</span></strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The active ingredients of <strong><span style=\"font-family:\"Calibri\",sans-serif\">Datura</span></strong> include the anticholinergic alkaloids <strong><span style=\"font-family:\"Calibri\",sans-serif\">atropine</span></strong>, scopolamine, and hyoscyamine. The seeds or other parts of the plant can be ingested or smoked.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Manifestations of Datura toxicity:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Dry hot skin (Temperature rises up to 42°C, a scarlet rash may also be appreciated).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Dilatation of pupils along with loss of accommodation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Diplopia.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Dryness of the mouth and throat, unquenchable thirst.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Dysphagia.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Dilatation of cutaneous blood vessels.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Dysarthria (Difficulty in talking).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Drunken gait.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Delirium.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Drowsiness.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Death due to respiratory or cardiac failure.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Opium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is derived from the <strong><span style=\"font-family:\"Calibri\",sans-serif\">poppy</span></strong> plant and includes natural opioids like morphine, codeine, and <strong><span style=\"font-family:\"Calibri\",sans-serif\">thebaine</span></strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Abrin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is a toxalbumin of the plant <strong><span style=\"font-family:\"Calibri\",sans-serif\">Abrus precatorius</span></strong>, and it acts by <strong><span style=\"font-family:\"Calibri\",sans-serif\">inhibiting protein synthesis</span></strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Toxic principles of Abrus precatorius:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Abrin (a toxalbumen).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Abrine (an amino acid).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Abralin (a glucoside).</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Abrin acts by inhibiting protein synthesis, leading to cell death. Clinical features after oral ingestion of these seeds include abdominal pain, nausea, vomiting, bloody diarrhea, and miosis. Faintness, dyspnea, and convulsions may also occur.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The poison obtained from <strong><span style=\"font-family:\"Calibri\",sans-serif\">Strychnos nux-vomica</span></strong> seeds is <strong><span style=\"font-family:\"Calibri\",sans-serif\">strychnine</span></strong>. Strychnine acts at the ventral horn by <strong><span style=\"font-family:\"Calibri\",sans-serif\">blocking the postganglionic glycine receptor</span></strong> sites in the spinal cord and brainstem. Glycine is an <strong><span style=\"font-family:\"Calibri\",sans-serif\">inhibitory neurotransmitter</span></strong> that acts at the postsynaptic membranes of ventral horn motor neurons. Hence, the blockade of these receptors results in unopposed muscle contraction, resulting in the classical clinical features:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Tonic-clonic seizures.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Opisthotonus (body arched in hypertension).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Risus sardonicus.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200741,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50186,
      "choices": [
        {
          "id": 200744,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Perceived control</span></span></p>"
        },
        {
          "id": 200745,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Behavioral modification</span></span></p>"
        },
        {
          "id": 200746,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Health motivation</span></span></p>"
        },
        {
          "id": 200747,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Self-efficacy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The following image shows a health belief model. What does box C stand for? (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-131705.jpg\" style=\"height:251px; width:500px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-131705.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9023213",
      "question_audio": null,
      "question_video": null,
      "map_id": 34782332,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. <strong><span style=\"font-family:\"Calibri\",sans-serif\">C) Health motivation</span></strong> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Box C stands for <strong><span style=\"font-family:\"Calibri\",sans-serif\">health motivation</span></strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The <strong><span style=\"font-family:\"Calibri\",sans-serif\">health belief model</span></strong> was proposed based on the idea that a person's health behavior changes in accordance with certain beliefs. It explains the relationship between a person's perceptions about a disease and their actions to prevent or manage it.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">The Health Belief Model consists of:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Perceived susceptibility</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: A person's belief in their risk of developing a disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Perceived severity</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: How serious a person considers the disease and its consequences.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Perceived benefits</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The belief in the positive outcomes of taking preventive actions.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Perceived barriers</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The potential obstacles in the way of taking actions to reduce risk.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Cues to action</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Factors that trigger the decision to make a health-related change.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Self-efficacy</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Confidence in one's ability to take action.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The <strong><span style=\"font-family:\"Calibri\",sans-serif\">\"C\" box refers to health motivation</span></strong>, which integrates all these elements. If a person is highly motivated, perceives a high risk of disease (high susceptibility and severity), and believes in the benefits of preventive action, they are more likely to take positive health-related actions.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Perceived control</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Perceived control is a person's belief in their ability to influence events or outcomes in their life. In the health belief model, perceived control can affect how likely a person is to take health actions but it’s distinct from health motivation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Behavioral modification</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This refers to the actions a person takes to change their behavior after assessing the situation. It is not the central driver (C) in this model but rather the outcome of health motivation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Self-efficacy</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is related to a person’s confidence in their ability to successfully perform health behaviors. While important, it does not represent box C in this context.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The health belief model is a framework for understanding how a person's beliefs about health and illness can influence their behavior. The key takeaway is that <strong><span style=\"font-family:\"Calibri\",sans-serif\">health motivation</span></strong> plays a central role in whether someone decides to take action to protect their health.</span></span></span></p>",
      "correct_choice_id": 200746,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50187,
      "choices": [
        {
          "id": 200748,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Osteoporotic compression fracture</span></span></span></p>"
        },
        {
          "id": 200749,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Lumbar stenosis</span> </span></span></p>"
        },
        {
          "id": 200750,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Thromboangiitis obliterans</span></span></span></p>"
        },
        {
          "id": 200751,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Atherosclerosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 65-year-old postmenopausal female patient comes with persistent backache not responding to conservative treatment. She has a history of lifting heavy weights 4 months back and progressively increasing pain that worsens on walking. The pain starts radiating down her legs after walking for a distance of around 100 m. However, she feels no pain on walking uphill. What is the most probable diagnosis? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q8604385",
      "question_audio": null,
      "question_video": null,
      "map_id": 34068969,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Lumbar stenosis </span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The given clinical scenario of an elderly woman with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">back pain that worsens on walking</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and is relieved when walking uphill points to the diagnosis of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">lumbar stenosis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Walking uphill may be preferred</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> as it flexes the spine and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">maximizes the spinal canal capacity</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, relieving the pain.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Spinal stenosis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is the narrowing of the spinal canal, leading to nerve compression. It can be congenital or acquired, with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">degeneration</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> being the most common cause. Other contributing factors include spondylolysis, trauma, infection, and metabolic disorders.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Degenerative spinal stenosis involves </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">disc degeneration</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">facet joint hypertrophy</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">ligamentum flavum calcification</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, all leading to </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">reduced spinal canal dimensions</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and nerve compression, resulting in </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">neurogenic claudication</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Symptoms include </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">back pain</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (most common), </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">sciatica</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, sensory disturbances in the legs, motor weakness, and sometimes urinary disturbances.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Pain typically occurs after standing or walking for a few minutes and is </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">relieved by sitting, squatting, or flexing the spine</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Osteoporotic compression fracture:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Though this can cause back pain, the classic presentation is sudden back pain after minimal trauma in elderly individuals with osteoporosis. The pain is typically not worsened by walking and doesn’t radiate down the legs like in lumbar stenosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Thromboangiitis obliterans: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This condition involves </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">inflammatory occlusion of small and medium-sized blood vessels</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and is often seen in young smokers. It typically presents with claudication of the lower extremities and ischemic pain, which is not relieved by walking uphill.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Atherosclerosis: Peripheral artery disease (PAD)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> due to atherosclerosis presents with intermittent claudication that is worsened by walking. However, the pain is due to poor blood flow and is typically not relieved by walking uphill or sitting, unlike the neurogenic claudication in lumbar stenosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Lumbar stenosis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> presents with back pain that worsens with standing and walking (neurogenic claudication) and is relieved by sitting, squatting, or walking uphill due to the flexion of the spine, which increases the spinal canal capacity and reduces nerve compression.</span></span></span></p>",
      "correct_choice_id": 200749,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50188,
      "choices": [
        {
          "id": 200752,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">3, 4</span></span></span></p>"
        },
        {
          "id": 200753,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 4</span></span></span></p>"
        },
        {
          "id": 200754,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 3, 4</span></span></span></p>"
        },
        {
          "id": 200755,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2, 3, 4</span> </span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A child presents with acute exacerbation of asthma. Which of the following would you do?<span style=\"font-family:\"Calibri Light\",sans-serif\"> </span>(INICET NOV 2022) </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Chest X-ray</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Oxygen administration</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Salbutamol nebulization three times in 60 minutes</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Administration of oral corticosteroids</span></span></span></li>\r\n</ol>",
      "unique_key": "Q7124413",
      "question_audio": null,
      "question_video": null,
      "map_id": 34070276,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D) 2, 3 ,4</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A child coming with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">acute exacerbation of asthma</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> will be administered </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">oxygen</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">salbutamol nebulization</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> three times in 60 minutes, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">oral corticosteroids</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Exacerbation of asthma</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> involves an increase in symptoms such as </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">cough, wheezing, and/or breathlessness</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. If the child has </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">cyanosis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, silent chest, poor respiratory effort, altered sensorium, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">oxygen saturation of <90%</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, the exacerbation is considered </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">life-threatening</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Based on severity, acute asthma is classified as </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">mild</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">moderate</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">severe</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. 3, 4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: While salbutamol nebulization and oral corticosteroids are important in managing an asthma exacerbation, omitting oxygen therapy (especially in cases of hypoxia) is incorrect.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. 1, 4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:  A chest X-ray is not routinely indicated in acute asthma exacerbations unless there is suspicion of another underlying condition (e.g., pneumonia, pneumothorax). Oxygen therapy and salbutamol nebulization are key for immediate management.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. 1, 3, 4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:  Similar to option B, a chest X-ray is not immediately necessary unless there is concern for an alternative diagnosis or complication.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">acute exacerbation of asthma</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, management includes </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">oxygen therapy</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">salbutamol nebulization</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">oral corticosteroids</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. A chest X-ray is only indicated if complications or other diagnoses are suspected.</span></span></span></p>",
      "correct_choice_id": 200755,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50189,
      "choices": [
        {
          "id": 200756,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Femoral nerve</span></span></span></p>"
        },
        {
          "id": 200757,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Genitofemoral nerve</span> </span></span></p>"
        },
        {
          "id": 200758,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Lateral cutaneous nerve of thigh</span></span></span></p>"
        },
        {
          "id": 200759,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Ilioinguinal nerve</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which nerve is blocked when local anesthesia is given below the inguinal ligament during femoral vein catheterization?(INICET NOV 2022)</span></span></p>",
      "unique_key": "Q9526027",
      "question_audio": null,
      "question_video": null,
      "map_id": 34148888,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B) Genitofemoral nerve</span></strong><strong> </strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">genitofemoral nerve</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is blocked when local anesthesia is given below the inguinal ligament during femoral vein catheterization.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The genitofemoral nerve originates from the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">L1 and L2 ventral rami</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. It divides into the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">genital</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">femoral branches</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> after crossing behind the ureter.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">genital branch</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> enters the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">inguinal canal</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> through the deep ring and accompanies the spermatic cord or round ligament. It exits the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">superficial inguinal ring</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and supplies the cremaster muscle and the skin of the external genitalia.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">femoral branch</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> descends lateral to the external iliac artery to pass behind the inguinal ligament and enters the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">femoral sheath</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> lateral to the femoral artery. It pierces the anterior wall of the femoral sheath and fascia lata, supplying them.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The genitofemoral nerve gives sensory supply to the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">anteromedial thigh</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> via the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">femoral branch</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. The genital branch supplies the skin of the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">scrotum in males</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">mons pubis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">labium majus</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> in females. It also innervates the cremaster muscle via the genital branch and is responsible for the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">cremasteric reflex</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Femoral nerve</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">femoral nerve</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> arises from the posterior division of the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">L2-L4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> spinal segments. It lies outside the femoral sheath and enters the femoral triangle lateral to the femoral artery. Since it lies outside the femoral sheath, it is not involved in femoral vein catheterization.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Lateral cutaneous nerve of the thigh</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This nerve provides sensory innervation to the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">anterolateral thigh</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Injury to this nerve leads to </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">meralgia paresthetica</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, causing pain and paresthesia in this region, but it does not relate to the femoral vein catheterization procedure.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Ilioinguinal nerve</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: The ilioinguinal nerve is most commonly injured during open hernia repair due to traction or thermal injury. It supplies the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">root of the penis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">scrotum</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, but is not relevant for femoral vein catheterization.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">genitofemoral nerve</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is blocked when local anesthesia is administered below the inguinal ligament during femoral vein catheterization. This nerve provides sensory innervation to the anteromedial thigh, scrotum in males, and mons pubis in females, and is responsible for the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">cremasteric reflex</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Understanding the anatomy of the inguinal region and its relation to the femoral triangle is crucial in procedures involving catheterization or surgery in this area.</span></span></span></p>",
      "correct_choice_id": 200757,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50190,
      "choices": [
        {
          "id": 200760,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The patient would need another point-of-care diagnostic test for the same clinical condition.</span></span></span></p>"
        },
        {
          "id": 200761,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Prevalence of the disease is 2%.</span></span></span></p>"
        },
        {
          "id": 200762,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Patient is less likely to have the disease.</span></span></span></p>"
        },
        {
          "id": 200763,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Patient has been wrongly ruled out due to false negativity.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A point-of-care diagnostic test with a sensitivity of 98% shows a negative test result in a patient. What does this imply?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(INICET NOV 2022)</span></span></p>",
      "unique_key": "Q8704812",
      "question_audio": null,
      "question_video": null,
      "map_id": 34463374,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">C) Patient is less likely to have the disease.</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A negative result in a diagnostic test with a sensitivity of 98% implies that the patient is less likely to have the disease.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Sensitivity</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is the proportion of all people with the disease who test positive. It is the probability that the test will be positive when the disease is present. The sensitivity of a test is determined by how many patients with the disease actually test positive (true positives) out of the total number of diseased individuals. In this case, a sensitivity of 98% means that 98% of people with the disease would test positive, so a negative result would likely indicate that the patient does not have the disease.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> The patient would </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">not need</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> another point-of-care diagnostic test for the same clinical condition because the sensitivity of the diagnostic test is 98%.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B.</span></strong> <strong><span style=\"font-family:\"Calibri\",sans-serif\">Prevalence</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> refers to the number of old and new cases at a given point in time or over a period of time in a given population. It cannot be derived from the given data.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">higher the sensitivity</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> of a diagnostic test, the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">lower</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> will be the number of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">false negatives</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Since the test has a 98% sensitivity, the patient most likely does not have the disease.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The higher the sensitivity of a diagnostic test, the fewer false negatives occur, meaning a negative result implies the patient is less likely to have the disease.</span></span></span></p>",
      "correct_choice_id": 200762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50191,
      "choices": [
        {
          "id": 200764,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Relative afferent pupillary defect is seen.</span></span></span></p>"
        },
        {
          "id": 200765,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">There is no pain on ocular movement.</span></span></span></p>"
        },
        {
          "id": 200766,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Multiple myeloma is a common cause.</span></span></span></p>"
        },
        {
          "id": 200767,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Oral corticosteroids are the mainstay of treatment.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following statements is true about optic neuritis? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q5828442",
      "question_audio": null,
      "question_video": null,
      "map_id": 34482904,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">A) Relative afferent pupillary defect is seen.</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In optic neuritis, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">relative afferent pupillary defect (RAPD)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> or Marcus Gunn pupil is seen. It is elicited by the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">swinging flashlight test</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Normally, both pupils remain constricted. In the presence of RAPD, both pupils dilate when moving the flashlight from the normal eye to the abnormal eye. This paradoxical response of the pupil to light is known as </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Marcus Gunn pupil</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Pain is actually </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">aggravated by ocular movement: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> particularly in upward or downward directions due to the attachment of the superior rectus muscle to the dura mater.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C.</span></strong> <strong><span style=\"font-family:\"Calibri\",sans-serif\">Multiple sclerosis: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">not multiple myeloma, is a well-known demyelinating cause of optic neuritis. Multiple sclerosis often presents with optic neuritis as an early sign.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D.</span></strong> <strong><span style=\"font-family:\"Calibri\",sans-serif\">Oral corticosteroid therapy alone is contraindicated: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> because it does not improve the outcome and is associated with an increased risk of new attacks of optic neuritis. Instead, intravenous </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">methylprednisolone</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> can be used, especially in patients showing radiological evidence of multiple sclerosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The relative afferent pupillary defect (RAPD), also called Marcus Gunn pupil, is a key diagnostic finding in optic neuritis, and multiple sclerosis is the common cause of this condition.</span></span></span></p>",
      "correct_choice_id": 200764,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50192,
      "choices": [
        {
          "id": 200768,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A-1, B-2, C-3, D-4</span></span></span></p>"
        },
        {
          "id": 200769,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A-4, B-1, C-2, D-3</span></span></span></p>"
        },
        {
          "id": 200770,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A-3, B-2, C-1, D-4</span></span></span></p>"
        },
        {
          "id": 200771,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A-4, B-3, C-2, D-1</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following: (INICET NOV 2024) </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Marjolin ulcer over the dorsum of the foot measuring 3 x 2 cm</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1.5 cm cervical lymph node in the neck</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Soft tissue sarcoma over mid-thigh</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Solitary thyroid nodule</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Excision biopsy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Core needle biopsy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">USG guided FNAC</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Wedge biopsy</span></span></span></li>\r\n</ol>",
      "unique_key": "Q9726042",
      "question_audio": null,
      "question_video": null,
      "map_id": 34284229,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B) A-4, B-1, C-2, D-3</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct answer is </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. A-4, B-1, C-2, D-3</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Here's why:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">A. Marjolin ulcer over the dorsum of the foot measuring 3 cm x 2 cm – Wedge biopsy: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Marjolin's ulcer is a rare and aggressive form of squamous cell carcinoma, which usually arises from a long-standing wound, ulcer, or scar. In this case, a wedge biopsy is the best diagnostic method because it takes a sample of tissue from the edge of the ulcer for histopathological evaluation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">B. 1.5 cm cervical lymph node in the neck – Excision biopsy: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">For lymph node pathology, an excision biopsy is preferred. This method removes the entire lymph node for complete histopathological examination, which is crucial for the diagnosis of malignancies or other pathological conditions.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Soft tissue sarcoma over mid-thigh – Core needle biopsy: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Soft tissue sarcomas are aggressive tumors that require precise diagnosis. A core needle biopsy allows the collection of tissue from the tumor without needing a large excision, thus minimizing risk and providing adequate material for histological analysis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Solitary thyroid nodule – USG guided FNAC: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Fine-needle aspiration cytology (FNAC) under ultrasound guidance is the investigation of choice for a solitary thyroid nodule. It is a minimally invasive method used to assess whether the nodule is benign or malignant, helping guide further management.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. A-1, B-2, C-3, D-4 : </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This option incorrectly matches the biopsy types. Marjolin's ulcer should be biopsied using a wedge biopsy (not excision), and soft tissue sarcoma requires a core needle biopsy (not FNAC).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. A-3, B-2, C-1, D-4: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This also mismatches the biopsy types. Marjolin's ulcer should not be evaluated with FNAC, and soft tissue sarcomas are better diagnosed with core needle biopsies rather than excision biopsies.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. A-4, B-3, C-2, D-1: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">The correct combination for a solitary thyroid nodule is USG-guided FNAC, not an excision biopsy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Marjolin's ulcer requires a wedge biopsy for diagnosis, soft tissue sarcomas are best diagnosed using core needle biopsy, and USG-guided FNAC is used for thyroid nodules.</span></span></span></p>",
      "correct_choice_id": 200769,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50193,
      "choices": [
        {
          "id": 200772,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">GIST (Gastrointestinal Stromal Tumor)</span></span></span></p>"
        },
        {
          "id": 200773,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Adenocarcinoma</span></span></span></p>"
        },
        {
          "id": 200774,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hodgkin's lymphoma</span></span></span></p>"
        },
        {
          "id": 200775,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">SCC (Squamous Cell Carcinoma)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A female patient was diagnosed with gastric cancer. On immunohistopathology, the biopsy sample was found to be positive for CD117 and negative for LCA, cytokeratin, and S100. What is the diagnosis? (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">LCA - Leukocyte common antigen<br />\r\nGIST - Gastrointestinal stromal tumors<br />\r\nSCC - Squamous cell carcinoma</span></span></span></p>",
      "unique_key": "Q9662927",
      "question_audio": null,
      "question_video": null,
      "map_id": 34487362,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) GIST </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">(Gastrointestinal Stromal Tumor)</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The clinical scenario, along with immunohistopathological findings showing positivity for </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">CD117</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and negativity for </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">LCA</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">cytokeratin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">S100</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, is strongly suggestive of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">gastrointestinal stromal tumors (GIST)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">CD117 (also known as c-KIT) is a marker that is characteristically expressed in GIST. These tumors arise from the interstitial cells of Cajal in the gastrointestinal tract, with the stomach being the most common site. GISTs often present with gastrointestinal symptoms such as bleeding, and they express specific markers like </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">CD117</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">PDGF receptor A</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and sometimes </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">CD34</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Other immunohistochemical (IHC) markers mentioned, like </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">S100</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">cytokeratin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">LCA</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, are seen in different types of cancers:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">S100</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is associated with melanoma.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Cytokeratin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is often found in squamous cell carcinoma.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">LCA</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is found in lymphomas.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">These negative results, combined with the positive CD117, make GIST the most likely diagnosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Adenocarcinoma: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Adenocarcinomas typically express markers such as cytokeratins (which are negative in this case), making this diagnosis less likely. Adenocarcinomas are not characterized by CD117 positivity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Hodgkin's lymphoma: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Hodgkin's lymphoma would typically express </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">LCA (leukocyte common antigen)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, which is negative in this case. Additionally, CD117 is not a marker for Hodgkin's lymphoma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. SCC (Squamous Cell Carcinoma): </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Squamous cell carcinoma typically shows </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">cytokeratin</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> positivity, which is absent here. Also, SCC does not usually express CD117.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Gastrointestinal stromal tumors (GIST) are identified by the expression of </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">CD117 (c-KIT)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> on immunohistochemistry, with the most common site being the stomach. Markers such as </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">S100</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">, </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">cytokeratin</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">, and </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">LCA</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> are negative in GIST but positive in other tumor types (melanoma, squamous cell carcinoma, and lymphoma, respectively).</span></span></p>",
      "correct_choice_id": 200772,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50194,
      "choices": [
        {
          "id": 200776,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Neurapraxia</span></span></span></p>"
        },
        {
          "id": 200777,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Axonapraxia</span></span></span></p>"
        },
        {
          "id": 200778,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Axonotmesis</span></span></span></p>"
        },
        {
          "id": 200779,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Neurotmesis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Disruption of the axon with an intact endoneurium is seen in which of the following?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(INICET NOV 2022)</span></span></p>",
      "unique_key": "Q7066071",
      "question_audio": null,
      "question_video": null,
      "map_id": 34130966,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) Axonotmesis</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Disruption of the axon with an intact endoneurium is seen in </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">axonotmesis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. In this condition, there is </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">axonal disruption</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (the inner axon is damaged), which leads to loss of conductivity, but the outer sheath of the nerve, including the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">endoneurium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">perineurium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, remains intact.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">axonotmesis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">There is a </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">loss of conduction</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, but the nerve’s continuity is maintained because the neural tubes are intact. The axon is disrupted, meaning that its continuity is broken, but the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">endoneurium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">perineurium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> remain intact.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">It occurs following trauma, such as </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">closed fractures</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">dislocations</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Wallerian degeneration</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> occurs distal to the lesion, where the axon disintegrates and is resorbed by phagocytes. Axonal regeneration then begins, with fine unmyelinated fibers growing from the proximal stumps into the endoneurial tubes.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Neurapraxia: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Neurapraxia is a </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">reversible physiological nerve conduction block</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> that causes temporary loss of sensation and motor function. This condition is associated with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">segmental demyelination</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> without axonal damage. It often follows </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">prolonged compression</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, such as in Saturday night palsy or crutch palsy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Axonapraxia: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Axonapraxia refers to disruption at the level of the axoplasm and is a temporary failure of nerve conduction. It is not associated with structural damage to the axon itself.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Neurotmesis: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Neurotmesis is the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">complete transection</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> of the nerve trunk, typically associated with more severe injuries like open wounds. In this case, both the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">axon</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">endoneurium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> are destroyed, leading to significant loss of function. The regenerating axons cannot re-enter the distal segment, resulting in poor recovery.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Axonotmesis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> involves the disruption of the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">axon</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> while the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">endoneurium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">perineurium</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> remain intact. This allows for axonal regeneration, unlike in more severe injuries like neurotmesis, where complete nerve continuity is lost.</span></span></span></p>",
      "correct_choice_id": 200778,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50195,
      "choices": [
        {
          "id": 200780,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1 and 4</span></span></span></p>"
        },
        {
          "id": 200781,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2 and 3</span></span></span></p>"
        },
        {
          "id": 200782,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2 and 4</span></span></span></p>"
        },
        {
          "id": 200783,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1 and 3</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient was brought following an RTA. He was found to have an incomplete lesion of the spinal cord. What would be seen if the central part of the cord was involved?</span> <span style=\"font-family:\"Calibri\",sans-serif\">(INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">LMN lesion of upper limbs and trunk and UMN of lower limbs.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">UMN lesion of upper limbs and trunk and LMN of lower limbs.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Bladder and bowel involvement.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Posterior tract involvement.</span></span></span></li>\r\n</ol>",
      "unique_key": "Q6978291",
      "question_audio": null,
      "question_video": null,
      "map_id": 34080049,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D) 1 and 3</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In this patient with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">central cord syndrome</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">LMN lesion of upper limbs and trunk</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">UMN of lower limbs</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">bladder and bowel</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> involvement will be seen.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Central cord syndrome</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> results from damage to the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">central region of the spinal cord</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, specifically affecting the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">gray matter nerve cells</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">decussating spinothalamic tracts</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> surrounding the central canal, which carry crude touch, pain, and temperature sensations.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This syndrome commonly occurs due to </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">hyperextension of the cervical spine</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, causing compression of the spinal cord. Other causes include </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">spinal trauma</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">syringomyelia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, or intrinsic cord tumors.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Key clinical features include:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Arm weakness > leg weakness</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> (upper limb motor loss is more severe than lower limb motor loss).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Dissociated sensory loss</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, with loss of crude touch, pain, and temperature sense, while proprioception and vibration senses are spared.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Bilateral lower motor neuron paralysis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> in the upper limbs and trunk (due to central damage), with upper motor neuron symptoms in the lower limbs.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Bladder and bowel dysfunction</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> are frequently involved, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Horner’s syndrome</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> can also occur.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This condition typically spares the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">posterior column</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, which is responsible for proprioception and fine touch.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. 1 and 4: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">While the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">LMN lesion of the upper limbs</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is correct, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">posterior tract involvement</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is incorrect, as the posterior columns (proprioception and vibration) are usually spared in central cord syndrome.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. 2 and 3: UMN lesions of the upper limbs and trunk</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> do not occur in central cord syndrome. Central cord syndrome primarily results in </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">LMN lesions</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> in the upper limbs, with </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">UMN signs</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> in the lower limbs.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. 2 and 4: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This combination incorrectly suggests </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">UMN lesions</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> in the upper limbs and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">posterior tract involvement</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, which are not features of central cord syndrome.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Central cord syndrome</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> is characterized by </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">upper limb motor weakness (LMN)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">, </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">lower limb UMN signs</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">, and </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">bladder and bowel dysfunction</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">. It often occurs following hyperextension injuries of the cervical spine and is marked by sensory dissociation (loss of pain and temperature, with sparing of proprioception and fine touch).</span></span></p>",
      "correct_choice_id": 200783,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50196,
      "choices": [
        {
          "id": 200784,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Bridging veins</span></span></span></p>"
        },
        {
          "id": 200785,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Middle meningeal artery</span></span></span></p>"
        },
        {
          "id": 200786,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Lenticulostriate artery</span></span></span></p>"
        },
        {
          "id": 200787,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Vertebral artery</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Bleeding as shown in the image is due to which of the following vessels? (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/11/screenshot-2024-10-11-193255.jpg\" style=\"height:264px; width:400px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/11/screenshot-2024-10-11-193255.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4959809",
      "question_audio": null,
      "question_video": null,
      "map_id": 34533778,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Bridging veins</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The image shows a bleed under the dura, which is suggestive of a </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">subdural hemorrhage (SDH)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. This type of hemorrhage typically results from the shearing of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">cortical bridging veins</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> that traverse the space between the arachnoid and dura mater.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Subdural hemorrhage</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> refers to a collection of blood in the space between the dura and the arachnoid layers of the meninges. Common causes include:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Trauma</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Use of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">anticoagulants</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> or </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">antiplatelets</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Alcohol abuse</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Battered baby syndrome</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The preferred diagnostic test for subdural hemorrhage is </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">non-contrast CT</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Middle meningeal artery: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">A rupture of the middle meningeal artery results in an </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">extradural (epidural) hemorrhage</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, which is not what is shown in the image.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Lenticulostriate artery: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">The lenticulostriate artery supplies the deep structures of the brain, and rupture leads to an </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">intraparenchymal hemorrhage</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, not a subdural hemorrhage.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Vertebral artery: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Vertebral artery dissection can lead to a </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">subarachnoid hemorrhage</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> or, in some cases, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">intraparenchymal hemorrhage</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, but not a subdural hemorrhage as seen in this case.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">subdural hemorrhage</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is caused by the tearing of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">bridging veins</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> between the dura and arachnoid. It is most commonly associated with head trauma, anticoagulant use, and alcohol abuse. The hallmark imaging finding is blood accumulation under the dura, and non-contrast CT is the investigation of choice.</span></span></span></p>",
      "correct_choice_id": 200784,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50197,
      "choices": [
        {
          "id": 200788,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 3, 2, 4 </span></span></span></p>"
        },
        {
          "id": 200789,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 2, 3, 4 </span></span></span></p>"
        },
        {
          "id": 200790,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2, 1, 3, 4 </span></span></span></p>"
        },
        {
          "id": 200791,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">2, 1, 4, 3 </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">What is the correct sequence of management in a patient who presents to the casualty with an RTA (Road Traffic Accident)?</span> <span style=\"font-family:\"Calibri\",sans-serif\">(INICET NOV 2022)  </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cervical spine stabilization</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Intubation</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">IV cannulation</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">CECT (Contrast-Enhanced CT)</span></span></span></li>\r\n</ol>",
      "unique_key": "Q9949848",
      "question_audio": null,
      "question_video": null,
      "map_id": 34667129,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) 1, 2, 3, 4 </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct sequence of management in a patient who presents to the casualty with an RTA is </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Cervical spine stabilization, Intubation, IV cannulation, and CECT</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, as per the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">ABCDE</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> protocol in trauma management.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">According to the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Advanced Trauma Life Support (ATLS)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> protocol, the management follows the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">primary survey</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> with the following steps:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Cervical spine stabilization</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Always prioritize stabilizing the cervical spine in trauma patients, especially in cases where spinal injury is suspected.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Intubation</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: After airway management, securing the airway via intubation is crucial to ensure oxygenation and prevent aspiration.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">IV cannulation</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Establish intravenous access for fluid resuscitation and medication administration.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">CECT</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Imaging, such as contrast-enhanced CT (CECT), is performed once the patient is stabilized.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. 1, 3, 2, 4: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">While cervical spine stabilization is correctly prioritized, IV cannulation should not occur before securing the airway with intubation. Airway management is always the top priority after stabilizing the cervical spine.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. 2, 1, 3, 4: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Intubation before cervical spine stabilization is incorrect because spinal injury protection takes precedence in trauma patients. Airway management should follow after ensuring the spine is stabilized.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. 2, 1, 4, 3: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Intubation before cervical spine stabilization is incorrect, and performing CECT before IV cannulation would delay critical fluid resuscitation and medication access.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">correct sequence</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> in the primary survey of trauma management includes </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">cervical spine stabilization</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">airway protection (intubation)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">intravenous access</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">imaging (CECT)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> to assess injuries. Following the ATLS protocol ensures patient stabilization and appropriate treatment priorities.</span></span></span></p>",
      "correct_choice_id": 200789,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50198,
      "choices": [
        {
          "id": 200792,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Interferon gamma </span></span></span></p>"
        },
        {
          "id": 200793,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Interleukin-2 </span></span></span></p>"
        },
        {
          "id": 200794,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Interleukin-12 </span></span></span></p>"
        },
        {
          "id": 200795,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Interleukin-4 </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Delayed hypersensitivity is due to ______. (INICET NOV 2022) </span></span></p>",
      "unique_key": "Q1664006",
      "question_audio": null,
      "question_video": null,
      "map_id": 34974882,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Interferon gamma</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Delayed hypersensitivity is due to </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">interferon-gamma (IFN-gamma)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Delayed hypersensitivity, also known as </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">type 4 hypersensitivity</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, is a </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">cell-mediated immune response</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> primarily mediated by </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">T cells</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. It occurs by two mechanisms:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">CD4+ T helper cells (Th1)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> mediated.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">CD8+ T cells</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> mediated.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<h4><span style=\"font-size:12pt\"><span style=\"font-family:\"Calibri Light\",sans-serif\"><em><span style=\"font-family:\"Calibri\",sans-serif\">CD4+ T helper cells mediated pathway:</span></em></span></span></h4>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Antigen peptides recognized by CD4+ T cells cause these cells to secrete </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">interleukin-2 (IL-2)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, which promotes the proliferation of T cells responding to the antigen. These T cells differentiate into Th1 or Th17 cells due to cytokines released from </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">antigen-presenting cells (APCs)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">APCs also release </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">interleukin-12</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, which further promotes differentiation to the Th1 subset. Inflammatory cytokines such as IL-1, IL-6, and IL-23 drive differentiation into the Th17 subset. These Th1 cells release </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">interferon-gamma (IFN-gamma)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, which alters macrophage activity to help clear the antigen.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Interferon-gamma causes several changes in macrophages:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Enhances their ability to </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">phagocytose</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and kill microorganisms.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Promotes </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">class 2 MHC molecule expression</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, improving antigen presentation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Increases secretion of pro-inflammatory cytokines such as </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">tumor necrosis factor (TNF)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">interleukin-1</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Amplifies the Th1 response</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> by promoting further release of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">interleukin-12</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<h4><span style=\"font-size:12pt\"><span style=\"font-family:\"Calibri Light\",sans-serif\"><em><span style=\"font-family:\"Calibri\",sans-serif\">CD8+ T cells mediated pathway:</span></em></span></span></h4>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">CD8+ T cells attack antigen-presenting target cells through the release of </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">perforins</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">granzymes</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, which induce apoptosis. In the process, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">interferon-gamma</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is also released, which drives the hypersensitivity reaction by stimulating inflammatory mediators.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Examples of delayed hypersensitivity reactions</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> include the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">tuberculin reaction</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">contact dermatitis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Interleukin-2: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Although </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">interleukin-2</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is involved in the proliferation of T cells and differentiation into Th1 cells, it does not directly cause delayed hypersensitivity. Its primary role is to enhance the response of T cells during the immune response.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Interleukin-12: Interleukin-12</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> helps to differentiate T cells into the Th1 subset and promotes the release of interferon-gamma, but it is not the primary mediator of delayed hypersensitivity itself. </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Interferon-gamma</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is the direct effector responsible for activating macrophages and driving the type 4 hypersensitivity reaction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Interleukin-4: Interleukin-4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is primarily involved in the differentiation of T cells into the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Th2 subset</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, which is related to humoral immunity and not to delayed hypersensitivity. Th2 responses are associated with allergies and antibody production rather than the cell-mediated immune response seen in delayed hypersensitivity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Interferon-gamma (IFN-gamma)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> plays a central role in </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">delayed (type IV) hypersensitivity</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">, as it activates macrophages and amplifies the immune response. This process is critical in conditions such as </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">tuberculin reactions</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> and </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">contact dermatitis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></p>",
      "correct_choice_id": 200792,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50199,
      "choices": [
        {
          "id": 200796,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Smell diskettes</span></span></span></p>"
        },
        {
          "id": 200797,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Arnold stick test </span></span></span></p>"
        },
        {
          "id": 200798,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">UPSIT</span></span></span></p>"
        },
        {
          "id": 200799,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">CC-SIT</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What test is not used for testing olfaction? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q7528618",
      "question_audio": null,
      "question_video": null,
      "map_id": 34132577,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Arnold stick test </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Arnold stick test</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is not a test used for olfaction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Tests used for olfaction include the following:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Smell diskettes</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> are used as a screening test for olfaction. These reusable diskettes are applied with 8 different odorants, and a questionnaire with illustrations is used to score the patient’s responses.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">University of Pennsylvania smell identification test (UPSIT)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is a commercially available, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">self-administered</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> test. It assesses the function of an individual's olfactory system by using microencapsulated odorants in scratch-and-sniff booklets.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">12-item version of UPSIT</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, known as the </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">cross-cultural smell identification test (CC-SIT)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, is useful for quantifying smell loss in a shorter time frame, taking less than 5 minutes. It is an effective means of assessing olfactory function.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Sniffin' sticks test</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is another method used to evaluate olfactory performance. This test is based on pen-like odor-dispensing devices.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Arnold stick test</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">not</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> used to test olfaction. Common tests for evaluating the olfactory system include </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">smell diskettes</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">UPSIT</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">, and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">CC-SIT</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></p>",
      "correct_choice_id": 200797,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}